assays_src_id,assays_cell_id,assays_curated_by,assays_description,assays_relationship_type,assays_assay_strain,assays_src_assay_id,assays_assay_organism,assays_assay_cell_type,assays_assay_subcellular_fraction,assays_assay_tax_id,assays_bao_format,assays_tid,assays_confidence_score,assays_assay_category,assays_tissue_id,assays_chembl_id,assays_assay_test_type,assays_assay_tissue,assays_doc_id,assays_assay_type,assays_assay_id,assays_variant_id
1,,Intermediate,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL618647,In vivo,Kidney,9866,A,7524,
1,,Intermediate,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL618648,In vivo,Kidney,9866,A,7525,
1,,Intermediate,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL618649,In vivo,Kidney,9866,A,7526,
1,,Intermediate,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL618650,In vivo,Liver,9866,A,7527,
1,,Intermediate,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL618651,In vivo,Liver,9866,A,7528,
1,,Intermediate,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL876497,In vivo,Liver,9866,A,7529,
1,,Intermediate,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL618652,In vivo,Lung,9866,A,7530,
1,,Intermediate,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL618653,In vivo,Lung,9866,A,7531,
1,,Intermediate,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL618654,In vivo,Lung,9866,A,7532,
1,,Intermediate,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618655,,,6351,A,7533,
1,,Intermediate,Compound was tested for solubility in water,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618656,,,1465,A,7534,
1,,Intermediate,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL618657,,,5182,P,7535,
1,,Intermediate,Solubility was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618658,,,17847,A,7536,
1,,Intermediate,solubility in water (ug/mL) at 37 degree C.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618659,,,15339,A,7537,
1,,Intermediate,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618660,,,5202,A,7538,
1,,Intermediate,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618661,,,1088,A,7539,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873807,,,3169,A,7540,
1,,Intermediate,Half life in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618662,,,5353,A,7541,
1,,Intermediate,Half life period after 3 mg/kg iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618663,In vivo,,2864,A,7542,
1,,Intermediate,Half life period after 3 mg/kg iv administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618664,In vivo,,2864,A,7543,
1,,Intermediate,Half life period after 3 mg/kg iv administration in the rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618665,In vivo,,2864,A,7544,
1,,Intermediate,Half life period in female Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876498,,,6362,A,7545,
1,,Intermediate,Half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618666,,,6249,A,7546,
1,,Intermediate,Half-life in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620440,,,3169,A,7547,
1,,Intermediate,Half-life in rats with metabolic oxidation,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620441,,,3169,A,7548,
1,,Intermediate,Half-life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620442,,,3169,A,7549,
1,,Intermediate,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620443,In vivo,,17260,A,7550,
1,,Intermediate,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620444,In vivo,,17260,A,7551,
1,,Intermediate,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620445,In vivo,,17260,A,7552,
1,,Intermediate,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620446,In vivo,,17260,A,7553,
1,,Intermediate,Biological half-life measured in plasma of rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620447,,Plasma,2879,A,7554,
1,,Intermediate,Biological half-life measured in plasma of rat; 22-25,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621129,,Plasma,2879,A,7555,
1,,Intermediate,Biological half-life measured in plasma of rat; 9-16,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621130,,Plasma,2879,A,7556,
1,,Intermediate,Compound was evaluated for its half life when administered intravenously in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873808,In vivo,,3184,A,7557,
1,,Intermediate,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876598,In vivo,,4891,A,7558,
1,,Intermediate,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621131,In vivo,,429,A,7559,
1,,Intermediate,Half life (T1/2) after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621132,In vivo,,5656,A,7560,
1,,Intermediate,Half life of compound after iv administration of 20 mg/kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621133,In vivo,,4413,A,7561,
1,,Expert,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621312,In vivo,,3598,A,7562,
1,,Intermediate,Half life of compound was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621313,,,17267,A,7563,
1,,Intermediate,Half life of compound was determined in rat blood,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621314,,Blood,4727,A,7564,
1,,Intermediate,Half life at 1 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621315,In vivo,,17651,A,7565,
1,,Intermediate,Half life at 10 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621316,In vivo,,17651,A,7566,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621317,,,401,A,7567,
1,,Intermediate,Half life in rats in hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621318,,,4942,A,7568,
1,,Intermediate,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621319,In vivo,,17735,A,7569,
1,,Intermediate,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621377,In vivo,,6056,A,7570,
1,,Intermediate,Half life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621378,,,5213,A,7571,
1,,Intermediate,Half life after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876599,In vivo,,6616,A,7572,
1,,Intermediate,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621379,In vivo,,5937,A,7573,
1,,Intermediate,Half life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621380,,Plasma,5819,A,7574,
1,,Intermediate,Half life in rat plasma; Not detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621381,,Plasma,5819,A,7575,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618515,,,6803,A,7576,
1,,Intermediate,Half life period of compound was determined after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618516,In vivo,,17804,A,7577,
1,,Intermediate,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618517,In vivo,,17804,A,7578,
1,,Intermediate,Half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618518,,,5948,A,7579,
1,,Intermediate,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618519,In vivo,,1916,A,7580,
1,,Intermediate,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618698,In vivo,,1916,A,7581,
1,,Intermediate,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618862,In vivo,,1916,A,7582,
1,,Intermediate,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618863,In vivo,,4890,A,7583,
1,,Intermediate,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618864,In vivo,,17764,A,7584,
1,,Intermediate,Half life time in rat the dose of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618865,In vivo,,4727,A,7585,
1,,Intermediate,Half-life 24 hr after 10 mg/kg iv administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618866,In vivo,,17509,A,7586,
1,,Intermediate,Half-life 24 hr after 2 mg/kg iv administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618867,In vivo,,17509,A,7587,
1,,Intermediate,Half-life consistent with the observed metabolic steady state in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875828,,,6597,A,7588,
1,,Intermediate,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618868,In vivo,,17735,A,7589,
1,,Intermediate,Half-life for oxidative metabolic stability was determined using male human,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618869,,,6597,A,7590,
1,,Intermediate,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618870,In vivo,,17670,A,7591,
1,,Intermediate,Half-life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618871,,Plasma,1696,A,7592,
1,,Intermediate,Half-life in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618872,,Plasma,1742,A,7593,
1,,Intermediate,Half-life in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873816,,,17800,A,7594,
1,,Autocuration,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL618873,,,12923,A,7595,
1,,Autocuration,Area under curve after oral dose of 0.1 mg//kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL621602,,,11954,A,7596,
1,,Autocuration,Area under curve after oral dose of 0.3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621603,,,11954,A,7597,
1,,Autocuration,Area under curve after oral dose of 1 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621604,,,11954,A,7598,
1,,Autocuration,Area under curve after oral dose of 10 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621605,,,11954,A,7599,
1,,Autocuration,Area under curve after oral dose of 23.4 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621606,,,11954,A,7600,
1,,Autocuration,Area under curve after oral dose of 3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621607,,,11954,A,7601,
1,,Autocuration,Area under curve after oral dose of 3.87 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621608,,,11954,A,7602,
1,,Autocuration,Area under curve was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL621609,,,5237,A,7603,
1,,Autocuration,Area under curve at a dose of 10 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621610,,,4026,A,7604,
1,,Intermediate,Area under curve was determined; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621611,,,5237,A,7605,
1,,Intermediate,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621612,,,14793,A,7606,
1,,Intermediate,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622308,,,14793,A,7607,
1,,Intermediate,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622309,,,14793,A,7608,
1,,Intermediate,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622310,,,14793,A,7609,
1,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622311,,,14793,A,7610,
1,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622312,,,14793,A,7611,
1,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622931,,,14793,A,7612,
1,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622932,,,14793,A,7613,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622736,,Plasma,14793,A,7614,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622737,,Plasma,14793,A,7615,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622738,,Plasma,14793,A,7616,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622739,,Plasma,14793,A,7617,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622740,,Plasma,14793,A,7618,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622741,,Plasma,14793,A,7619,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622742,,Plasma,14793,A,7620,
1,,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622743,,Plasma,14793,A,7621,
1,,Intermediate,AUC in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL622744,,Plasma,11637,A,7622,
1,,Autocuration,Area under curve was measured from the graph obtained from concentration Vs time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624134,,,11149,A,7623,
1,,Autocuration,Area under curve value of compound per hour after oral administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624135,,,10016,A,7624,
1,,Intermediate,Area under curve was determined after oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624136,,,17796,A,7625,
1,,Intermediate,Area under curve was determined after oral administration in rats; No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624137,,,17796,A,7626,
1,,Intermediate,Area under curve was determined after oral administration in rats;No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624320,,,17796,A,7627,
1,,Intermediate,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624321,,,12923,A,7628,
1,,Intermediate,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624322,,,15372,A,7629,
1,,Intermediate,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624323,,,15372,A,7630,
1,,Intermediate,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624324,,,15372,A,7631,
1,,Intermediate,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624325,,,15372,A,7632,
1,,Intermediate,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624326,,,15372,A,7633,
1,,Intermediate,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624327,,,15372,A,7634,
1,,Intermediate,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624328,,,15372,A,7635,
1,,Intermediate,Area under curve was determined in Dogs after peroral administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL627848,,,14169,A,7636,
1,,Intermediate,Area under curve was determined in Rats after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627849,,,14169,A,7637,
1,,Intermediate,Area under curve was determined in carotid blood of rat when administered intradermally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627850,,,14258,A,7638,
1,,Intermediate,Area under curve was determined in portal blood of rat when administered intradermally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627851,,,14258,A,7639,
1,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627852,,,15011,A,7640,
1,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627853,,,15011,A,7641,
1,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627854,,,15011,A,7642,
1,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627855,,,15011,A,7643,
1,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627856,,,15011,A,7644,
1,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL875339,,,15011,A,7645,
1,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627857,,,15011,A,7646,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627858,In vivo,Spleen,11195,A,7647,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627859,,Blood,10130,A,7648,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627860,,Brain,10130,A,7649,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627019,,Heart,10130,A,7650,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627020,,Liver,10130,A,7651,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627021,,Lung,10130,A,7652,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627022,,Muscle tissue,10130,A,7653,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627023,,,10130,A,7654,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627024,,Spleen,10130,A,7655,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627025,,Thyroid gland,10130,A,7656,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627026,,Kidney,10130,A,7657,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627027,,Blood,10130,A,7658,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627028,,Brain,10130,A,7659,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627029,,Heart,10130,A,7660,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627030,,Kidney,10130,A,7661,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627031,,Liver,10130,A,7662,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627032,,Lung,10130,A,7663,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627033,,Muscle tissue,10130,A,7664,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627034,,,10130,A,7665,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627035,,Spleen,10130,A,7666,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627036,,Thyroid gland,10130,A,7667,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL875340,,Blood,10130,A,7668,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627037,,Heart,10130,A,7669,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627038,,Kidney,10130,A,7670,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627039,,Liver,10130,A,7671,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627040,,Muscle tissue,10130,A,7672,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL624663,,Spleen,10130,A,7673,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL625963,,Thyroid gland,10130,A,7674,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL876799,,Brain,10130,A,7675,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626133,,Lung,10130,A,7676,
1,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626134,,,10130,A,7677,
1,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626135,,,6295,A,7678,
1,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626136,,,6296,A,7679,
1,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626137,,,6296,A,7680,
1,,Intermediate,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626138,,,6295,A,7681,
1,,Intermediate,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626139,,,6296,A,7682,
1,,Intermediate,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626140,In vivo,,17260,A,7683,
1,,Intermediate,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626141,In vivo,,17260,A,7684,
1,,Intermediate,C24h in rat p.o. at 20 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626142,,,17686,A,7685,
1,,Intermediate,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627930,In vivo,Muscle tissue,9866,A,7686,
1,,Intermediate,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627931,In vivo,Muscle tissue,9866,A,7687,
1,,Intermediate,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627932,In vivo,Muscle tissue,9866,A,7688,
1,,Intermediate,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627933,In vivo,Spleen,9866,A,7689,
1,,Intermediate,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627934,In vivo,Spleen,9866,A,7690,
1,,Intermediate,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627935,In vivo,Spleen,9866,A,7691,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627936,In vivo,Blood,9866,A,7692,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627937,In vivo,Blood,9866,A,7693,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627938,In vivo,Blood,9866,A,7694,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627939,In vivo,Blood,9866,A,7695,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627940,In vivo,Blood,9866,A,7696,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627941,In vivo,Blood,9866,A,7697,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL876800,In vivo,Blood,9866,A,7698,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627942,In vivo,Blood,9866,A,7699,
1,,Intermediate,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627943,In vivo,Blood,9866,A,7700,
1,,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627944,In vivo,Blood,9866,A,7701,
1,,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627945,In vivo,Blood,9866,A,7702,
1,,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628584,In vivo,Blood,9866,A,7703,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628585,In vivo,Blood,9866,A,7704,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628586,In vivo,Blood,9866,A,7705,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628587,In vivo,Blood,9866,A,7706,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628588,In vivo,Blood,9866,A,7707,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628589,In vivo,Blood,9866,A,7708,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625304,In vivo,Blood,9866,A,7709,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625305,In vivo,Blood,9866,A,7710,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625306,In vivo,Blood,9866,A,7711,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625307,In vivo,Blood,9866,A,7712,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625308,In vivo,Blood,9866,A,7713,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627740,In vivo,Blood,9866,A,7714,
1,,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627741,In vivo,Blood,9866,A,7715,
1,,Intermediate,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627742,In vivo,Blood,9866,A,7716,
1,,Intermediate,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627743,In vivo,Blood,9866,A,7717,
1,,Intermediate,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627744,In vivo,Blood,9866,A,7718,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627745,In vivo,Bone,9866,A,7719,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627746,In vivo,Bone,9866,A,7720,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627747,In vivo,Bone,9866,A,7721,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL876810,In vivo,Bone,9866,A,7722,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627748,In vivo,Bone,9866,A,7723,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627749,In vivo,Bone,9866,A,7724,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627750,In vivo,Bone,9866,A,7725,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618728,In vivo,Bone,9866,A,7726,
1,,Intermediate,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618729,In vivo,Bone,9866,A,7727,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618730,In vivo,Bone,9866,A,7728,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618731,In vivo,Bone,9866,A,7729,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618732,In vivo,Bone,9866,A,7730,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618733,In vivo,Bone,9866,A,7731,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618734,In vivo,Bone,9866,A,7732,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618735,In vivo,Bone,9866,A,7733,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL876602,In vivo,Bone,9866,A,7734,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618736,In vivo,Bone,9866,A,7735,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618737,In vivo,Bone,9866,A,7736,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618738,In vivo,Bone,9866,A,7737,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618739,In vivo,Bone,9866,A,7738,
1,,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618740,In vivo,Bone,9866,A,7739,
1,,Intermediate,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618741,In vivo,Bone,9866,A,7740,
1,,Intermediate,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618742,In vivo,Bone,9866,A,7741,
1,,Intermediate,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL618743,In vivo,Bone,9866,A,7742,
1,,Intermediate,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618744,In vivo,Plasma,17752,A,7743,
1,,Intermediate,Half-life in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618745,,,5610,A,7744,
1,,Intermediate,Half-life in rat after peroral administration at 10 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620479,In vivo,,5939,A,7745,
1,,Intermediate,Half-life in rat after peroral administration at 5 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620480,In vivo,,5939,A,7746,
1,,Intermediate,Half-life in rat at a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620481,In vivo,,17771,A,7747,
1,,Intermediate,Half-life was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620482,,,1974,A,7748,
1,,Intermediate,Half-life was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876603,,,4239,A,7749,
1,,Intermediate,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620483,In vivo,,6681,A,7750,
1,,Intermediate,Half-life period in rats after intravenous administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620484,In vivo,,17752,A,7751,
1,,Intermediate,Half-life period in rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620485,In vivo,,6046,A,7752,
1,,Intermediate,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620486,In vivo,,6685,A,7753,
1,,Intermediate,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620487,In vivo,,6685,A,7754,
1,,Intermediate,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620488,In vivo,,6685,A,7755,
1,,Intermediate,Half-life time in rat the dose of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620489,In vivo,,4727,A,7756,
1,,Intermediate,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620490,In vivo,,1088,A,7757,
1,,Intermediate,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620491,In vivo,,5610,A,7758,
1,,Intermediate,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876604,In vivo,Plasma,3032,A,7759,
1,,Intermediate,Oral half life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620492,In vivo,,5199,A,7760,
1,,Intermediate,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620493,In vivo,,14941,A,7761,
1,,Intermediate,Pharmacokinetic property (t1/2) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620494,In vivo,,4408,A,7762,
1,,Intermediate,Plasma elimination half-life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620495,,Plasma,2552,A,7763,
1,,Intermediate,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620496,In vivo,Plasma,5199,A,7764,
1,,Intermediate,Plasma half life was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620497,In vivo,Plasma,15662,A,7765,
1,,Intermediate,Plasma half-life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620498,,Plasma,1465,A,7766,
1,,Intermediate,Plasma half-life following oral administration in Fisher rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620499,In vivo,Plasma,1446,A,7767,
1,,Intermediate,Plasma half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620500,,Plasma,6824,A,7768,
1,,Intermediate,Plasmatic Half-life after intravenous administration to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873809,In vivo,Plasma,17533,A,7769,
1,,Intermediate,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620501,In vivo,,5979,A,7770,
1,,Intermediate,Terminal half life after intravenous administration (1 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620502,In vivo,,4689,A,7771,
1,,Intermediate,Terminal half life in Rat at a oral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620503,In vivo,,4689,A,7772,
1,,Intermediate,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620504,In vivo,,2463,A,7773,
1,,Intermediate,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876605,In vivo,,4883,A,7774,
1,,Intermediate,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620505,In vivo,,4883,A,7775,
1,,Intermediate,plasma half life was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873811,In vivo,Plasma,15662,A,7776,
1,,Expert,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624016,In vivo,,3598,A,7777,
1,,Intermediate,Half life of compound determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624017,,,4576,A,7778,
1,,Intermediate,Mean residence time determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624018,,,4576,A,7779,
1,,Intermediate,Plasma half life determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624019,,,4576,A,7780,
1,,Intermediate,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624020,In vivo,Brain,4910,A,7781,
1,,Intermediate,Compound was evaluated for pharmacokinetic parameter maximum time period,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624201,In vivo,,4891,A,7782,
1,,Intermediate,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL872528,In vivo,,429,A,7783,
1,,Intermediate,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624202,In vivo,,5974,A,7784,
1,,Intermediate,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624203,In vivo,,5974,A,7785,
1,,Intermediate,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624350,In vivo,,5974,A,7786,
1,,Intermediate,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621320,In vivo,,5974,A,7787,
1,,Intermediate,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621321,In vivo,,17582,A,7788,
1,,Intermediate,Maximum time (Tmax) required to reach Cmax in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621322,,,4026,A,7789,
1,,Intermediate,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621323,In vivo,,4890,A,7790,
1,,Intermediate,Maximum time of clearance of compound in rats after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621324,In vivo,,6571,A,7791,
1,,Intermediate,Maximum time at the dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621325,,,4727,A,7792,
1,,Intermediate,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL875837,In vivo,Plasma,17651,A,7793,
1,,Intermediate,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621326,In vivo,Plasma,17651,A,7794,
1,,Intermediate,Tmax in Guinea pig (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621327,In vivo,,14465,A,7795,
1,,Intermediate,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621328,In vivo,,14941,A,7796,
1,,Intermediate,Pharmacokinetic parameter (Tmax) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621329,In vivo,,5960,A,7797,
1,,Intermediate,Pharmacokinetic parameter (Tmax) was estimated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621330,In vivo,,5022,A,7798,
1,,Intermediate,Pharmacokinetic property (Tmax) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621331,In vivo,,4408,A,7799,
1,,Intermediate,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621332,In vivo,,5983,A,7800,
1,,Intermediate,T max in Rat at a oral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621333,In vivo,,4689,A,7801,
1,,Intermediate,T max was determined at 10 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621334,In vivo,,2792,A,7802,
1,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL621335,,,15011,A,7803,
1,,Intermediate,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621336,,,14180,A,7804,
1,,Intermediate,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621337,,,14180,A,7805,
1,,Intermediate,Area under curve was measured after i.v. administration into Beagle dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621338,,,14599,A,7806,
1,,Intermediate,Area under curve was measured after iv administration into Beagle dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL875838,,,14599,A,7807,
1,,Intermediate,Area under curve was measured after po administration into Beagle dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621339,,,14599,A,7808,
1,,Intermediate,Area under curve was measured after po administration into Beagle dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621340,,,14599,A,7809,
1,,Autocuration,Area under curve was measured at peroral dose of 3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621341,,,15675,A,7810,
1,,Autocuration,Area under curve was measured by using concentration Vs time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL621342,,,12706,A,7811,
1,,Autocuration,Area under curve was measured by using concentration Vs time; not tested,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL621343,,,12706,A,7812,
1,,Intermediate,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL621344,,,9750,A,7813,
1,,Intermediate,Area under curve(AUC) was measured in mice after oral administration.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL621345,,,9750,A,7814,
1,,Autocuration,Area under curve(AUC) value of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL621346,,,14691,A,7815,
1,,Autocuration,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL621347,,,14691,A,7816,
1,,Intermediate,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621348,,,14691,A,7817,
1,,Autocuration,Area under curve(carotid artery) was determined by the availability in blood,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL621349,,Blood,2939,A,7818,
1,,Autocuration,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL621350,,Blood,2939,A,7819,
1,,Autocuration,Area under curve(carotid artery) was determined by the availability in blood; No data,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL875839,,Blood,2939,A,7820,
1,,Autocuration,Area under curve(portal vein) was determined by the availability in blood,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL620211,,Blood,2939,A,7821,
1,,Autocuration,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL620212,,Blood,2939,A,7822,
1,,Autocuration,Area under curve(portal vein) was determined by the availability in blood; No data,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL620213,,Blood,2939,A,7823,
1,,Intermediate,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL620214,,Plasma,9552,A,7824,
1,,Intermediate,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL620215,,Plasma,9552,A,7825,
1,,Intermediate,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL620216,,Plasma,9552,A,7826,
1,,Intermediate,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL620888,,Plasma,9552,A,7827,
1,,Intermediate,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL620889,,Plasma,9552,A,7828,
1,,Autocuration,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL620890,,Plasma,9552,A,7829,
1,,Intermediate,Area under plasma time curve determined in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL620891,,Plasma,11911,A,7830,
1,,Autocuration,Area under the MAP curve measured over 5 min.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL620892,,,16618,A,7831,
1,,Intermediate,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL621079,,,14387,A,7832,
1,,Intermediate,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL621080,,,14387,A,7833,
1,,Intermediate,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621081,,,12836,A,7834,
1,,Intermediate,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL621082,,,12836,A,7835,
1,,Intermediate,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621083,,,12836,A,7836,
1,,Intermediate,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621084,,,14339,A,7837,
1,,Intermediate,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621085,,,14339,A,7838,
1,,Intermediate,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621086,,,14339,A,7839,
1,,Intermediate,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621087,,,10524,A,7840,
1,,Intermediate,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622607,,,9994,A,7841,
1,,Intermediate,Serum AUC in marmosets (IV dose),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622608,,,11325,A,7842,
1,,Autocuration,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624481,,,12536,A,7843,
1,,Autocuration,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624482,,,12536,A,7844,
1,,Autocuration,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624483,,,12536,A,7845,
1,,Autocuration,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624484,,,12536,A,7846,
1,,Autocuration,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624485,,,12536,A,7847,
1,,Intermediate,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624486,,,15556,A,7848,
1,,Autocuration,Area under the curve for the compound was calculated.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624487,,,2809,A,7849,
1,,Autocuration,Area under the curve in concentration/ time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624488,,,9511,A,7850,
1,,Intermediate,Area under the curve administered intraintestinal in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624489,,,12818,A,7851,
1,,Intermediate,Area under the curve administered intravenously in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625184,,,12818,A,7852,
1,,Autocuration,Area under the curve during intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625185,,,15118,A,7853,
1,,Autocuration,Area under the curve during intravenous administration; Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875954,,,15118,A,7854,
1,,Autocuration,Area under the curve during systemic administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625186,,,15118,A,7855,
1,,Autocuration,Area under the curve during systemic administration; Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625187,,,15118,A,7856,
1,,Autocuration,Area under the curve was calculated for the compound.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625188,,,2632,A,7857,
1,,Intermediate,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625189,,,14346,A,7858,
1,,Intermediate,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625190,,,14346,A,7859,
1,,Intermediate,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621733,,,14346,A,7860,
1,,Intermediate,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621734,,,14346,A,7861,
1,,Intermediate,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621735,,,11149,A,7862,
1,,Intermediate,Clearance of the drug was measured in the plasma of rat; No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621736,,Plasma,17796,A,7863,
1,,Intermediate,The pharmacokinetic parameter plasma clearance in vivo in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621737,,Plasma,5247,A,7864,
1,,Intermediate,Plasma clearance at the dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621738,,,4727,A,7865,
1,,Intermediate,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622806,In vivo,,5654,A,7866,
1,,Intermediate,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623519,In vivo,,5654,A,7867,
1,,Intermediate,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623520,In vivo,,17260,A,7868,
1,,Intermediate,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623521,In vivo,,17065,A,7869,
1,,Intermediate,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623522,In vivo,,17671,A,7870,
1,,Intermediate,Clearance rate in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623523,In vivo,,6672,A,7871,
1,,Intermediate,Clearance rate in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623690,In vivo,,6673,A,7872,
1,,Intermediate,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623691,In vivo,,5978,A,7873,
1,,Intermediate,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623692,In vivo,,5978,A,7874,
1,,Intermediate,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623693,In vivo,,5978,A,7875,
1,,Intermediate,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623694,In vivo,,5978,A,7876,
1,,Intermediate,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623695,In vivo,,4413,A,7877,
1,,Intermediate,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623696,In vivo,,2661,A,7878,
1,,Intermediate,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623697,In vivo,,2661,A,7879,
1,,Intermediate,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,1969.0,CHEMBL623698,In vivo,Plasma,5005,A,7880,
1,,Intermediate,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1969.0,CHEMBL623699,In vivo,Plasma,5005,A,7881,
1,,Intermediate,Mean (%CV) PK parameters for CL(mL/min/kg).,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623700,In vivo,,15765,A,7882,
1,,Intermediate,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623701,In vivo,,3747,A,7883,
1,,Intermediate,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623702,In vivo,Plasma,16366,A,7884,
1,,Intermediate,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623703,In vivo,,4199,A,7885,
1,,Intermediate,Plasma clearance in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623704,In vivo,,17267,A,7886,
1,,Intermediate,Plasma clearance in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623705,In vivo,,6535,A,7887,
1,,Intermediate,Plasma clearance in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623706,In vivo,,6535,A,7888,
1,,Intermediate,Plasma clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623707,In vivo,,5041,A,7889,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623708,In vivo,,5960,A,7890,
1,,Intermediate,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623709,In vivo,,5937,A,7891,
1,,Intermediate,Plasma clearance in rat by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623710,In vivo,,5871,A,7892,
1,,Intermediate,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623711,In vivo,,5874,A,7893,
1,,Intermediate,Plasma clearance in rat p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623712,In vivo,,6504,A,7894,
1,,Intermediate,Plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623713,In vivo,,6803,A,7895,
1,,Intermediate,Plasma clearance was determined; ND denotes no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623714,In vivo,,5041,A,7896,
1,,Intermediate,Plasma clearance was determined; ND denotes not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623715,In vivo,,5041,A,7897,
1,,Intermediate,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623716,In vivo,,1916,A,7898,
1,,Intermediate,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622980,In vivo,,5199,A,7899,
1,,Intermediate,Plasma administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622981,In vivo,,16367,A,7900,
1,,Intermediate,Plasma clearance of the compound in female Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622982,In vivo,,6362,A,7901,
1,,Intermediate,Plasma clearance was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622983,In vivo,,15662,A,7902,
1,,Intermediate,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622984,In vivo,,6215,A,7903,
1,,Intermediate,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622985,In vivo,,1466,A,7904,
1,,Intermediate,plasma clearance was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623631,In vivo,Plasma,15662,A,7905,
1,,Intermediate,In vivo CL/F determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623632,In vivo,,4723,A,7906,
1,,Intermediate,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623633,In vivo,Plasma,2792,A,7907,
1,,Intermediate,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623634,In vivo,Plasma,2792,A,7908,
1,,Intermediate,Compound was tested for the lower blood clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623635,In vivo,,5213,A,7909,
1,,Intermediate,Evaluated for the low clearance in rat (in vivo),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621195,In vivo,,4687,A,7910,
1,,Intermediate,Pharmacokinetic property (CLb)of the compound was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621196,In vivo,,3371,A,7911,
1,,Intermediate,Rapid clearance after intravenous administration in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875287,In vivo,,4690,A,7912,
1,,Intermediate,Clearance measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621197,In vivo,,5702,A,7913,
1,,Intermediate,Compound was evaluated for plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621198,In vivo,Plasma,740,A,7914,
1,,Intermediate,Low plasma clearance was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621199,In vivo,Plasma,4853,A,7915,
1,,Intermediate,Pharmacokinetic property (Clp) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621200,In vivo,,5789,A,7916,
1,,Intermediate,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621201,In vivo,,4527,A,7917,
1,,Intermediate,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621202,In vivo,,4527,A,7918,
1,,Intermediate,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621203,In vivo,,6518,A,7919,
1,,Intermediate,Plasma clearance after IV dosing at 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621204,In vivo,,6518,A,7920,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621205,In vivo,Heart,9866,A,7921,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621206,In vivo,Heart,9866,A,7922,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621207,In vivo,Heart,9866,A,7923,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621208,In vivo,Heart,9866,A,7924,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621209,In vivo,Heart,9866,A,7925,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL876484,In vivo,Heart,9866,A,7926,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621210,In vivo,Heart,9866,A,7927,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621211,In vivo,Heart,9866,A,7928,
1,,Intermediate,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621212,In vivo,Heart,9866,A,7929,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621213,In vivo,Heart,9866,A,7930,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621214,In vivo,Heart,9866,A,7931,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621215,In vivo,Heart,9866,A,7932,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621216,In vivo,Heart,9866,A,7933,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621217,In vivo,Heart,9866,A,7934,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621218,In vivo,Heart,9866,A,7935,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621219,In vivo,Heart,9866,A,7936,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621220,In vivo,Heart,9866,A,7937,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621221,In vivo,Heart,9866,A,7938,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621222,In vivo,Heart,9866,A,7939,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621223,In vivo,Heart,9866,A,7940,
1,,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL876485,In vivo,Heart,9866,A,7941,
1,,Intermediate,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621224,In vivo,Heart,9866,A,7942,
1,,Intermediate,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621225,In vivo,Heart,9866,A,7943,
1,,Intermediate,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621226,In vivo,Heart,9866,A,7944,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621227,In vivo,Kidney,9866,A,7945,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621228,In vivo,Kidney,9866,A,7946,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621229,In vivo,Kidney,9866,A,7947,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621230,In vivo,Kidney,9866,A,7948,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621231,In vivo,Kidney,9866,A,7949,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621232,In vivo,Kidney,9866,A,7950,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621233,In vivo,Kidney,9866,A,7951,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621234,In vivo,Kidney,9866,A,7952,
1,,Intermediate,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621235,In vivo,Kidney,9866,A,7953,
1,,Intermediate,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621236,In vivo,Kidney,9866,A,7954,
1,,Intermediate,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621237,In vivo,Kidney,9866,A,7955,
1,,Intermediate,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL876486,In vivo,Kidney,9866,A,7956,
1,,Intermediate,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622436,In vivo,Intestine,9866,A,7957,
1,,Intermediate,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622437,In vivo,Intestine,9866,A,7958,
1,,Intermediate,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622438,In vivo,Intestine,9866,A,7959,
1,,Intermediate,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622439,In vivo,Liver,9866,A,7960,
1,,Intermediate,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622440,In vivo,Liver,9866,A,7961,
1,,Intermediate,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622441,In vivo,Liver,9866,A,7962,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622442,In vivo,Liver,9866,A,7963,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622443,In vivo,Liver,9866,A,7964,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622444,In vivo,Liver,9866,A,7965,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622445,In vivo,Liver,9866,A,7966,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622446,In vivo,Liver,9866,A,7967,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622447,In vivo,Liver,9866,A,7968,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622448,In vivo,Liver,9866,A,7969,
1,,Intermediate,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622449,In vivo,Liver,9866,A,7970,
1,,Intermediate,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622450,In vivo,Liver,9866,A,7971,
1,,Intermediate,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622451,In vivo,Liver,9866,A,7972,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622452,In vivo,Liver,9866,A,7973,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622453,In vivo,Liver,9866,A,7974,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622454,In vivo,Liver,9866,A,7975,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622455,In vivo,Liver,9866,A,7976,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL876024,In vivo,Liver,9866,A,7977,
1,,Intermediate,T max was determined at 3 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622456,In vivo,,2792,A,7978,
1,,Intermediate,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622457,In vivo,,15078,A,7979,
1,,Intermediate,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622458,In vivo,,15078,A,7980,
1,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622459,,,15022,A,7981,
1,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873343,,,15022,A,7982,
1,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622460,,,15022,A,7983,
1,,Intermediate,Time for maximum plasma concentration determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622461,,Plasma,4576,A,7984,
1,,Intermediate,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622462,In vivo,Plasma,6681,A,7985,
1,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622463,In vivo,,16365,A,7986,
1,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622464,In vivo,,16365,A,7987,
1,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622465,In vivo,,16365,A,7988,
1,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622466,In vivo,,16365,A,7989,
1,,Intermediate,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622467,In vivo,,16365,A,7990,
1,,Intermediate,Time of maximum plasma concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622468,,Plasma,6824,A,7991,
1,,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876025,,Plasma,6685,A,7992,
1,,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622469,,Plasma,6685,A,7993,
1,,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622470,,Plasma,6685,A,7994,
1,,Intermediate,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622471,In vivo,,15662,A,7995,
1,,Intermediate,Time required to reach maximum concentration in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622472,,Plasma,1742,A,7996,
1,,Intermediate,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622473,In vivo,Plasma,2774,A,7997,
1,,Intermediate,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624282,In vivo,Plasma,5199,A,7998,
1,,Intermediate,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624283,In vivo,Plasma,12873,A,7999,
1,,Intermediate,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624284,In vivo,Plasma,12873,A,8000,
1,,Intermediate,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624285,In vivo,Plasma,1916,A,8001,
1,,Intermediate,Time to reach Cmax after oral administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624286,In vivo,,16367,A,8002,
1,,Intermediate,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624287,In vivo,,16366,A,8003,
1,,Intermediate,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624288,,,216,A,8004,
1,,Intermediate,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624289,In vivo,Plasma,6410,A,8005,
1,,Intermediate,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873344,In vivo,Plasma,6410,A,8006,
1,,Intermediate,Tmax after peroral administration (10 mg/kg) was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619623,In vivo,,6215,A,8007,
1,,Expert,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621399,In vivo,,3598,A,8008,
1,,Intermediate,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621400,In vivo,,4527,A,8009,
1,,Intermediate,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621401,In vivo,,17670,A,8010,
1,,Intermediate,Tmax was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621402,,,1465,A,8011,
1,,Intermediate,Tmax was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621403,,,2552,A,8012,
1,,Intermediate,Tmax after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621121,In vivo,,5656,A,8013,
1,,Intermediate,Tmax after peroral administration in rats at 2.4 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL872525,In vivo,,17764,A,8014,
1,,Intermediate,Tmax in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621122,,,5610,A,8015,
1,,Intermediate,Tmax in rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621123,In vivo,,6046,A,8016,
1,,Intermediate,Tmax in rat by po administration at a dose of 40 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621124,In vivo,,5874,A,8017,
1,,Intermediate,Tmax in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621125,,,17596,A,8018,
1,,Intermediate,Tmax was measured in rats after peroral administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621126,In vivo,,17804,A,8019,
1,,Intermediate,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621127,In vivo,,1908,A,8020,
1,,Intermediate,Tmax value after administration of 20 mg/Kg oral dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621128,In vivo,,2959,A,8021,
1,,Intermediate,Tmax value at a dose of 10 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618263,In vivo,,6757,A,8022,
1,,Intermediate,Tmax value at a dose of 100 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618264,In vivo,,6757,A,8023,
1,,Intermediate,Tmax value at a dose of 50 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618265,In vivo,,6757,A,8024,
1,,Intermediate,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618266,In vivo,Plasma,4186,A,8025,
1,,Intermediate,time required to reach maximum concentration (Cmax) after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618267,In vivo,,15662,A,8026,
1,,Intermediate,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL618450,,Urine,429,A,8027,
1,,Intermediate,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL618451,,Urine,429,A,8028,
1,,Intermediate,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618452,,,5546,A,8029,
1,,Intermediate,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL618453,,Urine,3173,A,8030,
1,,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL618454,,Urine,3173,A,8031,
1,,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL618455,,Urine,3173,A,8032,
1,,Intermediate,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618456,In vivo,,4257,A,8033,
1,,Intermediate,Compound distribution in rat tissues was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618457,In vivo,,6011,A,8034,
1,,Intermediate,Volume of distribution was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618458,In vivo,,5472,A,8035,
1,,Intermediate,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618459,,,14346,A,8036,
1,,Intermediate,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876733,,,14346,A,8037,
1,,Intermediate,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL618460,,,14346,A,8038,
1,,Intermediate,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618461,,,14346,A,8039,
1,,Autocuration,Area under the curve was determined after oral administration (300 uM/Kg),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL618462,,,15469,A,8040,
1,,Intermediate,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618463,,,14346,A,8041,
1,,Intermediate,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618464,,,14346,A,8042,
1,,Intermediate,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618465,,,14346,A,8043,
1,,Intermediate,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618466,,,14346,A,8044,
1,,Intermediate,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618467,,,14346,A,8045,
1,,Intermediate,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618468,,,15372,A,8046,
1,,Intermediate,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL618469,,Plasma,12935,A,8047,
1,,Intermediate,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL618470,,Plasma,12935,A,8048,
1,,Autocuration,Plasma drug AUC in rat (PO dose),U,,,,,,,BAO_0000218,22224,0,,,CHEMBL618471,,,14813,A,8049,
1,,Intermediate,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618472,,,15792,A,8050,
1,,Autocuration,Area under was determined at a dose of 30 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL618473,,,3579,A,8051,
1,,Intermediate,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL621699,,,12487,A,8052,
1,,Intermediate,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621700,,,12487,A,8053,
1,,Intermediate,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621701,,,12487,A,8054,
1,,Intermediate,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL621702,,,12487,A,8055,
1,,Intermediate,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621703,,,12487,A,8056,
1,,Intermediate,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL621704,,,12487,A,8057,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624259,,,12902,A,8058,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624260,,,12902,A,8059,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624430,,,12902,A,8060,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624431,,,12902,A,8061,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624432,,,12902,A,8062,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624433,,,12902,A,8063,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624434,,,12902,A,8064,
1,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624435,,,12902,A,8065,
1,,Intermediate,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618570,,,12745,A,8066,
1,,Intermediate,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618571,,,12745,A,8067,
1,,Intermediate,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618572,,,12745,A,8068,
1,,Intermediate,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618573,,,12745,A,8069,
1,,Intermediate,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619267,,,12745,A,8070,
1,,Intermediate,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619431,,,12745,A,8071,
1,,Intermediate,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619432,,,12745,A,8072,
1,,Intermediate,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619433,,,12745,A,8073,
1,,Autocuration,AUC in mice after oral dose (50 mg/kg),U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL619434,,Plasma,13298,A,8074,
1,,Intermediate,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1977.0,CHEMBL619435,,Serum,12226,A,8075,
1,,Autocuration,AUC (0-4 hr) ug/ml/h,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL619436,,Plasma,12634,A,8076,
1,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619437,,,14810,A,8077,
1,,Autocuration,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL619438,,,13889,A,8078,
1,,Intermediate,Compound was evaluated for Area under curve in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619439,,,10018,A,8079,
1,,Intermediate,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619440,,,8758,A,8080,
1,,Autocuration,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL619441,,,8758,F,8081,
1,,Intermediate,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619442,,,8758,A,8082,
1,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875156,,,2249,A,8083,
1,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL619443,,,2249,A,8084,
1,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL619444,,,2249,A,8085,
1,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623464,,,2249,A,8086,
1,,Intermediate,Compound was evaluated for area under curve when administered through oral route in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623465,,,15115,A,8087,
1,,Intermediate,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623466,In vivo,,6518,A,8088,
1,,Intermediate,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623467,In vivo,,6518,A,8089,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623468,In vivo,,6249,A,8090,
1,,Intermediate,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622660,In vivo,,2463,A,8091,
1,,Intermediate,Plasma clearance rate in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622661,In vivo,,4969,A,8092,
1,,Intermediate,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622662,In vivo,,17720,F,8093,
1,,Intermediate,Pharmacokinetic property (total body clearance) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622663,In vivo,,3457,A,8094,
1,,Intermediate,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622664,In vivo,,5983,A,8095,
1,,Intermediate,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622665,,,6295,A,8096,
1,,Intermediate,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622666,,,6296,A,8097,
1,,Intermediate,Cl in rat i.v. at 2 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621615,In vivo,,17686,A,8098,
1,,Intermediate,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621616,In vivo,,17764,A,8099,
1,,Intermediate,Clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621617,In vivo,,5503,A,8100,
1,,Intermediate,Clearance by intravenous administration of 3.4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621618,In vivo,,4368,A,8101,
1,,Intermediate,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621619,In vivo,,6005,A,8102,
1,,Intermediate,Clearance rate after i.v. administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621620,In vivo,,5031,A,8103,
1,,Intermediate,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621786,In vivo,,4890,A,8104,
1,,Intermediate,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621787,In vivo,,5182,A,8105,
1,,Intermediate,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621788,In vivo,,5979,A,8106,
1,,Intermediate,Clearance (Cl) after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621789,In vivo,,5656,A,8107,
1,,Intermediate,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621790,In vivo,,17804,A,8108,
1,,Intermediate,Compound was tested for plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621791,In vivo,Plasma,4839,A,8109,
1,,Intermediate,In vitro microsome metabolism clearance in rat was determined,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,,CHEMBL621792,In vitro,,5041,A,8110,
1,,Intermediate,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,,CHEMBL621793,In vitro,,5041,A,8111,
1,,Intermediate,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621794,In vivo,,5974,A,8112,
1,,Intermediate,In vivo plasma clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621795,In vivo,Plasma,5496,A,8113,
1,,Intermediate,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621796,In vivo,,5739,A,8114,
1,401.0,Intermediate,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,,,Rattus norvegicus,Hepatocyte,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621797,In vivo,Liver,5676,A,8115,
1,,Intermediate,Pharmacokinetic property (Plasma clearance) was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621798,In vivo,,4239,A,8116,
1,,Intermediate,Pharmacokinetic property (clearance) in rat i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621799,In vivo,,5676,A,8117,
1,,Intermediate,"Plasma Clearance was evaluated in rats, iv",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621800,In vivo,,1918,A,8118,
1,,Intermediate,Plasma clearance (in vivo) in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621801,In vivo,,17800,A,8119,
1,,Intermediate,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621802,In vivo,,6056,A,8120,
1,,Intermediate,Plasma clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618596,In vivo,,5496,A,8121,
1,,Intermediate,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618597,In vivo,,5939,A,8122,
1,,Intermediate,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618598,In vivo,,5939,A,8123,
1,,Intermediate,Plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618599,In vivo,,17752,A,8124,
1,,Intermediate,Plasma clearance rate determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618600,In vivo,,4576,A,8125,
1,,Intermediate,Plasma clearance was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618601,In vivo,,6011,A,8126,
1,,Intermediate,Plasma clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618602,In vivo,,5510,A,8127,
1,,Intermediate,Plasma clearance value in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618603,In vivo,,5948,A,8128,
1,,Intermediate,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL618604,Ex vivo,Liver,6125,A,8129,
1,,Intermediate,Clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618605,In vivo,,4839,A,8130,
1,,Intermediate,Total body clearance in rat i.v. at 2 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618606,In vivo,,17686,A,8131,
1,,Intermediate,Clearance of compound in rats after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618607,In vivo,,6571,A,8132,
1,,Intermediate,Clearance after iv administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618608,In vivo,,3364,A,8133,
1,,Intermediate,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618609,In vivo,,13569,A,8134,
1,,Intermediate,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618610,In vivo,,13569,A,8135,
1,,Intermediate,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618611,In vivo,,13569,A,8136,
1,,Intermediate,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618612,In vivo,,13569,A,8137,
1,,Intermediate,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618613,In vivo,,13569,A,8138,
1,,Intermediate,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621076,In vivo,,13569,A,8139,
1,,Intermediate,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621077,In vivo,,13569,A,8140,
1,,Intermediate,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621078,In vivo,,17670,A,8141,
1,,Intermediate,Clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621251,In vivo,,5970,A,8142,
1,,Intermediate,Clearance in rat after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621252,In vivo,,6495,A,8143,
1,,Intermediate,Clearance in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621253,In vivo,,4590,A,8144,
1,,Intermediate,Clearance rate following an oral dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621254,In vivo,,6193,A,8145,
1,,Intermediate,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621255,In vivo,,2832,A,8146,
1,,Intermediate,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621256,In vivo,Plasma,1052,A,8147,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621257,In vivo,Liver,9866,A,8148,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621258,In vivo,Liver,9866,A,8149,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621259,In vivo,Liver,9866,A,8150,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621260,In vivo,Liver,9866,A,8151,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL876494,In vivo,Liver,9866,A,8152,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621261,In vivo,Liver,9866,A,8153,
1,,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621262,In vivo,Liver,9866,A,8154,
1,,Intermediate,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621263,In vivo,Liver,9866,A,8155,
1,,Intermediate,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621264,In vivo,Liver,9866,A,8156,
1,,Intermediate,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621265,In vivo,Muscle tissue,9866,A,8157,
1,,Intermediate,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621266,In vivo,Muscle tissue,9866,A,8158,
1,,Intermediate,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621267,In vivo,Muscle tissue,9866,A,8159,
1,,Intermediate,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621268,In vivo,Muscle tissue,9866,A,8160,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621269,In vivo,Muscle tissue,9866,A,8161,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621270,In vivo,Muscle tissue,9866,A,8162,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621271,In vivo,Muscle tissue,9866,A,8163,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621272,In vivo,Muscle tissue,9866,A,8164,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621273,In vivo,Muscle tissue,9866,A,8165,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621274,In vivo,Muscle tissue,9866,A,8166,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL876495,In vivo,Muscle tissue,9866,A,8167,
1,,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621275,In vivo,Muscle tissue,9866,A,8168,
1,,Intermediate,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621276,In vivo,Muscle tissue,9866,A,8169,
1,,Intermediate,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621277,In vivo,Muscle tissue,9866,A,8170,
1,,Intermediate,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621278,In vivo,Intestine,9866,A,8171,
1,,Intermediate,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621279,In vivo,Intestine,9866,A,8172,
1,,Intermediate,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621280,In vivo,Intestine,9866,A,8173,
1,,Intermediate,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621281,In vivo,Spleen,9866,A,8174,
1,,Intermediate,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621282,In vivo,Spleen,9866,A,8175,
1,,Intermediate,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621283,In vivo,Spleen,9866,A,8176,
1,,Intermediate,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621284,In vivo,Spleen,9866,A,8177,
1,,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621285,In vivo,Spleen,9866,A,8178,
1,,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621286,In vivo,Spleen,9866,A,8179,
1,,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL623220,In vivo,Spleen,9866,A,8180,
1,,Intermediate,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL623221,In vivo,Spleen,9866,A,8181,
1,,Intermediate,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL876029,In vivo,Spleen,9866,A,8182,
1,,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL623222,In vivo,Stomach,9866,A,8183,
1,,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL623223,In vivo,Stomach,9866,A,8184,
1,,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL621445,In vivo,Stomach,9866,A,8185,
1,,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621446,In vivo,Blood,13950,A,8186,
1,,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621447,In vivo,Blood,13950,A,8187,
1,,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL619681,In vivo,Blood,13950,A,8188,
1,,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL619682,In vivo,Blood,13950,A,8189,
1,,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL619683,In vivo,Blood,13950,A,8190,
1,,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619684,In vivo,Brain,13950,A,8191,
1,,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619685,In vivo,Brain,13950,A,8192,
1,,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619686,In vivo,Brain,13950,A,8193,
1,,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619687,In vivo,Brain,13950,A,8194,
1,,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619688,In vivo,Brain,13950,A,8195,
1,,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL619689,In vivo,Heart,13950,A,8196,
1,,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL619690,In vivo,Heart,13950,A,8197,
1,,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL619691,In vivo,Heart,13950,A,8198,
1,,Intermediate,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619692,In vivo,,6062,A,8199,
1,,Expert,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619693,,,3598,A,8200,
1,,Intermediate,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619694,In vivo,,1908,A,8201,
1,,Intermediate,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619695,In vivo,,17596,A,8202,
1,,Intermediate,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619696,In vivo,,4891,A,8203,
1,,Intermediate,Compound was evaluated for volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619697,In vivo,,740,A,8204,
1,,Intermediate,Steady state volume distribution was determined; steady state(ss),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619698,In vivo,,16366,A,8205,
1,,Intermediate,Steady state volume of distribution after iv administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619699,In vivo,,3364,A,8206,
1,,Intermediate,Steady state volume of distribution dosing at 3 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619700,In vivo,,2552,A,8207,
1,,Intermediate,The compound was evaluated for volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619701,In vivo,,406,A,8208,
1,,Intermediate,The compound was tested for volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL619702,In vivo,,12500,A,8209,
1,,Intermediate,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620335,In vivo,,12500,A,8210,
1,,Intermediate,Volume distribution (VD) after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620336,In vivo,,5656,A,8211,
1,,Intermediate,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620337,In vivo,,17671,A,8212,
1,,Intermediate,Volume distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620520,In vivo,,1094,A,8213,
1,,Intermediate,Volume distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620521,In vivo,,5833,A,8214,
1,,Intermediate,Volume distribution in rat after peroral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875825,In vivo,,5939,A,8215,
1,,Intermediate,Volume distribution in rat after peroral administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620522,In vivo,,5939,A,8216,
1,,Intermediate,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620523,In vivo,,6005,A,8217,
1,,Intermediate,Volume of distribution in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620524,In vivo,,1696,A,8218,
1,,Intermediate,Volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620525,In vivo,,6672,A,8219,
1,,Intermediate,Volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620526,In vivo,,6673,A,8220,
1,,Intermediate,Volume of distribution in rat by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620527,In vivo,,5871,A,8221,
1,,Intermediate,Volume of distribution in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620528,In vivo,,6803,A,8222,
1,,Intermediate,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620529,In vivo,,5199,A,8223,
1,,Intermediate,Volume distribution at the dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620530,,,4727,A,8224,
1,,Intermediate,Steady state volume of distribution was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620531,In vivo,,16367,A,8225,
1,,Intermediate,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,,CHEMBL620532,In vivo,,5005,A,8226,
1,,Intermediate,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL620533,In vivo,,5005,A,8227,
1,,Intermediate,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL620534,In vivo,,5005,A,8228,
1,,Intermediate,Mean (%CV) PK parameters for Vdss(mL/kg).,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620535,In vivo,,15765,A,8229,
1,,Intermediate,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875826,In vivo,,2792,A,8230,
1,,Intermediate,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620536,In vivo,,2792,A,8231,
1,,Intermediate,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620537,In vivo,,5334,A,8232,
1,,Intermediate,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618526,In vivo,,5334,A,8233,
1,,Intermediate,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618527,In vivo,,5739,A,8234,
1,,Intermediate,Pharmacokinetic property (Vdss) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618528,In vivo,,5789,A,8235,
1,,Intermediate,Pharmacokinetic property (vdss) was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618529,In vivo,,4239,A,8236,
1,,Intermediate,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618530,In vivo,,4709,A,8237,
1,,Intermediate,Volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618531,In vivo,,6642,A,8238,
1,,Intermediate,The pharmacokinetic parameter volume of distribution in vivo in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618532,In vivo,,5247,A,8239,
1,,Intermediate,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618533,In vivo,,17720,F,8240,
1,,Intermediate,Vdss in rat i.v. at 2 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618534,In vivo,,17686,A,8241,
1,,Intermediate,Volume distribution after intravenous administration (1 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618535,In vivo,,4689,A,8242,
1,,Intermediate,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618536,In vivo,,5654,A,8243,
1,,Intermediate,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618537,In vivo,,5654,A,8244,
1,,Intermediate,Volume distribution at a dose of 10 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618538,In vivo,,4527,A,8245,
1,,Intermediate,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618539,In vivo,,4521,A,8246,
1,,Intermediate,Volume distribution was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618540,In vivo,,6057,A,8247,
1,,Intermediate,Volume distribution was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618541,In vivo,,5510,A,8248,
1,,Intermediate,Volume of distribution after intravenous administration was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618542,In vivo,,2938,A,8249,
1,,Intermediate,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622544,In vivo,,6679,A,8250,
1,,Intermediate,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622545,In vivo,,6685,A,8251,
1,,Intermediate,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622546,In vivo,,6685,A,8252,
1,,Intermediate,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622547,In vivo,,6685,A,8253,
1,,Intermediate,Volume of distribution in steady state was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622548,In vivo,,5145,A,8254,
1,,Intermediate,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622549,In vivo,,6467,A,8255,
1,,Intermediate,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622550,In vivo,,6467,A,8256,
1,,Intermediate,Compound was evaluated for area under curve when administered through oral route to mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622551,,,15115,A,8257,
1,,Intermediate,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622552,,,8758,A,8258,
1,,Intermediate,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622553,,,8758,A,8259,
1,,Autocuration,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622554,In vivo,,8267,F,8260,
1,,Intermediate,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622555,,,8267,A,8261,
1,,Intermediate,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622556,,,14239,A,8262,
1,,Intermediate,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622557,,,14239,A,8263,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL622558,,Blood,10754,A,8264,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL622559,,Blood,10754,A,8265,
1,,Intermediate,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622560,,,10754,A,8266,
1,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622561,,,14681,A,8267,
1,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622562,,,14681,A,8268,
1,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622563,,,14681,A,8269,
1,,Autocuration,Concentration of compound in Central nervous system,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622564,,,13118,A,8270,
1,,Autocuration,Concentration of compound in Central nervous system; Not detectable,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622565,,,13118,A,8271,
1,,Intermediate,"Concentration of diester in the blood, following oral administration in mice",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622566,,,13318,A,8272,
1,,Intermediate,"Concentration of monoester in the blood, following oral administration in mice",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624515,,,13318,A,8273,
1,,Intermediate,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624516,,,13318,A,8274,
1,,Autocuration,Evaluated for Pharmacokinetic property: Area under the curve,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624517,,,15692,A,8275,
1,,Intermediate,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624518,,,14839,A,8276,
1,,Intermediate,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624519,,,14839,A,8277,
1,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624520,,,14839,A,8278,
1,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624521,,,14839,A,8279,
1,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624522,,,14839,A,8280,
1,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624523,,,14839,A,8281,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624409,,,14839,A,8282,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624410,,,14839,A,8283,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL624411,,,14839,A,8284,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623531,,,14839,A,8285,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623532,,,14839,A,8286,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623533,,,14839,A,8287,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623534,,,14839,A,8288,
1,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623535,,,14839,A,8289,
1,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623536,,,14839,A,8290,
1,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623537,,,14839,A,8291,
1,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623538,,,14839,A,8292,
1,,Intermediate,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623539,,,14839,A,8293,
1,,Intermediate,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623540,,,14839,A,8294,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623541,,,14839,A,8295,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623542,,,14839,A,8296,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623543,,,14839,A,8297,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623544,,,14839,A,8298,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623545,,,14839,A,8299,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623546,,,14839,A,8300,
1,,Intermediate,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623547,In vivo,Plasma,5408,A,8301,
1,,Intermediate,High i.v. clearance in Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623548,In vivo,,6827,A,8302,
1,,Intermediate,In vitro clearance in rat liver microsomes,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623549,In vitro,Liver,17538,A,8303,
1,,Intermediate,Intrinsic clearance in rat liver microsomes was determined,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623550,In vitro,Liver,6331,A,8304,
1,401.0,Intermediate,Intrinsic clearance in rat hepatocytes was determined,N,,,Rattus norvegicus,Hepatocyte,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL875276,In vitro,Liver,5948,A,8305,
1,,Intermediate,Plasma Clearance was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621872,In vivo,,4026,A,8306,
1,,Intermediate,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621873,In vivo,,6647,A,8307,
1,,Intermediate,Plasma clearance in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621874,In vivo,,1696,A,8308,
1,,Intermediate,Plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621875,In vivo,,6597,A,8309,
1,,Intermediate,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621876,In vivo,,347,A,8310,
1,,Intermediate,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621877,In vivo,,16423,A,8311,
1,,Intermediate,Plasma clearance was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621878,In vivo,,2879,A,8312,
1,,Intermediate,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621879,In vivo,,4883,A,8313,
1,,Intermediate,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621880,In vivo,Plasma,5328,A,8314,
1,,Intermediate,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621881,In vivo,,5160,A,8315,
1,,Intermediate,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621882,In vivo,,17582,A,8316,
1,,Intermediate,Total clearance at 1 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875283,In vivo,,17651,A,8317,
1,,Intermediate,Total clearance at 10 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621883,In vivo,,17651,A,8318,
1,,Intermediate,Clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621884,In vivo,,6596,A,8319,
1,,Intermediate,Plasma clearance rate determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621885,In vivo,,4796,A,8320,
1,,Intermediate,Clearance of compound in rat was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621886,In vivo,,6850,A,8321,
1,,Intermediate,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621887,In vivo,Plasma,5932,A,8322,
1,,Intermediate,Pharmacokinetic property (blood clearance) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621888,In vivo,,3371,A,8323,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621889,In vivo,,2083,A,8324,
1,,Intermediate,Plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621890,In vivo,,4942,A,8325,
1,,Intermediate,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621891,In vitro,Liver,6838,A,8326,
1,,Intermediate,Clearance in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621892,In vivo,,5353,A,8327,
1,,Intermediate,Clearance rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621893,In vivo,,6641,A,8328,
1,,Intermediate,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621894,In vivo,,6641,A,8329,
1,,Intermediate,Clearance rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621895,In vivo,,6641,A,8330,
1,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875284,In vivo,,6444,A,8331,
1,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618699,In vivo,,6444,A,8332,
1,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618700,In vivo,,6444,A,8333,
1,,Intermediate,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618701,In vivo,,6211,A,8334,
1,,Intermediate,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876600,In vivo,Plasma,12873,A,8335,
1,,Intermediate,Clearance of compound in rat after 1 mg/kg i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618702,In vivo,,6570,A,8336,
1,,Intermediate,Compound was evaluated for Hepatic clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618703,In vivo,,3341,A,8337,
1,,Intermediate,In vivo clearance after 5 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618704,In vivo,,4891,A,8338,
1,,Intermediate,Compound was tested for plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618705,In vivo,Plasma,1094,A,8339,
1,,Intermediate,Hepatic clearance after intravenous administration was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618706,In vivo,,2938,A,8340,
1,,Intermediate,Lower clearance in rat (i.v.) at 0.5 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618707,In vivo,,17853,A,8341,
1,,Intermediate,Pharmacokinetic parameter expressed as plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618708,In vivo,Plasma,6049,A,8342,
1,,Intermediate,Pharmacokinetic property (Clp) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618709,In vivo,,5789,A,8343,
1,,Intermediate,Plasma clearance in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618710,In vivo,,4514,A,8344,
1,,Intermediate,Plasma clearance (Clp) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618711,In vivo,,6448,A,8345,
1,,Intermediate,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618712,In vivo,,6062,A,8346,
1,,Intermediate,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618713,In vivo,,5710,A,8347,
1,,Intermediate,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618714,In vivo,,4709,A,8348,
1,,Intermediate,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618715,In vivo,,4521,A,8349,
1,,Intermediate,Plasma clearance in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618716,In vivo,,1742,A,8350,
1,,Intermediate,Plasma clearance measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876601,In vivo,,6057,A,8351,
1,,Intermediate,Plasma clearance was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618717,In vivo,,6057,A,8352,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618718,In vivo,,5145,A,8353,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618719,In vivo,,5833,A,8354,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618720,In vivo,,6453,A,8355,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618721,In vivo,,6640,A,8356,
1,,Intermediate,Plasma clearance in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621477,In vivo,,6305,A,8357,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621478,In vivo,,6642,A,8358,
1,,Intermediate,Plasma clearance was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621479,In vivo,,5472,A,8359,
1,,Intermediate,Plasma clearance was evaluated in rat; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621480,In vivo,,5472,A,8360,
1,,Intermediate,Plasma clearance rate was determined for the compound in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621481,In vivo,,5144,A,8361,
1,,Intermediate,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621482,In vivo,,6685,A,8362,
1,,Intermediate,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621483,In vivo,,6685,A,8363,
1,,Intermediate,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621484,In vivo,,6685,A,8364,
1,,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621485,In vivo,Heart,13950,A,8365,
1,,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL621486,In vivo,Heart,13950,A,8366,
1,,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621487,In vivo,Intestine,13950,A,8367,
1,,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621488,In vivo,Intestine,13950,A,8368,
1,,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621489,In vivo,Intestine,13950,A,8369,
1,,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621490,In vivo,Intestine,13950,A,8370,
1,,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL621491,In vivo,Intestine,13950,A,8371,
1,,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621492,In vivo,Kidney,13950,A,8372,
1,,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621493,In vivo,Kidney,13950,A,8373,
1,,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621494,In vivo,Kidney,13950,A,8374,
1,,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621495,In vivo,Kidney,13950,A,8375,
1,,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621496,In vivo,Kidney,13950,A,8376,
1,,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621497,In vivo,Liver,13950,A,8377,
1,,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621498,In vivo,Liver,13950,A,8378,
1,,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621499,In vivo,Liver,13950,A,8379,
1,,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL618634,In vivo,Liver,13950,A,8380,
1,,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL618635,In vivo,Liver,13950,A,8381,
1,,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL618636,In vivo,Lung,13950,A,8382,
1,,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL619737,In vivo,Lung,13950,A,8383,
1,,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL619738,In vivo,Lung,13950,A,8384,
1,,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624329,In vivo,Lung,13950,A,8385,
1,,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624330,In vivo,Lung,13950,A,8386,
1,,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624331,In vivo,Muscle tissue,13950,A,8387,
1,,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624332,In vivo,Muscle tissue,13950,A,8388,
1,,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624333,In vivo,Muscle tissue,13950,A,8389,
1,,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624334,In vivo,Muscle tissue,13950,A,8390,
1,,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624335,In vivo,Muscle tissue,13950,A,8391,
1,,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL620016,In vivo,Spleen,13950,A,8392,
1,,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL620169,In vivo,Spleen,13950,A,8393,
1,,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL620170,In vivo,Spleen,13950,A,8394,
1,,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL620171,In vivo,Spleen,13950,A,8395,
1,,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL620172,In vivo,Spleen,13950,A,8396,
1,,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL620173,In vivo,Stomach,13950,A,8397,
1,,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL620174,In vivo,Stomach,13950,A,8398,
1,,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL620175,In vivo,Stomach,13950,A,8399,
1,,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL620176,In vivo,Stomach,13950,A,8400,
1,,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL620177,In vivo,Stomach,13950,A,8401,
1,,Intermediate,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL620178,,Cerebellum,13950,A,8402,
1,,Intermediate,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL620179,,Cerebellum,13950,A,8403,
1,,Intermediate,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620180,,,13950,A,8404,
1,,Intermediate,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620181,In vivo,,6570,A,8405,
1,,Intermediate,Volume of distribution of compound in rats after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620182,In vivo,,6571,A,8406,
1,,Intermediate,Volume of distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620183,In vivo,,6453,A,8407,
1,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620184,In vivo,,6444,A,8408,
1,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620185,In vivo,,6444,A,8409,
1,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620186,In vivo,,6444,A,8410,
1,,Intermediate,Volume of distribution was determined in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620187,In vivo,,5353,A,8411,
1,,Intermediate,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620188,In vivo,,5334,A,8412,
1,,Intermediate,Volume of distribution was reported in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620189,In vivo,,5334,A,8413,
1,,Intermediate,Volumes of distribution in rat after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620190,In vivo,,6641,A,8414,
1,,Intermediate,Volumes of distribution in rat after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620191,In vivo,,6641,A,8415,
1,,Intermediate,Volumes of distribution in rat after po administration; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620192,In vivo,,6641,A,8416,
1,,Intermediate,Pharmacokinetic property (Volume) in rat i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620193,In vivo,,5676,A,8417,
1,,Intermediate,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620194,In vivo,,6410,A,8418,
1,,Intermediate,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876730,In vivo,,17670,A,8419,
1,,Intermediate,Volume distribution in rat after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620195,In vivo,,6495,A,8420,
1,,Intermediate,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620196,In vivo,,5408,A,8421,
1,,Intermediate,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620197,In vivo,,4883,A,8422,
1,,Intermediate,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620198,In vivo,,6647,A,8423,
1,,Intermediate,Volume of distribution in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620199,In vivo,,6495,A,8424,
1,,Intermediate,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620200,In vivo,,2661,A,8425,
1,,Intermediate,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620201,In vivo,,2661,A,8426,
1,,Intermediate,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620202,In vivo,,5974,A,8427,
1,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620203,In vivo,,5974,A,8428,
1,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620204,In vivo,,5974,A,8429,
1,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620205,In vivo,,5974,A,8430,
1,,Intermediate,Pharmacokinetic parameter (Vss) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624664,In vivo,,5960,A,8431,
1,,Intermediate,Pharmacokinetic property (Volume) in rat i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624665,In vivo,,5676,A,8432,
1,,Intermediate,Pharmacokinetic property (Vss) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624666,,,5948,A,8433,
1,,Intermediate,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624667,In vivo,,5979,A,8434,
1,,Intermediate,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624668,In vivo,,5978,A,8435,
1,,Intermediate,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624669,In vivo,,5978,A,8436,
1,,Intermediate,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624670,In vivo,,5978,A,8437,
1,,Intermediate,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624671,In vivo,,5978,A,8438,
1,,Intermediate,Steady state volume distribution in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624672,In vivo,,6448,A,8439,
1,,Intermediate,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624673,In vivo,Plasma,12873,A,8440,
1,,Intermediate,Steady state volume of distribution determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624674,In vivo,,4576,A,8441,
1,,Intermediate,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624675,In vivo,,17582,A,8442,
1,,Intermediate,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621728,In vivo,,1466,A,8443,
1,,Intermediate,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621729,,,5182,A,8444,
1,,Intermediate,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621730,,,5182,A,8445,
1,,Intermediate,Volume distribution in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621731,In vivo,,6535,A,8446,
1,,Intermediate,Volume distribution in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621732,In vivo,,6535,A,8447,
1,,Intermediate,Volume in steady state distribution value was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621908,In vivo,,5041,A,8448,
1,,Intermediate,Volume in steady state distribution value was determined; ND denotes no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875347,In vivo,,5041,A,8449,
1,,Intermediate,Volume in steady state distribution value was determined; ND denotes not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621909,In vivo,,5041,A,8450,
1,,Intermediate,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621910,In vivo,,17065,A,8451,
1,,Intermediate,Volume of distribution at steady state was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621911,In vivo,,6597,A,8452,
1,,Intermediate,Volume of distribution at steady state was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621912,In vivo,,15662,A,8453,
1,,Intermediate,Volume of distribution in steady state was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621913,In vivo,,6485,A,8454,
1,,Intermediate,Volume of distribution in steady state was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621914,In vivo,,17655,A,8455,
1,,Intermediate,Volume of distribution after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621915,In vivo,,6616,A,8456,
1,,Intermediate,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621916,In vivo,,1916,A,8457,
1,,Intermediate,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL621917,In vivo,Liver,16438,A,8458,
1,,Intermediate,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL621918,In vivo,Liver,16438,A,8459,
1,,Intermediate,Biodistribution of compound (oxidized form) in spleen tissue,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL621919,In vivo,Spleen,16438,A,8460,
1,,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL621920,In vivo,Spleen,16438,A,8461,
1,,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL621921,In vivo,Spleen,16438,A,8462,
1,,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL622401,In vivo,Spleen,16438,A,8463,
1,,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL875348,In vivo,Spleen,16438,A,8464,
1,,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL622402,In vivo,Spleen,16438,A,8465,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL622403,In vivo,Blood,16438,A,8466,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL622404,In vivo,Blood,16438,A,8467,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622405,In vivo,Brain,16438,A,8468,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622406,In vivo,Brain,16438,A,8469,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622407,In vivo,Brain,16438,A,8470,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL622408,In vivo,Heart,16438,A,8471,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL622409,In vivo,Heart,16438,A,8472,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL622410,In vivo,Heart,16438,A,8473,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL622411,In vivo,Kidney,16438,A,8474,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL627864,In vivo,Kidney,16438,A,8475,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL627865,In vivo,Kidney,16438,A,8476,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627866,In vivo,Liver,16438,A,8477,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627751,In vivo,Liver,16438,A,8478,
1,,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL627752,In vivo,Spleen,16438,A,8479,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL627753,In vivo,Spleen,16438,A,8480,
1,,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL627754,In vivo,Spleen,16438,A,8481,
1,,Intermediate,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627755,,,12467,A,8482,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627756,In vivo,Brain,17208,A,8483,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627757,In vivo,Brain,17208,A,8484,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627758,In vivo,Brain,17208,A,8485,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627759,In vivo,Brain,17208,A,8486,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627760,In vivo,Brain,17208,A,8487,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627761,In vivo,Brain,17208,A,8488,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL876811,In vivo,Heart,17208,A,8489,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL627762,In vivo,Heart,17208,A,8490,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL627763,In vivo,Heart,17208,A,8491,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL627764,In vivo,Heart,17208,A,8492,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL627765,In vivo,Heart,17208,A,8493,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL627766,In vivo,Heart,17208,A,8494,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL627767,In vivo,Kidney,17208,A,8495,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL627768,In vivo,Kidney,17208,A,8496,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL628422,In vivo,Kidney,17208,A,8497,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL628423,In vivo,Kidney,17208,A,8498,
1,,Intermediate,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628424,In vivo,,5089,A,8499,
1,,Intermediate,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628425,In vivo,,5089,A,8500,
1,,Intermediate,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628426,In vivo,,4257,A,8501,
1,,Intermediate,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628427,In vivo,,6679,A,8502,
1,,Intermediate,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626938,In vivo,,5546,A,8503,
1,,Intermediate,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626939,In vivo,,6141,A,8504,
1,,Intermediate,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626940,In vivo,,5334,A,8505,
1,,Intermediate,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626941,In vivo,,5334,A,8506,
1,,Intermediate,Plasma clearance was reported in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626942,In vivo,,5334,A,8507,
1,,Intermediate,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876812,In vivo,,4689,A,8508,
1,,Intermediate,Plasma clearance of compound in rats was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626943,In vivo,,6848,A,8509,
1,,Intermediate,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626944,In vivo,,6848,A,8510,
1,,Intermediate,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626945,In vivo,,6467,A,8511,
1,,Intermediate,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626946,In vivo,,6467,A,8512,
1,,Intermediate,Plasma clearance rate in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626856,In vivo,,4956,A,8513,
1,,Intermediate,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626857,In vivo,,5529,A,8514,
1,,Intermediate,The compound was evaluated for plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626858,In vivo,Plasma,406,A,8515,
1,,Intermediate,Total plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627018,In vivo,Plasma,17655,A,8516,
1,,Intermediate,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625331,In vivo,Blood,3293,A,8517,
1,,Intermediate,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625332,In vivo,Blood,4075,A,8518,
1,,Intermediate,C max was determined at 10 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877590,In vivo,,2792,A,8519,
1,,Intermediate,C max was determined at 3 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625333,In vivo,,2792,A,8520,
1,,Intermediate,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625334,In vivo,,17594,A,8521,
1,,Intermediate,Cmax after single intravenous bolus of 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625335,In vivo,,17594,A,8522,
1,,Intermediate,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625336,In vivo,,4762,A,8523,
1,,Intermediate,Cmax 24 hr after 10 mg/kg oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625337,In vivo,,17509,A,8524,
1,,Intermediate,Cmax 24 hr after 2 mg/kg oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625338,In vivo,,17509,A,8525,
1,,Intermediate,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625339,In vivo,Plasma,1466,A,8526,
1,,Intermediate,Cmax in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625340,In vivo,,6535,A,8527,
1,,Intermediate,Cmax in rat after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625341,In vivo,,6535,A,8528,
1,,Intermediate,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622687,In vivo,,3169,A,8529,
1,,Intermediate,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622688,In vivo,Plasma,6515,A,8530,
1,,Intermediate,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622689,In vivo,Blood,11149,A,8531,
1,,Intermediate,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL620295,In vivo,Blood,11149,A,8532,
1,,Intermediate,Cmax after 10 mg/kg oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620296,In vivo,,17858,A,8533,
1,,Intermediate,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620297,In vivo,,6518,A,8534,
1,,Intermediate,Cmax after IV dosing at 1 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620298,In vivo,,6518,A,8535,
1,,Intermediate,Cmax after oral administration at 20 mpk in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620299,In vivo,,4426,A,8536,
1,,Intermediate,Cmax after oral administration at 20 mpk in rats; Not performed.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620300,In vivo,,4426,A,8537,
1,,Intermediate,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620301,In vivo,,4426,A,8538,
1,,Intermediate,Cmax after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620302,In vivo,,5656,A,8539,
1,,Intermediate,Cmax after oral administration at a dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620303,In vivo,,6518,A,8540,
1,,Intermediate,Cmax after oral administration at a dose of 4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620304,In vivo,,6518,A,8541,
1,,Intermediate,Cmax in rats after 20 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620305,In vivo,,6113,A,8542,
1,,Intermediate,Cmax after peroral administration in rats at 2.4 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620306,In vivo,,17764,A,8543,
1,,Intermediate,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620307,In vivo,,4756,A,8544,
1,,Intermediate,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620308,In vivo,,4756,A,8545,
1,,Intermediate,Cmax by administering at 20 mg/kg p.o. in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620309,In vivo,,6402,A,8546,
1,,Intermediate,Cmax in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620310,In vivo,,5610,A,8547,
1,,Intermediate,Cmax in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620311,In vivo,,5207,A,8548,
1,,Intermediate,Cmax in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620312,In vivo,,6011,A,8549,
1,,Intermediate,Cmax in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620313,In vivo,,6504,A,8550,
1,,Intermediate,Cmax in rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620314,In vivo,,6046,A,8551,
1,,Intermediate,Cmax in rat at the dose of 1 mg/kg i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620315,In vivo,,6504,A,8552,
1,,Intermediate,Cmax in rat by po administration at a dose of 40 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620316,In vivo,,5874,A,8553,
1,,Intermediate,Cmax in rat p.o. at 20 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620317,In vivo,,17686,A,8554,
1,,Intermediate,Cmax in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620318,In vivo,,5836,A,8555,
1,,Intermediate,Cmax in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620319,In vivo,,17596,A,8556,
1,,Intermediate,Cmax was evaluated after 20 uM/kg of peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620320,In vivo,,16423,A,8557,
1,,Intermediate,Cmax was measured in rats after peroral administration at 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620321,In vivo,,17804,A,8558,
1,,Intermediate,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620322,In vivo,,1908,A,8559,
1,,Intermediate,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620323,,,13950,A,8560,
1,,Intermediate,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1870.0,CHEMBL620324,,Frontal cortex,13950,A,8561,
1,,Intermediate,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1870.0,CHEMBL620325,,Frontal cortex,13950,A,8562,
1,,Intermediate,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL620326,,Hippocampus,13950,A,8563,
1,,Intermediate,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL620327,,Hippocampus,13950,A,8564,
1,,Intermediate,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620328,,,13950,A,8565,
1,,Intermediate,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620329,,,13950,A,8566,
1,,Intermediate,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1891.0,CHEMBL620330,,Midbrain,13950,A,8567,
1,,Intermediate,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1891.0,CHEMBL875286,,Midbrain,13950,A,8568,
1,,Intermediate,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620331,,,13950,A,8569,
1,,Intermediate,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620332,,,13950,A,8570,
1,,Intermediate,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL620333,,Striatum,13950,A,8571,
1,,Intermediate,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL620334,,Striatum,13950,A,8572,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621015,,Blood,16434,A,8573,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621016,,Blood,16434,A,8574,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621191,,Blood,16434,A,8575,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621192,,Blood,16434,A,8576,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621193,,Blood,16434,A,8577,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621194,,Blood,16434,A,8578,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624204,,Blood,16434,A,8579,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624205,,Blood,16434,A,8580,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624206,,Blood,16435,A,8581,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624207,,Blood,16435,A,8582,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624208,,Blood,16435,A,8583,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624209,,Blood,16435,A,8584,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624210,,Blood,16435,A,8585,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624211,,Blood,16435,A,8586,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624212,,Blood,16435,A,8587,
1,,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624213,,Blood,16435,A,8588,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL876611,,Blood,16434,A,8589,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624214,,Blood,16434,A,8590,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624215,,Blood,16434,A,8591,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624216,,Blood,16435,A,8592,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624217,,Blood,16435,A,8593,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624218,,Blood,16435,A,8594,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624219,,Blood,16435,A,8595,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624220,,Blood,16435,A,8596,
1,,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624221,,Blood,16435,A,8597,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624222,,,16434,A,8598,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624223,,,16434,A,8599,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624224,,,16434,A,8600,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624225,,,16434,A,8601,
1,,Intermediate,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622420,In vivo,,17764,A,8602,
1,,Intermediate,Volume of steady state distribution after i.v. administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622421,In vivo,,5031,A,8603,
1,,Intermediate,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622422,In vivo,,6215,A,8604,
1,,Intermediate,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622423,In vivo,,17671,A,8605,
1,,Intermediate,Vss was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622424,In vivo,,17752,A,8606,
1,,Intermediate,Vss in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622425,In vivo,,6596,A,8607,
1,,Intermediate,Vss was evaluated after 10 uM/kg of intra arterial administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876612,In vivo,,16423,A,8608,
1,,Intermediate,volume of distribution at steady state was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622426,In vivo,,15662,A,8609,
1,,Intermediate,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622427,In vivo,,6062,A,8610,
1,,Intermediate,Pharmacokinetic (PK) parameter Vz in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622428,In vivo,,5874,A,8611,
1,,Intermediate,Volume distribution in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622429,In vivo,,4942,A,8612,
1,,Intermediate,Volume of distribution in rat; No data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622430,In vivo,,17796,A,8613,
1,,Intermediate,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622431,In vivo,,4890,A,8614,
1,,Intermediate,% absorption predicted from in vitro rat ileum transport studies,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2116.0,CHEMBL622432,,Ileum,15765,A,8615,
1,,Intermediate,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622433,In vivo,,13569,A,8616,
1,,Intermediate,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622434,In vivo,,13569,A,8617,
1,,Intermediate,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622435,In vivo,,13569,A,8618,
1,,Intermediate,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618748,In vivo,,13569,A,8619,
1,,Intermediate,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618749,In vivo,,13569,A,8620,
1,,Intermediate,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618750,In vivo,,13569,A,8621,
1,,Intermediate,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618751,In vivo,,13569,A,8622,
1,,Intermediate,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618752,In vivo,,13569,A,8623,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618753,In vivo,,4576,A,8624,
1,,Intermediate,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL618754,In vivo,Plasma,750,A,8625,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618755,In vivo,,750,A,8626,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618756,In vivo,,4590,A,8627,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618757,In vivo,,1716,A,8628,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618758,In vivo,,1974,A,8629,
1,,Intermediate,Oral bioavailability in rat (dose 30 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621088,In vivo,,4502,A,8630,
1,,Intermediate,Pharmacokinetic property (cLogP) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621089,,,3371,A,8631,
1,,Intermediate,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621090,,Blood,9099,F,8632,
1,,Intermediate,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621091,,Blood,9099,F,8633,
1,,Intermediate,Clearance in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876731,In vivo,,4590,A,8634,
1,,Intermediate,Compound was evaluated for its clearance when administered intravenously in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621092,In vivo,,3184,A,8635,
1,,Intermediate,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621093,In vivo,,16456,A,8636,
1,,Intermediate,Blood: Brain distribution ratio is determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621094,,,4199,A,8637,
1,,Intermediate,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621095,,,4199,A,8638,
1,,Intermediate,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621096,,,4199,A,8639,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621097,In vivo,Kidney,8677,A,8640,
1,,Intermediate,Percent dose excreted in 0-48 hours administered ip to male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621098,,,7449,F,8641,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL621099,,Cerebellum,11977,A,8642,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL621100,,Cerebellum,11977,A,8643,
1,,Intermediate,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL621101,,Cerebellum,11977,A,8644,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL621102,,Cerebellum,11977,A,8645,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL876732,,Cerebellum,11977,A,8646,
1,,Intermediate,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621103,,,11977,A,8647,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621104,,,11977,A,8648,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621105,,,11977,A,8649,
1,,Intermediate,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621106,,,11977,A,8650,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621107,,,11977,A,8651,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621108,,,11977,A,8652,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621109,,,11977,A,8653,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL621110,In vivo,Kidney,17208,A,8654,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL621111,In vivo,Kidney,17208,A,8655,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL622541,In vivo,Liver,17208,A,8656,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL622542,In vivo,Liver,17208,A,8657,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL622543,In vivo,Liver,17208,A,8658,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL624412,In vivo,Liver,17208,A,8659,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL624413,In vivo,Liver,17208,A,8660,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL624414,In vivo,Liver,17208,A,8661,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624415,In vivo,Lung,17208,A,8662,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624416,In vivo,Lung,17208,A,8663,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624417,In vivo,Lung,17208,A,8664,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624418,In vivo,Lung,17208,A,8665,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624419,In vivo,Lung,17208,A,8666,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL624420,In vivo,Lung,17208,A,8667,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL624421,In vivo,Muscle tissue,17208,A,8668,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL624422,In vivo,Muscle tissue,17208,A,8669,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL624423,In vivo,Muscle tissue,17208,A,8670,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL625123,In vivo,Muscle tissue,17208,A,8671,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL625124,In vivo,Muscle tissue,17208,A,8672,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL625125,In vivo,Muscle tissue,17208,A,8673,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL625126,In vivo,Zone of skin,17208,A,8674,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL626947,In vivo,Zone of skin,17208,A,8675,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL626948,In vivo,Zone of skin,17208,A,8676,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL626949,In vivo,Zone of skin,17208,A,8677,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL626950,In vivo,Zone of skin,17208,A,8678,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL626951,In vivo,Zone of skin,17208,A,8679,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626952,In vivo,Spleen,17208,A,8680,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626953,In vivo,Spleen,17208,A,8681,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626954,In vivo,Spleen,17208,A,8682,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626955,In vivo,Spleen,17208,A,8683,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626956,In vivo,Spleen,17208,A,8684,
1,,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL626957,In vivo,Spleen,17208,A,8685,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626958,In vivo,Blood,17208,A,8686,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626959,In vivo,Blood,17208,A,8687,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626960,In vivo,Blood,17208,A,8688,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626961,In vivo,Blood,17208,A,8689,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL627589,In vivo,Blood,17208,A,8690,
1,,Intermediate,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL627590,In vivo,Blood,17208,A,8691,
1,,Intermediate,Time taken for EC90 was determined when tested in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627591,,,3132,A,8692,
1,,Intermediate,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627592,,,3132,A,8693,
1,,Intermediate,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627593,In vivo,,16597,A,8694,
1,,Intermediate,Half life in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627594,,,5727,A,8695,
1,,Intermediate,Half life period in mouse after 10 mg/Kg dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL876813,In vivo,,5302,A,8696,
1,,Intermediate,Half life period in mouse after 10 mg/kg dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627595,In vivo,,5302,A,8697,
1,,Intermediate,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627596,In vivo,,6348,A,8698,
1,,Intermediate,Cmax value at 5 mg/kg po was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627597,In vivo,,5964,A,8699,
1,,Intermediate,Cmax value evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627598,In vivo,,6078,A,8700,
1,,Intermediate,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627599,In vivo,Brain,5206,A,8701,
1,,Intermediate,Cmax value after administration of 20 mg/Kg oral dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627600,In vivo,,2959,A,8702,
1,,Intermediate,Cmax value at 1 mg/kg po in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627601,In vivo,,5964,A,8703,
1,,Intermediate,Cmax value at 5 mg/kg po in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627776,In vivo,,5964,A,8704,
1,,Intermediate,Cmax value at a dose of 10 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627777,In vivo,,6757,A,8705,
1,,Intermediate,Cmax value at a dose of 100 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627778,In vivo,,6757,A,8706,
1,,Intermediate,Cmax value at a dose of 50 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627779,In vivo,,6757,A,8707,
1,,Intermediate,Cmax value in rats at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876814,In vivo,,17617,A,8708,
1,,Intermediate,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627780,In vivo,,1445,A,8709,
1,,Intermediate,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627781,In vivo,,6082,A,8710,
1,,Intermediate,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627782,In vivo,,1446,A,8711,
1,,Intermediate,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627783,In vivo,Plasma,5407,A,8712,
1,,Intermediate,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627784,In vivo,Plasma,2690,A,8713,
1,,Intermediate,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627785,In vivo,,2661,A,8714,
1,,Intermediate,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627786,In vivo,,2661,A,8715,
1,,Intermediate,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627787,In vivo,Plasma,4891,A,8716,
1,,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627788,In vivo,Plasma,2807,A,8717,
1,,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626579,In vivo,Plasma,2807,A,8718,
1,,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626580,In vivo,Plasma,2807,A,8719,
1,,Intermediate,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876815,In vivo,,3634,A,8720,
1,,Intermediate,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626581,In vivo,Plasma,1881,A,8721,
1,,Intermediate,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626582,In vivo,Plasma,1881,A,8722,
1,,Intermediate,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626583,In vivo,,429,A,8723,
1,,Intermediate,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626205,In vivo,,5974,A,8724,
1,,Intermediate,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626206,In vivo,,5974,A,8725,
1,,Intermediate,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626207,In vivo,,5974,A,8726,
1,,Intermediate,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623882,In vivo,,5974,A,8727,
1,,Intermediate,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623883,In vivo,,17582,A,8728,
1,,Intermediate,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623884,In vivo,,17582,A,8729,
1,,Intermediate,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623885,In vivo,Plasma,3032,A,8730,
1,,Intermediate,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623886,In vivo,Plasma,6295,A,8731,
1,,Intermediate,Maximal concentration in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623887,In vivo,,6619,A,8732,
1,,Intermediate,Maximal concentration after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623888,In vivo,,6616,A,8733,
1,,Intermediate,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623889,In vivo,Plasma,3249,A,8734,
1,,Intermediate,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623890,In vivo,Plasma,17791,A,8735,
1,,Intermediate,Cmax in rat plasma after oral dose (50 mg/Kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623891,In vivo,Plasma,17791,A,8736,
1,,Intermediate,Maximal plasma concentration was determined.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623892,In vivo,Plasma,1360,A,8737,
1,,Intermediate,Maximal plasma drug concentration was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623893,In vivo,Plasma,2552,A,8738,
1,,Intermediate,Maximal concentration in rats after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877616,In vivo,,6571,A,8739,
1,,Intermediate,Maximum concentration in rat after 2 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623894,In vivo,,6570,A,8740,
1,,Intermediate,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623895,In vivo,Plasma,6567,A,8741,
1,,Intermediate,Maximum concentration of compound in rat was evaluated.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623896,In vivo,,3031,A,8742,
1,,Intermediate,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623897,In vivo,,3436,A,8743,
1,,Intermediate,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623898,In vivo,,3436,A,8744,
1,,Intermediate,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623899,In vivo,,2083,A,8745,
1,,Intermediate,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623900,In vivo,,3436,A,8746,
1,,Intermediate,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623901,In vivo,,4527,A,8747,
1,,Intermediate,Maximum concentration was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623902,In vivo,,1974,A,8748,
1,,Intermediate,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1359.0,CHEMBL623903,In vivo,Cerebrospinal fluid,3307,A,8749,
1,,Intermediate,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623904,In vivo,Plasma,3307,A,8750,
1,,Intermediate,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL877617,In vivo,Plasma,1916,A,8751,
1,,Intermediate,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623905,In vivo,,1500,A,8752,
1,,Intermediate,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623906,In vivo,,1500,A,8753,
1,,Intermediate,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623907,In vivo,Plasma,4186,A,8754,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623908,,,16434,A,8755,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623909,,,16434,A,8756,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623910,,,16434,A,8757,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623911,,,16434,A,8758,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623912,,,16435,A,8759,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624616,,,16435,A,8760,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624617,,,16435,A,8761,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624618,,,16435,A,8762,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624619,,,16435,A,8763,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624794,,,16435,A,8764,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624795,,,16435,A,8765,
1,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623921,,,16435,A,8766,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623922,,,16434,A,8767,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623923,,,16434,A,8768,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623924,,,16434,A,8769,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623925,,,16435,A,8770,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623926,,,16435,A,8771,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623927,,,16435,A,8772,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623928,,,16435,A,8773,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623929,,,16435,A,8774,
1,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623930,,,16435,A,8775,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623931,,Brain,16434,A,8776,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622165,,Brain,16434,A,8777,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621249,,Brain,16434,A,8778,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621250,,Brain,16434,A,8779,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621448,,Brain,16434,A,8780,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621449,,Brain,16434,A,8781,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621450,,Brain,16434,A,8782,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621451,,Brain,16434,A,8783,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621452,,Brain,16435,A,8784,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621453,,Brain,16435,A,8785,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621454,,Brain,16435,A,8786,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621455,,Brain,16435,A,8787,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621456,,Brain,16435,A,8788,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625145,,Brain,16435,A,8789,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL875847,,Brain,16435,A,8790,
1,,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625146,,Brain,16435,A,8791,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625147,,Brain,16434,A,8792,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625148,,Brain,16434,A,8793,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625149,,Brain,16434,A,8794,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625150,,Brain,16435,A,8795,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625151,,Brain,16435,A,8796,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625152,,Brain,16435,A,8797,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625153,,Brain,16435,A,8798,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625154,,Brain,16435,A,8799,
1,,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625155,,Brain,16435,A,8800,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625156,,,11977,A,8801,
1,,Intermediate,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624354,,,11977,A,8802,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL624355,,Hippocampus,11977,A,8803,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL624356,,Hippocampus,11977,A,8804,
1,,Intermediate,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL624357,,Hippocampus,11977,A,8805,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL624358,,Hippocampus,11977,A,8806,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL624359,,Striatum,11977,A,8807,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL624360,,Striatum,11977,A,8808,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL624361,,Striatum,11977,A,8809,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL624362,,Striatum,11977,A,8810,
1,,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL624363,,Striatum,11977,A,8811,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624364,In vivo,Blood,11977,A,8812,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624365,In vivo,Blood,11977,A,8813,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624366,In vivo,Blood,11977,A,8814,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624367,In vivo,Blood,11977,A,8815,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624368,In vivo,Brain,11977,A,8816,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624369,In vivo,Brain,11977,A,8817,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624370,In vivo,Brain,11977,A,8818,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625069,In vivo,Brain,11977,A,8819,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625070,In vivo,Brain,11977,A,8820,
1,,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626051,In vivo,Heart,11977,A,8821,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626052,In vivo,Heart,11977,A,8822,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626053,In vivo,Heart,11977,A,8823,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626054,In vivo,Heart,11977,A,8824,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626055,In vivo,Heart,11977,A,8825,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626056,In vivo,Kidney,11977,A,8826,
1,,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626057,In vivo,Kidney,11977,A,8827,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625193,In vivo,Kidney,11977,A,8828,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625194,In vivo,Kidney,11977,A,8829,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625195,In vivo,Liver,11977,A,8830,
1,,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625196,In vivo,Liver,11977,A,8831,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625197,In vivo,Liver,11977,A,8832,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625198,In vivo,Liver,11977,A,8833,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627929,In vivo,Liver,11977,A,8834,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627074,In vivo,Lung,11977,A,8835,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627075,In vivo,Lung,11977,A,8836,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627076,In vivo,Lung,11977,A,8837,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627077,In vivo,Lung,11977,A,8838,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627078,In vivo,Lung,11977,A,8839,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627079,In vivo,Muscle tissue,11977,A,8840,
1,,Intermediate,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL873824,In vivo,,4573,A,8841,
1,,Intermediate,Half life in mouse plasma was determined at dose 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627080,In vivo,Plasma,3132,A,8842,
1,,Intermediate,Half life was determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627081,,,17718,A,8843,
1,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627082,In vivo,,17728,A,8844,
1,,Intermediate,Half-life in male mice after 1 mg/kg intravenous dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627083,In vivo,,5961,A,8845,
1,,Intermediate,Half life in mice plasma,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627085,,Plasma,17731,A,8847,
1,,Intermediate,Half life in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627086,,,17592,A,8848,
1,,Intermediate,Half life in mouse plasma at dose 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627087,In vivo,Plasma,3132,A,8849,
1,,Intermediate,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627088,In vivo,,17729,A,8850,
1,,Intermediate,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627089,In vivo,,17729,A,8851,
1,,Intermediate,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627090,In vivo,,17729,A,8852,
1,,Intermediate,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627091,In vivo,,3277,A,8853,
1,,Intermediate,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627092,In vivo,,3760,A,8854,
1,,Intermediate,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL876785,In vivo,,3760,A,8855,
1,,Intermediate,Half-life by iv administration in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627093,In vivo,,2862,A,8856,
1,,Intermediate,Half-life by oral administration in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627094,In vivo,,2862,A,8857,
1,,Intermediate,Half-life in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627095,,,5980,A,8858,
1,,Intermediate,Half-life using mouse brain homogenate,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627096,,Brain,6159,A,8859,
1,,Intermediate,Half-life was measured in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627097,,,6254,A,8860,
1,,Intermediate,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627098,In vivo,,6062,A,8861,
1,,Intermediate,Half-life period was determined in mouse blood,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL627099,,Blood,1574,A,8862,
1,,Intermediate,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL627100,,Brain,56,A,8863,
1,,Intermediate,Plasma half life in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627101,,Plasma,993,A,8864,
1,,Intermediate,Stability of the peptide in the presence of mouse serum,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627102,,,6652,A,8865,
1,,Intermediate,Terminal half life of compound was determined in mouse,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627103,,,17852,A,8866,
1,,Intermediate,Terminal half life was evaluated in mice after intravenous administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627104,In vivo,,2675,A,8867,
1,,Intermediate,Terminal half life was evaluated in mice after oral administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627105,In vivo,,2675,A,8868,
1,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL876786,,,499,A,8869,
1,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL873825,,,499,A,8870,
1,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627106,,,499,A,8871,
1,,Intermediate,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626336,In vivo,,14239,A,8872,
1,,Intermediate,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL877462,In vivo,,5506,A,8873,
1,,Intermediate,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626337,In vivo,,5506,A,8874,
1,,Intermediate,Half life after intraperitoneal administration of 100 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626338,,,17734,A,8875,
1,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626339,In vivo,,17728,A,8876,
1,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626340,In vivo,,17728,A,8877,
1,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625377,In vivo,,17728,A,8878,
1,,Intermediate,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625378,In vivo,,17728,A,8879,
1,,Intermediate,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625379,In vivo,,17728,A,8880,
1,,Autocuration,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,,,Sus scrofa,,Microsomes,9823.0,BAO_0000251,22224,0,,,CHEMBL625380,,,14294,A,8881,
1,,Autocuration,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,,,Sus scrofa,,Microsomes,9823.0,BAO_0000251,22224,0,,,CHEMBL625381,,,14294,A,8882,
1,,Autocuration,Stability to porcine renal DHP-I,U,,,Sus scrofa,,,9823.0,BAO_0000019,22224,0,,,CHEMBL625382,,,6056,A,8883,
1,,Autocuration,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,,,Sus scrofa,,,9823.0,BAO_0000218,22224,0,,,CHEMBL873828,In vivo,,1317,A,8884,
1,,Autocuration,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,,,Sus scrofa,,,9823.0,BAO_0000218,22224,0,,,CHEMBL625383,In vivo,,1317,A,8885,
1,,Autocuration,Half-life of the parent prodrug in porcine esterase solution,U,,,Sus scrofa,,,9823.0,BAO_0000019,22224,0,,,CHEMBL625384,,,5229,A,8886,
1,,Autocuration,"First order rate constant, k was determined in in pig liver Esterase",U,,,Sus scrofa,,,9823.0,BAO_0000019,22224,0,,,CHEMBL625385,,,4231,A,8887,
1,,Autocuration,Half life of the in pig liver Esterase,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL625386,,Liver,4231,A,8888,
1,,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623571,,Liver,5318,A,8889,
1,,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623572,,Liver,5318,A,8890,
1,,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623573,,Liver,5318,A,8891,
1,,Autocuration,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623574,,Liver,3305,A,8892,
1,,Autocuration,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623575,,Liver,3305,A,8893,
1,,Autocuration,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623749,,Liver,2842,A,8894,
1,,Autocuration,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623750,,Liver,2842,A,8895,
1,,Autocuration,Half-life in vitro in pig liver,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623751,In vitro,Liver,889,A,8896,
1,,Autocuration,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,,,Sus scrofa,,,9823.0,BAO_0000221,22224,0,,2107.0,CHEMBL623752,,Liver,1904,A,8897,
1,,Intermediate,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623753,In vivo,Plasma,4186,A,8898,
1,,Intermediate,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623754,In vivo,Plasma,2774,A,8899,
1,,Intermediate,Maximum concentration in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623755,In vivo,Plasma,1742,A,8900,
1,,Intermediate,Maximum concentration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623756,In vivo,,3169,A,8901,
1,,Intermediate,Maximum concentration in rats at 1-2 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623757,In vivo,,3169,A,8902,
1,,Intermediate,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623758,In vivo,,2081,A,8903,
1,,Intermediate,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623759,In vivo,Brain,3307,A,8904,
1,,Intermediate,Maximum concentration at the dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623760,In vivo,,4727,A,8905,
1,,Intermediate,Maximum concentration was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623761,In vivo,,6597,A,8906,
1,,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623762,In vivo,Plasma,16365,A,8907,
1,,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL877594,In vivo,Plasma,16365,A,8908,
1,,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623763,In vivo,Plasma,16365,A,8909,
1,,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623764,In vivo,Plasma,16365,A,8910,
1,,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623765,In vivo,Plasma,16365,A,8911,
1,,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623766,In vivo,Blood,2591,A,8912,
1,,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623767,In vivo,Blood,2591,A,8913,
1,,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623768,In vivo,Blood,2591,A,8914,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623769,In vivo,Plasma,5978,A,8915,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623770,In vivo,Plasma,5978,A,8916,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623771,In vivo,Plasma,5978,A,8917,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623772,In vivo,Plasma,5978,A,8918,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623773,In vivo,Plasma,5978,A,8919,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623774,In vivo,Plasma,5978,A,8920,
1,,Intermediate,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623775,In vivo,Plasma,5978,A,8921,
1,,Intermediate,Cmax in rat (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623776,In vivo,,14465,A,8922,
1,,Intermediate,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622191,In vivo,Plasma,4723,A,8923,
1,,Intermediate,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622192,In vivo,Plasma,4723,A,8924,
1,,Intermediate,Maximum plasma concentration determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622193,In vivo,Plasma,4576,A,8925,
1,,Intermediate,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622194,In vivo,Plasma,12873,A,8926,
1,,Intermediate,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622195,In vivo,Plasma,12873,A,8927,
1,,Intermediate,Maximum plasma concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622196,In vivo,Plasma,6824,A,8928,
1,,Intermediate,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622197,In vivo,Plasma,17065,A,8929,
1,,Intermediate,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622198,In vivo,Plasma,2932,A,8930,
1,,Intermediate,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622199,In vivo,Plasma,2932,A,8931,
1,,Intermediate,Maximum plasma concentration of compound was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622200,In vivo,Plasma,2879,A,8932,
1,,Intermediate,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622201,In vivo,Plasma,2864,A,8933,
1,,Intermediate,Maximum plasma concentration after oral administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623990,In vivo,Plasma,16367,A,8934,
1,,Intermediate,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623991,In vivo,Plasma,17717,A,8935,
1,,Intermediate,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623992,In vivo,Plasma,17717,A,8936,
1,,Intermediate,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623993,In vivo,Plasma,17717,A,8937,
1,,Intermediate,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623994,In vivo,Plasma,17717,A,8938,
1,,Intermediate,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623995,In vivo,Plasma,17720,F,8939,
1,,Intermediate,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623996,In vivo,Plasma,17720,F,8940,
1,,Intermediate,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623997,In vivo,Plasma,17720,F,8941,
1,,Intermediate,Maximum plasma concentration dosed orally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623998,In vivo,Plasma,4516,A,8942,
1,,Intermediate,Maximum plasma concentration dosed orally in rats after 6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623999,In vivo,Plasma,4516,A,8943,
1,,Intermediate,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624000,In vivo,Plasma,4516,A,8944,
1,,Intermediate,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624001,In vivo,Plasma,5199,A,8945,
1,,Intermediate,Maximum plasma concentration in rat after po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624002,In vivo,Plasma,17538,A,8946,
1,,Intermediate,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624003,In vivo,Plasma,6685,A,8947,
1,,Intermediate,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624004,In vivo,Plasma,6685,A,8948,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624005,,Heart,16434,A,8949,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624006,,Heart,16434,A,8950,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624007,,Heart,16434,A,8951,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624008,,Heart,16434,A,8952,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624009,,Heart,16434,A,8953,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL874387,,Heart,16434,A,8954,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624010,,Heart,16434,A,8955,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624011,,Heart,16434,A,8956,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624012,,Heart,16435,A,8957,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624013,,Heart,16435,A,8958,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624736,,Heart,16435,A,8959,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624737,,Heart,16435,A,8960,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624738,,Heart,16434,A,8961,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624739,,Heart,16434,A,8962,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624740,,Heart,16434,A,8963,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624896,,Heart,16435,A,8964,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624897,,Heart,16435,A,8965,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624108,,Heart,16435,A,8966,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624109,,Heart,16435,A,8967,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624110,,Heart,16435,A,8968,
1,,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624111,,Heart,16435,A,8969,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624112,,Heart,16435,A,8970,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624113,,Heart,16435,A,8971,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL619709,,Heart,16435,A,8972,
1,,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL619710,,Heart,16435,A,8973,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619711,,Kidney,16434,A,8974,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619712,,Kidney,16434,A,8975,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619713,,Kidney,16434,A,8976,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619714,,Kidney,16434,A,8977,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619715,,Kidney,16434,A,8978,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619716,,Kidney,16434,A,8979,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619717,,Kidney,16434,A,8980,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619718,,Kidney,16434,A,8981,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619719,,Kidney,16435,A,8982,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL875329,,Kidney,16435,A,8983,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619720,,Kidney,16435,A,8984,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619721,,Kidney,16435,A,8985,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619722,,Kidney,16435,A,8986,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619723,,Kidney,16435,A,8987,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619724,,Kidney,16435,A,8988,
1,,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619725,,Kidney,16435,A,8989,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619726,,Kidney,16434,A,8990,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619727,,Kidney,16434,A,8991,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619728,,Kidney,16434,A,8992,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL619729,,Kidney,16435,A,8993,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL619730,In vivo,Muscle tissue,11977,A,8994,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL619731,In vivo,Muscle tissue,11977,A,8995,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL619732,In vivo,Muscle tissue,11977,A,8996,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL619733,In vivo,Muscle tissue,11977,A,8997,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL619734,In vivo,Muscle tissue,11977,A,8998,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL619735,In vivo,Zone of skin,11977,A,8999,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL875330,In vivo,Zone of skin,11977,A,9000,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL628465,In vivo,Zone of skin,11977,A,9001,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL628466,In vivo,Zone of skin,11977,A,9002,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL628467,In vivo,Zone of skin,11977,A,9003,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628468,In vivo,Spleen,11977,A,9004,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628469,In vivo,Spleen,11977,A,9005,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628470,In vivo,Spleen,11977,A,9006,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628471,In vivo,Spleen,11977,A,9007,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628472,In vivo,Spleen,11977,A,9008,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL625191,In vivo,Thyroid gland,11977,A,9009,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL625192,In vivo,Thyroid gland,11977,A,9010,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL875337,In vivo,Thyroid gland,11977,A,9011,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626341,In vivo,Thyroid gland,11977,A,9012,
1,,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626342,In vivo,Thyroid gland,11977,A,9013,
1,,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621943,In vivo,Liver,11977,A,9014,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621944,,,3748,A,9015,
1,,Intermediate,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621945,,,15765,A,9016,
1,,Intermediate,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621946,,,4871,A,9017,
1,,Intermediate,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621947,,,4871,A,9018,
1,,Intermediate,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621948,,,4872,A,9019,
1,,Intermediate,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621949,,,4872,A,9020,
1,,Intermediate,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621950,,,5413,A,9021,
1,,Intermediate,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621951,,,5413,A,9022,
1,,Intermediate,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621952,In vivo,Blood,15272,A,9023,
1,,Intermediate,Stability (%) in rat liver microsomes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621953,,Liver,4689,A,9024,
1,,Intermediate,Area under curve was calculated after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621954,,,6057,A,9025,
1,,Intermediate,Area under the curve was calculated after iv administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621955,,,6057,A,9026,
1,,Intermediate,Area under the curve was calculated in rat after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621956,,,6057,A,9027,
1,,Intermediate,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621957,,,6211,A,9028,
1,,Intermediate,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621958,,,5710,A,9029,
1,,Intermediate,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621959,,,5710,A,9030,
1,,Intermediate,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621960,,,17853,A,9031,
1,,Intermediate,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621961,,,17853,A,9032,
1,,Intermediate,p value of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621962,,,15765,A,9033,
1,,Intermediate,p value of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876787,,,15765,F,9034,
1,,Intermediate,p value of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621963,,,15765,A,9035,
1,,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622637,,Stomach,6175,A,9036,
1,,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622638,,Stomach,6175,A,9037,
1,,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL626561,,Stomach,6175,A,9038,
1,,Autocuration,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000019,22224,0,,,CHEMBL626562,,,7991,F,9039,
1,,Autocuration,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626563,,,429,A,9040,
1,,Autocuration,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626564,,,429,A,9041,
1,,Autocuration,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626565,In vivo,,6253,A,9042,
1,,Autocuration,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626566,In vivo,,6253,A,9043,
1,,Autocuration,Clearance rate in rabbits,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626567,In vivo,,3615,A,9044,
1,,Autocuration,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626568,In vivo,,4059,A,9045,
1,,Autocuration,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626569,In vivo,,5124,A,9046,
1,,Autocuration,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626570,In vivo,,5124,A,9047,
1,,Autocuration,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626571,In vivo,,5124,A,9048,
1,,Autocuration,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626572,In vivo,,429,A,9049,
1,,Autocuration,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1969.0,CHEMBL626573,In vivo,Plasma,4059,A,9050,
1,,Autocuration,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,,,Oryctolagus cuniculus,,Microsomes,9986.0,BAO_0000251,22224,0,,2107.0,CHEMBL626574,,Liver,9659,A,9051,
1,,Autocuration,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,,,Oryctolagus cuniculus,,Microsomes,9986.0,BAO_0000251,22224,0,,2107.0,CHEMBL626575,,Liver,9659,A,9052,
1,,Autocuration,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626576,,,3639,A,9053,
1,,Autocuration,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626577,,,3639,A,9054,
1,,Autocuration,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL626578,In vivo,,3639,A,9055,
1,,Autocuration,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL625263,In vivo,,5124,A,9056,
1,,Autocuration,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL625264,In vivo,,5124,A,9057,
1,,Autocuration,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL625265,In vivo,,5124,A,9058,
1,,Autocuration,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,,,Oryctolagus cuniculus,,Microsomes,9986.0,BAO_0000251,22224,0,,,CHEMBL625266,,,14294,A,9059,
1,,Autocuration,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,,,Oryctolagus cuniculus,,Microsomes,9986.0,BAO_0000251,22224,0,,,CHEMBL876796,,,14294,A,9060,
1,,Autocuration,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL625267,In vivo,,429,A,9061,
1,,Autocuration,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1969.0,CHEMBL625268,In vivo,Plasma,5124,A,9062,
1,,Autocuration,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1969.0,CHEMBL625269,In vivo,Plasma,5124,A,9063,
1,,Autocuration,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1969.0,CHEMBL624689,In vivo,Plasma,5124,A,9064,
1,,Autocuration,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL624690,In vivo,,429,A,9065,
1,,Autocuration,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1088.0,CHEMBL624691,,Urine,429,A,9066,
1,,Autocuration,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,1088.0,CHEMBL624692,,Urine,429,A,9067,
1,,Autocuration,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL624693,In vivo,,4059,A,9068,
1,,Autocuration,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL624694,In vivo,,4137,A,9069,
1,,Autocuration,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000221,22224,0,,,CHEMBL877596,In vitro,,11672,A,9070,
1,,Autocuration,Time within which only 10% of the drug was degraded,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000019,22224,0,,,CHEMBL624695,,,12886,A,9071,
1,,Autocuration,Half life period in rabbit liver homogenate,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000221,22224,0,,2107.0,CHEMBL624696,,Liver,3853,A,9072,
1,,Autocuration,Half life value in rabbits,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000019,22224,0,,,CHEMBL624697,,,3615,A,9073,
1,,Autocuration,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,178.0,CHEMBL624698,In vivo,Blood,6253,A,9074,
1,,Autocuration,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,178.0,CHEMBL624699,In vivo,Blood,6253,A,9075,
1,,Autocuration,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,22224,0,,,CHEMBL624700,In vivo,,6077,A,9076,
1,,Intermediate,AUC 0-8 hr value in rats at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622903,,Plasma,17617,A,9077,
1,,Intermediate,AUC after administration at 2000 mg/kg/day in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622904,,Plasma,17594,A,9078,
1,,Intermediate,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622905,,Plasma,6149,A,9079,
1,,Intermediate,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622906,,Plasma,17260,A,9080,
1,,Intermediate,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622907,,Plasma,17260,A,9081,
1,,Intermediate,AUC in rat after oral administration at 10.5 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622908,,Plasma,6644,A,9082,
1,,Intermediate,AUC in rat after oral administration at 11.2 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622909,,Plasma,6644,A,9083,
1,,Intermediate,AUC in rat after oral administration at 9.7 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622910,,Plasma,6644,A,9084,
1,,Intermediate,AUC in rat brain after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622911,,Brain,6495,A,9085,
1,,Intermediate,AUC in rat p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622912,,Plasma,6504,A,9086,
1,,Intermediate,AUC in rat p.o. at 20 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622913,,Plasma,17686,A,9087,
1,,Intermediate,AUC in rat plasma after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622914,,Plasma,6495,A,9088,
1,,Intermediate,AUC in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622915,,Plasma,216,A,9089,
1,,Intermediate,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622916,,Plasma,1908,A,9090,
1,,Intermediate,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622917,,Plasma,1908,A,9091,
1,,Intermediate,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622918,In vivo,Plasma,6685,A,9092,
1,,Intermediate,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622919,In vivo,Plasma,216,A,9093,
1,,Intermediate,Maximum plasma concentration was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622920,In vivo,Plasma,6049,A,9094,
1,,Intermediate,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622921,In vivo,Plasma,2463,A,9095,
1,,Intermediate,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622922,In vivo,Plasma,6679,A,9096,
1,,Intermediate,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622923,In vivo,Plasma,6681,A,9097,
1,,Intermediate,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL877604,In vivo,Plasma,4890,A,9098,
1,,Intermediate,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622924,In vivo,Plasma,6410,A,9099,
1,,Intermediate,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622925,In vivo,Plasma,6410,A,9100,
1,,Intermediate,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622926,In vivo,Plasma,16366,A,9101,
1,,Intermediate,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623625,In vivo,Plasma,6227,A,9102,
1,,Expert,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623626,In vivo,Plasma,3598,A,9103,
1,,Intermediate,Maximum plasma drug concentration was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623627,In vivo,Plasma,1465,A,9104,
1,,Intermediate,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623628,In vivo,,4368,A,9105,
1,,Intermediate,Mean peak plasma concentration was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623629,In vivo,Plasma,15662,A,9106,
1,,Intermediate,Mean peak plasma concentration was observed after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623630,In vivo,Plasma,15662,A,9107,
1,,Intermediate,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623804,In vivo,,5355,A,9108,
1,,Intermediate,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623805,In vivo,,5355,A,9109,
1,,Intermediate,Peak oral plasma concentration was determined in rats by oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623806,In vivo,Plasma,1567,A,9110,
1,,Intermediate,Peak plasma concentration (Cmax) was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623807,In vivo,Plasma,4026,A,9111,
1,,Intermediate,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623808,In vivo,Plasma,6193,A,9112,
1,,Intermediate,Peak plasma concentration (Cmax) in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623809,In vivo,Plasma,4026,A,9113,
1,,Intermediate,Peak plasma concentration at 1 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623810,In vivo,Plasma,6485,A,9114,
1,,Intermediate,Peak plasma concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623811,In vivo,Plasma,17655,A,9115,
1,,Intermediate,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623812,In vivo,Plasma,14941,A,9116,
1,,Intermediate,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877605,In vivo,,5394,A,9117,
1,,Intermediate,Pharmacokinetic property (Cmax) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623813,In vivo,,4408,A,9118,
1,,Intermediate,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623814,In vivo,,5983,A,9119,
1,,Intermediate,Cmax in rat after 3mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623815,In vivo,,4878,A,9120,
1,,Intermediate,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,Sprague-Dawley,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623816,In vivo,,5862,A,9121,
1,,Intermediate,Cmax in rats after 20 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623145,In vivo,,4517,A,9122,
1,,Intermediate,Cmax in rat plasma after 30mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623146,In vivo,Plasma,5932,A,9123,
1,,Intermediate,Plasma concentration after oral administration of 100 mg/kg to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623147,In vivo,Plasma,5436,A,9124,
1,,Intermediate,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623042,In vivo,Brain,4910,A,9125,
1,,Intermediate,Tested for the Cmax in rat at 10 mg/kg per orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623043,In vivo,,4950,A,9126,
1,,Intermediate,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623044,In vivo,,15078,A,9127,
1,,Intermediate,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623045,In vivo,,15078,A,9128,
1,,Intermediate,Bioavailability as oral Cmax in rats at 30 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623046,In vivo,,3360,A,9129,
1,,Intermediate,Bioavailability as oral Cmax in rats at 6hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623226,In vivo,,3360,A,9130,
1,,Intermediate,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623227,In vivo,,15022,A,9131,
1,,Intermediate,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623228,In vivo,,15022,A,9132,
1,,Intermediate,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623229,In vivo,,15022,A,9133,
1,,Intermediate,The maximum plasma levels for the compounds were determined by LC-MS.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623230,In vivo,Plasma,5160,A,9134,
1,,Intermediate,mean peak plasma concentration was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623231,In vivo,Plasma,15662,A,9135,
1,,Intermediate,mean peak plasma concentration was observed after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623232,In vivo,Plasma,15662,A,9136,
1,,Intermediate,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623233,,,4709,A,9137,
1,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623234,,,3535,A,9138,
1,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623235,,,3535,A,9139,
1,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623236,,,3535,A,9140,
1,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623237,,,3535,A,9141,
1,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623238,,,3535,A,9142,
1,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623239,,,3535,A,9143,
1,,Intermediate,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1969.0,CHEMBL623240,In vivo,Plasma,5005,A,9144,
1,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL623241,,Hypothalamus,6326,A,9145,
1,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL623242,,Hypothalamus,6326,A,9146,
1,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874394,,,6326,A,9147,
1,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623243,,,6326,A,9148,
1,,Intermediate,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623244,,,17411,A,9149,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623245,,Kidney,16435,A,9150,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623246,,Kidney,16435,A,9151,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623247,,Kidney,16435,A,9152,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623248,,Kidney,16435,A,9153,
1,,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623249,,Kidney,16435,A,9154,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625072,,Liver,16434,A,9155,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625073,,Liver,16434,A,9156,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625074,,Liver,16434,A,9157,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625075,,Liver,16434,A,9158,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625076,,Liver,16434,A,9159,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625077,,Liver,16434,A,9160,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625078,,Liver,16434,A,9161,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL874395,,Liver,16434,A,9162,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625079,,Liver,16435,A,9163,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625080,,Liver,16435,A,9164,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625081,,Liver,16435,A,9165,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625082,,Liver,16435,A,9166,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625083,,Liver,16435,A,9167,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625084,,Liver,16435,A,9168,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625085,,Liver,16435,A,9169,
1,,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625086,,Liver,16435,A,9170,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625087,,Liver,16434,A,9171,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625088,,Liver,16434,A,9172,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622205,,Liver,16434,A,9173,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622206,,Liver,16435,A,9174,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622207,,Liver,16435,A,9175,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622366,,Liver,16435,A,9176,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622367,,Liver,16435,A,9177,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL875331,,Liver,16435,A,9178,
1,,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622368,,Liver,16435,A,9179,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622369,,Lung,16434,A,9180,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622370,,Lung,16434,A,9181,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622371,,Lung,16434,A,9182,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622372,,Lung,16434,A,9183,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622373,,Lung,16434,A,9184,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622374,,Lung,16434,A,9185,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622375,,Lung,16434,A,9186,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622376,,Lung,16434,A,9187,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622377,,Lung,16435,A,9188,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622378,,Lung,16435,A,9189,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622379,,Lung,16435,A,9190,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622380,,Lung,16435,A,9191,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622381,,Lung,16435,A,9192,
1,,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622382,,Lung,16435,A,9193,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622383,,Lung,16434,A,9194,
1,,Intermediate,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL875332,,Stomach,6175,A,9195,
1,,Intermediate,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622384,,Stomach,6175,A,9196,
1,,Intermediate,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622385,,Stomach,6175,A,9197,
1,,Intermediate,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622386,,Stomach,6175,A,9198,
1,,Intermediate,The compound was tested for the plasma binding in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622387,,,10839,A,9199,
1,,Intermediate,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622388,,,16459,A,9200,
1,,Intermediate,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622389,,,16459,A,9201,
1,,Intermediate,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622390,,,16459,A,9202,
1,,Intermediate,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622391,,,16459,A,9203,
1,,Intermediate,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622392,,,16459,A,9204,
1,,Intermediate,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622393,,,16459,A,9205,
1,,Intermediate,Plasma level at 2 hr after administration of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622394,,,3278,A,9206,
1,,Intermediate,plasma level at 2 hr after administration of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622395,,,3278,A,9207,
1,,Intermediate,Stability in rat serum measured as % recovery at 1 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL622396,,Serum,4684,A,9208,
1,,Intermediate,Stability in rat serum measured as % recovery at 10 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624894,,Serum,4684,A,9209,
1,,Intermediate,Stability in rat serum measured as % recovery at 10 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624895,,Serum,4684,A,9210,
1,,Intermediate,Stability in rat serum measured as % recovery at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624058,,Serum,4684,A,9211,
1,,Intermediate,Stability in rat serum measured as % recovery at 3 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624059,,Serum,4684,A,9212,
1,,Intermediate,Stability in rat serum measured as % recovery at 3 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624060,,Serum,4684,A,9213,
1,,Intermediate,Stability in rat serum measured as % recovery at 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624061,,Serum,4684,A,9214,
1,,Intermediate,Stability in rat serum measured as % recovery at 5 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL624062,,Serum,4684,A,9215,
1,,Intermediate,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624063,In vivo,,16456,A,9216,
1,,Intermediate,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624064,In vivo,,16456,A,9217,
1,,Intermediate,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624065,,Plasma,723,A,9218,
1,,Intermediate,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624066,,Plasma,723,A,9219,
1,,Intermediate,Half life tested in mature male rat at a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877490,In vivo,,5160,A,9220,
1,,Intermediate,Half life after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874442,In vivo,,4709,A,9221,
1,,Intermediate,Half life period after administration (30 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626890,In vivo,,5633,A,9222,
1,,Intermediate,Half life period in rat after 5 mg/Kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626891,In vivo,,5302,A,9223,
1,,Intermediate,Half life period in rat after 5 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626892,In vivo,,5302,A,9224,
1,,Intermediate,Half life period was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626893,,,17791,A,9225,
1,,Intermediate,Half life period was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626894,,,17791,A,9226,
1,,Intermediate,Half life period was evaluated in rat; 0.5-1.0,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626895,,,17791,A,9227,
1,,Intermediate,Half life period was evaluated in rat; 5.9-7.5,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626896,,,17791,A,9228,
1,,Intermediate,Half-life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626897,,Plasma,14512,A,9229,
1,,Intermediate,Half-life time in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626898,,,6230,A,9230,
1,,Intermediate,Terminal half-life after iv administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626899,In vivo,,3364,A,9231,
1,,Intermediate,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626900,In vivo,,6874,A,9232,
1,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626901,,,857,A,9233,
1,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626902,In vivo,,858,A,9234,
1,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626903,In vivo,,858,A,9235,
1,,Intermediate,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874443,In vivo,,5355,A,9236,
1,,Intermediate,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626904,In vivo,,5355,A,9237,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626905,,,6305,A,9238,
1,,Intermediate,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873830,In vivo,Plasma,13501,A,9239,
1,,Intermediate,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626906,In vivo,,17594,A,9240,
1,,Intermediate,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631076,In vivo,Plasma,4186,A,9241,
1,,Intermediate,Biological half-life was measured in plasma of rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631077,,Plasma,2932,A,9242,
1,,Intermediate,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631078,In vivo,,17065,A,9243,
1,,Intermediate,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631079,In vivo,,15765,A,9244,
1,,Intermediate,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631080,In vivo,,2713,A,9245,
1,,Intermediate,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631081,In vivo,,2661,A,9246,
1,,Intermediate,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631239,In vivo,,2661,A,9247,
1,,Intermediate,Compound was evaluated for plasma half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631240,,Plasma,740,A,9248,
1,,Intermediate,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631241,,Plasma,6597,A,9249,
1,,Intermediate,AUC value after administration of 20 mg/Kg oral dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631242,,Plasma,2959,A,9250,
1,,Intermediate,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631243,,Plasma,17594,A,9251,
1,,Intermediate,AUC0-96 after administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL874444,,Plasma,17596,A,9252,
1,,Intermediate,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631244,,Plasma,17594,A,9253,
1,,Intermediate,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631245,,,3293,A,9254,
1,,Intermediate,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627162,,,6757,A,9255,
1,,Intermediate,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627163,,,6757,A,9256,
1,,Intermediate,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627164,,,6757,A,9257,
1,,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627165,,Kidney,5979,A,9258,
1,,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627166,,,5979,A,9259,
1,,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627167,,,5979,A,9260,
1,,Intermediate,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627822,,,4026,A,9261,
1,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627823,,,5355,A,9262,
1,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627824,,,5355,A,9263,
1,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627825,,,5355,A,9264,
1,,Intermediate,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627826,,,5633,A,9265,
1,,Intermediate,Area under curve (Pharmacokinetic property) was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627827,,,1716,A,9266,
1,,Intermediate,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627828,,,1716,A,9267,
1,,Intermediate,Area under curve after intravenous administration (1 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627829,,,4689,A,9268,
1,,Intermediate,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627830,,,4527,A,9269,
1,,Intermediate,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627831,,,4527,A,9270,
1,,Intermediate,Area under curve in male SD rats was observed after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627832,,,15662,A,9271,
1,,Intermediate,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627833,,,4413,A,9272,
1,,Expert,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627834,,,3598,A,9273,
1,,Expert,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628004,,,3598,A,9274,
1,,Intermediate,Area under curve at 5 mg/kg po was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628005,,,5964,A,9275,
1,,Intermediate,Area under curve in Rat at a oral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628006,,,4689,A,9276,
1,,Intermediate,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628007,,,4186,A,9277,
1,,Intermediate,Area under curve was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625676,,,5510,A,9278,
1,,Intermediate,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631309,,,17858,A,9279,
1,,Intermediate,Area under curve after intravenous administration at 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631310,,,17804,A,9280,
1,,Intermediate,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631311,,,6106,A,9281,
1,,Intermediate,Area under curve at 4 hr in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631312,,,5964,A,9282,
1,,Intermediate,Area under curve at a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631313,,,4026,A,9283,
1,,Intermediate,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631314,,,4756,A,9284,
1,,Intermediate,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631315,,,4756,A,9285,
1,,Intermediate,Area under curve for a 2-mpk po dose in SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631316,,,5862,A,9286,
1,,Intermediate,Area under curve in SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631317,,,5862,A,9287,
1,,Intermediate,Area under curve in rat after oral administration at 13 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874471,,,6644,A,9288,
1,,Intermediate,Area under curve in rat by po administration at 0-24 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631318,,,5871,A,9289,
1,,Intermediate,Area under curve in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631319,,Plasma,5919,A,9290,
1,,Intermediate,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631320,,,5939,A,9291,
1,,Intermediate,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631321,,,5939,A,9292,
1,,Intermediate,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631322,,,10,A,9293,
1,,Intermediate,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631323,,,11149,A,9294,
1,,Intermediate,Area under curve value in rat at a dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631324,,,5302,A,9295,
1,,Intermediate,Area under curve was determined after oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631325,,,17796,A,9296,
1,,Intermediate,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631326,,,4890,A,9297,
1,,Intermediate,Area under curve was determined after peroral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631327,,,6011,A,9298,
1,,Intermediate,Area under curve was determined at a dose 30 mpk administered orally.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631328,,,5375,A,9299,
1,,Intermediate,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631329,,,17764,A,9300,
1,,Intermediate,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627217,,,4368,A,9301,
1,,Intermediate,Area under curve was determined in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626352,,,5610,A,9302,
1,,Intermediate,Area under curve was determined in rat after PO administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626353,,,5833,A,9303,
1,,Intermediate,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626354,,,4257,A,9304,
1,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626355,,,5937,A,9305,
1,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626356,,,5932,A,9306,
1,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626357,,,5932,A,9307,
1,,Intermediate,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626358,,,17411,A,9308,
1,,Intermediate,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626359,,,17411,A,9309,
1,,Intermediate,Peak plasma concentration in rat at a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626360,,Plasma,17771,A,9310,
1,,Intermediate,Plasma concentration at 2 hr in rats was evaluated.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626361,,,1628,A,9311,
1,,Intermediate,Plasma concentration at 2 hr in rats was evaluated; Not available,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626362,,,1628,A,9312,
1,,Intermediate,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626363,,,17411,A,9313,
1,,Intermediate,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626970,,,4910,A,9314,
1,,Intermediate,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626971,,,4910,A,9315,
1,,Intermediate,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626972,,Plasma,4910,A,9316,
1,,Intermediate,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626973,,Plasma,4910,A,9317,
1,,Intermediate,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626974,,Plasma,4910,A,9318,
1,,Intermediate,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL874592,,Plasma,4910,A,9319,
1,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626975,,,5510,A,9320,
1,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626976,,,5510,A,9321,
1,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626977,,,5510,A,9322,
1,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626978,,,5510,A,9323,
1,,Intermediate,PK study was carried to determine the relative absorption ranking in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626979,,,16427,A,9324,
1,,Intermediate,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626980,In vivo,Plasma,4689,A,9325,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626981,,Blood,11450,A,9326,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626982,,Blood,11450,A,9327,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626983,,Blood,11450,A,9328,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622522,,Blood,11450,A,9329,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622523,,Blood,11450,A,9330,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622524,,Blood,11450,A,9331,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622525,,Brain,11450,A,9332,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622526,,Brain,11450,A,9333,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619849,,Brain,11450,A,9334,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL619850,,Brain,11450,A,9335,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623864,,Brain,11450,A,9336,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623865,,Brain,11450,A,9337,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623866,,Heart,11450,A,9338,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623867,,Heart,11450,A,9339,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL877615,,Heart,11450,A,9340,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623868,,Heart,11450,A,9341,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623869,,Heart,11450,A,9342,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623870,,Heart,11450,A,9343,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL623871,,Lung,16434,A,9344,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL623872,,Lung,16434,A,9345,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622129,,Lung,16435,A,9346,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622130,,Lung,16435,A,9347,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622131,,Lung,16435,A,9348,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622132,,Lung,16435,A,9349,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622133,,Lung,16435,A,9350,
1,,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622134,,Lung,16435,A,9351,
1,,Intermediate,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622135,,Lung,16435,A,9352,
1,,Intermediate,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622136,,Lung,16435,A,9353,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622137,,Muscle tissue,16434,A,9354,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622138,,Muscle tissue,16434,A,9355,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623017,,Muscle tissue,16434,A,9356,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623018,,Muscle tissue,16434,A,9357,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623019,,Muscle tissue,16434,A,9358,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623020,,Muscle tissue,16434,A,9359,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623021,,Muscle tissue,16434,A,9360,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623022,,Muscle tissue,16434,A,9361,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623023,,Muscle tissue,16435,A,9362,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623024,,Muscle tissue,16435,A,9363,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623025,,Muscle tissue,16435,A,9364,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620545,,Muscle tissue,16435,A,9365,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620546,,Muscle tissue,16435,A,9366,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620547,,Muscle tissue,16435,A,9367,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620548,,Muscle tissue,16435,A,9368,
1,,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620549,,Muscle tissue,16435,A,9369,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620550,,Muscle tissue,16434,A,9370,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620551,,Muscle tissue,16434,A,9371,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620552,,Muscle tissue,16434,A,9372,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620553,,Muscle tissue,16435,A,9373,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620554,,Muscle tissue,16435,A,9374,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL875845,,Muscle tissue,16435,A,9375,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620555,,Muscle tissue,16435,A,9376,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620556,,Muscle tissue,16435,A,9377,
1,,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620557,,Muscle tissue,16435,A,9378,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620558,,,16434,A,9379,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620559,,,16434,A,9380,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622939,,,16434,A,9381,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622940,,,16434,A,9382,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622941,,,16434,A,9383,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622942,,,16434,A,9384,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622943,,,16434,A,9385,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622944,,,16434,A,9386,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622945,,,16435,A,9387,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622946,,,16435,A,9388,
1,,Intermediate,Compound was evaluated for terminal half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622947,,,3341,A,9389,
1,,Intermediate,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622948,In vivo,Plasma,3634,A,9390,
1,,Intermediate,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622949,In vivo,Plasma,3634,A,9391,
1,,Intermediate,Compound was tested for its half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622950,,,4839,A,9392,
1,,Intermediate,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,1969.0,CHEMBL622951,In vivo,Plasma,5005,A,9393,
1,,Intermediate,Compound was tested for its plasma half life in Sprague Dawley rats,U,,,Rattus norvegicus,,,10116.0,BAO_0000366,22224,0,,1969.0,CHEMBL622952,,Plasma,5005,A,9394,
1,,Intermediate,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,,,Rattus norvegicus,,,10116.0,BAO_0000366,22224,0,,1969.0,CHEMBL622953,,Plasma,5005,A,9395,
1,,Intermediate,Compound was tested for plasma half-life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873818,,Plasma,1094,A,9396,
1,,Intermediate,Elimination half life after i.v. administration of compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622954,In vivo,,5031,A,9397,
1,,Intermediate,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622955,In vivo,,6518,A,9398,
1,,Intermediate,Elimination half-life after IV dosing at 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875229,In vivo,,6518,A,9399,
1,,Intermediate,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622956,In vivo,,6518,A,9400,
1,,Intermediate,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622957,In vivo,,6518,A,9401,
1,,Intermediate,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622958,In vivo,Brain,5408,A,9402,
1,,Intermediate,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622959,In vivo,Plasma,5408,A,9403,
1,,Intermediate,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622960,In vivo,Brain,5408,A,9404,
1,,Intermediate,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622961,In vivo,Plasma,5408,A,9405,
1,,Intermediate,Evaluated for the half life in rat (in vivo),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622962,In vivo,,4687,A,9406,
1,,Intermediate,Hafl life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622963,,,6640,A,9407,
1,,Intermediate,Hafl life rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622964,,,6640,A,9408,
1,,Intermediate,Hafl life rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622965,,,6641,A,9409,
1,,Intermediate,Hafl life rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622966,,,6640,A,9410,
1,,Intermediate,Hafl life rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622967,,,6641,A,9411,
1,,Intermediate,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622968,In vivo,Kidney,17411,A,9412,
1,,Intermediate,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622969,In vivo,Liver,17411,A,9413,
1,,Intermediate,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL875327,In vivo,Lung,17411,A,9414,
1,,Intermediate,Half life in rat after 1 mg/kg i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628638,In vivo,,6570,A,9415,
1,,Intermediate,Half life in rat after 2 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628639,In vivo,,6570,A,9416,
1,,Intermediate,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625840,In vivo,,17411,A,9417,
1,,Intermediate,Half life of 10 mg/kg oral dose determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625841,In vivo,,4722,A,9418,
1,,Intermediate,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625842,In vivo,,5978,A,9419,
1,,Intermediate,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625843,In vivo,,5978,A,9420,
1,,Intermediate,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625844,In vivo,,5978,A,9421,
1,,Intermediate,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873822,In vivo,,5978,A,9422,
1,,Intermediate,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625845,In vivo,,5978,A,9423,
1,,Intermediate,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627059,In vivo,,5978,A,9424,
1,,Intermediate,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627060,In vivo,,5978,A,9425,
1,,Intermediate,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627061,In vivo,,5978,A,9426,
1,,Intermediate,Half life of compound at 5 mg/kg after po administration was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627709,In vivo,,4762,A,9427,
1,,Intermediate,Half life of compound determined after intravenous administration to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627710,In vivo,,5327,A,9428,
1,,Intermediate,Half life of compound was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627711,,,4847,A,9429,
1,,Intermediate,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627712,In vivo,Plasma,17720,A,9430,
1,,Intermediate,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627713,In vivo,,4723,A,9431,
1,,Intermediate,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627714,In vivo,,4723,A,9432,
1,,Intermediate,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,,,Macaca fascicularis,,,9541.0,BAO_0000218,22224,0,,,CHEMBL627889,In vivo,,4256,A,9433,
1,,Intermediate,Half life determined in rat by intravenous administration,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL627890,In vivo,,4256,A,9434,
1,,Intermediate,Half life determined in rats after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627891,In vivo,,4722,A,9435,
1,,Intermediate,Half life in rat plasma after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627892,In vivo,Plasma,6535,A,9436,
1,,Intermediate,Half life in rat plasma after administration of 2 mg/kg iv,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627893,In vivo,Plasma,6535,A,9437,
1,,Intermediate,Half life in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627894,,Plasma,1435,A,9438,
1,,Intermediate,Half life in rat plasma was determined; NA means not applicable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627895,,Plasma,1435,A,9439,
1,,Intermediate,Half life in rat was tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627896,,,5206,A,9440,
1,,Intermediate,Half life measured in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627897,,Plasma,6080,A,9441,
1,,Intermediate,Half life recorded in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627898,,,4449,A,9442,
1,,Intermediate,Half life was calculated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627899,,,6057,A,9443,
1,,Intermediate,Half life was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873823,,,6057,A,9444,
1,,Intermediate,Half life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627900,,,3747,A,9445,
1,,Intermediate,Half life after 10 mg/kg oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627901,In vivo,,17858,A,9446,
1,,Intermediate,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627902,In vivo,,16365,A,9447,
1,,Intermediate,Half life after administering orally a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627903,In vivo,,16365,A,9448,
1,,Intermediate,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627904,,,5031,A,9449,
1,,Intermediate,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627905,,,4722,A,9450,
1,,Intermediate,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627906,,,6078,A,9451,
1,,Intermediate,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627907,,,6078,A,9452,
1,,Intermediate,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876783,,,6078,A,9453,
1,,Intermediate,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627908,,,6078,A,9454,
1,,Intermediate,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627909,,,17065,A,9455,
1,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627910,,,1353,A,9456,
1,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627911,,,1353,A,9457,
1,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627912,,,1353,A,9458,
1,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627913,,,1353,A,9459,
1,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627914,,,1353,A,9460,
1,,Intermediate,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627915,,,16423,A,9461,
1,,Intermediate,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627916,,,16423,A,9462,
1,,Intermediate,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627917,,,6062,A,9463,
1,,Intermediate,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627918,,,6056,A,9464,
1,,Intermediate,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627919,,,5182,A,9465,
1,,Intermediate,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627920,,,6410,A,9466,
1,,Intermediate,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627921,,,6410,A,9467,
1,,Intermediate,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627922,,,4723,A,9468,
1,,Intermediate,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876784,,,4723,A,9469,
1,,Intermediate,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627923,,,4723,A,9470,
1,,Intermediate,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626208,,,4723,A,9471,
1,,Intermediate,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626209,,,4723,A,9472,
1,,Intermediate,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626210,,,4723,A,9473,
1,,Intermediate,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627994,,Plasma,2463,A,9474,
1,,Intermediate,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627995,,,4709,A,9475,
1,,Intermediate,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627996,,,4075,A,9476,
1,,Intermediate,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627997,,,5394,A,9477,
1,,Intermediate,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627998,,,2661,A,9478,
1,,Intermediate,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628640,,,2661,A,9479,
1,,Intermediate,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628641,,,2661,A,9480,
1,,Intermediate,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628642,,,2661,A,9481,
1,,Intermediate,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628643,,,17791,A,9482,
1,,Intermediate,Compound was tested for area under curve in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628644,,,2591,A,9483,
1,,Intermediate,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628645,,,6567,A,9484,
1,,Intermediate,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628646,,,6211,A,9485,
1,,Intermediate,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628647,,,5529,A,9486,
1,,Intermediate,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628648,,,5408,A,9487,
1,,Intermediate,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625358,,,5408,A,9488,
1,,Intermediate,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625359,,,5408,A,9489,
1,,Intermediate,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625360,,,5408,A,9490,
1,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625361,,,429,A,9491,
1,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625362,,,429,A,9492,
1,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625363,,,429,A,9493,
1,,Intermediate,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625364,,,4796,A,9494,
1,,Intermediate,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625365,,,5974,A,9495,
1,,Intermediate,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625366,,,5974,A,9496,
1,,Intermediate,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625367,,,5974,A,9497,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625368,,Kidney,11450,A,9498,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625369,,Kidney,11450,A,9499,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625370,,Kidney,11450,A,9500,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625371,,Kidney,11450,A,9501,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625372,,Kidney,11450,A,9502,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625373,,Kidney,11450,A,9503,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625374,,Liver,11450,A,9504,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL877593,,Liver,11450,A,9505,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625375,,Liver,11450,A,9506,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625376,,Liver,11450,A,9507,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621973,,Liver,11450,A,9508,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621974,,Liver,11450,A,9509,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL621975,,Lung,11450,A,9510,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622166,,Lung,11450,A,9511,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622167,,Lung,11450,A,9512,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622168,,Lung,11450,A,9513,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622169,,Lung,11450,A,9514,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622170,,Lung,11450,A,9515,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622171,,Thyroid gland,11450,A,9516,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622172,,Thyroid gland,11450,A,9517,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622173,,Thyroid gland,11450,A,9518,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622174,,Thyroid gland,11450,A,9519,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622175,,Thyroid gland,11450,A,9520,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622176,,Thyroid gland,11450,A,9521,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622177,,Thyroid gland,11450,A,9522,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622178,,Thyroid gland,11450,A,9523,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622179,,Thyroid gland,11450,A,9524,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622180,,Thyroid gland,11450,A,9525,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622181,,,16435,A,9526,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622182,,,16435,A,9527,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622183,,,16435,A,9528,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622184,,,16435,A,9529,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622185,,,16435,A,9530,
1,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622186,,,16435,A,9531,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622187,,,16434,A,9532,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625002,,,16434,A,9533,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622090,,,16434,A,9534,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622091,,,16435,A,9535,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622092,,,16435,A,9536,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622093,,,16435,A,9537,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622094,,,16435,A,9538,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622095,,,16435,A,9539,
1,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622264,,,16435,A,9540,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622265,,Spleen,16434,A,9541,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622266,,Spleen,16434,A,9542,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622267,,Spleen,16434,A,9543,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622268,,Spleen,16434,A,9544,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622269,,Spleen,16434,A,9545,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625071,,Spleen,16434,A,9546,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621621,,Spleen,16434,A,9547,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621622,,Spleen,16434,A,9548,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621623,,Spleen,16435,A,9549,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621624,,Spleen,16435,A,9550,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621625,,Spleen,16435,A,9551,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621626,,Spleen,16435,A,9552,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621627,,Spleen,16435,A,9553,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621628,,Spleen,16435,A,9554,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL875328,,Spleen,16435,A,9555,
1,,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621629,,Spleen,16435,A,9556,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621630,,Spleen,16434,A,9557,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621631,,Spleen,16434,A,9558,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621632,,Spleen,16434,A,9559,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621633,,Spleen,16435,A,9560,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621634,,Spleen,16435,A,9561,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621635,,Spleen,16435,A,9562,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621636,,Spleen,16435,A,9563,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621637,,Spleen,16435,A,9564,
1,,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL621638,,Spleen,16435,A,9565,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618883,,,16434,A,9566,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618884,,,16434,A,9567,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628627,,,16434,A,9568,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628628,,,16434,A,9569,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628629,,,16434,A,9570,
1,,Intermediate,Half life after administering orally a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628630,In vivo,,16365,A,9571,
1,,Intermediate,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628631,In vivo,,16365,A,9572,
1,,Intermediate,Half life after administering intravenously a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628632,In vivo,,16365,A,9573,
1,,Intermediate,Half life after oral dosing in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628633,In vivo,,526,A,9574,
1,,Intermediate,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628634,In vivo,,16365,A,9575,
1,,Intermediate,Half life by intravenous administration of 3.4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627789,In vivo,,4368,A,9576,
1,,Intermediate,Half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627790,,,3371,A,9577,
1,,Intermediate,Half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627791,,,6448,A,9578,
1,,Intermediate,Half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627792,,,6453,A,9579,
1,,Intermediate,Half life in rat after intravenous administration of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627793,In vivo,,4353,A,9580,
1,,Intermediate,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627794,In vivo,Plasma,4353,A,9581,
1,,Intermediate,Half life in rat after po administration of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627795,In vivo,,4353,A,9582,
1,,Intermediate,Half life in rat after po administration of the compound; ND means Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627796,In vivo,,4353,A,9583,
1,,Intermediate,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL875335,In vivo,Plasma,4353,A,9584,
1,,Intermediate,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627797,In vivo,Plasma,4353,A,9585,
1,,Intermediate,Half life in rat i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627798,In vivo,,5789,A,9586,
1,,Intermediate,Half life in rat i.v. at 2 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627799,In vivo,,17686,A,9587,
1,,Intermediate,Half life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627800,,,6495,A,9588,
1,,Intermediate,Half life in rats after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627801,In vivo,,484,A,9589,
1,,Intermediate,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627802,In vivo,,6467,A,9590,
1,,Expert,Half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627803,,,6642,A,9591,
1,,Intermediate,Half life was evaluated after intravenous administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873820,In vivo,,16367,A,9592,
1,,Intermediate,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627804,,,1369,A,9593,
1,,Intermediate,Half life was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627805,,,5472,A,9594,
1,,Intermediate,Half life was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627806,,,6049,A,9595,
1,,Intermediate,Half life was evaluated in rat; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627107,,,5472,A,9596,
1,,Intermediate,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627108,In vivo,,16366,A,9597,
1,,Intermediate,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627109,In vivo,,11149,A,9598,
1,,Intermediate,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627110,In vivo,Blood,11149,A,9599,
1,,Intermediate,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL627111,In vivo,,2891,A,9600,
1,,Intermediate,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL627112,In vivo,,2891,A,9601,
1,,Intermediate,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL627113,In vivo,,2891,A,9602,
1,,Intermediate,Half life was measured in rat at dose of 30 mg/kg by po administration,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL627114,In vivo,,2891,A,9603,
1,,Intermediate,Half life (t1/2) was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627115,,,4026,A,9604,
1,,Intermediate,Half life period at a dose of 10 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627116,,,4527,A,9605,
1,,Intermediate,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627117,In vivo,,4527,A,9606,
1,,Intermediate,Half life period was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627118,,,5503,A,9607,
1,,Intermediate,Half life period after intravenous administration at 20 mpk in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627119,In vivo,,4426,A,9608,
1,,Intermediate,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627120,In vivo,,4426,A,9609,
1,,Intermediate,Half life period after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626922,In vivo,,6109,A,9610,
1,,Intermediate,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626923,In vivo,,5654,A,9611,
1,,Intermediate,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626924,In vivo,,5654,A,9612,
1,,Intermediate,Half life period in 80% rat plasma at 37 degree Centigrade,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626925,,Plasma,4755,A,9613,
1,,Intermediate,Half life period in SD rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626926,,,5862,A,9614,
1,,Intermediate,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626927,,Plasma,1515,A,9615,
1,,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626928,,Plasma,1515,A,9616,
1,,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626929,,Plasma,1515,A,9617,
1,,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626930,,Plasma,1515,A,9618,
1,,Intermediate,Half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626931,,,5960,A,9619,
1,,Intermediate,Half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626932,,,6103,A,9620,
1,,Intermediate,Half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626933,,,6317,A,9621,
1,,Intermediate,Half life period in rat after oral administration at 10.5 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873826,In vivo,,6644,A,9622,
1,,Intermediate,Half life period in rat after oral administration at 11.2 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626934,In vivo,,6644,A,9623,
1,,Intermediate,Half life period in rat after oral administration at 13 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626935,In vivo,,6644,A,9624,
1,,Intermediate,Half life period in rat after oral administration at 9.7 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626936,In vivo,,6644,A,9625,
1,,Intermediate,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626937,,,5974,A,9626,
1,,Intermediate,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625906,,,6295,A,9627,
1,,Intermediate,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625907,,,6296,A,9628,
1,,Intermediate,PK study was carried to determine AUC (area under curve) value in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625908,,,16427,A,9629,
1,,Intermediate,Pharmacokinetic parameter AUC after intravenous administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625909,,,16367,A,9630,
1,,Intermediate,Pharmacokinetic parameter AUC after oral administration to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625910,,,16367,A,9631,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625911,,,16365,A,9632,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625912,,,16365,A,9633,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626538,,,16365,A,9634,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876794,,,16365,A,9635,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626539,,,16365,A,9636,
1,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626540,,,16365,A,9637,
1,,Intermediate,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626541,,,5394,A,9638,
1,,Intermediate,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626542,,,5394,A,9639,
1,,Intermediate,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626543,,,2792,A,9640,
1,,Intermediate,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626544,,,2792,A,9641,
1,,Intermediate,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626545,,,2792,A,9642,
1,,Intermediate,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626546,,,2792,A,9643,
1,,Intermediate,Pharmacokinetic parameter area under curve was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626547,,,5334,A,9644,
1,,Intermediate,Pharmacokinetic property (AUC) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626548,,,4408,A,9645,
1,,Intermediate,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626549,,,5983,A,9646,
1,,Intermediate,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626550,,,4397,A,9647,
1,,Intermediate,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626551,,,4397,A,9648,
1,,Intermediate,Pharmacokinetic property was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623777,,,5491,A,9649,
1,,Intermediate,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623778,,,5491,A,9650,
1,,Intermediate,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623779,,,5491,A,9651,
1,,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623780,,Plasma,4199,A,9652,
1,,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622015,,Plasma,4199,A,9653,
1,,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622016,,Plasma,4199,A,9654,
1,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622017,,,5173,A,9655,
1,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622018,,,5173,A,9656,
1,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622019,,,5173,A,9657,
1,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622020,,,5173,A,9658,
1,,Intermediate,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622021,,,16366,A,9659,
1,,Intermediate,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622022,,,16366,A,9660,
1,,Intermediate,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622023,,,5327,A,9661,
1,,Intermediate,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622024,,,6681,A,9662,
1,,Intermediate,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622693,,,12873,A,9663,
1,,Intermediate,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622694,,,12873,A,9664,
1,,Intermediate,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622695,,,6685,A,9665,
1,,Intermediate,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622696,,,6685,A,9666,
1,,Intermediate,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622697,,,6685,A,9667,
1,,Intermediate,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622874,,,6619,A,9668,
1,,Intermediate,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622875,,,6619,A,9669,
1,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622876,,,10363,A,9670,
1,,Intermediate,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622877,,,4796,A,9671,
1,,Intermediate,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622878,,,4910,A,9672,
1,,Intermediate,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622879,,Plasma,4910,A,9673,
1,,Intermediate,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877602,,,4839,A,9674,
1,,Intermediate,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622880,,,15078,A,9675,
1,,Intermediate,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622881,,,15078,A,9676,
1,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622882,,,15078,A,9677,
1,,Intermediate,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622883,,,15078,A,9678,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622884,,Thyroid gland,11450,A,9679,
1,,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622885,,Thyroid gland,11450,A,9680,
1,,Intermediate,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622886,,,8151,A,9681,
1,,Intermediate,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622887,,,8151,A,9682,
1,,Intermediate,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622888,,Urine,8151,A,9683,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622889,In vivo,Blood,8677,A,9684,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622890,In vivo,Blood,8677,A,9685,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622891,In vivo,Blood,8677,A,9686,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL877603,In vivo,Blood,8677,A,9687,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622892,In vivo,Brain,8677,A,9688,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622893,In vivo,Brain,8677,A,9689,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622894,In vivo,Brain,8677,A,9690,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622895,In vivo,Brain,8677,A,9691,
1,,Intermediate,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622896,In vivo,Brain,8677,A,9692,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622897,In vivo,Heart,8677,A,9693,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622898,In vivo,Heart,8677,A,9694,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622899,In vivo,Heart,8677,A,9695,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622900,In vivo,Kidney,8677,A,9696,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624114,In vivo,Kidney,8677,A,9697,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624115,In vivo,Kidney,8677,A,9698,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624116,In vivo,Kidney,8677,A,9699,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624117,In vivo,Liver,8677,A,9700,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624118,In vivo,Liver,8677,A,9701,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624119,In vivo,Liver,8677,A,9702,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624120,In vivo,Liver,8677,A,9703,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624121,In vivo,Lung,8677,A,9704,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624122,In vivo,Lung,8677,A,9705,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624123,In vivo,Lung,8677,A,9706,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624124,In vivo,Lung,8677,A,9707,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624125,In vivo,Muscle tissue,8677,A,9708,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624126,In vivo,Muscle tissue,8677,A,9709,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624127,In vivo,Muscle tissue,8677,A,9710,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624128,In vivo,Muscle tissue,8677,A,9711,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL624129,In vivo,Zone of skin,8677,A,9712,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL624130,In vivo,Zone of skin,8677,A,9713,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL622340,In vivo,Zone of skin,8677,A,9714,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL622341,In vivo,Zone of skin,8677,A,9715,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622342,In vivo,Intestine,8677,A,9716,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622343,In vivo,Intestine,8677,A,9717,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622344,In vivo,Intestine,8677,A,9718,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622345,In vivo,Intestine,8677,A,9719,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622346,In vivo,Spleen,8677,A,9720,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622347,In vivo,Spleen,8677,A,9721,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622348,In vivo,Spleen,8677,A,9722,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622349,In vivo,Spleen,8677,A,9723,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622350,,,16434,A,9724,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622351,,,16434,A,9725,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622352,,,16434,A,9726,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622353,,,16435,A,9727,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622354,,,16435,A,9728,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622355,,,16435,A,9729,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622356,,,16435,A,9730,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622357,,,16435,A,9731,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622358,,,16435,A,9732,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622359,,,16435,A,9733,
1,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874393,,,16435,A,9734,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622872,,,16434,A,9735,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622873,,,16434,A,9736,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623047,,,16434,A,9737,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623048,,,16435,A,9738,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623049,,,16435,A,9739,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623050,,,16435,A,9740,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623051,,,16435,A,9741,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623052,,,16435,A,9742,
1,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626343,,,16435,A,9743,
1,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626344,,,16434,A,9744,
1,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626345,,,16434,A,9745,
1,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626346,,,16434,A,9746,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626347,,,16434,A,9747,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626348,,,16434,A,9748,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626349,,,16434,A,9749,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626350,,,16435,F,9750,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626351,,,16435,A,9751,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627650,,,16435,A,9752,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627651,,,16435,F,9753,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627652,,,16435,A,9754,
1,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627653,,,16435,A,9755,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627654,,,13091,A,9756,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627835,,,13091,A,9757,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627836,,,13091,A,9758,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627837,,,13091,A,9759,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627838,,,13091,A,9760,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875338,,,13091,A,9761,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627839,,,13091,A,9762,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627840,,,13091,A,9763,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627841,,,13091,A,9764,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627842,,,13091,A,9765,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627843,,,13091,A,9766,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627844,,,13091,A,9767,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627845,,,13091,A,9768,
1,,Intermediate,Half life period in rat by iv administration at a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627846,In vivo,,5874,A,9769,
1,,Intermediate,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627847,,Plasma,1515,A,9770,
1,,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873821,,Plasma,1515,A,9771,
1,,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626079,,Plasma,1515,A,9772,
1,,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626080,,Plasma,1515,A,9773,
1,,Intermediate,Half life period was evaluated in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626081,,Plasma,5491,A,9774,
1,,Intermediate,Half life period was evaluated in rat plasma; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL875344,,Plasma,5491,A,9775,
1,,Intermediate,Half life period was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626082,,,1918,A,9776,
1,,Intermediate,"Half life period was evaluated in rats, iv",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626250,In vivo,,1918,A,9777,
1,,Intermediate,Half life period after intravenous administration at 5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626251,In vivo,,6113,A,9778,
1,,Intermediate,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626252,In vivo,,5546,A,9779,
1,,Intermediate,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626253,In vivo,,5553,A,9780,
1,,Intermediate,Half life stability of compound was evaluated in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626254,,Plasma,4188,A,9781,
1,,Intermediate,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626255,In vivo,,6215,A,9782,
1,,Intermediate,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626256,In vivo,,6141,A,9783,
1,,Intermediate,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626257,In vivo,,5182,A,9784,
1,,Intermediate,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626258,In vivo,,5182,A,9785,
1,,Intermediate,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626259,In vivo,,5710,A,9786,
1,,Intermediate,Half in rat i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626260,In vivo,,5789,A,9787,
1,,Intermediate,Half period in rat after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875345,In vivo,,6011,A,9788,
1,,Intermediate,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626261,In vivo,,17594,A,9789,
1,,Intermediate,Half-life measured in in vitro Cathepsin B assay in rat liver,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626262,In vitro,Liver,12357,A,9790,
1,,Intermediate,Half-life of compound was determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626263,,,5210,A,9791,
1,,Intermediate,Half-life at 10 mg/kg in rat upon intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625270,In vivo,,17596,A,9792,
1,,Intermediate,Half-life determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625271,,,6672,A,9793,
1,,Intermediate,Half-life determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625272,,,6673,A,9794,
1,,Intermediate,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625273,In vivo,Brain,4910,A,9795,
1,,Intermediate,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625274,,Plasma,3741,A,9796,
1,,Intermediate,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625275,In vivo,,17671,A,9797,
1,,Intermediate,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625276,In vivo,Plasma,4910,A,9798,
1,,Intermediate,Half-life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625277,,Plasma,17537,A,9799,
1,,Intermediate,Half-life in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625278,,Plasma,4965,A,9800,
1,,Intermediate,Half-life in rat plasma; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625279,,Plasma,17537,A,9801,
1,,Intermediate,Half-life in rat serum,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL625280,,Serum,6124,A,9802,
1,,Intermediate,Half-life in rat serum; na is not available,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL876797,,Serum,6124,A,9803,
1,,Intermediate,Half-life was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625281,,,6078,A,9804,
1,,Intermediate,Half-life was calculated in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL873827,,Plasma,17668,A,9805,
1,,Intermediate,Half-life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625282,,,3185,A,9806,
1,,Intermediate,Half-life was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625283,,,4883,A,9807,
1,,Intermediate,Half-life after administration of 20 mg/Kg oral dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625284,In vivo,,2959,A,9808,
1,,Intermediate,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625285,In vivo,,4029,A,9809,
1,,Intermediate,Half-life after intravenous administration in female rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625286,In vivo,,4029,A,9810,
1,,Intermediate,Half-life after intravenous administration in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625287,In vivo,,4029,A,9811,
1,,Intermediate,Half-life after intravenous dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625288,In vivo,,6180,A,9812,
1,,Intermediate,Half-life in a rat liver homogenate preparation,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625289,,Liver,1557,A,9813,
1,,Intermediate,Half-life in plasma of rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625290,,Plasma,12500,A,9814,
1,,Intermediate,Half-life in plasma of rat at dose of 3-10 mgkg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876798,,Plasma,12500,A,9815,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625291,,,5064,A,9816,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625292,,,5145,A,9817,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625293,,,5147,A,9818,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622832,,,5833,A,9819,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622833,,,6596,A,9820,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622834,,,17655,A,9821,
1,,Intermediate,Half-life in rat after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622835,In vivo,,6495,A,9822,
1,,Intermediate,Half-life in rat after po administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622836,In vivo,,17538,A,9823,
1,,Intermediate,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622837,In vivo,,17538,A,9824,
1,,Intermediate,Half-life in rat at 3 mg/kg dose administered intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622838,In vivo,,10,A,9825,
1,,Intermediate,Half-life in rat brain homogenate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622839,,Brain,17669,A,9826,
1,,Intermediate,Half-life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622840,,Plasma,17065,A,9827,
1,,Intermediate,Half-life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622841,,,4333,A,9828,
1,,Intermediate,Half-life in Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622842,,,6827,A,9829,
1,,Intermediate,Half-life in vitro in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622843,In vitro,Plasma,889,A,9830,
1,,Intermediate,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622844,In vitro,Plasma,889,A,9831,
1,,Intermediate,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622845,,,3747,A,9832,
1,,Intermediate,The area under the curve of compound was measured at the dose of 100 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622846,,,15022,A,9833,
1,,Intermediate,The area under the curve of compound was measured at the dose of 300 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622847,,,15022,A,9834,
1,,Intermediate,The area under the curve of compound was measured at the dose of 30 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622848,,,15022,A,9835,
1,,Intermediate,Bioavailability as oral AUC in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622849,In vivo,,3360,A,9836,
1,,Intermediate,The plasma concentration versus time curve (AUC) was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622850,,Plasma,5334,A,9837,
1,,Intermediate,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876807,,,17411,A,9838,
1,,Intermediate,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622851,,,17411,A,9839,
1,,Intermediate,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622852,,,17411,A,9840,
1,,Intermediate,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622853,,,6570,A,9841,
1,,Intermediate,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622854,,,6570,A,9842,
1,,Intermediate,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622855,,,17411,A,9843,
1,,Intermediate,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622856,,Plasma,14941,A,9844,
1,,Intermediate,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622857,,Plasma,14941,A,9845,
1,,Intermediate,AUC in rat after po administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622858,,Plasma,17538,A,9846,
1,,Intermediate,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622859,,Plasma,17752,A,9847,
1,,Intermediate,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622860,,,17509,A,9848,
1,,Intermediate,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622861,,,17509,A,9849,
1,,Intermediate,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622862,,,17509,A,9850,
1,,Intermediate,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622863,,,17509,A,9851,
1,,Intermediate,Area under curve value 6 hr after po administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623817,,,17509,A,9852,
1,,Intermediate,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623818,,,17717,A,9853,
1,,Intermediate,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623819,,,17717,A,9854,
1,,Intermediate,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623820,,,17717,A,9855,
1,,Intermediate,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623821,,,17717,A,9856,
1,,Intermediate,AUC normalized for dose (AUCN) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623822,,Plasma,6642,A,9857,
1,,Intermediate,Area under curve in rat after p.o. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623823,,,6640,A,9858,
1,,Intermediate,Area under curve in rat after p.o. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623824,,,6641,A,9859,
1,,Intermediate,Area under curve in rat after p.o. administration; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623825,,,6641,A,9860,
1,,Intermediate,Area under curve in rat after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622070,,,6641,A,9861,
1,,Intermediate,Area under curve (carotid artery) value of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622071,,,3603,A,9862,
1,,Intermediate,Bioavailability expressed as the area under curve of rat carotid artery,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622072,,,3550,A,9863,
1,,Intermediate,Area under curve in male SD rats was observed after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622073,,,15662,A,9864,
1,,Intermediate,Area under curve of the compound was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622074,,,17720,A,9865,
1,,Intermediate,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622075,,,5407,A,9866,
1,,Intermediate,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622076,,Plasma,17752,A,9867,
1,,Intermediate,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622077,,Plasma,17752,A,9868,
1,,Intermediate,Area under curve (portal vein) value of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622078,,,3603,A,9869,
1,,Intermediate,Bioavailability expressed as the area under curve of rat portal vein,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622079,,,3550,A,9870,
1,,Intermediate,Area Under plasma concentration time curve in rat upon peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622080,,Plasma,17655,A,9871,
1,,Intermediate,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877612,,,17582,A,9872,
1,,Intermediate,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622081,,,17582,A,9873,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622082,,,17791,A,9874,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622083,,,17791,A,9875,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats; 30-80,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622084,,,17791,A,9876,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats; 50-60,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622085,,,17791,A,9877,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622086,,,17791,A,9878,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats; peptide,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622087,,,17791,A,9879,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622088,,Blood,7768,A,9880,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622089,,Blood,7768,A,9881,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623685,,Blood,7768,A,9882,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623686,,Blood,7768,A,9883,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL623687,In vivo,Stomach,8677,A,9884,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL623688,In vivo,Stomach,8677,A,9885,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL623689,In vivo,Stomach,8677,A,9886,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,945.0,CHEMBL622485,In vivo,Stomach,8677,A,9887,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622486,In vivo,Thyroid gland,8677,A,9888,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL877613,In vivo,Thyroid gland,8677,A,9889,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622487,In vivo,Thyroid gland,8677,A,9890,
1,,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622488,In vivo,Thyroid gland,8677,A,9891,
1,,Intermediate,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622489,In vivo,Heart,8677,A,9892,
1,,Intermediate,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622490,,Urine,6899,A,9893,
1,,Intermediate,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622491,,Urine,6899,A,9894,
1,,Intermediate,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622492,,Liver,6899,A,9895,
1,,Intermediate,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622493,,Urine,6899,A,9896,
1,,Intermediate,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622494,,Urine,6899,A,9897,
1,,Intermediate,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622495,,Muscle tissue,8677,A,9898,
1,,Intermediate,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622496,,,6899,A,9899,
1,,Intermediate,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622497,,Urine,6899,A,9900,
1,,Intermediate,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622498,,,2189,A,9901,
1,,Intermediate,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624918,,Urine,2189,A,9902,
1,,Intermediate,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624919,,Urine,2189,A,9903,
1,,Intermediate,Biodistribution of compound in rat blood after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624920,In vivo,Blood,10839,A,9904,
1,,Intermediate,Biodistribution of compound in rat blood after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624921,In vivo,Blood,10839,A,9905,
1,,Intermediate,Biodistribution of compound in rat brain after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624922,In vivo,Brain,10839,A,9906,
1,,Intermediate,Biodistribution of compound in rat heart after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624923,In vivo,Heart,10839,A,9907,
1,,Intermediate,Biodistribution of compound in rat heart after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624924,In vivo,Heart,10839,A,9908,
1,,Intermediate,Biodistribution of compound in rat kidney after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624925,In vivo,Kidney,10839,A,9909,
1,,Intermediate,Biodistribution of compound in rat kidney after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624926,In vivo,Kidney,10839,A,9910,
1,,Intermediate,Biodistribution of compound in rat liver after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624927,In vivo,Liver,10839,A,9911,
1,,Intermediate,Biodistribution of compound in rat liver after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL874402,In vivo,Liver,10839,A,9912,
1,,Intermediate,Biodistribution of compound in rat lung after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624928,In vivo,Lung,10839,A,9913,
1,,Intermediate,Biodistribution of compound in rat lung after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624929,In vivo,Lung,10839,A,9914,
1,,Intermediate,Biodistribution of compound in rat muscle after 5 min of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624930,In vivo,Muscle tissue,10839,A,9915,
1,,Intermediate,Biodistribution of compound in rat muscle after 5 min of administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624931,In vivo,Muscle tissue,10839,A,9916,
1,,Intermediate,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624932,,Heart,4043,A,9917,
1,,Intermediate,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624933,,Heart,4043,A,9918,
1,,Intermediate,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624934,,Liver,4043,A,9919,
1,,Intermediate,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624935,,Liver,4043,A,9920,
1,,Intermediate,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624936,,,4043,A,9921,
1,,Intermediate,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624937,,,4043,A,9922,
1,,Intermediate,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL624938,,Spleen,4043,A,9923,
1,,Intermediate,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL624939,,Spleen,4043,A,9924,
1,,Intermediate,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624940,,,4043,A,9925,
1,,Intermediate,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874403,,,4043,A,9926,
1,,Intermediate,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624941,,,1446,A,9927,
1,,Intermediate,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624942,,Urine,9971,A,9928,
1,,Intermediate,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624943,,Urine,9971,A,9929,
1,,Intermediate,% Bioavailability after 1 day of the drug administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624944,In vivo,,5765,A,9930,
1,,Intermediate,% Bioavailability after 4 day of the drug administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624945,In vivo,,5765,A,9931,
1,,Intermediate,Absolute bioavailability was evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624946,In vivo,,4257,A,9932,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624947,,,13091,A,9933,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624948,,,13091,A,9934,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624949,,,13091,A,9935,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622025,,Kidney,13091,A,9936,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622026,,Kidney,13091,A,9937,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622027,,Kidney,13091,A,9938,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622028,,Kidney,13091,A,9939,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622029,,Liver,13091,A,9940,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622208,,Liver,13091,A,9941,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622209,,Liver,13091,A,9942,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622210,,Liver,13091,A,9943,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622211,,,13091,A,9944,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622212,,,13091,A,9945,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622213,,,13091,A,9946,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874404,,,13091,A,9947,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620452,,Muscle tissue,13091,A,9948,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620453,,Muscle tissue,13091,A,9949,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL620454,,Muscle tissue,13091,A,9950,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624067,,Muscle tissue,13091,A,9951,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624068,,,13091,A,9952,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL624069,,Female gonad,13091,A,9953,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL624070,,Female gonad,13091,A,9954,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL624071,,Female gonad,13091,A,9955,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL624072,,Uterus,13091,A,9956,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL624073,,Uterus,13091,A,9957,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL624788,,Uterus,13091,A,9958,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL624789,,Uterus,13091,A,9959,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624790,,,13091,A,9960,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624791,,,13091,A,9961,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624792,,,13091,A,9962,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624793,,,13091,A,9963,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL877491,,Muscle tissue,13091,A,9964,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624957,,Muscle tissue,13091,A,9965,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624958,,Muscle tissue,13091,A,9966,
1,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624959,,Muscle tissue,13091,A,9967,
1,,Intermediate,Dissociation constant was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624960,,,11977,A,9968,
1,,Intermediate,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624961,,,14941,A,9969,
1,,Intermediate,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624962,,,15078,A,9970,
1,,Intermediate,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624963,,,15078,A,9971,
1,,Intermediate,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624964,,,4755,A,9972,
1,,Intermediate,LogP value was evaluated in the in situ rat gut perfusion assay,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624965,,,589,A,9973,
1,,Intermediate,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624966,In vivo,,17582,A,9974,
1,,Intermediate,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624967,In vivo,,5031,A,9975,
1,,Intermediate,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624968,In vivo,,17764,A,9976,
1,,Intermediate,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624969,,,17720,A,9977,
1,,Expert,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624970,,,2862,F,9978,
1,,Intermediate,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624971,,,16423,A,9979,
1,,Intermediate,Half-life was evaluated after 20 uM/kg of peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624972,In vivo,,16423,A,9980,
1,,Intermediate,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624973,In vivo,,6005,A,9981,
1,,Intermediate,Half-life was evaluated in plasma of rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL624974,,Plasma,2938,A,9982,
1,,Intermediate,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624975,In vivo,,6410,A,9983,
1,,Intermediate,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877492,In vivo,,6410,A,9984,
1,,Intermediate,Half-life was measured in rat after an iv dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624976,In vivo,,6062,A,9985,
1,,Intermediate,Half-life period of compound in rats after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624977,In vivo,,6571,A,9986,
1,,Intermediate,Half-life period of compound was measured in rat plasma.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626848,,Plasma,3136,A,9987,
1,,Intermediate,Half-life period of compound was measured in rat plasma; ND is not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626849,,Plasma,3136,A,9988,
1,,Intermediate,Half-life period of compound was measured in rat plasma; not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626850,,Plasma,3136,A,9989,
1,,Intermediate,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626851,In vivo,,4521,A,9990,
1,,Intermediate,Half-life period in rat by iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626852,In vivo,,5871,A,9991,
1,,Intermediate,Half-life period in rats following intravenous administration at 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626853,In vivo,,6077,A,9992,
1,,Intermediate,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626854,In vivo,,6679,A,9993,
1,,Intermediate,Half-life period was determined for the compound in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627486,,,5144,A,9994,
1,,Intermediate,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627487,In vivo,,4498,A,9995,
1,,Intermediate,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627488,In vivo,,4498,A,9996,
1,,Intermediate,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627489,In vivo,,1908,A,9997,
1,,Intermediate,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627490,In vivo,,6211,A,9998,
1,,Intermediate,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873829,In vivo,,5529,A,9999,
1,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627655,In vivo,,6444,A,10000,
1,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625994,In vivo,,6444,A,10001,
1,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625995,In vivo,,6444,A,10002,
1,,Intermediate,Half-life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625996,,,5207,A,10003,
1,,Intermediate,In vitro half life in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625850,In vitro,Plasma,530,A,10004,
1,,Intermediate,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625851,In vitro,Plasma,1116,A,10005,
1,,Intermediate,In vitro half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625852,In vitro,,3219,A,10006,
1,,Intermediate,In vivo half life period after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625853,In vivo,,6109,A,10007,
1,,Intermediate,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625854,In vivo,,17582,A,10008,
1,,Intermediate,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874450,In vivo,,17582,A,10009,
1,,Intermediate,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625855,In vivo,,5974,A,10010,
1,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625856,In vivo,,5974,A,10011,
1,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625857,In vivo,,5974,A,10012,
1,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873831,In vivo,,5974,A,10013,
1,,Intermediate,Longer half-life in rat (i.v.) at 0.5 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625858,In vivo,,17853,A,10014,
1,,Intermediate,Longer half-life in rat (p.o.) at 2.0 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625859,In vivo,,17853,A,10015,
1,,Intermediate,Pharmacokinetic property (half life) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625860,,,3457,A,10016,
1,,Intermediate,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625861,In vivo,,2792,A,10017,
1,,Intermediate,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625862,In vivo,,2792,A,10018,
1,,Intermediate,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625863,In vivo,,2792,A,10019,
1,,Intermediate,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625864,In vivo,,2792,A,10020,
1,,Intermediate,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625865,In vivo,,5739,A,10021,
1,,Intermediate,Pharmacokinetic half time was determined intravenously in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625866,In vivo,,15765,A,10022,
1,,Intermediate,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625867,In vivo,Plasma,6567,A,10023,
1,,Intermediate,Plasma half life of hydrolysis of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625868,,Plasma,2448,A,10024,
1,,Intermediate,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625869,In vivo,Plasma,5423,A,10025,
1,,Intermediate,Plasma half life period was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL874451,,Plasma,4853,A,10026,
1,,Intermediate,Plasma half-life in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625870,,Plasma,4514,A,10027,
1,,Intermediate,Plasma half-life in Sprague-Dawley rats; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625871,,Plasma,4514,A,10028,
1,,Intermediate,Plasma half-life in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625872,,Plasma,1500,A,10029,
1,,Intermediate,Plasma half-life in rats; <MQL,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625873,,Plasma,1500,A,10030,
1,,Intermediate,Plasma half-life period (0-8 h) was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625874,,Plasma,5334,A,10031,
1,,Intermediate,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625875,,Plasma,5334,A,10032,
1,,Intermediate,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625876,In vivo,Plasma,5334,A,10033,
1,,Intermediate,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631258,In vivo,Plasma,5334,A,10034,
1,,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631259,,Plasma,4956,A,10035,
1,,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631260,,Plasma,4956,A,10036,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631261,,Blood,7768,A,10037,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631262,,Blood,7768,A,10038,
1,,Intermediate,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631263,,Blood,7768,A,10039,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631264,,,7768,A,10040,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631265,,,7768,A,10041,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631266,,,7768,A,10042,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631267,,,7768,A,10043,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631268,,,7768,A,10044,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631269,,,7768,A,10045,
1,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631270,,,7768,A,10046,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631271,,Heart,7768,A,10047,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631272,,Heart,7768,A,10048,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631273,,Heart,7768,A,10049,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631274,,Heart,7768,A,10050,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631275,,Heart,7768,A,10051,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626984,,Heart,7768,A,10052,
1,,Intermediate,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626985,,Heart,7768,A,10053,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626986,,Liver,7768,A,10054,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626987,,Liver,7768,A,10055,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626988,,Liver,7768,A,10056,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626989,,Liver,7768,A,10057,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626990,,Liver,7768,A,10058,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626991,,Liver,7768,A,10059,
1,,Intermediate,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626992,,Liver,7768,A,10060,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626993,,Lung,7768,A,10061,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL874593,,Lung,7768,A,10062,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626994,,Lung,7768,A,10063,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626995,,Lung,7768,A,10064,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626190,,Lung,7768,A,10065,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626191,,Lung,7768,A,10066,
1,,Intermediate,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626364,,Lung,7768,A,10067,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626365,,Thyroid gland,7768,A,10068,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626366,,Thyroid gland,7768,A,10069,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626367,,Thyroid gland,7768,A,10070,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626368,,Thyroid gland,7768,A,10071,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626369,,Thyroid gland,7768,A,10072,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626370,,Thyroid gland,7768,A,10073,
1,,Intermediate,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626371,In vivo,,4498,A,10074,
1,,Intermediate,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626372,In vivo,,4498,A,10075,
1,,Intermediate,Bioavailability after a dose of 10 mg/kg p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626373,In vivo,,3603,A,10076,
1,,Intermediate,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626374,In vivo,,6215,A,10077,
1,,Intermediate,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626375,In vivo,,5710,A,10078,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626376,In vivo,,5710,A,10079,
1,,Intermediate,Bioavailability in rat po was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626377,In vivo,,5676,A,10080,
1,,Intermediate,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626378,In vivo,,17667,A,10081,
1,,Intermediate,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626379,In vivo,,17667,A,10082,
1,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626380,In vivo,,6848,A,10083,
1,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626381,In vivo,,6848,A,10084,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626382,In vivo,,17267,A,10085,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley) (female),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626383,In vivo,,6362,A,10086,
1,,Intermediate,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874652,In vivo,,17671,A,10087,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626384,In vivo,,17671,A,10088,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626385,In vivo,,4333,A,10089,
1,,Intermediate,Bioavailability in rat at an oral dose of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626386,In vivo,,6077,A,10090,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626387,In vivo,,3278,A,10091,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626388,In vivo,,5964,A,10092,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626389,In vivo,,4884,A,10093,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626390,In vivo,,4905,A,10094,
1,,Intermediate,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626391,In vivo,,4884,A,10095,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626392,In vivo,,6850,A,10096,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626393,In vivo,,2864,A,10097,
1,,Intermediate,Bioavailability was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623026,In vivo,,5780,A,10098,
1,,Intermediate,Bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623027,In vivo,,1465,A,10099,
1,,Intermediate,Bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623028,In vivo,,5199,A,10100,
1,,Intermediate,Bioavailability in rat after 1 day dosing,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623029,In vivo,,5765,A,10101,
1,,Intermediate,Bioavailability in rat after 4 day dosing,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623030,In vivo,,5765,A,10102,
1,,Intermediate,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623031,In vivo,,6518,A,10103,
1,,Intermediate,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623032,In vivo,,6518,A,10104,
1,,Intermediate,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623033,In vivo,,6518,A,10105,
1,,Intermediate,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623034,In vivo,,6518,A,10106,
1,,Intermediate,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623035,In vivo,,2083,A,10107,
1,,Intermediate,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623036,In vivo,,17260,A,10108,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623037,In vivo,,4956,A,10109,
1,,Intermediate,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623038,In vivo,,4368,A,10110,
1,,Intermediate,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL874385,In vivo,Plasma,17752,A,10111,
1,,Intermediate,Bioavailability in rat (Fisher) (fasted),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623039,In vivo,,1446,A,10112,
1,,Intermediate,Bioavailability in monkey after po administration of 10 mg/kg dose,U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL623040,In vivo,,2891,A,10113,
1,,Intermediate,Oral bioavailability in monkey (dose 10 mg/kg),U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL623041,In vivo,,2891,A,10114,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623741,In vivo,,6672,A,10115,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623742,In vivo,,6673,A,10116,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623743,In vivo,,17655,A,10117,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623744,In vivo,,17796,A,10118,
1,,Intermediate,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623745,In vivo,,17853,A,10119,
1,,Intermediate,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623746,In vivo,,4521,A,10120,
1,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623747,In vivo,,4940,A,10121,
1,,Intermediate,Bioavailability in rat after po administration of 30 mg/kg dose,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL623748,In vivo,,2891,A,10122,
1,,Intermediate,Bioavailability in rat after po administration of 30 mg/kg dose,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL623916,In vivo,,2891,A,10123,
1,,Intermediate,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623917,In vivo,,4521,A,10124,
1,,Intermediate,Bioavailability in rat (dose 2 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623918,In vivo,,17686,A,10125,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874386,In vivo,,17796,A,10126,
1,,Intermediate,Bioavailability in rat; Only traces detected in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623919,In vivo,Plasma,17796,A,10127,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623920,In vivo,,5064,A,10128,
1,,Intermediate,Bioavailability upon oral administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623148,In vivo,,5147,A,10129,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623149,In vivo,,1916,A,10130,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623150,In vivo,,6049,A,10131,
1,,Intermediate,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623151,In vivo,,1445,A,10132,
1,,Intermediate,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623152,In vivo,,1445,A,10133,
1,,Expert,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623153,,,2862,F,10134,
1,,Expert,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623154,,,2862,F,10135,
1,,Intermediate,In vitro and metabolic stability was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623155,,,4194,A,10136,
1,,Intermediate,In vitro metabolic stability in rat hepatocytes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623156,,,4194,A,10137,
1,,Intermediate,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623157,,,5486,A,10138,
1,401.0,Intermediate,Metabolic rate for compound was observed in rat hepatocytes,N,,,Rattus norvegicus,Hepatocyte,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623158,In vitro,Liver,17582,A,10139,
1,,Intermediate,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623159,,,5600,A,10140,
1,,Intermediate,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874390,,,14294,A,10141,
1,,Intermediate,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623160,,,14294,A,10142,
1,,Intermediate,Metabolism of compound in rat S9 microsomes; Trace,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623161,,,14294,A,10143,
1,,Intermediate,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623162,,,17847,A,10144,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623163,,,11020,A,10145,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623164,,,11020,A,10146,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623165,,,11020,A,10147,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623166,,,11020,A,10148,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624983,,,11020,A,10149,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624984,,,11020,A,10150,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624985,,,11020,A,10151,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622970,,,11020,A,10152,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622971,,,11020,A,10153,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622972,,,11020,A,10154,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622973,,,11020,A,10155,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622974,,,11020,A,10156,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622975,,,11020,A,10157,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622976,,,11020,A,10158,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622977,,,11020,A,10159,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624351,,,11020,A,10160,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624352,,,11020,A,10161,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624353,,,11020,A,10162,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622397,,,11020,A,10163,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622398,,,11020,A,10164,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622399,,,11020,A,10165,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622400,,,11020,A,10166,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628428,,,11020,A,10167,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628590,,,11020,A,10168,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628591,,,11020,A,10169,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628592,,,11020,A,10170,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628593,,,11020,A,10171,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875333,,,11020,A,10172,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628594,,,11020,A,10173,
1,,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628595,,Plasma,4969,A,10174,
1,,Intermediate,Stability in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628596,,Plasma,6737,A,10175,
1,,Intermediate,Stability in rat plasma was determined; ND= no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628597,,Plasma,6737,A,10176,
1,,Intermediate,Tested for plasma half life period in rat (0-8 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628598,,Plasma,5089,A,10177,
1,,Intermediate,Tested for plasma half life period in rat (0-8 hr); Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628599,,Plasma,5089,A,10178,
1,,Intermediate,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628600,In vivo,,1466,A,10179,
1,,Intermediate,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628601,In vivo,,1466,A,10180,
1,,Intermediate,Tested for the half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628602,,,4950,A,10181,
1,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628603,In vitro,,2412,A,10182,
1,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628604,In vitro,,2412,A,10183,
1,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628605,In vitro,,2412,A,10184,
1,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628606,In vitro,,2412,A,10185,
1,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628607,In vitro,,2412,A,10186,
1,,Intermediate,The biological half life the compound was measured at the dose of 100 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628608,,,15022,A,10187,
1,,Intermediate,The biological half life the compound was measured at the dose of 30 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628609,,,15022,A,10188,
1,,Intermediate,The compound was evaluated for plasma half life period in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628610,,Plasma,406,A,10189,
1,,Intermediate,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL873819,In vivo,,15078,A,10190,
1,,Intermediate,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628611,In vivo,,15078,A,10191,
1,,Intermediate,The pharmacokinetic parameter half-life period in vivo in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628612,In vivo,,5247,A,10192,
1,,Intermediate,"The pharmacokinetic property, Half-life was determined",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628613,In vivo,,5041,A,10193,
1,,Intermediate,"The pharmacokinetic property, Half-life in rat in vivo",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628614,In vivo,,5041,A,10194,
1,,Intermediate,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628615,In vivo,,5041,A,10195,
1,,Intermediate,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628616,In vivo,,5041,A,10196,
1,,Intermediate,The plasma half life period in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627924,,Plasma,3918,A,10197,
1,,Intermediate,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627925,,Liver,2906,A,10198,
1,,Intermediate,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627926,In vivo,,6467,A,10199,
1,,Intermediate,t1/2 (apparent elimination)of the compound was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627927,,,5510,A,10200,
1,,Intermediate,t1/2 value in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627928,,,3788,A,10201,
1,,Intermediate,Half life in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627539,,,17796,A,10202,
1,,Intermediate,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876790,In vivo,Plasma,12873,A,10203,
1,,Intermediate,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL858186,In vivo,,5983,A,10204,
1,,Intermediate,Half-life period in fasted rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627540,,,15765,A,10205,
1,,Intermediate,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627541,In vivo,,2661,A,10206,
1,,Intermediate,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627715,In vivo,,2661,A,10207,
1,,Intermediate,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627716,In vivo,,429,A,10208,
1,,Intermediate,Maximum time required to achieve Cmax was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627717,,,17655,A,10209,
1,,Intermediate,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627718,In vivo,,17717,A,10210,
1,,Intermediate,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627719,In vivo,,17717,A,10211,
1,,Intermediate,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627720,In vivo,,17717,A,10212,
1,,Intermediate,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627721,In vivo,,6570,A,10213,
1,,Intermediate,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627722,In vivo,,6570,A,10214,
1,,Intermediate,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627723,In vivo,,5978,A,10215,
1,,Intermediate,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626058,In vivo,,5978,A,10216,
1,,Intermediate,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626059,In vivo,,5978,A,10217,
1,,Intermediate,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626060,In vivo,,5978,A,10218,
1,,Intermediate,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626061,In vivo,Plasma,17720,A,10219,
1,,Intermediate,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876791,In vivo,,4723,A,10220,
1,,Intermediate,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626062,In vivo,,4723,A,10221,
1,,Intermediate,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626063,In vivo,,4756,A,10222,
1,,Intermediate,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626064,In vivo,,4756,A,10223,
1,,Intermediate,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626065,In vivo,Plasma,17720,A,10224,
1,,Intermediate,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626066,In vivo,Plasma,17720,A,10225,
1,,Intermediate,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626067,In vivo,,1466,A,10226,
1,,Intermediate,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626068,,,7449,F,10227,
1,,Intermediate,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626069,,,7449,F,10228,
1,,Intermediate,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626070,,,7449,F,10229,
1,,Intermediate,Percent total excretion of N-methoxyacetaminophen glucuronide,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626071,,,7449,F,10230,
1,,Intermediate,Percent total excretion of N-methoxyacetaminophen sulfate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626072,,,7449,F,10231,
1,,Intermediate,Percent total excretion of acetaminophen,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626073,,,7449,F,10232,
1,,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626741,,Thyroid gland,7768,A,10233,
1,,Intermediate,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626742,,,17655,A,10234,
1,,Intermediate,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626743,,,17735,A,10235,
1,,Intermediate,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876792,,,5960,A,10236,
1,,Intermediate,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626744,,,17735,A,10237,
1,,Intermediate,Compound was tested for antidiuretic activity in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626745,,,7116,A,10238,
1,,Intermediate,AUC in rat after 3mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626746,In vivo,Plasma,4878,A,10239,
1,,Intermediate,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626747,,,5939,A,10240,
1,,Intermediate,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626748,,,5939,A,10241,
1,,Intermediate,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626749,,,16367,A,10242,
1,,Intermediate,Oral Bioavailability was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626750,,,16366,A,10243,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626751,,,4426,A,10244,
1,,Intermediate,Oral bioavailability in rat; Not performed.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626913,,,4426,A,10245,
1,,Intermediate,Bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626914,,,5041,A,10246,
1,,Intermediate,Bioavailability was determined; ND denotes no data,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626915,,,5041,A,10247,
1,,Intermediate,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626916,,,1500,A,10248,
1,,Intermediate,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626917,,,1500,A,10249,
1,,Intermediate,Binding towards rat plasma protein at 10 uM,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626918,,,17409,A,10250,
1,,Intermediate,Binding towards rat plasma protein at 100 uM,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626919,,,17409,A,10251,
1,,Intermediate,Bioavailability in rat (dose 20 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626920,In vivo,,2959,A,10252,
1,,Intermediate,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621976,In vivo,,13501,A,10253,
1,,Intermediate,Bioavailability in rat after 5 mg/kg oral gavage,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877599,In vivo,,6567,A,10254,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621977,In vivo,,6571,A,10255,
1,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621978,In vivo,,6715,A,10256,
1,,Intermediate,Bioavailability in rat (dose 3 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621979,In vivo,,6715,A,10257,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621980,In vivo,,2932,A,10258,
1,,Intermediate,Bioavailability of the compound in rats after administration of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621981,In vivo,,4171,A,10259,
1,,Intermediate,Bioavailability after administration of 10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621982,In vivo,,17509,A,10260,
1,,Intermediate,Bioavailability after administration of 2 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL882953,In vivo,,17509,A,10261,
1,,Intermediate,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621983,In vivo,,4527,A,10262,
1,,Intermediate,Bioavailability in dogs was determined; high,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621984,In vivo,,4026,A,10263,
1,,Intermediate,Bioavailability in monkey after intravenous administration at 1 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621985,In vivo,,6659,A,10264,
1,,Intermediate,Bioavailability in monkey after peroral administration at 10 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621986,In vivo,,6659,A,10265,
1,,Intermediate,Bioavailability in rat after intravenous administration at 1 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621987,In vivo,,6659,A,10266,
1,,Intermediate,Bioavailability in rat after intravenous administration at 2 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877600,In vivo,,6659,F,10267,
1,,Intermediate,Bioavailability in rat after peroral administration at 30 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621988,In vivo,,6659,A,10268,
1,,Intermediate,Bioavailability in rat after peroral administration at at 100 mpk,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621989,In vivo,,6659,F,10269,
1,,Intermediate,Bioavailability in rats was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621990,In vivo,,6597,A,10270,
1,,Intermediate,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621991,In vivo,,1202,A,10271,
1,,Intermediate,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621992,In vivo,,1202,A,10272,
1,,Intermediate,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621993,In vivo,,1202,A,10273,
1,,Intermediate,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621994,In vivo,,1202,A,10274,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621995,In vivo,,5207,A,10275,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621996,In vivo,,5970,A,10276,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621997,In vivo,,17538,A,10277,
1,,Intermediate,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621998,In vivo,,17538,A,10278,
1,,Intermediate,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621999,In vivo,,1466,A,10279,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622000,In vivo,,2879,A,10280,
1,,Intermediate,Bioavailability was measured in rat after oral administration; 2-4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622001,In vivo,,2879,A,10281,
1,,Intermediate,Bioavailability was measured in rat after oral administration; 3-7,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622002,In vivo,,2879,A,10282,
1,,Intermediate,Bioavailability in rat (intraduodenal administration),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622003,In vivo,,3777,A,10283,
1,,Intermediate,Bioavailability in rat (intraduodenal administration),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877601,In vivo,,3777,A,10284,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624871,In vivo,,3777,A,10285,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622004,In vivo,,3777,A,10286,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL882954,In vivo,,5423,A,10287,
1,,Intermediate,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622005,In vivo,,16365,A,10288,
1,,Intermediate,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622006,In vivo,,16365,A,10289,
1,,Intermediate,Bioavailability was measured in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622007,In vivo,,4239,A,10290,
1,,Intermediate,Bioavailability was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622008,In vivo,,5438,A,10291,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622009,In vivo,,5334,A,10292,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622010,In vivo,,5334,A,10293,
1,,Intermediate,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622011,In vivo,,4199,A,10294,
1,,Intermediate,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622012,In vivo,,4199,A,10295,
1,,Intermediate,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622013,In vivo,,4199,A,10296,
1,,Intermediate,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622014,In vivo,,4890,A,10297,
1,,Intermediate,Bioavailability was determined at 3 mg/kg po dose in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624749,In vivo,,2792,A,10298,
1,,Intermediate,Oral bioavailability in rat (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624750,In vivo,,5529,A,10299,
1,,Intermediate,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624751,In vivo,,6685,A,10300,
1,,Intermediate,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624752,In vivo,,6685,A,10301,
1,,Intermediate,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624753,In vivo,,6685,A,10302,
1,,Intermediate,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624754,In vivo,,6005,A,10303,
1,,Intermediate,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624755,In vivo,,6410,A,10304,
1,,Intermediate,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624756,In vivo,,6410,A,10305,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624757,In vivo,,6103,A,10306,
1,,Intermediate,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624758,In vivo,,6410,A,10307,
1,,Intermediate,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622270,In vivo,,6410,A,10308,
1,,Intermediate,Bioavailability in rat (Sprague-Dawley),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622271,In vivo,,5353,A,10309,
1,,Intermediate,Bioavailability in rat at the dose of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622272,In vivo,,4727,A,10310,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622273,In vivo,,17804,A,10311,
1,,Intermediate,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622274,In vivo,,5809,A,10312,
1,,Intermediate,Bioavailability value of compound in rats was determined after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622275,In vivo,,17804,A,10313,
1,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622276,In vivo,,3634,A,10314,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622277,In vivo,,3341,A,10315,
1,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622278,In vivo,,2690,A,10316,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622279,In vivo,,3184,A,10317,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622280,In vivo,,740,A,10318,
1,,Intermediate,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624083,In vivo,,1806,A,10319,
1,,Intermediate,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624084,In vivo,,4891,A,10320,
1,,Intermediate,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624085,In vivo,,3634,A,10321,
1,,Intermediate,Compound was tested for bioavailability in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624086,In vivo,,64,A,10322,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624087,In vivo,,4839,A,10323,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624088,In vivo,,1094,A,10324,
1,,Intermediate,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,,CHEMBL624089,In vivo,,5005,A,10325,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL624090,In vivo,,5005,A,10326,
1,,Intermediate,Evaluated for the bioavailability in rat (in vivo),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624091,In vivo,,4687,A,10327,
1,,Intermediate,F value of compound in rats was determined after peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624092,In vivo,,17804,A,10328,
1,,Intermediate,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624093,In vivo,,5974,A,10329,
1,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624094,In vivo,,5974,A,10330,
1,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624095,In vivo,,5974,A,10331,
1,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624096,In vivo,,5974,A,10332,
1,,Intermediate,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624097,In vivo,,1088,A,10333,
1,,Intermediate,Maximum fall in carotid flow in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624098,In vivo,,1742,A,10334,
1,,Intermediate,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874392,In vivo,,4689,A,10335,
1,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624099,In vivo,,2463,A,10336,
1,,Intermediate,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624100,In vivo,,5654,A,10337,
1,,Intermediate,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624101,In vivo,,5654,A,10338,
1,,Intermediate,Oral bioavailability in rat (male Wistar),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624102,In vivo,,6874,A,10339,
1,,Intermediate,Oral bioavailability after administration (30 mg/kg) in rat; good,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624103,In vivo,,5633,A,10340,
1,,Intermediate,Oral bioavailability at the dose of 2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624104,In vivo,,5496,A,10341,
1,,Intermediate,Oral bioavailability determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624105,In vivo,,2358,A,10342,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624106,In vivo,,16456,A,10343,
1,,Intermediate,Oral bioavailability in rat (dose single 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624107,In vivo,,5302,A,10344,
1,,Intermediate,Oral bioavailability in rat (dose single 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623943,In vivo,,5302,A,10345,
1,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623944,In vivo,,5302,A,10346,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623945,,,11020,A,10347,
1,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623946,,,11020,A,10348,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623947,,,11020,A,10349,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623948,,,11020,A,10350,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623949,,,11020,A,10351,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623950,,,11020,A,10352,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874398,,,11020,A,10353,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623951,,,11020,A,10354,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623952,,,11020,A,10355,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623953,,,11020,A,10356,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623954,,,11020,A,10357,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623955,,,11020,A,10358,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623956,,,11020,A,10359,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627807,,,11020,A,10360,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627808,,,11020,A,10361,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627809,,,11020,A,10362,
1,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627810,,,11020,A,10363,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627811,,,11020,A,10364,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627812,,,11020,A,10365,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627813,,,11020,A,10366,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627814,,,11020,A,10367,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875336,,,11020,A,10368,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627815,,,11020,A,10369,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627816,,,11020,A,10370,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627817,,,11020,A,10371,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627818,,,11020,A,10372,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627819,,,11020,A,10373,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627820,,,11020,A,10374,
1,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627821,,,11020,A,10375,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628464,,,11020,A,10376,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626239,,,11020,A,10377,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626240,,,11020,A,10378,
1,,Intermediate,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626241,,,11020,A,10379,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626242,,,11020,A,10380,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626243,,,11020,A,10381,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626244,,,11020,A,10382,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626907,,,11020,A,10383,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626908,,,11020,A,10384,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626909,,,11020,A,10385,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626910,,,11020,A,10386,
1,,Intermediate,Percent total excretion of acetaminophen cysteine conjugate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875342,,,7449,F,10387,
1,,Intermediate,Percent total excretion of acetaminophen glucuronide,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626911,,,7449,F,10388,
1,,Intermediate,Percent total excretion of acetaminophen sulfate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626912,,,7449,F,10389,
1,,Intermediate,Percent total excretion of acetaminophen-mercapturic acid,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627065,,,7449,F,10390,
1,,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627066,,Urine,3172,A,10391,
1,,Intermediate,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627067,In vivo,,16456,A,10392,
1,,Autocuration,Biodistribution of compound in rat muscle after 5 min of administration,U,,,ratrat,,,8656.0,BAO_0000218,22224,0,,2385.0,CHEMBL627068,In vivo,Muscle tissue,10839,A,10393,
1,,Autocuration,Biodistribution of compound in rat muscle after 5 min of administration.,U,,,ratrat,,,8656.0,BAO_0000218,22224,0,,2385.0,CHEMBL627069,In vivo,Muscle tissue,10839,A,10394,
1,,Autocuration,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL627070,In vivo,,5334,A,10395,
1,,Autocuration,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL627071,In vivo,,5334,A,10396,
1,,Autocuration,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL627072,In vivo,,5334,A,10397,
1,,Autocuration,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL627073,In vivo,,5334,A,10398,
1,,Autocuration,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL625387,In vivo,,5334,A,10399,
1,,Autocuration,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,,CHEMBL625388,In vivo,,5334,A,10400,
1,,Autocuration,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,1969.0,CHEMBL625389,In vivo,Plasma,5334,A,10401,
1,,Autocuration,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,,,Ovis aries,,,9940.0,BAO_0000218,22224,0,,1969.0,CHEMBL875343,In vivo,Plasma,5334,A,10402,
1,,Intermediate,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,,,Serpentes,,,8570.0,BAO_0000218,50497,1,,,CHEMBL876795,,,1735,A,10403,
1,,Intermediate,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,,,Serpentes,,,8570.0,BAO_0000218,50497,1,,,CHEMBL626552,,,1469,A,10404,
1,,Intermediate,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,,,Serpentes,,,8570.0,BAO_0000218,50497,1,,,CHEMBL626553,,,1336,A,10405,
1,,Autocuration,The human biological plasma half life of the compound,U,,,Homo sapiens,,,9606.0,BAO_0000366,22224,0,,1969.0,CHEMBL626554,,Plasma,12403,A,10406,
1,,Intermediate,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626555,,Urine,8151,A,10407,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626556,,,8004,A,10408,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626557,,,8004,A,10409,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626558,,,8004,A,10410,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626559,,,8004,A,10411,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626560,,,8004,A,10412,
1,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876803,,,8004,A,10413,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627964,,,8004,A,10414,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627965,,,8004,A,10415,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627966,,,8004,A,10416,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627967,,,8004,A,10417,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627968,,,8004,A,10418,
1,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627969,,,8004,A,10419,
1,,Intermediate,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627970,,,8004,A,10420,
1,,Intermediate,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627971,,Blood,8004,A,10421,
1,,Intermediate,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627972,,Blood,8004,A,10422,
1,,Expert,Dissociation constant against binding to human cyclophilin A,D,,,Homo sapiens,,,9606.0,BAO_0000357,180,9,,,CHEMBL856029,,,15917,B,10423,
1,,Expert,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,,,Bos taurus,,,9913.0,BAO_0000019,11591,8,,,CHEMBL627973,,,12396,B,10424,
1,,Autocuration,-Log C was determined by performing the electroshock minimum test,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627974,,,7065,A,10425,
1,,Autocuration,-Log C was determined by performing the foot shock test,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627975,,,7065,A,10426,
1,,Autocuration,-Log C was determined by performing the incl screen test,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627976,,,7065,A,10427,
1,,Autocuration,-Log C was determined by performing the maximum electroshock test,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627977,,,7065,A,10428,
1,,Autocuration,-Log C was determined by performing the pentylenetetrazole test,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627978,,,7065,A,10429,
1,,Autocuration,Tested for experimental arotinoid inhibitory dose,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627979,,,12415,A,10430,
1,,Autocuration,Negative log transformed activity,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL876804,,,10256,A,10431,
1,,Autocuration,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627980,,,7991,A,10432,
1,,Intermediate,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL627981,,,14342,A,10433,
1,,Intermediate,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL627982,,,14342,A,10434,
1,,Intermediate,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL627983,,,14342,A,10435,
1,,Intermediate,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,2116.0,CHEMBL627984,,Ileum,14342,A,10436,
1,,Autocuration,Solubility in water was determined; values expressed as -log,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL627985,,,6047,P,10437,
1,,Autocuration,Ratio of Kcat to that of Km was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627986,,,17269,A,10438,
1,,Autocuration,Observed first order rate constant,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627987,,,10026,A,10439,
1,,Autocuration,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627988,,,14583,A,10440,
1,,Intermediate,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627989,In vivo,,2661,A,10441,
1,,Intermediate,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627990,In vivo,,2661,A,10442,
1,,Intermediate,Oral Bioavailability after administration of 10 mg/kg in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876805,In vivo,,4029,A,10443,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627991,In vivo,,17735,A,10444,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627992,In vivo,,4576,A,10445,
1,,Intermediate,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627993,In vivo,,17582,A,10446,
1,,Intermediate,Oral bioavailability at 1 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622817,In vivo,,17651,A,10447,
1,,Intermediate,Oral bioavailability at 10 mg/kg was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622818,In vivo,,17651,A,10448,
1,,Intermediate,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622819,In vivo,,17670,A,10449,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL872267,In vivo,,5045,A,10450,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622820,In vivo,,1696,A,10451,
1,,Intermediate,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622821,In vivo,,17764,A,10452,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622822,In vivo,,6448,A,10453,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622823,In vivo,,6596,A,10454,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622824,In vivo,,17547,A,10455,
1,,Intermediate,Oral bioavailability in rat at a dose of 3 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622825,In vivo,,17771,A,10456,
1,,Intermediate,Oral bioavailability in rat after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622901,In vivo,,6495,A,10457,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622902,In vivo,,4558,A,10458,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621844,In vivo,,17596,A,10459,
1,,Intermediate,Oral bioavailability in Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621845,In vivo,,6827,A,10460,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621846,In vivo,,4026,A,10461,
1,,Intermediate,Oral bioavailability in rat (dose 30 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621847,In vivo,,10,A,10462,
1,,Intermediate,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877609,In vivo,,17717,A,10463,
1,,Intermediate,Bioavailability in rat (dose 3 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621848,In vivo,,17717,A,10464,
1,,Intermediate,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621849,In vivo,,17717,A,10465,
1,,Intermediate,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622030,In vivo,,17717,A,10466,
1,,Intermediate,Percent oral bioavailability determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622031,In vivo,,4796,A,10467,
1,,Intermediate,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622032,In vivo,,4883,A,10468,
1,,Intermediate,The compound was evaluated for bioavailability in rats; 32-51,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622033,In vivo,,2137,A,10469,
1,,Intermediate,Bioavailability in rat (dose 20 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622034,In vivo,,2959,A,10470,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622035,In vivo,,1361,A,10471,
1,,Intermediate,Bioavailability percent in rat at the dose of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL882966,In vivo,,4727,A,10472,
1,,Intermediate,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622036,In vivo,,16423,A,10473,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622037,In vivo,,5206,A,10474,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622038,In vivo,,6448,A,10475,
1,,Intermediate,Bioavailability in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622039,In vivo,,17723,A,10476,
1,,Intermediate,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622040,In vivo,Blood,17738,A,10477,
1,,Intermediate,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622041,In vivo,Blood,17738,A,10478,
1,,Intermediate,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622042,In vivo,Blood,17738,A,10479,
1,,Intermediate,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622043,In vivo,Blood,17738,A,10480,
1,,Intermediate,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622044,In vivo,Blood,17738,A,10481,
1,,Intermediate,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL622045,In vivo,Bone,17738,A,10482,
1,,Intermediate,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL622046,In vivo,Bone,17738,A,10483,
1,,Intermediate,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL622047,In vivo,Bone,17738,A,10484,
1,,Intermediate,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL877610,In vivo,Bone,17738,A,10485,
1,,Intermediate,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622048,In vivo,Brain,17738,A,10486,
1,,Intermediate,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622049,In vivo,Brain,17738,A,10487,
1,,Intermediate,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622050,In vivo,Brain,17738,A,10488,
1,,Intermediate,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622051,In vivo,Brain,17738,A,10489,
1,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622052,In vivo,,17738,A,10490,
1,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622053,In vivo,,17738,A,10491,
1,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622054,In vivo,,17738,A,10492,
1,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622055,In vivo,,17738,A,10493,
1,,Intermediate,Oral bioavailability in rats was determined; High,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622056,In vivo,,5237,A,10494,
1,,Intermediate,Oral bioavailability in the rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622057,In vivo,,5503,A,10495,
1,,Intermediate,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628008,In vivo,,15765,A,10496,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622058,In vivo,,15660,A,10497,
1,,Intermediate,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622059,In vivo,,5978,A,10498,
1,,Intermediate,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622060,In vivo,,5978,A,10499,
1,,Intermediate,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622061,In vivo,,5978,A,10500,
1,,Intermediate,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622062,In vivo,,5978,A,10501,
1,,Intermediate,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622063,In vivo,,5656,A,10502,
1,,Expert,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877611,In vivo,,3598,A,10503,
1,,Intermediate,Oral bioavailability of compound in Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622064,In vivo,,4216,A,10504,
1,,Intermediate,Oral bioavailability of compound in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622065,In vivo,,17839,A,10505,
1,,Intermediate,Oral bioavailability in rat (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622066,In vivo,,6570,A,10506,
1,,Intermediate,Oral bioavailability of compound in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622067,In vivo,,5334,A,10507,
1,,Intermediate,Oral bioavailability of compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622068,In vivo,,6886,A,10508,
1,,Intermediate,Oral bioavailability of compound was determined in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622069,In vivo,,5210,A,10509,
1,,Intermediate,Oral bioavailability at a dose of 30 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624796,In vivo,,4170,A,10510,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624797,In vivo,,6028,A,10511,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623053,In vivo,,6028,A,10512,
1,,Intermediate,Oral bioavailability evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623054,In vivo,,6078,A,10513,
1,,Intermediate,Oral bioavailability in fasted rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623055,In vivo,,6168,A,10514,
1,,Intermediate,Oral bioavailability in fed rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623056,In vivo,,6168,A,10515,
1,,Intermediate,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623057,In vivo,,5160,A,10516,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623058,In vivo,,6057,A,10517,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623059,In vivo,,6535,A,10518,
1,,Intermediate,Oral bioavailability in rat after administration of 10 mg/kg po,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623060,In vivo,,6535,A,10519,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623061,In vivo,,4194,A,10520,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623062,In vivo,,6230,A,10521,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623063,In vivo,,6619,A,10522,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623064,In vivo,,17607,A,10523,
1,,Intermediate,Oral bioavailability in ratrs,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623065,In vivo,,4942,A,10524,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623066,In vivo,,4942,A,10525,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623067,In vivo,,6646,A,10526,
1,,Intermediate,Oral bioavailability in rats was determined; High,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623068,In vivo,,5237,A,10527,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623069,In vivo,,6646,A,10528,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623070,In vivo,,4449,A,10529,
1,,Intermediate,Oral bioavailability was calculated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623071,In vivo,,6057,A,10530,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623072,In vivo,,2552,A,10531,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623073,In vivo,,5496,A,10532,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623074,In vivo,,6484,A,10533,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623075,In vivo,,6485,A,10534,
1,,Intermediate,Oral bioavailability after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623076,In vivo,,6616,A,10535,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623077,In vivo,,4969,A,10536,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623078,In vivo,,5862,A,10537,
1,,Intermediate,Oral bioavailability in Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623079,In vivo,,4514,A,10538,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623080,In vivo,,4514,A,10539,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623081,In vivo,,4514,A,10540,
1,,Intermediate,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623082,In vivo,,5546,A,10541,
1,,Intermediate,Oral bioavailability in fasted rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874400,In vivo,,6168,A,10542,
1,,Intermediate,Oral bioavailability in fed rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623083,In vivo,,6168,A,10543,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623084,In vivo,,3624,A,10544,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623085,In vivo,,5213,A,10545,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623086,In vivo,,5496,A,10546,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623087,In vivo,,5553,A,10547,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623088,In vivo,,5833,A,10548,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623089,In vivo,,5836,A,10549,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623090,In vivo,,5865,A,10550,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623091,In vivo,,5960,A,10551,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623092,In vivo,,6249,A,10552,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623093,In vivo,,6448,A,10553,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874401,In vivo,,6453,A,10554,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623094,In vivo,,6640,A,10555,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623095,In vivo,,17607,A,10556,
1,,Intermediate,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623096,In vivo,,5939,A,10557,
1,,Intermediate,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624913,In vivo,,5939,A,10558,
1,,Intermediate,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624914,In vivo,,6281,A,10559,
1,,Intermediate,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624915,In vivo,,5874,A,10560,
1,,Intermediate,Oral bioavailability in rat; Not measured,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624916,In vivo,,5213,A,10561,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624917,In vivo,,4964,A,10562,
1,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625157,,,11020,A,10563,
1,,Intermediate,In vitro metabolic potential in rat liver microsomes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625158,,Liver,6251,A,10564,
1,,Intermediate,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625159,In vivo,,1568,A,10565,
1,,Intermediate,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625160,In vivo,,3032,A,10566,
1,,Intermediate,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625161,In vivo,,3748,A,10567,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625162,In vivo,,401,A,10568,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625163,In vivo,,6512,A,10569,
1,,Intermediate,Oral bioavailability in rats at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625164,In vivo,,17617,A,10570,
1,,Intermediate,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625165,In vivo,,6679,A,10571,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625166,In vivo,,6742,A,10572,
1,,Intermediate,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625167,,,589,A,10573,
1,,Intermediate,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625168,,,589,A,10574,
1,,Intermediate,Plasma clearance of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625169,In vivo,,3185,A,10575,
1,,Intermediate,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626264,In vivo,,17596,A,10576,
1,,Intermediate,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626265,In vivo,,2713,A,10577,
1,,Intermediate,The compound was tested for plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626266,In vivo,Plasma,12500,A,10578,
1,,Intermediate,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626267,In vivo,Plasma,12500,A,10579,
1,,Intermediate,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626268,,,2713,A,10580,
1,,Intermediate,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626269,,,1446,A,10581,
1,,Intermediate,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626270,,,6227,A,10582,
1,,Intermediate,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626271,,,4709,A,10583,
1,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626272,,,5510,A,10584,
1,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626273,,,5510,A,10585,
1,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875346,,,5510,A,10586,
1,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626274,,,5510,A,10587,
1,,Intermediate,Compound was tested for protein binding in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626275,,,4514,A,10588,
1,,Intermediate,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624646,,,2713,A,10589,
1,,Intermediate,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624647,,,2713,A,10590,
1,,Intermediate,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624648,,Liver,5340,A,10591,
1,,Intermediate,Area under curve ratio was determined (po/iv) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624649,,,12058,A,10592,
1,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624650,,,11195,A,10593,
1,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624651,,,11195,A,10594,
1,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624652,,,11195,A,10595,
1,,Intermediate,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624653,,,6495,A,10596,
1,,Intermediate,Ratio of AUCbrain to AUCplasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624654,,,6078,A,10597,
1,,Intermediate,Ratio of brain to plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624655,,,5656,A,10598,
1,,Intermediate,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624656,,,4910,A,10599,
1,,Intermediate,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624657,,,4910,A,10600,
1,,Intermediate,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624658,,,4910,A,10601,
1,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624659,,,10130,A,10602,
1,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624660,,,10130,A,10603,
1,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624661,,,10130,A,10604,
1,,Intermediate,Steady state brain :blood ratio was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624662,,,5213,A,10605,
1,,Intermediate,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625199,,,4910,A,10606,
1,,Intermediate,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625200,,,4910,A,10607,
1,,Intermediate,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625201,,,4910,A,10608,
1,,Intermediate,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625202,,,4910,A,10609,
1,,Intermediate,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625203,,,2083,A,10610,
1,,Intermediate,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625204,,,2082,A,10611,
1,,Intermediate,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625205,,,2082,A,10612,
1,,Intermediate,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625206,,,6351,A,10613,
1,,Autocuration,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625207,,,14583,A,10614,
1,,Autocuration,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625208,,,14583,A,10615,
1,495.0,Intermediate,In vivo absorption in Caco-2 cell line monolayers was determined,N,,,Homo sapiens,Caco-2,,9606.0,BAO_0000218,50587,1,,,CHEMBL625209,,,4608,A,10616,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625210,,,13668,P,10617,
1,,Intermediate,Area under curve was determine after peroral administration at 10 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625211,,,5669,A,10618,
1,,Intermediate,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL625212,,,5669,A,10619,
1,,Intermediate,Area under curve was determine after peroral administration at 160 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625213,,,5669,A,10620,
1,,Intermediate,Area under curve was determine after peroral administration at 20 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625214,,,5669,A,10621,
1,,Intermediate,Area under curve was determine after peroral administration at 50 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874542,,,5669,A,10622,
1,,Autocuration,Calculated partition coefficient (clogP) (AlogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625215,,,6472,P,10623,
1,,Autocuration,Activated partial thromboplastin time measured,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625216,,,15106,A,10624,
1,,Autocuration,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,,,,,,,BAO_0000100,22224,0,,,CHEMBL625217,,,15207,P,10625,
1,,Autocuration,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,,,,,,,BAO_0000100,22224,0,,,CHEMBL625218,,,15207,P,10626,
1,,Intermediate,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL622864,,Plasma,13941,A,10627,
1,,Intermediate,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622865,,Plasma,13941,A,10628,
1,,Intermediate,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622866,,Plasma,13941,A,10629,
1,,Intermediate,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL622867,,Plasma,13941,A,10630,
1,,Intermediate,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,1969.0,CHEMBL876808,,Plasma,15240,A,10631,
1,,Autocuration,AUC in brain,U,,,,,,,BAO_0000019,22224,0,,955.0,CHEMBL627725,,Brain,10655,A,10632,
1,,Autocuration,AUC in serum,U,,,,,,,BAO_0000019,22224,0,,1977.0,CHEMBL627726,,Serum,10655,A,10633,
1,,Autocuration,AUC was determined,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627727,,Plasma,6504,A,10634,
1,,Autocuration,AUC of the compound.,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627728,,Plasma,10615,A,10635,
1,,Autocuration,AUC value (0-4 hr),U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627729,,Plasma,10353,A,10636,
1,,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627730,,Plasma,14907,A,10637,
1,,Autocuration,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627731,,Plasma,14907,A,10638,
1,,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627732,,Plasma,14907,A,10639,
1,,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL627733,,Plasma,14907,A,10640,
1,,Intermediate,AUC(area under curve) was determined after intravenous administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627734,,Plasma,16359,A,10641,
1,,Intermediate,AUC(area under curve) was determined after oral administration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627735,,Plasma,16359,A,10642,
1,,Intermediate,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,1969.0,CHEMBL627736,,Plasma,15240,A,10643,
1,,Intermediate,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876809,,Plasma,15240,A,10644,
1,,Autocuration,Area Under Curve after oral dosing of 100 uM/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627737,,,15469,A,10645,
1,,Autocuration,Area Under Curve after oral dosing of 30 uM/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627738,,,15469,A,10646,
1,,Autocuration,Area Under Curve was measured by ploting the graph between concentration verses time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627739,,,13520,A,10647,
1,,Intermediate,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626143,,,17025,A,10648,
1,,Autocuration,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626144,,,17025,A,10649,
1,,Intermediate,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL626145,,,17025,A,10650,
1,,Intermediate,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626146,,,17025,A,10651,
1,,Intermediate,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626147,,Blood,12032,A,10652,
1,,Autocuration,Area under curve (AUC) was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626148,,,10291,A,10653,
1,,Autocuration,Area under curve (AUC) following ip administration at 1 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626149,,,5767,A,10654,
1,,Autocuration,Area under curve (AUC) was determined; ND is Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626150,,,1434,A,10655,
1,,Intermediate,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626151,,,14925,A,10656,
1,,Intermediate,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626152,,,14925,A,10657,
1,,Intermediate,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626153,,,14925,A,10658,
1,,Autocuration,Area under curve (AUR) was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626154,,,1434,A,10659,
1,,Autocuration,Area under curve at 1 uM/dg administered intravenously,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626155,,,11883,A,10660,
1,,Autocuration,Area under curve at 10 uM/dg administered perorally,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626156,,,11883,A,10661,
1,,Autocuration,Area under curve at 2 uM/dg administered intravenously,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626157,,,11883,A,10662,
1,,Autocuration,Area under curve at 20 uM/dg administered perorally,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626158,,,11883,A,10663,
1,,Intermediate,Area under curve at a peroral dose of 3 mg/kg in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626159,,,15233,A,10664,
1,,Intermediate,Area under curve at a peroral dose of 3 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626160,,,15233,A,10665,
1,,Intermediate,Area under curve at an iv dose of 1 mg/kg in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626161,,,15233,A,10666,
1,,Intermediate,Area under curve at an iv dose of 1 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626162,,,15233,A,10667,
1,,Autocuration,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626163,,,12978,A,10668,
1,,Autocuration,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626164,,,12978,A,10669,
1,,Intermediate,Area under curve measured as conc vs time after intravenous administration to mice.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626165,,,11355,A,10670,
1,,Intermediate,Area under curve measured as conc vs time after peroral administration to mice.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626166,,,11355,A,10671,
1,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626167,,,12923,A,10672,
1,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626168,,,12923,A,10673,
1,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL877463,,,12923,A,10674,
1,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626169,,,12923,A,10675,
1,,Intermediate,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626170,In vivo,Heart,17738,A,10676,
1,,Intermediate,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626171,In vivo,Heart,17738,A,10677,
1,,Intermediate,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626172,In vivo,Heart,17738,A,10678,
1,,Intermediate,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626173,In vivo,Heart,17738,A,10679,
1,,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626174,In vivo,Kidney,17738,A,10680,
1,,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626175,In vivo,Kidney,17738,A,10681,
1,,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626176,In vivo,Kidney,17738,A,10682,
1,,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626177,In vivo,Kidney,17738,A,10683,
1,,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622499,In vivo,Kidney,17738,A,10684,
1,,Intermediate,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622500,In vivo,Liver,17738,A,10685,
1,,Intermediate,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622501,In vivo,Liver,17738,A,10686,
1,,Intermediate,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622502,In vivo,Liver,17738,A,10687,
1,,Intermediate,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622503,In vivo,Liver,17738,A,10688,
1,,Intermediate,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL877614,In vivo,Liver,17738,A,10689,
1,,Intermediate,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624839,In vivo,Lung,17738,A,10690,
1,,Intermediate,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624840,In vivo,Lung,17738,A,10691,
1,,Intermediate,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624841,In vivo,Lung,17738,A,10692,
1,,Intermediate,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624842,In vivo,Lung,17738,A,10693,
1,,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624843,In vivo,Muscle tissue,17738,A,10694,
1,,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624844,In vivo,Muscle tissue,17738,A,10695,
1,,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624845,In vivo,Muscle tissue,17738,A,10696,
1,,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL621904,In vivo,Muscle tissue,17738,A,10697,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621905,In vivo,Blood,11195,A,10698,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL874382,In vivo,Blood,11195,A,10699,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL621906,In vivo,Blood,11195,A,10700,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL621907,In vivo,Brain,11195,A,10701,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622096,In vivo,Brain,11195,A,10702,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622097,In vivo,Brain,11195,A,10703,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622098,In vivo,Heart,11195,A,10704,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622099,In vivo,Heart,11195,A,10705,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622100,In vivo,Heart,11195,A,10706,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622101,In vivo,Kidney,11195,A,10707,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622102,In vivo,Kidney,11195,A,10708,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622103,In vivo,Kidney,11195,A,10709,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622104,In vivo,Liver,11195,A,10710,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622105,In vivo,Liver,11195,A,10711,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622106,In vivo,Liver,11195,A,10712,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622107,In vivo,Lung,11195,A,10713,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622108,In vivo,Lung,11195,A,10714,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622109,In vivo,Lung,11195,A,10715,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622110,In vivo,Muscle tissue,11195,A,10716,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622111,In vivo,Muscle tissue,11195,A,10717,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL874383,In vivo,Muscle tissue,11195,A,10718,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL622112,In vivo,Zone of skin,11195,A,10719,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL622113,In vivo,Zone of skin,11195,A,10720,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL622114,In vivo,Zone of skin,11195,A,10721,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622115,In vivo,Spleen,11195,A,10722,
1,,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622116,In vivo,Spleen,11195,A,10723,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622117,In vivo,,6193,A,10724,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622118,In vivo,,6803,A,10725,
1,,Intermediate,Oral bioavailability in rats at 6 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622119,In vivo,,6647,A,10726,
1,,Intermediate,Oral bioavailability in rat (dose 6 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622120,In vivo,,6647,A,10727,
1,,Intermediate,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622121,In vivo,,6647,A,10728,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622122,In vivo,,6640,A,10729,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622123,In vivo,,6641,A,10730,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622124,In vivo,,6641,A,10731,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622125,In vivo,,6642,A,10732,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622126,In vivo,,5472,A,10733,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620455,In vivo,,6141,A,10734,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620456,In vivo,,4390,A,10735,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620457,In vivo,,5472,A,10736,
1,,Intermediate,Oral bioavailability was evaluated; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620458,In vivo,,5472,A,10737,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620459,In vivo,,5438,A,10738,
1,,Intermediate,Oral bioavailability in rat by oral dosing,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620460,In vivo,,4883,A,10739,
1,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620461,In vivo,,1908,A,10740,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620462,In vivo,,4853,A,10741,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620463,In vivo,,4853,A,10742,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620464,In vivo,,4853,A,10743,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620465,In vivo,,4853,A,10744,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620466,In vivo,,4853,A,10745,
1,,Intermediate,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620467,In vivo,,4853,A,10746,
1,,Intermediate,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620468,In vivo,,4853,A,10747,
1,,Intermediate,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620469,In vivo,,12873,A,10748,
1,,Intermediate,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620470,In vivo,,12873,A,10749,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620471,In vivo,,3169,A,10750,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620472,In vivo,,6305,A,10751,
1,,Intermediate,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620473,In vivo,,4762,A,10752,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620474,In vivo,,17847,A,10753,
1,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620475,In vivo,,6211,A,10754,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620476,In vivo,,6011,A,10755,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620477,In vivo,,6317,A,10756,
1,,Intermediate,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620478,In vivo,,6644,A,10757,
1,,Intermediate,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618768,In vivo,,6644,A,10758,
1,,Intermediate,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618769,In vivo,,6644,A,10759,
1,,Intermediate,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618770,In vivo,,6644,A,10760,
1,,Intermediate,Oral bioavailability (dose 20 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618771,In vivo,,6113,A,10761,
1,,Intermediate,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618772,In vivo,,5937,A,10762,
1,,Intermediate,Oral bioavailability in rat at 10 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618773,In vivo,,5711,A,10763,
1,,Intermediate,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875842,In vivo,,17717,A,10764,
1,,Intermediate,Bioavailability in rat (dose 3 mg/kg i.v.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618774,In vivo,,17717,A,10765,
1,,Intermediate,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618775,In vivo,,17717,A,10766,
1,,Intermediate,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618776,In vivo,,17717,A,10767,
1,,Intermediate,Percent bioavailability (F) in rats after iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618777,In vivo,,4722,A,10768,
1,,Intermediate,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618778,In vivo,,4722,A,10769,
1,,Intermediate,Bioavailability in rat (dose 5 uM/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618779,In vivo,,4353,A,10770,
1,,Intermediate,Oral bioavailability,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618780,In vivo,,15662,A,10771,
1,,Intermediate,Bioavailability in rat (dose 2 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618781,In vivo,,4756,A,10772,
1,,Intermediate,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618782,In vivo,,4756,A,10773,
1,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618783,In vivo,,3436,A,10774,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618784,In vivo,,17800,A,10775,
1,,Intermediate,Percent oral bioavailability evaluated in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618785,In vivo,,15762,A,10776,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618786,In vivo,,5089,A,10777,
1,,Intermediate,Percent oral bioavailability in rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618787,In vivo,,5089,A,10778,
1,,Intermediate,Oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618788,In vivo,,3185,A,10779,
1,,Intermediate,Bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618789,In vivo,,5145,A,10780,
1,,Intermediate,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618790,In vivo,,3457,A,10781,
1,,Intermediate,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618791,In vivo,,3457,A,10782,
1,,Intermediate,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875843,In vivo,,5983,A,10783,
1,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL618792,In vivo,,5739,A,10784,
1,,Intermediate,Cmax at a dose of 30 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623395,In vivo,,3579,A,10785,
1,,Autocuration,Cmax in monkeys at a dose of 1 mg/kg,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL623396,In vivo,,17788,A,10786,
1,,Intermediate,Cmax in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623397,In vivo,,14956,A,10787,
1,,Intermediate,Cmax in rats at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623398,In vivo,,17788,A,10788,
1,,Intermediate,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623399,In vivo,,9750,A,10789,
1,,Autocuration,"Cmax value at a dose of 12.7 uM/kg, po",U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623400,In vivo,,12767,A,10790,
1,,Autocuration,"Cmax value at a dose of 6.3 uM/kg, iv",U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623401,In vivo,,12767,A,10791,
1,,Autocuration,"Cmax value at a dose of 7.1 uM/kg, iv",U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623402,In vivo,,12767,A,10792,
1,,Autocuration,Cmax value of compound was determined after 1 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623403,In vivo,,12703,A,10793,
1,,Autocuration,Cmax value of the compound,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623404,In vivo,,15778,A,10794,
1,,Intermediate,Cmax value administered intraintestinal in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625997,In vivo,,12818,A,10795,
1,,Intermediate,Cmax value administered perorally was determined in rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625998,In vivo,,14964,A,10796,
1,,Autocuration,Cmax value at the dose of 2.3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625999,In vivo,,15808,A,10797,
1,,Autocuration,Cmax value at the dose of 5 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626000,In vivo,,15808,A,10798,
1,,Autocuration,Cmax value in the period of 8 hr after dosing. ,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626001,In vivo,,15778,A,10799,
1,,Autocuration,Cmax value at a oral dose of 20 mg/kg; Not tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626002,In vivo,,3715,A,10800,
1,,Autocuration,Cmax value at a oral dose of 20 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626003,In vivo,,3715,A,10801,
1,,Intermediate,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626004,In vivo,,1446,A,10802,
1,,Intermediate,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL626005,In vivo,,15240,A,10803,
1,,Intermediate,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626006,In vivo,,15240,A,10804,
1,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626007,In vivo,Plasma,14810,A,10805,
1,,Intermediate,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL626008,In vivo,Plasma,14239,A,10806,
1,,Intermediate,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2107.0,CHEMBL626009,In vivo,Liver,12555,A,10807,
1,,Intermediate,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626010,In vivo,,10754,A,10808,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626011,In vivo,Blood,10754,A,10809,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626012,In vivo,Blood,10754,A,10810,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626013,In vivo,Blood,10754,A,10811,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL626014,In vivo,Blood,10754,A,10812,
1,,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL877496,In vivo,Blood,10754,A,10813,
1,,Intermediate,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626015,In vivo,,14600,F,10814,
1,,Intermediate,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626016,In vivo,,14600,F,10815,
1,,Intermediate,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626017,In vivo,,14600,F,10816,
1,,Intermediate,Bioavailability as maximal plasma concentration in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626018,In vivo,Plasma,13543,A,10817,
1,,Intermediate,Bioavailability as maximal plasma concentration in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626692,In vivo,Plasma,13543,A,10818,
1,,Intermediate,Bioavailability as maximal plasma concentration in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626693,In vivo,Plasma,13543,A,10819,
1,,Autocuration,Bioavailability as maximal plasma concentration in rats,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1969.0,CHEMBL626694,In vivo,Plasma,13543,A,10820,
1,,Intermediate,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626695,In vivo,Blood,14600,A,10821,
1,,Intermediate,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626696,In vivo,Blood,14600,A,10822,
1,,Intermediate,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626697,In vivo,Blood,14600,A,10823,
1,,Intermediate,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626859,In vivo,Blood,14600,A,10824,
1,,Intermediate,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626860,In vivo,Blood,14600,A,10825,
1,,Intermediate,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL626861,In vivo,Blood,14600,A,10826,
1,,Intermediate,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626296,In vivo,,14681,A,10827,
1,,Autocuration,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626297,In vivo,,15905,A,10828,
1,,Autocuration,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626298,In vivo,Plasma,15905,A,10829,
1,,Intermediate,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626299,In vivo,Plasma,13304,A,10830,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626300,In vivo,Plasma,15137,A,10831,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626301,In vivo,Plasma,15137,A,10832,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626962,In vivo,Plasma,15137,A,10833,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626963,In vivo,Plasma,15137,A,10834,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626964,In vivo,Plasma,15137,A,10835,
1,,Intermediate,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL626965,In vivo,Plasma,14839,A,10836,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL626966,In vivo,Plasma,14839,A,10837,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL626967,In vivo,Plasma,14839,A,10838,
1,,Intermediate,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL626968,In vivo,Plasma,14839,A,10839,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626969,,Heart,8418,A,10840,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627126,,Heart,8418,A,10841,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631276,,Heart,8418,A,10842,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631277,,Heart,8418,A,10843,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631278,,Heart,8418,A,10844,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL874457,,Heart,8418,A,10845,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631279,,Heart,8418,A,10846,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631280,,Heart,8418,A,10847,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631281,,Heart,8418,A,10848,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631968,,Heart,8418,A,10849,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631969,,Heart,8418,A,10850,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631970,,Heart,8418,A,10851,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631971,,Heart,8418,A,10852,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL631972,,Heart,8418,A,10853,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630435,,Heart,8418,A,10854,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630436,,Heart,8418,A,10855,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630437,,Heart,8418,A,10856,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630438,,Heart,8418,A,10857,
1,,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630439,,Heart,8418,A,10858,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630440,,Kidney,8418,A,10859,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630441,,Kidney,8418,A,10860,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630442,,Kidney,8418,A,10861,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625234,,Kidney,8418,A,10862,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625235,,Kidney,8418,A,10863,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625236,,Kidney,8418,A,10864,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625237,,Kidney,8418,A,10865,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626125,,Kidney,8418,A,10866,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626126,,Kidney,8418,A,10867,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626127,,Kidney,8418,A,10868,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626128,,Kidney,8418,A,10869,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626129,,Kidney,8418,A,10870,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626130,,Kidney,8418,A,10871,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626131,,Kidney,8418,A,10872,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626132,,Kidney,8418,A,10873,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626752,,Kidney,8418,A,10874,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626753,,Kidney,8418,A,10875,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626754,,Kidney,8418,A,10876,
1,,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626755,,Kidney,8418,A,10877,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626756,,Liver,8418,A,10878,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626757,,Liver,8418,A,10879,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626758,,Liver,8418,A,10880,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626759,,Liver,8418,A,10881,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626760,,Liver,8418,A,10882,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626394,,,6996,A,10883,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626395,,,6996,A,10884,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626396,,,6996,A,10885,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626397,,,6996,A,10886,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626398,,,6996,A,10887,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626399,,,6996,A,10888,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874653,,,6996,A,10889,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626400,,,6996,A,10890,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626401,,,6996,A,10891,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626402,,,6996,A,10892,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626403,,,6996,A,10893,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626404,,,6996,A,10894,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626405,,,6996,A,10895,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625529,,,6996,A,10896,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625530,,,6996,A,10897,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625531,,,6996,A,10898,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625532,,,6996,A,10899,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625533,,,6996,A,10900,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875474,,,6996,A,10901,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625534,,,6996,A,10902,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625535,,,6996,A,10903,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625536,,,6996,A,10904,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625537,,,6996,A,10905,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625538,,,6996,A,10906,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625539,,,6996,A,10907,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625540,,,6996,A,10908,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625541,,,6996,A,10909,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625542,,,6996,A,10910,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625543,,,6996,A,10911,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625544,,,6996,A,10912,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625545,,,6996,A,10913,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625546,,,6996,A,10914,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625547,,,6996,A,10915,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625548,,,6996,A,10916,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625549,,,6996,A,10917,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625550,,,6996,A,10918,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625551,,,6996,A,10919,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL875475,,,6996,A,10920,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625552,,,6996,A,10921,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625553,,,6996,A,10922,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625554,,,6996,A,10923,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625555,,,6996,A,10924,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625556,,,6996,A,10925,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624986,,,6996,A,10926,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624987,,,6996,A,10927,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624988,,,6996,A,10928,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624989,In vivo,Artery,9025,A,10929,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624990,In vivo,Artery,9025,A,10930,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL874391,In vivo,Artery,9025,A,10931,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624991,In vivo,Artery,9025,A,10932,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624992,In vivo,Artery,9025,A,10933,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624993,In vivo,Artery,9025,A,10934,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624994,In vivo,Artery,9025,A,10935,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624995,In vivo,Artery,9025,A,10936,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624996,In vivo,Artery,9025,A,10937,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624997,In vivo,Artery,9025,A,10938,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624998,In vivo,Artery,9025,A,10939,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624999,In vivo,Artery,9025,A,10940,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL882955,In vivo,Artery,9025,A,10941,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625000,In vivo,Artery,9025,A,10942,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625001,In vivo,Artery,9025,A,10943,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625089,In vivo,Artery,9025,A,10944,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625090,In vivo,Artery,9025,A,10945,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625091,In vivo,Artery,9025,A,10946,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625092,In vivo,Artery,9025,A,10947,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625093,In vivo,Artery,9025,A,10948,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625094,In vivo,Artery,9025,A,10949,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL625095,In vivo,Artery,9025,A,10950,
1,,Intermediate,Compound was evaluated for its bioavailability in the dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625096,In vivo,,2249,A,10951,
1,,Intermediate,Compound was evaluated for its bioavailability in the rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625097,In vivo,,2249,A,10952,
1,,Autocuration,Compound was evaluated for oral bioavailability,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL882956,In vivo,,17515,A,10953,
1,,Intermediate,Compound was evaluated for percentage of Oral bioavailability in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625098,In vivo,,14541,A,10954,
1,,Autocuration,Bioavailability in guinea pig,U,,,Cavia porcellus,,,10141.0,BAO_0000218,22224,0,,,CHEMBL625099,In vivo,,12797,A,10955,
1,,Intermediate,Compound was evaluated for the oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625100,In vivo,,12797,A,10956,
1,,Intermediate,Compound was evaluated for the oral bioavailability in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625101,In vivo,,12797,A,10957,
1,,Intermediate,Compound was evaluated for the oral bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874396,In vivo,,12797,A,10958,
1,,Autocuration,Bioavailability in dog (dosed i.v.),U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL625102,In vivo,,11727,F,10959,
1,,Intermediate,Compound was tested for in vivo bioavailability in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625103,In vivo,,13249,A,10960,
1,,Intermediate,Compound was tested for in vivo bioavailability in hamsters,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL625104,In vivo,,13249,A,10961,
1,,Autocuration,Compound was tested for in vivo bioavailability in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625105,In vivo,,13249,A,10962,
1,,Intermediate,Compound was tested for in vivo bioavailability in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625106,In vivo,,13249,A,10963,
1,,Autocuration,Oral bioavailability in mouse,U,,,Mus musculus,,,10090.0,BAO_0000218,22224,0,,,CHEMBL625107,In vivo,,9552,A,10964,
1,,Intermediate,Compound was tested for percent of oral bioavailability in mice; 56-74,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625108,In vivo,,9552,A,10965,
1,,Autocuration,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,,,Mus musculus,,,10090.0,BAO_0000218,22224,0,,,CHEMBL625109,In vivo,,14839,A,10966,
1,,Autocuration,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,,,Macaca fascicularis,,,9541.0,BAO_0000218,22224,0,,,CHEMBL625110,In vivo,,14839,A,10967,
1,,Autocuration,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,,,Macaca fascicularis,,,9541.0,BAO_0000218,22224,0,,,CHEMBL625111,In vivo,,14839,A,10968,
1,,Intermediate,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625112,In vivo,,14839,A,10969,
1,,Intermediate,Oral bioavailability in nude mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL875334,In vivo,,14839,A,10970,
1,,Autocuration,Bioavailability in monkey (i.d. dosing),U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL628617,In vivo,,11219,A,10971,
1,,Autocuration,Bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL628618,In vivo,,9552,A,10972,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628619,In vivo,,11732,A,10973,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628620,In vivo,,11732,A,10974,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL628621,In vivo,,14839,A,10975,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL628622,In vivo,,14839,A,10976,
1,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL628623,In vivo,,14839,A,10977,
1,,Intermediate,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL628624,In vivo,Plasma,14839,A,10978,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL628625,In vivo,Plasma,14839,A,10979,
1,,Intermediate,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL628626,In vivo,Plasma,14839,A,10980,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627041,In vivo,Plasma,14839,A,10981,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627042,In vivo,Plasma,14839,A,10982,
1,,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627043,In vivo,Plasma,14839,A,10983,
1,,Autocuration,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL627044,In vivo,Plasma,13932,A,10984,
1,,Intermediate,Cmax in mouse plasma,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL627045,In vivo,Plasma,11637,A,10985,
1,,Autocuration,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL627046,In vivo,Plasma,11637,A,10986,
1,,Intermediate,Maximal plasma concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627047,In vivo,Plasma,13960,A,10987,
1,,Intermediate,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627048,In vivo,Plasma,15905,A,10988,
1,,Intermediate,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627049,In vivo,,14062,A,10989,
1,,Intermediate,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627050,In vivo,,14062,A,10990,
1,,Intermediate,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627051,In vivo,,14062,A,10991,
1,,Intermediate,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627052,In vivo,,14062,A,10992,
1,,Intermediate,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627053,In vivo,,14062,A,10993,
1,,Intermediate,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627054,In vivo,,14062,A,10994,
1,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627055,In vivo,,15011,A,10995,
1,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627056,In vivo,,15011,A,10996,
1,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627057,In vivo,,15011,A,10997,
1,,Intermediate,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627058,In vivo,,15011,A,10998,
1,,Intermediate,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626211,In vivo,,15011,A,10999,
1,,Autocuration,Maximum Concentration of the compound.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626212,In vivo,,10291,A,11000,
1,,Intermediate,Maximum Concentration was measured after iv administration into Beagle dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626213,In vivo,,14599,A,11001,
1,,Intermediate,Maximum Concentration was measured after iv administration into Beagle dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626214,In vivo,,14599,A,11002,
1,,Intermediate,Maximum Concentration was measured after po administration into Beagle dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626215,In vivo,,14599,A,11003,
1,,Intermediate,Maximum Concentration was measured after po administration into Beagle dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626216,In vivo,,14599,A,11004,
1,,Autocuration,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626217,In vivo,Blood,12767,A,11005,
1,,Autocuration,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626218,In vivo,Blood,12767,A,11006,
1,,Autocuration,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626219,In vivo,Blood,12767,A,11007,
1,,Autocuration,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626220,In vivo,Blood,12767,A,11008,
1,,Autocuration,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626221,In vivo,Blood,12767,A,11009,
1,,Autocuration,Maximum blood level reached at dose of 10.6 uM/kg orally,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626222,In vivo,Blood,12767,A,11010,
1,,Intermediate,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL626223,In vivo,,14706,A,11011,
1,,Intermediate,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL626224,In vivo,,14706,A,11012,
1,,Intermediate,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL626225,In vivo,Brain,14793,A,11013,
1,,Intermediate,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL626226,In vivo,Brain,14793,A,11014,
1,,Intermediate,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL626227,In vivo,Brain,14793,A,11015,
1,,Intermediate,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL626228,In vivo,Brain,14793,A,11016,
1,,Intermediate,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626229,In vivo,,14793,A,11017,
1,,Intermediate,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626921,In vivo,,14793,A,11018,
1,,Intermediate,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876793,In vivo,,14793,A,11019,
1,,Intermediate,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625309,In vivo,,14793,A,11020,
1,,Intermediate,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,,,Bacillus subtilis,,,1423.0,BAO_0000218,50278,1,,,CHEMBL625310,In vivo,,10524,A,11021,
1,,Autocuration,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625311,In vivo,,11871,A,11022,
1,,Intermediate,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625312,In vivo,,11871,A,11023,
1,,Autocuration,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625313,In vivo,,3437,A,11024,
1,,Intermediate,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625314,In vivo,,12038,A,11025,
1,,Intermediate,Maximum concentration in male rats after iv administration of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625315,In vivo,,12038,A,11026,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625316,,Liver,8418,A,11027,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625317,,Liver,8418,A,11028,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625318,,Liver,8418,A,11029,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625319,,Liver,8418,A,11030,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625320,,Liver,8418,A,11031,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625321,,Liver,8418,A,11032,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625322,,Liver,8418,A,11033,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL876801,,Liver,8418,A,11034,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625323,,Liver,8418,A,11035,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625324,,Liver,8418,A,11036,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625325,,Liver,8418,A,11037,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625326,,Liver,8418,A,11038,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625327,,Liver,8418,A,11039,
1,,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625328,,Liver,8418,A,11040,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625329,,Lung,8418,A,11041,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625330,,Lung,8418,A,11042,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627774,,Lung,8418,A,11043,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627775,,Lung,8418,A,11044,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627949,,Lung,8418,A,11045,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627950,,Lung,8418,A,11046,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627951,,Lung,8418,A,11047,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627952,,Lung,8418,A,11048,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627953,,Lung,8418,A,11049,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627954,,Lung,8418,A,11050,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627955,,Lung,8418,A,11051,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627956,,Lung,8418,A,11052,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL876802,,Lung,8418,A,11053,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627957,,Lung,8418,A,11054,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627958,,Lung,8418,A,11055,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627959,,Lung,8418,A,11056,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627960,,Lung,8418,A,11057,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627961,,Lung,8418,A,11058,
1,,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627962,,Lung,8418,A,11059,
1,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627963,,,9796,A,11060,
1,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624759,,,9796,A,11061,
1,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624760,,,9796,A,11062,
1,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624761,,,9796,A,11063,
1,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877607,,,9796,A,11064,
1,,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624762,,Liver,9796,A,11065,
1,,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624763,,Liver,9796,A,11066,
1,,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624764,,Liver,9796,A,11067,
1,,Intermediate,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624765,,Liver,9796,A,11068,
1,,Intermediate,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624766,,Liver,9796,A,11069,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624767,,,6996,A,11070,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624768,,,6996,A,11071,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624769,,,6996,A,11072,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624770,,,6996,A,11073,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624771,,,6996,A,11074,
1,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624772,,,6996,A,11075,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624773,,,6996,A,11076,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624774,,,6996,A,11077,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624775,,,6996,A,11078,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624776,,,6996,A,11079,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624777,,,6996,A,11080,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624778,,,6996,A,11081,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624779,,,6996,A,11082,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624780,,,6996,A,11083,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624781,,,6996,A,11084,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877608,,,6996,A,11085,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624782,,,6996,A,11086,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624783,,,6996,A,11087,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624784,,,6996,A,11088,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624785,,,6996,A,11089,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624786,,,6996,A,11090,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624787,,,6996,A,11091,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628676,,,6996,A,11092,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621842,,,6996,A,11093,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL621843,,,6996,A,11094,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623873,,,6996,A,11095,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623874,,,6996,A,11096,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623875,,,6996,A,11097,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623876,,,6996,A,11098,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623877,,,6996,A,11099,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623878,,,6996,A,11100,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623879,,,6996,A,11101,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623880,,,6996,A,11102,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623881,,,6996,A,11103,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623957,,,6996,A,11104,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623958,,,6996,A,11105,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623959,,,6996,A,11106,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623960,,,6996,A,11107,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623961,,,6996,A,11108,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623962,,,6996,A,11109,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624676,,,6996,A,11110,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624677,,,6996,A,11111,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624678,,,6996,A,11112,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624679,,,6996,A,11113,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624680,,,6996,A,11114,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL624849,In vivo,,11732,A,11115,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL624850,In vivo,,11732,A,11116,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL874399,In vivo,,11732,A,11117,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL624851,In vivo,,11732,A,11118,
1,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL624852,In vivo,,11732,A,11119,
1,,Autocuration,Oral bioavailability in rat (dose 10 mg/kg),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL624853,In vivo,,13359,A,11120,
1,,Autocuration,Oral bioavailability in rat (Sprague-Dawley),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL624854,In vivo,,16618,A,11121,
1,,Autocuration,Oral bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL624855,In vivo,,13960,A,11122,
1,,Autocuration,Oral bioavailability in rats was determined in vivo,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL624856,In vivo,,13917,A,11123,
1,,Autocuration,Oral bioavailability in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL882957,In vivo,,14266,A,11124,
1,,Autocuration,Oral bioavailability of compound in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL624857,In vivo,,12359,A,11125,
1,,Intermediate,Oral bioavailability of compound in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622202,In vivo,,12359,A,11126,
1,,Autocuration,Bioavailability in rat of PMEA prodrug,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL622203,In vivo,,12359,A,11127,
1,,Intermediate,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625522,In vivo,,12359,A,11128,
1,,Autocuration,Serum conc at 3 hours following 25 mg/kg dose,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,,CHEMBL622868,In vivo,,10791,A,11129,
1,,Autocuration,Urine conc 0-5 hours following 25 mg/kg dose,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,1088.0,CHEMBL622869,In vivo,Urine,10791,A,11130,
1,,Autocuration,Urine conc 0-24 hours following 25 mg/kg dose,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,1088.0,CHEMBL622870,In vivo,Urine,10791,A,11131,
1,,Autocuration,Oral bioavailability in African green monkeys; 20-25,U,,,Chlorocebus aethiops,,,9534.0,BAO_0000218,22224,0,,,CHEMBL622871,In vivo,,138,A,11132,
1,,Intermediate,Oral bioavailability in cynomolgus monkey.,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL620560,In vivo,,14521,A,11133,
1,,Autocuration,Oral bioavailability in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL620561,In vivo,,13953,A,11134,
1,,Intermediate,Oral bioavailability in dog at 10 mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL620562,In vivo,,12836,A,11135,
1,,Intermediate,Oral bioavailability in hamster at 10 mg/kg oral dose,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL620563,In vivo,,12836,A,11136,
1,,Intermediate,Oral bioavailability in rat at 10 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL620564,In vivo,,12836,A,11137,
1,,Autocuration,Oral bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL872265,In vivo,,14521,A,11138,
1,,Autocuration,Oral bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL620565,In vivo,,13953,A,11139,
1,,Autocuration,Oral bioavailability,U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL620566,In vivo,,6799,A,11140,
1,,Autocuration,Oral bioavailability was determined; range 49-102%,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL620567,In vivo,,11311,A,11141,
1,,Intermediate,Oral bioavailability was determined in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL620568,In vivo,,4013,A,11142,
1,,Autocuration,Oral bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL620569,In vivo,,4013,A,11143,
1,,Autocuration,Oral bioavailability,U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL620570,In vivo,,17591,A,11144,
1,,Autocuration,Oral bioavailability was determined; Not orally available,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL620571,In vivo,,17591,A,11145,
1,,Intermediate,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL620572,In vivo,,15011,A,11146,
1,,Autocuration,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,,,Mus musculus,,,10090.0,BAO_0000218,22224,0,,,CHEMBL620573,In vivo,,15011,A,11147,
1,,Autocuration,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,,,Mus musculus,,,10090.0,BAO_0000218,22224,0,,,CHEMBL620574,In vivo,,15011,A,11148,
1,,Autocuration,Oral bioavailability in Rhesus monkey,U,,,Macaca mulatta,,,9544.0,BAO_0000218,22224,0,,,CHEMBL620575,In vivo,,9552,A,11149,
1,,Autocuration,Oral bioavailability in dog (female mongrel),U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL620576,In vivo,,9552,A,11150,
1,,Autocuration,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875846,In vivo,,3639,A,11151,
1,,Autocuration,Oral bioavailability in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL620577,In vivo,,13397,A,11152,
1,,Autocuration,Percentage Bioavailability was evaluated.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL620578,In vivo,,3031,A,11153,
1,,Autocuration,Bioavailability in rat administered i.d.,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL620579,In vivo,,12818,A,11154,
1,,Autocuration,Bioavailability,U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL621248,In vivo,,4847,A,11155,
1,,Autocuration,Bioavailability in dog (male Beagle) i.v. administration,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL625390,In vivo,,12421,A,11156,
1,,Autocuration,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625391,In vivo,,11966,A,11157,
1,,Autocuration,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL872266,In vivo,,11218,A,11158,
1,,Autocuration,Oral bioavailability in rat (Sprague-Dawley) (male),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625392,In vivo,,13129,A,11159,
1,,Intermediate,The oral bioavailability was measured on rats after oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625393,In vivo,,12350,A,11160,
1,,Intermediate,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625394,In vivo,,2231,A,11161,
1,,Intermediate,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL625395,In vivo,,2231,A,11162,
1,,Autocuration,Bioavailability in rat (dose 10 mg/kg i.d.),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625396,In vivo,,12187,A,11163,
1,,Autocuration,Bioavailability in dog (male Beagle) i.v. administration,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL625397,In vivo,,12421,A,11164,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625398,In vivo,,13256,A,11165,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL625399,In vivo,Blood,13256,A,11166,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2037.0,CHEMBL626074,In vivo,Cerebellum,13256,A,11167,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626075,In vivo,,13256,A,11168,
1,,Intermediate,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626076,In vivo,Plasma,2231,A,11169,
1,,Intermediate,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL626077,In vivo,Plasma,2231,A,11170,
1,,Intermediate,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626078,In vivo,Blood,12178,A,11171,
1,,Autocuration,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL625846,In vivo,Blood,12178,A,11172,
1,,Autocuration,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL625847,In vivo,Blood,12178,A,11173,
1,,Expert,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625848,In vivo,,15633,A,11174,
1,,Intermediate,Maximum concentration of compound in plasma administered orally to rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625849,In vivo,Plasma,14258,A,11175,
1,,Intermediate,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626023,In vivo,Plasma,14224,A,11176,
1,,Intermediate,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626024,In vivo,Plasma,14224,A,11177,
1,,Intermediate,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626025,In vivo,Plasma,14224,A,11178,
1,,Autocuration,Maximum concentration after 10 mg/kg by oral administration,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626026,In vivo,,5566,A,11179,
1,,Autocuration,Maximum concentration at a dose of 1.5 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626027,In vivo,,16935,A,11180,
1,,Autocuration,Maximum concentration at a dose of 2.0 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626028,In vivo,,16935,A,11181,
1,,Intermediate,Maximum concentration in dog plasma,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626029,In vivo,Plasma,14224,A,11182,
1,,Autocuration,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626030,In vivo,Plasma,12536,A,11183,
1,,Autocuration,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626031,In vivo,Plasma,12536,A,11184,
1,,Autocuration,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626032,In vivo,Plasma,12536,A,11185,
1,,Autocuration,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626033,In vivo,Plasma,12536,A,11186,
1,,Autocuration,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626034,In vivo,Plasma,12536,A,11187,
1,,Intermediate,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626035,In vivo,Plasma,9994,A,11188,
1,,Autocuration,Maximum concentration in plasma at Tmax,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626036,In vivo,Plasma,1434,A,11189,
1,,Expert,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626037,In vivo,Plasma,12836,A,11190,
1,,Intermediate,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,1969.0,CHEMBL626038,In vivo,Plasma,12836,A,11191,
1,,Intermediate,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626039,In vivo,Plasma,12836,A,11192,
1,,Intermediate,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626040,In vivo,Plasma,12545,A,11193,
1,,Intermediate,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1969.0,CHEMBL626041,In vivo,Plasma,13856,A,11194,
1,,Autocuration,Maximum concentration was calculated,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626042,In vivo,,3550,A,11195,
1,,Autocuration,Maximum concentration was calculated.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626043,In vivo,,2632,A,11196,
1,,Autocuration,Maximum concentration at a peroral dose of 10 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626044,In vivo,,5566,A,11197,
1,,Autocuration,Maximum concentration of the drug at 10 uM/dg administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626045,In vivo,,11883,A,11198,
1,,Autocuration,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626046,In vivo,,11883,A,11199,
1,,Intermediate,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626047,In vivo,Plasma,14122,A,11200,
1,,Intermediate,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,1969.0,CHEMBL626048,In vivo,Plasma,14122,A,11201,
1,,Intermediate,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626049,In vivo,Plasma,14122,A,11202,
1,,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626050,In vivo,Plasma,12542,A,11203,
1,,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL874541,In vivo,Plasma,12542,A,11204,
1,,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,1969.0,CHEMBL622826,In vivo,Plasma,12542,A,11205,
1,,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,1969.0,CHEMBL622827,In vivo,Plasma,12542,A,11206,
1,,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622828,In vivo,Plasma,12542,A,11207,
1,,Intermediate,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622829,In vivo,Plasma,14080,A,11208,
1,,Intermediate,Maximum concentration reached following intravenous administration in male rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876806,In vivo,,11911,A,11209,
1,,Intermediate,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622830,In vivo,,13204,A,11210,
1,,Intermediate,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622831,In vivo,,13204,A,11211,
1,,Intermediate,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626794,In vivo,,14346,A,11212,
1,,Intermediate,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626795,In vivo,,14346,A,11213,
1,,Intermediate,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626796,In vivo,,14346,A,11214,
1,,Intermediate,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626797,In vivo,,14346,A,11215,
1,,Intermediate,Maximum drug concentration is determined after oral dosing in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626798,In vivo,,14127,A,11216,
1,,Intermediate,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626799,In vivo,,14339,A,11217,
1,,Intermediate,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626800,In vivo,,14339,A,11218,
1,,Autocuration,Maximum plasma concentration,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626801,In vivo,Plasma,13494,A,11219,
1,,Intermediate,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876816,In vivo,Plasma,14925,A,11220,
1,,Intermediate,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626802,In vivo,Plasma,14474,A,11221,
1,,Intermediate,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626803,In vivo,Plasma,14474,A,11222,
1,,Autocuration,Maximum plasma concentration following oral administration of 30 umol/kg,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626804,In vivo,Plasma,13917,A,11223,
1,,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626805,,Plasma,9796,A,11224,
1,,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626309,,Plasma,9796,A,11225,
1,,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626310,,Plasma,9796,A,11226,
1,,Intermediate,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626311,,Plasma,9796,A,11227,
1,,Intermediate,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626312,,Plasma,9796,A,11228,
1,,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626313,,Uterus,9796,A,11229,
1,,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626314,,Uterus,9796,A,11230,
1,,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626315,,Uterus,9796,A,11231,
1,,Intermediate,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626316,,Uterus,9796,A,11232,
1,,Intermediate,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626317,,Uterus,9796,A,11233,
1,,Intermediate,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626318,,,8363,A,11234,
1,,Intermediate,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626319,,,8363,A,11235,
1,,Intermediate,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626320,,,8363,A,11236,
1,,Intermediate,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875053,,,8363,A,11237,
1,,Intermediate,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626321,,,8363,A,11238,
1,,Intermediate,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626322,,,8363,A,11239,
1,,Intermediate,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626323,,,8363,A,11240,
1,,Intermediate,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626324,,,8363,A,11241,
1,,Intermediate,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626325,,,8363,A,11242,
1,,Intermediate,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626326,,,8363,A,11243,
1,,Intermediate,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626327,,,8363,A,11244,
1,,Intermediate,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626328,,,8363,A,11245,
1,,Intermediate,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626329,,Blood,8684,A,11246,
1,,Intermediate,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626330,,Blood,8684,A,11247,
1,,Intermediate,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626331,,Blood,8684,A,11248,
1,,Intermediate,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626332,,Blood,8684,A,11249,
1,,Intermediate,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626333,,Blood,8684,A,11250,
1,,Intermediate,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626334,,Blood,8684,A,11251,
1,,Intermediate,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626335,,Blood,8684,A,11252,
1,,Intermediate,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624798,,Blood,8684,A,11253,
1,,Intermediate,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624799,,Brain,8684,A,11254,
1,,Intermediate,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624800,,Brain,8684,A,11255,
1,,Intermediate,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624801,,Brain,8684,A,11256,
1,,Intermediate,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624802,,Brain,8684,A,11257,
1,,Intermediate,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624803,,Brain,8684,A,11258,
1,,Intermediate,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624804,,Brain,8684,A,11259,
1,,Intermediate,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624805,,Brain,8684,A,11260,
1,,Intermediate,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL624806,,Brain,8684,A,11261,
1,,Intermediate,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624807,,,8684,A,11262,
1,,Intermediate,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624808,,,8684,A,11263,
1,,Intermediate,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624809,,,8684,A,11264,
1,,Intermediate,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624810,,,8684,A,11265,
1,,Intermediate,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877618,,,8684,A,11266,
1,,Intermediate,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624811,,,8684,A,11267,
1,,Intermediate,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624812,,,8684,A,11268,
1,,Intermediate,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624813,,,8684,A,11269,
1,,Intermediate,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624814,,,8684,A,11270,
1,,Intermediate,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624815,,,8684,A,11271,
1,,Intermediate,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624816,,,8684,A,11272,
1,,Intermediate,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624817,,,8684,A,11273,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624818,,,6996,A,11274,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624819,,,6996,A,11275,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624820,,,6996,A,11276,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624821,,,6996,A,11277,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624822,,,6996,A,11278,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624823,,,6996,A,11279,
1,,Intermediate,Observed diffusion coefficient in organic solvent for Escherichia coli,N,,,Escherichia coli,,,562.0,BAO_0000218,50212,1,,,CHEMBL624824,,,15599,A,11280,
1,,Intermediate,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624825,,Blood,9614,A,11281,
1,,Intermediate,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624826,,Blood,9614,A,11282,
1,,Intermediate,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2081.0,CHEMBL876817,,Cardiac atrium,9614,A,11283,
1,,Intermediate,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2081.0,CHEMBL624827,,Cardiac atrium,9614,A,11284,
1,,Intermediate,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624828,,,9614,A,11285,
1,,Intermediate,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624829,,,9614,A,11286,
1,,Intermediate,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624830,,Liver,9614,A,11287,
1,,Intermediate,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624831,,Liver,9614,A,11288,
1,,Intermediate,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2081.0,CHEMBL624832,,Cardiac atrium,9614,A,11289,
1,,Intermediate,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2081.0,CHEMBL624833,,Cardiac atrium,9614,A,11290,
1,,Intermediate,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624834,,,9614,A,11291,
1,,Intermediate,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624835,,,9614,A,11292,
1,,Intermediate,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL624836,,Spleen,9614,A,11293,
1,,Intermediate,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL624837,,Spleen,9614,A,11294,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624838,,Blood,9071,A,11295,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622188,,Blood,9071,A,11296,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622189,,Heart,9071,A,11297,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622190,,Heart,9071,A,11298,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625170,,Heart,9071,A,11299,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625171,,Kidney,9071,A,11300,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625172,,Kidney,9071,A,11301,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625173,,Kidney,9071,A,11302,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625174,,Liver,9071,A,11303,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625175,,Liver,9071,A,11304,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625176,,Liver,9071,A,11305,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625177,,Lung,9071,A,11306,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625178,,Lung,9071,A,11307,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625179,,Lung,9071,A,11308,
1,,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625180,,Lung,9071,A,11309,
1,,Autocuration,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625181,,,10677,A,11310,
1,,Intermediate,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL625182,,Urine,9750,A,11311,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625183,,,8319,A,11312,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875848,,,8319,A,11313,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622260,,,8319,A,11314,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622261,,,8319,A,11315,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622262,,,8319,A,11316,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622263,,Kidney,8319,A,11317,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622418,,Kidney,8319,A,11318,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622419,,Liver,8319,A,11319,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623388,In vivo,,13256,A,11320,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL623389,In vivo,Liver,13256,A,11321,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623390,In vivo,,13256,A,11322,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623391,In vivo,,13256,A,11323,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL623392,In vivo,Blood,13256,A,11324,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2037.0,CHEMBL623393,In vivo,Cerebellum,13256,A,11325,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623394,In vivo,,13256,A,11326,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618885,In vivo,,13256,A,11327,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618886,In vivo,Liver,13256,A,11328,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618887,In vivo,,13256,A,11329,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619535,In vivo,,13256,A,11330,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL619536,In vivo,Blood,13256,A,11331,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2037.0,CHEMBL619537,In vivo,Cerebellum,13256,A,11332,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619705,In vivo,,13256,A,11333,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619706,In vivo,,13256,A,11334,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL619707,In vivo,Liver,13256,A,11335,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL619708,In vivo,,13256,A,11336,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625219,In vivo,,13256,A,11337,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL625220,In vivo,Blood,13256,A,11338,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2037.0,CHEMBL625221,In vivo,Cerebellum,13256,A,11339,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625222,In vivo,,13256,A,11340,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625223,In vivo,,13256,A,11341,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL625224,In vivo,Liver,13256,A,11342,
1,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625225,In vivo,,13256,A,11343,
1,,Intermediate,Biodistribution in Rat blood after 24 hours of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625226,In vivo,Blood,8829,A,11344,
1,,Intermediate,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625227,In vivo,Blood,8829,A,11345,
1,,Intermediate,Biodistribution in Rat blood after 30 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625228,In vivo,Blood,8829,A,11346,
1,,Intermediate,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL875354,In vivo,Blood,8829,A,11347,
1,,Intermediate,Biodistribution in Rat blood after 5 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625229,In vivo,Blood,8829,A,11348,
1,,Intermediate,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625230,In vivo,Blood,8829,A,11349,
1,,Intermediate,Biodistribution in Rat heart after 24 hours of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625231,In vivo,Heart,8829,A,11350,
1,,Intermediate,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625900,In vivo,Heart,8829,A,11351,
1,,Intermediate,Biodistribution in Rat heart after 30 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625901,In vivo,Heart,8829,A,11352,
1,,Intermediate,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625902,In vivo,Heart,8829,A,11353,
1,,Intermediate,Biodistribution in Rat heart after 5 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625903,In vivo,Heart,8829,A,11354,
1,,Intermediate,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625904,In vivo,Heart,8829,A,11355,
1,,Intermediate,Biodistribution in Rat liver after 24 hours of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625905,In vivo,Liver,8829,A,11356,
1,,Intermediate,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627861,In vivo,Liver,8829,A,11357,
1,,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627862,In vivo,Liver,8829,A,11358,
1,,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627863,In vivo,Liver,8829,A,11359,
1,,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627769,In vivo,Liver,8829,A,11360,
1,,Intermediate,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL627770,In vivo,Plasma,13249,A,11361,
1,,Intermediate,Cmax in cynomolgus monkey (PO dose),N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL627771,In vivo,,13622,A,11362,
1,,Intermediate,Cmax in rat (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627772,In vivo,,13622,A,11363,
1,,Intermediate,Cmax in rat (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627773,In vivo,,13622,A,11364,
1,,Intermediate,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621922,In vivo,Plasma,13494,A,11365,
1,,Intermediate,Cmax in rat plasma after oral dose (10 mg/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621923,In vivo,Plasma,12170,A,11366,
1,,Autocuration,Cmax in plasma after oral dose (10 mg/kg),U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621924,In vivo,Plasma,12170,A,11367,
1,,Intermediate,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL621925,In vivo,Plasma,17025,A,11368,
1,,Autocuration,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL621926,In vivo,Plasma,17025,A,11369,
1,,Intermediate,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1969.0,CHEMBL621927,In vivo,Plasma,17025,A,11370,
1,,Intermediate,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621928,In vivo,Plasma,17025,A,11371,
1,,Intermediate,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621929,In vivo,Plasma,14187,A,11372,
1,,Intermediate,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL621930,In vivo,Plasma,14816,A,11373,
1,,Intermediate,Maximum plasma concentration after oral dosing in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621931,In vivo,Plasma,17820,A,11374,
1,,Autocuration,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621932,In vivo,Plasma,14380,A,11375,
1,,Autocuration,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621933,In vivo,Plasma,14380,A,11376,
1,,Intermediate,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL621934,In vivo,Plasma,14691,A,11377,
1,,Intermediate,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL621935,In vivo,Plasma,14691,A,11378,
1,,Intermediate,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL621936,In vivo,Plasma,13375,A,11379,
1,,Autocuration,Maximum plasma concentration was determined,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621937,In vivo,Plasma,6236,A,11380,
1,,Autocuration,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621938,In vivo,Plasma,14380,A,11381,
1,,Autocuration,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621939,In vivo,Plasma,14380,A,11382,
1,,Autocuration,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621940,In vivo,Plasma,14380,A,11383,
1,,Autocuration,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621941,In vivo,Plasma,14380,A,11384,
1,,Autocuration,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL621942,In vivo,Plasma,14380,A,11385,
1,,Autocuration,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626178,In vivo,Plasma,14380,A,11386,
1,,Autocuration,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626179,In vivo,Plasma,14380,A,11387,
1,,Autocuration,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626180,In vivo,Plasma,14380,A,11388,
1,,Intermediate,Plasma Cmax in rat (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626181,In vivo,Plasma,13622,A,11389,
1,,Intermediate,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626182,In vivo,,15372,A,11390,
1,,Intermediate,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626183,In vivo,,15372,A,11391,
1,,Intermediate,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626184,In vivo,,15372,A,11392,
1,,Intermediate,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626185,In vivo,,15372,A,11393,
1,,Intermediate,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626186,In vivo,Plasma,14925,A,11394,
1,,Intermediate,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL877589,In vivo,Plasma,14925,A,11395,
1,,Autocuration,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626187,In vivo,,11883,A,11396,
1,,Autocuration,Maximum concentration of the drug at 20 uM/dg administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626188,In vivo,,11883,A,11397,
1,,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626189,In vivo,,13391,A,11398,
1,,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL626855,In vivo,Blood,13391,A,11399,
1,,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL623781,In vivo,Blood,13391,A,11400,
1,,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL623782,In vivo,Blood,13391,A,11401,
1,,Intermediate,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623783,In vivo,Plasma,16360,A,11402,
1,,Intermediate,Cmax in dog plasma after 1mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL623784,In vivo,Plasma,3673,A,11403,
1,,Intermediate,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL623785,In vivo,Plasma,14431,A,11404,
1,,Intermediate,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623786,In vivo,Plasma,14431,A,11405,
1,,Intermediate,Oral maximum concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623787,In vivo,,14964,A,11406,
1,,Intermediate,Oral maximum concentration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623788,In vivo,,14964,A,11407,
1,,Intermediate,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL623789,In vivo,Plasma,14209,A,11408,
1,,Intermediate,Peak concentration in blood after intravenous administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL623790,In vivo,Blood,11355,A,11409,
1,,Intermediate,Peak concentration in blood after peroral administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL623791,In vivo,Blood,11355,A,11410,
1,,Intermediate,Peak concentration in rat plasma was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623792,In vivo,Plasma,11966,A,11411,
1,,Autocuration,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL623793,In vivo,Plasma,8918,A,11412,
1,,Intermediate,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL623794,In vivo,Plasma,8918,A,11413,
1,,Intermediate,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623795,In vivo,Plasma,8918,A,11414,
1,,Intermediate,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623796,,,8684,A,11415,
1,,Intermediate,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623797,,,8684,A,11416,
1,,Intermediate,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623798,,,8684,A,11417,
1,,Intermediate,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623799,,,8684,A,11418,
1,,Intermediate,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624490,,Intestine,8684,A,11419,
1,,Intermediate,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624491,,Intestine,8684,A,11420,
1,,Intermediate,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624492,,Intestine,8684,A,11421,
1,,Intermediate,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624493,,Intestine,8684,A,11422,
1,,Intermediate,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL877595,,Intestine,8684,A,11423,
1,,Intermediate,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624494,,Intestine,8684,A,11424,
1,,Intermediate,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624495,,Intestine,8684,A,11425,
1,,Intermediate,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL624681,,Intestine,8684,A,11426,
1,,Intermediate,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624682,,,8684,A,11427,
1,,Intermediate,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624683,,,8684,A,11428,
1,,Intermediate,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624684,,,8684,A,11429,
1,,Intermediate,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624685,,,8684,A,11430,
1,,Intermediate,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624686,,,8684,A,11431,
1,,Intermediate,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624687,,,8684,A,11432,
1,,Intermediate,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624688,,,8684,A,11433,
1,,Intermediate,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627161,,,8684,A,11434,
1,,Intermediate,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622127,,,8684,A,11435,
1,,Intermediate,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622128,,,8684,A,11436,
1,,Intermediate,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874384,,,8684,A,11437,
1,,Intermediate,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624898,,,8684,A,11438,
1,,Intermediate,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624899,,,8684,A,11439,
1,,Intermediate,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624900,,,8684,A,11440,
1,,Intermediate,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624901,,,8684,A,11441,
1,,Intermediate,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624902,,,8684,A,11442,
1,,Intermediate,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624903,,,8684,A,11443,
1,,Intermediate,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624904,,,8684,A,11444,
1,,Intermediate,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624905,,,8684,A,11445,
1,,Intermediate,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624906,,,8684,A,11446,
1,,Intermediate,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624907,,,8684,A,11447,
1,,Intermediate,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624908,,,8684,A,11448,
1,,Intermediate,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624909,,,8684,A,11449,
1,,Intermediate,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624910,,,8684,A,11450,
1,,Intermediate,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624911,,Muscle tissue,8684,A,11451,
1,,Intermediate,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL874388,,Muscle tissue,8684,A,11452,
1,,Intermediate,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL624912,,Muscle tissue,8684,A,11453,
1,,Intermediate,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622930,,Muscle tissue,8684,A,11454,
1,,Intermediate,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623121,,Muscle tissue,8684,A,11455,
1,,Intermediate,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623122,,Muscle tissue,8684,A,11456,
1,,Intermediate,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623123,,Muscle tissue,8684,A,11457,
1,,Intermediate,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623124,,Muscle tissue,8684,A,11458,
1,,Intermediate,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623125,,,8684,A,11459,
1,,Intermediate,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623126,,,8684,A,11460,
1,,Intermediate,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623127,,,8684,A,11461,
1,,Intermediate,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623128,,,8684,A,11462,
1,,Intermediate,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623129,,,8684,A,11463,
1,,Intermediate,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623130,,,8684,A,11464,
1,,Intermediate,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623131,,,8684,A,11465,
1,,Intermediate,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623132,,,8684,A,11466,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623133,,Liver,8319,A,11467,
1,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623134,,,8319,A,11468,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874389,,,8319,A,11469,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623135,,,8319,A,11470,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623136,,,8319,A,11471,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623137,,,8319,A,11472,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623138,,,8319,A,11473,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623139,,Kidney,8319,A,11474,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623140,,Kidney,8319,A,11475,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623141,,Liver,8319,A,11476,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623142,,Liver,8319,A,11477,
1,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623143,,,8319,A,11478,
1,,Intermediate,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL623144,,Urine,14571,A,11479,
1,,Intermediate,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623405,,Urine,14571,A,11480,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624074,,,8319,A,11481,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624075,,,8319,A,11482,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624076,,,8319,A,11483,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624077,,,8319,A,11484,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624078,,,8319,A,11485,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624079,,Kidney,8319,A,11486,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624261,,Kidney,8319,A,11487,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624262,,,8319,A,11488,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624263,,,8319,A,11489,
1,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624264,,,8319,A,11490,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624265,,,8319,A,11491,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624266,,,8319,A,11492,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624267,,,8319,A,11493,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624268,,,8319,A,11494,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875227,,,8319,A,11495,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624269,,Kidney,8319,A,11496,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624270,,Kidney,8319,A,11497,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624271,,,8319,A,11498,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624272,,,8319,A,11499,
1,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624273,,,8319,A,11500,
1,,Intermediate,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624274,,Urine,12064,A,11501,
1,,Intermediate,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624275,,Urine,12064,A,11502,
1,,Intermediate,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624276,,Urine,12064,A,11503,
1,,Intermediate,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624277,,Urine,12038,A,11504,
1,,Autocuration,% dose converted to 2-amino-5-chlorophenyl sulfate,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624278,,,14314,A,11505,
1,,Autocuration,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624279,,,14314,A,11506,
1,,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL624280,,Feces,11488,A,11507,
1,,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL624281,,Feces,11488,A,11508,
1,,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL622933,,Feces,11488,A,11509,
1,,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL622934,,Feces,11488,A,11510,
1,,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622935,In vivo,Liver,8829,A,11511,
1,,Intermediate,Biodistribution in Rat liver after 5 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622936,In vivo,Liver,8829,A,11512,
1,,Intermediate,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL875228,In vivo,Liver,8829,A,11513,
1,,Intermediate,Biodistribution in Rat lung after 24 hours of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622937,In vivo,Lung,8829,A,11514,
1,,Intermediate,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622938,In vivo,Lung,8829,A,11515,
1,,Intermediate,Biodistribution in Rat lung after 30 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL619736,In vivo,Lung,8829,A,11516,
1,,Intermediate,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625117,In vivo,Lung,8829,A,11517,
1,,Intermediate,Biodistribution in Rat lung after 5 minutes of iv administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625118,In vivo,Lung,8829,A,11518,
1,,Intermediate,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625119,In vivo,Lung,8829,A,11519,
1,,Intermediate,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL625120,In vivo,Cerebellum,14972,A,11520,
1,,Intermediate,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625121,In vivo,,14972,A,11521,
1,,Intermediate,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000006.0,CHEMBL625122,In vivo,Thalamus,14972,A,11522,
1,,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL622204,In vivo,Blood,14608,A,11523,
1,,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL877503,In vivo,Blood,14608,A,11524,
1,,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627127,In vivo,Blood,14608,A,11525,
1,,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,,,,,,,BAO_0000218,22224,0,,10000000.0,CHEMBL627128,In vivo,Hippocampus,14608,A,11526,
1,,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,,,,,,,BAO_0000218,22224,0,,10000000.0,CHEMBL627129,In vivo,Hippocampus,14608,A,11527,
1,,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,,,,,,,BAO_0000218,22224,0,,10000000.0,CHEMBL627130,In vivo,Hippocampus,14608,A,11528,
1,,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627131,In vivo,Brain,14608,A,11529,
1,,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627132,In vivo,Brain,14608,A,11530,
1,,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL627133,In vivo,Brain,14608,A,11531,
1,,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL627134,In vivo,Cerebellum,14608,A,11532,
1,,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL627135,In vivo,Cerebellum,14608,A,11533,
1,,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL627136,In vivo,Cerebellum,14608,A,11534,
1,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628435,In vivo,,14608,A,11535,
1,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628436,In vivo,,14608,A,11536,
1,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628437,In vivo,,14608,A,11537,
1,,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL628438,In vivo,Heart,14608,A,11538,
1,,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL628439,In vivo,Heart,14608,A,11539,
1,,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL628440,In vivo,Heart,14608,A,11540,
1,,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628441,In vivo,Hippocampus,14608,A,11541,
1,,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628442,In vivo,Hippocampus,14608,A,11542,
1,,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628443,In vivo,Hippocampus,14608,A,11543,
1,,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628444,In vivo,Kidney,14608,A,11544,
1,,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628445,In vivo,Kidney,14608,A,11545,
1,,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL877504,In vivo,Kidney,14608,A,11546,
1,,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628446,In vivo,Liver,14608,A,11547,
1,,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626874,In vivo,Liver,14608,A,11548,
1,,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626875,In vivo,Liver,14608,A,11549,
1,,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626876,In vivo,Lung,14608,A,11550,
1,,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626877,In vivo,Lung,14608,A,11551,
1,,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626878,In vivo,Lung,14608,A,11552,
1,,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL626879,In vivo,Muscle tissue,14608,A,11553,
1,,Autocuration,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL626880,In vivo,Plasma,8918,A,11554,
1,,Intermediate,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL626881,In vivo,Plasma,8918,A,11555,
1,,Intermediate,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626882,In vivo,Plasma,8918,A,11556,
1,,Intermediate,Peak plasma concentration was measured in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626883,In vivo,Plasma,14470,A,11557,
1,,Intermediate,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626884,In vivo,,14393,A,11558,
1,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626885,In vivo,,14886,A,11559,
1,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626886,In vivo,,14886,A,11560,
1,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626887,In vivo,,14886,A,11561,
1,,Intermediate,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626888,In vivo,,14393,A,11562,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626889,In vivo,,13465,A,11563,
1,,Autocuration,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626761,In vivo,,13465,A,11564,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626762,In vivo,,13465,A,11565,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626763,In vivo,,13465,A,11566,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626764,In vivo,,13465,A,11567,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626765,In vivo,,13465,A,11568,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626766,In vivo,,13465,A,11569,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626767,In vivo,,13465,A,11570,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626768,In vivo,,13465,A,11571,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626769,In vivo,,13465,A,11572,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL874463,In vivo,,13465,A,11573,
1,,Autocuration,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626770,In vivo,,13465,A,11574,
1,,Autocuration,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626771,In vivo,,13465,A,11575,
1,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626772,In vivo,,13465,A,11576,
1,,Intermediate,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL626773,In vivo,,14731,A,11577,
1,,Intermediate,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626774,In vivo,,14731,A,11578,
1,,Intermediate,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626775,In vivo,,13376,A,11579,
1,,Intermediate,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626776,In vivo,,13376,A,11580,
1,,Intermediate,Maximum concentration (Cmax) in rat when administered orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626777,In vivo,,14443,A,11581,
1,,Autocuration,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL626778,In vivo,Plasma,13465,A,11582,
1,,Autocuration,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL626779,In vivo,,16359,A,11583,
1,,Autocuration,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL626780,In vivo,,16359,A,11584,
1,,Autocuration,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626781,In vivo,Plasma,15618,A,11585,
1,,Intermediate,Pharmacokinetic profile Cmax was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632164,In vivo,,14554,A,11586,
1,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL632165,In vivo,,11537,A,11587,
1,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL632166,In vivo,,11537,A,11588,
1,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL632167,In vivo,,11537,A,11589,
1,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL632168,In vivo,,11537,A,11590,
1,,Autocuration,Cmax in rat plasma,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1969.0,CHEMBL632169,In vivo,Plasma,2021,A,11591,
1,,Intermediate,Cmax in dog plasma after 30mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL632170,In vivo,Plasma,5932,A,11592,
1,,Intermediate,Cmax in rat plasma after 30mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632171,In vivo,Plasma,5932,A,11593,
1,,Intermediate,Plasma level in rats at 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632172,In vivo,Plasma,17320,A,11594,
1,,Intermediate,Tested for maximum plasma concentration in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL632173,In vivo,Plasma,15831,A,11595,
1,,Intermediate,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632174,In vivo,,15078,A,11596,
1,,Intermediate,The Cmax values in female wistar rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632175,In vivo,,14941,A,11597,
1,,Intermediate,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL632176,In vivo,Plasma,15343,A,11598,
1,,Intermediate,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632177,In vivo,Plasma,15343,A,11599,
1,,Intermediate,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632178,In vivo,Plasma,14856,A,11600,
1,,Intermediate,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632179,In vivo,,13129,A,11601,
1,,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632180,In vivo,Blood,13098,A,11602,
1,,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632181,In vivo,Blood,13098,A,11603,
1,,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632182,In vivo,Blood,13098,A,11604,
1,,Autocuration,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,,,Mus musculus,,,10090.0,BAO_0000218,22224,0,,178.0,CHEMBL632183,In vivo,Blood,15478,A,11605,
1,,Intermediate,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL632184,In vivo,,15341,A,11606,
1,,Intermediate,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874470,In vivo,,15341,A,11607,
1,,Intermediate,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631302,,,8684,A,11608,
1,,Intermediate,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631303,,,8684,A,11609,
1,,Intermediate,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631304,,,8684,A,11610,
1,,Intermediate,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631305,,,8684,A,11611,
1,,Intermediate,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631306,,,8684,A,11612,
1,,Intermediate,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631307,,,8684,A,11613,
1,,Intermediate,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631308,,,8684,A,11614,
1,,Intermediate,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625557,,,8684,A,11615,
1,,Intermediate,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625558,,Spleen,8684,A,11616,
1,,Intermediate,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625559,,Spleen,8684,A,11617,
1,,Intermediate,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625560,,Spleen,8684,A,11618,
1,,Intermediate,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625561,,Spleen,8684,A,11619,
1,,Intermediate,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625562,,Spleen,8684,A,11620,
1,,Intermediate,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL875320,,Spleen,8684,A,11621,
1,,Intermediate,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625563,,Spleen,8684,A,11622,
1,,Intermediate,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625564,,Spleen,8684,A,11623,
1,,Intermediate,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL625565,,Uterus,8684,A,11624,
1,,Intermediate,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL625566,,Uterus,8684,A,11625,
1,,Intermediate,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL625567,,Uterus,8684,A,11626,
1,,Intermediate,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL625568,,Uterus,8684,A,11627,
1,,Intermediate,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL628217,,Uterus,8684,A,11628,
1,,Intermediate,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL628218,,Uterus,8684,A,11629,
1,,Intermediate,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL628219,,Uterus,8684,A,11630,
1,,Intermediate,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL628220,,Uterus,8684,A,11631,
1,,Autocuration,Distribution in the blood after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628221,,,8926,A,11632,
1,,Autocuration,Distribution in the blood after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628222,,,8926,A,11633,
1,,Autocuration,Distribution in the blood after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628223,,,8926,A,11634,
1,,Autocuration,Distribution in the blood after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628224,,,8926,A,11635,
1,,Autocuration,Distribution in the blood after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628225,,,8926,A,11636,
1,,Autocuration,Distribution in the blood after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628226,,,8926,A,11637,
1,,Autocuration,Distribution in the bone after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628227,,,8926,A,11638,
1,,Autocuration,Distribution in the bone after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875481,,,8926,A,11639,
1,,Autocuration,Distribution in the bone after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628228,,,8926,A,11640,
1,,Autocuration,Distribution in the bone after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628229,,,8926,A,11641,
1,,Autocuration,Distribution in the bone after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628230,,,8926,A,11642,
1,,Autocuration,Distribution in the bone after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628231,,,8926,A,11643,
1,,Autocuration,Distribution in the heart after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628232,,,8926,A,11644,
1,,Autocuration,Distribution in the heart after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628233,,,8926,A,11645,
1,,Autocuration,Distribution in the heart after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628234,,,8926,A,11646,
1,,Autocuration,Distribution in the heart after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628235,,,8926,A,11647,
1,,Autocuration,Distribution in the heart after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628236,,,8926,A,11648,
1,,Autocuration,Distribution in the heart after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628237,,,8926,A,11649,
1,,Autocuration,Distribution in the kidneys after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628238,,,8926,A,11650,
1,,Autocuration,Distribution in the kidneys after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628239,,,8926,A,11651,
1,,Autocuration,Distribution in the kidneys after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628240,,,8926,A,11652,
1,,Autocuration,Distribution in the kidneys after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628241,,,8926,A,11653,
1,,Autocuration,Distribution in the kidneys after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628242,,,8926,A,11654,
1,,Autocuration,Distribution in the kidneys after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875482,,,8926,A,11655,
1,,Autocuration,Distribution in the liver after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628243,,,8926,A,11656,
1,,Autocuration,Distribution in the liver after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628244,,,8926,A,11657,
1,,Autocuration,Distribution in the liver after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628245,,,8926,A,11658,
1,,Autocuration,Distribution in the liver after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628246,,,8926,A,11659,
1,,Autocuration,Distribution in the liver after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628247,,,8926,A,11660,
1,,Autocuration,Distribution in the liver after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628248,,,8926,A,11661,
1,,Autocuration,Distribution in the lung after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628249,,,8926,A,11662,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625452,,,14839,A,11663,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625453,,,14839,A,11664,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625454,,,14839,A,11665,
1,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623844,,,14839,A,11666,
1,,Intermediate,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623845,,,12178,A,11667,
1,,Intermediate,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623846,,,12178,A,11668,
1,,Autocuration,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623847,,,12178,A,11669,
1,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623848,,,12186,A,11670,
1,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623849,,,12186,A,11671,
1,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623850,,,12186,A,11672,
1,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623851,,,12186,A,11673,
1,,Autocuration,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL623852,,,12187,A,11674,
1,,Intermediate,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL624551,,,12187,A,11675,
1,,Intermediate,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL624552,,,12187,A,11676,
1,,Autocuration,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL624553,,,12187,A,11677,
1,,Autocuration,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL624554,,,12187,A,11678,
1,,Intermediate,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624555,,,12187,A,11679,
1,,Intermediate,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624741,,,12187,A,11680,
1,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624742,,,14122,A,11681,
1,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL624743,,,14122,A,11682,
1,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877606,,,14122,A,11683,
1,,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL624744,,,13391,A,11684,
1,,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL624745,,Blood,13391,A,11685,
1,,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL624746,,Blood,13391,A,11686,
1,,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL624747,,Blood,13391,A,11687,
1,,Autocuration,Oral absorption expressed as Area under curve was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624748,,,16360,A,11688,
1,,Intermediate,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622504,,,3673,A,11689,
1,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622505,,,14122,A,11690,
1,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL622506,,,14122,A,11691,
1,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL622507,,,14122,A,11692,
1,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622508,,,14122,A,11693,
1,,Autocuration,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622509,,,13889,A,11694,
1,,Intermediate,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622510,,,14393,A,11695,
1,,Intermediate,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622511,,,17279,A,11696,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL622512,,,14548,A,11697,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL622513,,,14548,A,11698,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL622514,,,14548,A,11699,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622515,,,14548,A,11700,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622516,,,14548,A,11701,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622517,,,14548,A,11702,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622518,,,14548,A,11703,
1,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622519,,,14548,A,11704,
1,,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622520,In vivo,Muscle tissue,14608,A,11705,
1,,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622521,In vivo,Muscle tissue,14608,A,11706,
1,,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL625113,In vivo,Zone of skin,14608,A,11707,
1,,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL625114,In vivo,Zone of skin,14608,A,11708,
1,,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL874397,In vivo,Zone of skin,14608,A,11709,
1,,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625115,In vivo,Spleen,14608,A,11710,
1,,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625116,In vivo,Spleen,14608,A,11711,
1,,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL623932,In vivo,Spleen,14608,A,11712,
1,,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL623933,In vivo,Striatum,14608,A,11713,
1,,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL623934,In vivo,Striatum,14608,A,11714,
1,,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL623935,In vivo,Striatum,14608,A,11715,
1,,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL623936,In vivo,Thyroid gland,14608,A,11716,
1,,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL623937,In vivo,Thyroid gland,14608,A,11717,
1,,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL623938,In vivo,Thyroid gland,14608,A,11718,
1,,Intermediate,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623939,,,15383,A,11719,
1,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623940,,,15383,A,11720,
1,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623941,,,15383,A,11721,
1,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627216,,,15383,A,11722,
1,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623942,,,15383,A,11723,
1,,Intermediate,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL618793,,Brain,15383,A,11724,
1,,Intermediate,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL618794,,Brain,15383,A,11725,
1,,Intermediate,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL618795,,Brain,15383,A,11726,
1,,Intermediate,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618796,,,15383,A,11727,
1,,Intermediate,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618797,,,15383,A,11728,
1,,Intermediate,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618798,,Kidney,15383,A,11729,
1,,Intermediate,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618799,,Kidney,15383,A,11730,
1,,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618800,,Kidney,15383,A,11731,
1,,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618801,,Kidney,15383,A,11732,
1,,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618802,,Kidney,15383,A,11733,
1,,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL618803,,Kidney,15383,A,11734,
1,,Intermediate,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618804,,Liver,15383,A,11735,
1,,Intermediate,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618805,,Liver,15383,A,11736,
1,,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618806,,Liver,15383,A,11737,
1,,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618807,,Liver,15383,A,11738,
1,,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618808,,Liver,15383,A,11739,
1,,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL618809,,Liver,15383,A,11740,
1,,Intermediate,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL618810,,Muscle tissue,15383,A,11741,
1,,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL618811,,Muscle tissue,15383,A,11742,
1,,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL875844,,Muscle tissue,15383,A,11743,
1,,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL618812,,Muscle tissue,15383,A,11744,
1,,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL618813,,Muscle tissue,15383,A,11745,
1,,Intermediate,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618814,,,15383,A,11746,
1,,Intermediate,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618815,,,15383,A,11747,
1,,Intermediate,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618816,,,15383,A,11748,
1,,Intermediate,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL618817,,,15383,A,11749,
1,,Intermediate,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL620544,,,15383,A,11750,
1,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626230,In vivo,,15341,A,11751,
1,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626231,In vivo,,15341,A,11752,
1,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626232,In vivo,,15341,A,11753,
1,,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626233,In vivo,Plasma,14906,A,11754,
1,,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626234,In vivo,Plasma,14906,A,11755,
1,,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL875341,In vivo,Plasma,14906,A,11756,
1,,Intermediate,The maximum plasma concentration (100 mg/kg) administered orally in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL626235,In vivo,Plasma,14215,A,11757,
1,,Autocuration,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,,,Callithrix,,,9481.0,BAO_0000218,22224,0,,1969.0,CHEMBL626236,In vivo,Plasma,14215,A,11758,
1,,Autocuration,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL626237,In vivo,Plasma,14215,A,11759,
1,,Intermediate,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626238,In vivo,Plasma,14215,A,11760,
1,,Intermediate,The maximum plasma concentration (200 mg/kg) administered orally in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL622412,In vivo,Plasma,14215,A,11761,
1,,Intermediate,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623114,In vivo,Plasma,14215,A,11762,
1,,Autocuration,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,,,Callithrix,,,9481.0,BAO_0000218,22224,0,,1969.0,CHEMBL623115,In vivo,Plasma,14215,A,11763,
1,,Autocuration,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL623116,In vivo,Plasma,14215,A,11764,
1,,Autocuration,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,1969.0,CHEMBL623117,In vivo,Plasma,14215,A,11765,
1,,Intermediate,The maximum plasma concentration (400 mg/kg) administered orally in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL623118,In vivo,Plasma,14215,A,11766,
1,,Intermediate,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623119,In vivo,Plasma,14215,A,11767,
1,,Intermediate,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623120,In vivo,Plasma,14215,A,11768,
1,,Intermediate,The maximum plasma concentration (800 mg/kg) administered orally in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL623286,In vivo,Plasma,14215,A,11769,
1,,Intermediate,The maximum plasma concentration was measured on rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623287,In vivo,Plasma,14067,A,11770,
1,,Intermediate,The maximum plasma concentration was measured on rats after oral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623288,In vivo,Plasma,12350,A,11771,
1,,Intermediate,Plasma drug Cmax in rat (PO dose),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623289,In vivo,Plasma,14813,A,11772,
1,,Autocuration,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623290,In vivo,,12536,A,11773,
1,,Intermediate,maximum Plasma concentration in Dog was determined after Peroral administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL623291,In vivo,Plasma,14169,A,11774,
1,,Intermediate,maximum Plasma concentration in Rats was determined after Peroral administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623292,In vivo,Plasma,14169,A,11775,
1,,Intermediate,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL623293,In vivo,Plasma,15604,A,11776,
1,,Autocuration,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL623294,In vivo,Plasma,15604,A,11777,
1,,Intermediate,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623295,In vivo,Plasma,15604,A,11778,
1,,Intermediate,maximum concentration was measured when administered through oral route in mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623296,In vivo,,14387,A,11779,
1,,Intermediate,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL875349,,,15115,A,11780,
1,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL623297,,,15115,A,11781,
1,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL623298,,,15115,A,11782,
1,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL623299,,,15115,A,11783,
1,,Intermediate,Pharmacokinetic parameter was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623300,,,16359,A,11784,
1,,Intermediate,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623301,,,12829,A,11785,
1,,Intermediate,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623302,,,12829,A,11786,
1,,Intermediate,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623303,,,12829,A,11787,
1,,Intermediate,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623304,,,12829,A,11788,
1,,Intermediate,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623305,,,12829,A,11789,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623306,,Plasma,15137,A,11790,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623307,,Plasma,15137,A,11791,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL623308,,Plasma,15137,A,11792,
1,,Intermediate,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL623309,,Plasma,15137,A,11793,
1,,Intermediate,Plasma Concentration after 120 min of oral administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623310,,,13509,A,11794,
1,,Intermediate,Plasma Concentration after 30 min of oral administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623311,,,13509,A,11795,
1,,Intermediate,Plasma Concentration after 60 min of oral administration to mice,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL623312,,,13509,A,11796,
1,,Intermediate,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL875350,,,13509,A,11797,
1,,Intermediate,Plasma Concentration after 90 min of oral administration to mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628635,,,13509,A,11798,
1,,Intermediate,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628636,,,12064,A,11799,
1,,Intermediate,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628637,,,12064,A,11800,
1,,Intermediate,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628058,,,12064,A,11801,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628059,,,10677,A,11802,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628060,,,10677,A,11803,
1,,Autocuration,Distribution in the lung after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628061,,,8926,A,11804,
1,,Autocuration,Distribution in the lung after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628062,,,8926,A,11805,
1,,Autocuration,Distribution in the lung after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628063,,,8926,A,11806,
1,,Autocuration,Distribution in the lung after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628064,,,8926,A,11807,
1,,Autocuration,Distribution in the lung after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628065,,,8926,A,11808,
1,,Autocuration,Distribution in the muscle after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2385.0,CHEMBL628066,,Muscle tissue,8926,A,11809,
1,,Autocuration,Distribution in the muscle after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2385.0,CHEMBL628067,,Muscle tissue,8926,A,11810,
1,,Intermediate,Distribution in the muscle after 30 min of intravenous administration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2385.0,CHEMBL874646,,Muscle tissue,8926,A,11811,
1,,Autocuration,Distribution in the muscle after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2385.0,CHEMBL628068,,Muscle tissue,8926,A,11812,
1,,Autocuration,Distribution in the muscle after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2385.0,CHEMBL628069,,Muscle tissue,8926,A,11813,
1,,Autocuration,Distribution in the muscle after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2385.0,CHEMBL628070,,Muscle tissue,8926,A,11814,
1,,Autocuration,Distribution in the spleen after 120 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628071,,Spleen,8926,A,11815,
1,,Autocuration,Distribution in the spleen after 15 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628072,,Spleen,8926,A,11816,
1,,Autocuration,Distribution in the spleen after 30 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628073,,Spleen,8926,A,11817,
1,,Autocuration,Distribution in the spleen after 5 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628074,,Spleen,8926,A,11818,
1,,Autocuration,Distribution in the spleen after 60 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628075,,Spleen,8926,A,11819,
1,,Autocuration,Distribution in the spleen after 90 min of intravenous administration,U,,,,,,,BAO_0000019,22224,0,,2106.0,CHEMBL628076,,Spleen,8926,A,11820,
1,,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1235.0,CHEMBL628077,,Adrenal cortex,7570,A,11821,
1,,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628078,,Blood,7570,A,11822,
1,,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628079,,Liver,7570,A,11823,
1,,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL628080,,Female gonad,7570,A,11824,
1,,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628081,,Thyroid gland,7570,A,11825,
1,,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1235.0,CHEMBL628082,,Adrenal cortex,7570,A,11826,
1,,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL874647,,Blood,7570,A,11827,
1,,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626406,,Liver,7570,A,11828,
1,,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL626407,,Female gonad,7570,A,11829,
1,,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626408,,Thyroid gland,7570,A,11830,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626409,,Blood,8608,A,11831,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626410,,Blood,8608,A,11832,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626411,,Blood,8608,A,11833,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626412,,Blood,8608,A,11834,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626413,,Blood,8608,A,11835,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626414,,Blood,8608,A,11836,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626415,,Blood,8608,A,11837,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626416,,Blood,8608,A,11838,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627062,,Blood,8608,A,11839,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627063,,Blood,8608,A,11840,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627064,,Blood,8608,A,11841,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627227,,Blood,8608,A,11842,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627228,,Blood,8608,A,11843,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627229,,Blood,8608,A,11844,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625792,,Blood,8608,A,11845,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625793,,Blood,8608,A,11846,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625794,,Blood,8608,A,11847,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625795,,Blood,8608,A,11848,
1,,Intermediate,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625796,,,13792,A,11849,
1,,Intermediate,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625797,,,13376,A,11850,
1,,Intermediate,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625798,,,13376,A,11851,
1,,Autocuration,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875613,,,14380,A,11852,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625799,,,14380,A,11853,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625800,,,14380,A,11854,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625801,,,14380,A,11855,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625802,,,14380,A,11856,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625803,,,14380,A,11857,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625804,,,14380,A,11858,
1,,Autocuration,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622530,,,14380,A,11859,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622531,,,13701,A,11860,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622532,,,13701,A,11861,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623176,,,13701,A,11862,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623177,,,13701,A,11863,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623178,,,13701,A,11864,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623179,,,13701,A,11865,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623180,,,13701,A,11866,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623181,,,13701,A,11867,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624131,,,13701,A,11868,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624132,,,13701,A,11869,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624133,,,13701,A,11870,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624846,,,13701,A,11871,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624847,,,13701,A,11872,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL624848,,,13701,A,11873,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625012,,,13701,A,11874,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625013,,,13701,A,11875,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625014,,,13701,A,11876,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625015,,,13701,A,11877,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625016,,,13701,A,11878,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625017,,,13701,A,11879,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625018,,,13701,A,11880,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625019,,,13701,A,11881,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625020,,,13701,A,11882,
1,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625021,,,13701,A,11883,
1,,Intermediate,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625022,,,14393,A,11884,
1,,Intermediate,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625023,,,14731,A,11885,
1,,Intermediate,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL625024,,,14731,A,11886,
1,,Intermediate,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL627626,,,14731,A,11887,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,,,,,,BAO_0000218,22224,0,,955.0,CHEMBL627627,,Brain,13758,A,11888,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,,,,,,,BAO_0000218,22224,0,,1977.0,CHEMBL627628,,Serum,13758,A,11889,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,,,,,,BAO_0000218,22224,0,,955.0,CHEMBL627629,,Brain,13758,A,11890,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,,,,,,,BAO_0000218,22224,0,,1977.0,CHEMBL627630,,Serum,13758,A,11891,
1,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627631,,,16359,A,11892,
1,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629515,,,16359,A,11893,
1,,Intermediate,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL629516,,Spleen,15383,A,11894,
1,,Intermediate,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL629517,,Spleen,15383,A,11895,
1,,Intermediate,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL629518,,Spleen,15383,A,11896,
1,,Intermediate,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL877499,,,15383,A,11897,
1,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629519,,,15383,A,11898,
1,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629520,,,15383,A,11899,
1,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629521,,,15383,A,11900,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629522,,,14439,A,11901,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629523,,,14439,A,11902,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629524,,,14439,A,11903,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629525,,,14439,A,11904,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629526,,,14439,A,11905,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629527,,,14439,A,11906,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629528,,,14439,A,11907,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629529,,,14439,A,11908,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629530,,,14439,A,11909,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629531,,,14439,A,11910,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628656,,,14439,A,11911,
1,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628657,,,14439,A,11912,
1,,Intermediate,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628658,In vivo,,13751,A,11913,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628659,In vivo,,13751,A,11914,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877500,In vivo,,13751,A,11915,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628660,In vivo,,13751,A,11916,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628661,In vivo,,13751,A,11917,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628662,In vivo,,13751,A,11918,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628663,In vivo,,13751,A,11919,
1,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628664,In vivo,,13751,A,11920,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628665,In vivo,Blood,13751,A,11921,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628666,In vivo,Blood,13751,A,11922,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628667,In vivo,Blood,13751,A,11923,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628668,In vivo,Blood,13751,A,11924,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628669,In vivo,Blood,13751,A,11925,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628670,In vivo,Blood,13751,A,11926,
1,,Intermediate,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628671,In vivo,Blood,13751,A,11927,
1,,Intermediate,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL628672,In vivo,Bone,13751,A,11928,
1,,Intermediate,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL630300,In vivo,Bone,13751,A,11929,
1,,Intermediate,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL629787,In vivo,Bone,13751,A,11930,
1,,Intermediate,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL629788,In vivo,Bone,13751,A,11931,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629789,In vivo,Brain,13751,A,11932,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629790,In vivo,Brain,13751,A,11933,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629791,In vivo,Brain,13751,A,11934,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629792,In vivo,Brain,13751,A,11935,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629793,In vivo,Brain,13751,A,11936,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629794,In vivo,Brain,13751,A,11937,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874459,,,10677,A,11938,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629795,,,10677,A,11939,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629796,,,10677,A,11940,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629797,,,10677,A,11941,
1,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629798,,,10677,A,11942,
1,,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2369.0,CHEMBL629799,In vivo,Adrenal gland,10911,A,11943,
1,,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2369.0,CHEMBL629800,In vivo,Adrenal gland,10911,A,11944,
1,,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2369.0,CHEMBL629801,In vivo,Adrenal gland,10911,A,11945,
1,,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2369.0,CHEMBL629802,In vivo,Adrenal gland,10911,A,11946,
1,,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2369.0,CHEMBL629803,In vivo,Adrenal gland,10911,A,11947,
1,,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629804,In vivo,Blood,10911,A,11948,
1,,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629805,In vivo,Blood,10911,A,11949,
1,,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629806,In vivo,Blood,10911,A,11950,
1,,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629807,In vivo,Blood,10911,A,11951,
1,,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629808,In vivo,Blood,10911,A,11952,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629809,In vivo,Brain,10911,A,11953,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629810,In vivo,Brain,10911,A,11954,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629811,In vivo,Brain,10911,A,11955,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629812,In vivo,Brain,10911,A,11956,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629813,In vivo,Brain,10911,A,11957,
1,,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL874460,In vivo,Brain,10911,A,11958,
1,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629814,In vivo,,10911,A,11959,
1,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629815,In vivo,,10911,A,11960,
1,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629816,In vivo,,10911,A,11961,
1,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629817,In vivo,,10911,A,11962,
1,,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626643,In vivo,Kidney,10911,A,11963,
1,,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626644,In vivo,Kidney,10911,A,11964,
1,,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626806,In vivo,Kidney,10911,A,11965,
1,,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626807,In vivo,Kidney,10911,A,11966,
1,,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627261,In vivo,Liver,10911,A,11967,
1,,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627262,In vivo,Liver,10911,A,11968,
1,,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627263,In vivo,Liver,10911,A,11969,
1,,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627264,In vivo,Liver,10911,A,11970,
1,,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627265,In vivo,Lung,10911,A,11971,
1,,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627266,In vivo,Lung,10911,A,11972,
1,,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627267,In vivo,Lung,10911,A,11973,
1,,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627268,In vivo,Lung,10911,A,11974,
1,,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627269,In vivo,Muscle tissue,10911,A,11975,
1,,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627270,In vivo,Muscle tissue,10911,A,11976,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627271,,,8608,A,11977,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627946,,,8608,A,11978,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875472,,,8608,A,11979,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627947,,,8608,A,11980,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627948,,,8608,A,11981,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628113,,,8608,A,11982,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628114,,,8608,A,11983,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628115,,,8608,A,11984,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628116,,,8608,A,11985,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628117,,,8608,A,11986,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628118,,,8608,A,11987,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628119,,,8608,A,11988,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628120,,,8608,A,11989,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628121,,,8608,A,11990,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628122,,,8608,A,11991,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627297,,,8608,A,11992,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627298,,,8608,A,11993,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627299,,,8608,A,11994,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627300,,,8608,A,11995,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627301,,,8608,A,11996,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627302,,,8608,A,11997,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627303,,,8608,A,11998,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627304,,,8608,A,11999,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627305,,,8608,A,12000,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627306,,,8608,A,12001,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623982,,,8608,A,12002,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623983,,,8608,A,12003,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623984,,,8608,A,12004,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623985,,,8608,A,12005,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623986,,,8608,A,12006,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623987,,,8608,A,12007,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623988,,,8608,A,12008,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623989,,,8608,A,12009,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622215,,,8608,A,12010,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622216,,,8608,A,12011,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877481,,,8608,A,12012,
1,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622217,,,16359,A,12013,
1,,Intermediate,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622218,,,13701,A,12014,
1,,Intermediate,Pharmacokinetic profile AUC was evaluated in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622219,,,14554,A,12015,
1,,Autocuration,Pharmacokinetic property (Area under curve),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622220,,,6241,A,12016,
1,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622221,,,11537,A,12017,
1,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622222,,,11537,A,12018,
1,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL622223,,,11537,A,12019,
1,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622224,,,11537,A,12020,
1,,Autocuration,Plasma concentration (AUC) was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622225,,,13118,A,12021,
1,,Autocuration,Plasma concentration (AUC) was determined; Not detectable,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622226,,,13118,A,12022,
1,,Intermediate,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL624154,,,9562,A,12023,
1,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624155,,,10363,A,12024,
1,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624156,,,10363,A,12025,
1,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624157,,,10363,A,12026,
1,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624158,,,10363,A,12027,
1,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624159,,,12504,A,12028,
1,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624160,,,12504,A,12029,
1,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624161,,,12504,A,12030,
1,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624162,,,12504,A,12031,
1,,Intermediate,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624163,,,13317,A,12032,
1,,Intermediate,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624164,,,15078,A,12033,
1,,Intermediate,The AUC(0-infinity) values in female wistar rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624165,,,14941,A,12034,
1,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624166,,,15078,A,12035,
1,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624167,,,15078,A,12036,
1,,Intermediate,The AUC(0-t)values in female wistar rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624168,,,14941,A,12037,
1,,Intermediate,The Area under the concentration time curve of compound was measured on rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624169,,,14067,A,12038,
1,,Intermediate,The area under curve (100 mg/kg) administered orally in humans,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL624170,,,14215,A,12039,
1,,Autocuration,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,,,Callithrix,,,9481.0,BAO_0000218,22224,0,,,CHEMBL624171,,,14215,A,12040,
1,,Autocuration,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL624172,,,14215,A,12041,
1,,Intermediate,The area under curve (15 mg/kg) administered intravenously in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624173,,,14215,A,12042,
1,,Intermediate,The area under curve (200 mg/kg) administered orally in humans,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL877488,,,14215,A,12043,
1,,Intermediate,The area under curve (25 mg/kg) administered intravenously in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624174,,,14215,A,12044,
1,,Autocuration,The area under curve (25 mg/kg) administered orally in marmoset,U,,,Callithrix,,,9481.0,BAO_0000218,22224,0,,,CHEMBL624175,,,14215,A,12045,
1,,Autocuration,The area under curve (25 mg/kg) administered orally in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL624176,,,14215,A,12046,
1,,Intermediate,The area under curve (30 mg/kg) administered orally in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624177,,,14215,A,12047,
1,,Intermediate,The area under curve (400 mg/kg) administered orally in humans,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL624178,,,14215,A,12048,
1,,Intermediate,The area under curve (50 mg/kg) administered orally in fasted rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624179,,,14215,A,12049,
1,,Intermediate,The area under curve (50 mg/kg) administered orally in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627689,,,14215,A,12050,
1,,Intermediate,The area under curve (800 mg/kg) administered orally in humans,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL627690,,,14215,A,12051,
1,,Autocuration,The compound was evaluated for area under the curve,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627691,,,11324,A,12052,
1,,Autocuration,The compound was evaluated for area under the curve in marmosets,U,,,Callithrix,,,9481.0,BAO_0000019,22224,0,,,CHEMBL627692,,,11324,A,12053,
1,,Autocuration,The compound was evaluated for area under the curve in marmosets,U,,,Callithrix,,,9481.0,BAO_0000019,22224,0,,,CHEMBL627693,,,11324,A,12054,
1,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627694,,,13875,A,12055,
1,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627695,,,13875,A,12056,
1,,Autocuration,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627696,,,13875,A,12057,
1,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627697,,,13875,A,12058,
1,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627698,,,13875,A,12059,
1,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627699,,,13875,A,12060,
1,,Intermediate,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627700,,,13807,A,12061,
1,,Intermediate,Total drug exposure is determined after oral dosing in rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627701,,,14127,A,12062,
1,,Autocuration,Total drug exposure (5 mg/kg) when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627702,,,15116,A,12063,
1,,Autocuration,Total drug exposure (5 mg/kg) when administered orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627703,,,15116,A,12064,
1,,Autocuration,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626873,,,15604,A,12065,
1,,Intermediate,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629583,,,15604,A,12066,
1,,Intermediate,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629584,,,15604,A,12067,
1,,Intermediate,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629585,,,15604,A,12068,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629586,In vivo,Brain,13751,A,12069,
1,,Intermediate,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL629587,In vivo,Brain,13751,A,12070,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629588,In vivo,,13751,A,12071,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629589,In vivo,,13751,A,12072,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629590,In vivo,,13751,A,12073,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629591,In vivo,,13751,A,12074,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629592,In vivo,,13751,A,12075,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629593,In vivo,,13751,A,12076,
1,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629594,In vivo,,13751,A,12077,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL629595,In vivo,Heart,13751,A,12078,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630290,In vivo,Heart,13751,A,12079,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627137,In vivo,Heart,13751,A,12080,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627138,In vivo,Heart,13751,A,12081,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627139,In vivo,Heart,13751,A,12082,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627140,In vivo,Heart,13751,A,12083,
1,,Intermediate,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627141,In vivo,Heart,13751,A,12084,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627142,In vivo,Kidney,13751,A,12085,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627143,In vivo,Kidney,13751,A,12086,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL874449,In vivo,Kidney,13751,A,12087,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627144,In vivo,Kidney,13751,A,12088,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627145,In vivo,Kidney,13751,A,12089,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627146,In vivo,Kidney,13751,A,12090,
1,,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627147,In vivo,Kidney,13751,A,12091,
1,,Intermediate,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627148,In vivo,Liver,13751,A,12092,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627149,In vivo,Lung,13751,A,12093,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL632160,In vivo,Lung,13751,A,12094,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL632161,In vivo,Lung,13751,A,12095,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL632162,In vivo,Lung,13751,A,12096,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL632163,In vivo,Lung,13751,A,12097,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL874469,In vivo,Lung,13751,A,12098,
1,,Intermediate,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627182,In vivo,Lung,13751,A,12099,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627183,In vivo,Muscle tissue,13751,A,12100,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627184,In vivo,Muscle tissue,13751,A,12101,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627185,In vivo,Muscle tissue,13751,A,12102,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627186,In vivo,Muscle tissue,13751,A,12103,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627187,In vivo,Muscle tissue,13751,A,12104,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627188,In vivo,Muscle tissue,13751,A,12105,
1,,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627189,In vivo,Muscle tissue,13751,A,12106,
1,,Intermediate,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627190,In vivo,,13751,A,12107,
1,,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627191,In vivo,Liver,13751,A,12108,
1,,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627192,In vivo,Liver,13751,A,12109,
1,,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627193,In vivo,Liver,13751,A,12110,
1,,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL874590,In vivo,Muscle tissue,10911,A,12111,
1,,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627194,In vivo,Muscle tissue,10911,A,12112,
1,,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627195,In vivo,Muscle tissue,10911,A,12113,
1,,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL627196,In vivo,Female gonad,10911,A,12114,
1,,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL627197,In vivo,Female gonad,10911,A,12115,
1,,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL627198,In vivo,Female gonad,10911,A,12116,
1,,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL627199,In vivo,Female gonad,10911,A,12117,
1,,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,992.0,CHEMBL627200,In vivo,Female gonad,10911,A,12118,
1,,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627201,In vivo,Plasma,10911,A,12119,
1,,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627202,In vivo,Plasma,10911,A,12120,
1,,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627203,In vivo,Plasma,10911,A,12121,
1,,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627204,In vivo,Plasma,10911,A,12122,
1,,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627205,In vivo,Spleen,10911,A,12123,
1,,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627206,In vivo,Spleen,10911,A,12124,
1,,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627207,In vivo,Spleen,10911,A,12125,
1,,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627208,In vivo,Spleen,10911,A,12126,
1,,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627209,In vivo,Thyroid gland,10911,A,12127,
1,,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627210,In vivo,Thyroid gland,10911,A,12128,
1,,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627211,In vivo,Thyroid gland,10911,A,12129,
1,,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627212,In vivo,Thyroid gland,10911,A,12130,
1,,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL627213,In vivo,Uterus,10911,A,12131,
1,,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626599,In vivo,Uterus,10911,A,12132,
1,,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626600,In vivo,Uterus,10911,A,12133,
1,,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL626601,In vivo,Uterus,10911,A,12134,
1,,Autocuration,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627484,,,8081,A,12135,
1,,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL627485,,Plasma,17248,A,12136,
1,,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL628147,,Plasma,17248,A,12137,
1,,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL628148,,Plasma,17248,A,12138,
1,,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628149,,Plasma,17248,A,12139,
1,,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628150,,Plasma,17248,A,12140,
1,,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628318,,Plasma,17248,A,12141,
1,,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628319,,Plasma,17248,A,12142,
1,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL875609,,,15592,A,12143,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628320,,,7040,A,12144,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628321,,,7040,A,12145,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628322,,,7040,A,12146,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628323,,,7040,A,12147,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628324,,,7040,A,12148,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628325,,,7040,A,12149,
1,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628326,,,7040,A,12150,
1,,Intermediate,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL628327,,Adrenal medulla,9614,A,12151,
1,,Intermediate,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL628328,,Adrenal medulla,9614,A,12152,
1,,Intermediate,"Concentration of compound in blood of dog 1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL628329,,Blood,9614,A,12153,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628330,,Liver,8608,A,12154,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628331,,Liver,8608,A,12155,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628332,,Liver,8608,A,12156,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628333,,Liver,8608,A,12157,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628334,,Liver,8608,A,12158,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628335,,Liver,8608,A,12159,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628336,,Liver,8608,A,12160,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628337,,Liver,8608,A,12161,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628338,,Liver,8608,A,12162,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL875610,,Liver,8608,A,12163,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628339,,Liver,8608,A,12164,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628340,,Liver,8608,A,12165,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628341,,Liver,8608,A,12166,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622214,,Liver,8608,A,12167,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623167,,Liver,8608,A,12168,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623168,,Liver,8608,A,12169,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623169,,Liver,8608,A,12170,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623170,,Liver,8608,A,12171,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627224,,Lung,8608,A,12172,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL875634,,Lung,8608,A,12173,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627225,,Lung,8608,A,12174,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627226,,Lung,8608,A,12175,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626083,,Lung,8608,A,12176,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626084,,Lung,8608,A,12177,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626085,,Lung,8608,A,12178,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626086,,Lung,8608,A,12179,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626087,,Lung,8608,A,12180,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626088,,Lung,8608,A,12181,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626089,,Lung,8608,A,12182,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626090,,Lung,8608,A,12183,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626091,,Lung,8608,A,12184,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626092,,Lung,8608,A,12185,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626093,,Lung,8608,A,12186,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626094,,Lung,8608,A,12187,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626095,,Lung,8608,A,12188,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL626096,,Lung,8608,A,12189,
1,,Autocuration,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626097,,,15604,A,12190,
1,,Intermediate,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626098,,,15604,A,12191,
1,,Autocuration,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626099,,Plasma,1806,A,12192,
1,,Autocuration,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL626100,,Plasma,1806,A,12193,
1,,Intermediate,AUC 0-inf in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626101,,Plasma,17237,A,12194,
1,,Intermediate,AUC 0-inf in guinea pig,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,1969.0,CHEMBL626102,,Plasma,17237,A,12195,
1,,Intermediate,AUC 0-t in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626103,,Plasma,17237,A,12196,
1,,Intermediate,AUC 0-t in guinea pig,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,1969.0,CHEMBL628391,,Plasma,17237,A,12197,
1,,Intermediate,The compound was tested for brain to plasma partition in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628392,,,15194,A,12198,
1,,Intermediate,The compound was tested for brain to plasma partition in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628393,,,15194,A,12199,
1,,Autocuration,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,,,,,,,BAO_0000019,22224,0,,178.0,CHEMBL628394,,Blood,8787,A,12200,
1,,Intermediate,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628395,,,17025,A,12201,
1,,Autocuration,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL628396,,,17025,A,12202,
1,,Intermediate,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL628397,,,17025,A,12203,
1,,Intermediate,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628398,,,17025,A,12204,
1,,Intermediate,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL628399,,,4236,A,12205,
1,,Intermediate,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628400,,,15343,A,12206,
1,,Intermediate,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874907,,,15343,A,12207,
1,,Autocuration,Area under curve of the compound was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628401,,,17720,A,12208,
1,,Autocuration,AUC in monkeys at a dose of 1 mg/kg,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL628402,,Plasma,17788,A,12209,
1,,Intermediate,AUC in rats at a dose of 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628403,,Plasma,17788,A,12210,
1,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 2,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628404,,,8778,A,12211,
1,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628405,,,8778,A,12212,
1,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 7,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628406,,,8778,A,12213,
1,,Intermediate,Compound was evaluated for its absorption in the rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628407,,,2249,A,12214,
1,,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628408,,Urine,8881,A,12215,
1,,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629171,,Urine,8881,A,12216,
1,,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629172,,Urine,8881,A,12217,
1,,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629173,,Urine,8881,A,12218,
1,,Intermediate,In vitro percent permeability into rat ileum,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629174,,,15286,A,12219,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-17,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629175,,,15286,A,12220,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-18,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629176,,,15286,A,12221,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-19,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629177,,,15286,A,12222,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 12-15,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629178,,,15286,A,12223,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 13-19,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631869,,,15286,A,12224,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 14-17,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631870,,,15286,A,12225,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 15-18,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631871,,,15286,A,12226,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 2-5,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631872,,,15286,A,12227,
1,,Autocuration,In vitro percent permeability into rat ileum; Range is 23-42,U,,,,,,,BAO_0000221,22224,0,,2116.0,CHEMBL875775,,Ileum,15286,A,12228,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 28-36,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631873,,,15286,A,12229,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 29-35,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631874,,,15286,A,12230,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 46-66,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631875,,,15286,A,12231,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 50-68,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631876,,,15286,A,12232,
1,,Intermediate,In vitro percent permeability into rat ileum; Range is 78-81,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631877,,,15286,A,12233,
1,,Intermediate,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631878,,,15286,A,12234,
1,,Intermediate,In vitro percent permeability into rat ileum; nd indicates not detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631879,,,15286,A,12235,
1,,Intermediate,In vitro percent permeability into rat ileum; nt indicates not detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631880,,,15286,A,12236,
1,,Intermediate,In vitro percent permeability into rat ileum; nt indicates not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631881,,,15286,A,12237,
1,,Intermediate,Compound was tested for oral absorption in bile-duct cannulated rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631882,,,13770,A,12238,
1,,Intermediate,Compound was tested for oral absorption in bile-duct cannulated rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630749,,,13770,A,12239,
1,,Intermediate,Oral absorption using Caco-2 cell monolayers.,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL630750,,,5202,A,12240,
1,,Intermediate,Percent of the drug absorbed after administration to humans was determined,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL630253,,,14920,A,12241,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL630254,,Plasma,14103,A,12242,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL630255,,Plasma,14103,A,12243,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL630256,,Plasma,14103,A,12244,
1,,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL875781,In vivo,Liver,13751,A,12245,
1,,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL630257,In vivo,Liver,13751,A,12246,
1,,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL630258,In vivo,Liver,13751,A,12247,
1,,Intermediate,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630259,,,15807,A,12248,
1,,Intermediate,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL630260,,Striatum,15807,A,12249,
1,,Intermediate,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL630261,,Striatum,15807,A,12250,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630262,,,14950,A,12251,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630263,,,14950,A,12252,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630264,,,14950,A,12253,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630265,,,14950,A,12254,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630266,,,14950,A,12255,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630267,,Kidney,14950,A,12256,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630268,,Kidney,14950,A,12257,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630269,,,14950,A,12258,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630270,,,14950,A,12259,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630141,,Lung,14950,A,12260,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630142,,Lung,14950,A,12261,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630143,,Muscle tissue,14950,A,12262,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630144,,Muscle tissue,14950,A,12263,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2367.0,CHEMBL630145,,Prostate gland,14950,A,12264,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2367.0,CHEMBL630146,,Prostate gland,14950,A,12265,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630147,,,14950,A,12266,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630148,,,14950,A,12267,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630149,,,14950,A,12268,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630150,,Spleen,14950,A,12269,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630151,,Spleen,14950,A,12270,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL632031,,Thyroid gland,14950,A,12271,
1,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL632032,,Thyroid gland,14950,A,12272,
1,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632033,,,14950,A,12273,
1,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632034,,,14950,A,12274,
1,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL632035,,Muscle tissue,14950,A,12275,
1,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632036,,,14950,A,12276,
1,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL632037,,Thyroid gland,14950,A,12277,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632038,,Blood,8631,A,12278,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632039,,Blood,8631,A,12279,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632040,,Blood,8631,A,12280,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL632041,,Blood,8631,A,12281,
1,,Intermediate,"Concentration of compound in blood of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,178.0,CHEMBL632042,,Blood,9614,A,12282,
1,,Intermediate,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL632043,,,9614,A,12283,
1,,Intermediate,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL632044,,,9614,A,12284,
1,,Intermediate,"Concentration of compound in liver of dog 1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2107.0,CHEMBL632045,,Liver,9614,A,12285,
1,,Intermediate,"Concentration of compound in liver of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2107.0,CHEMBL632046,,Liver,9614,A,12286,
1,,Intermediate,"Concentration of compound in lung of dog 1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2048.0,CHEMBL632047,,Lung,9614,A,12287,
1,,Intermediate,"Concentration of compound in lung of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2048.0,CHEMBL632048,,Lung,9614,A,12288,
1,,Intermediate,"Concentration of compound in muscle of dog 1, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2385.0,CHEMBL632049,,Muscle tissue,9614,A,12289,
1,,Intermediate,"Concentration of compound in muscle of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2385.0,CHEMBL876418,,Muscle tissue,9614,A,12290,
1,,Intermediate,"Concentration of compound in spleen of dog 1,after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2106.0,CHEMBL632050,,Spleen,9614,A,12291,
1,,Intermediate,"Concentration of compound in spleen of dog 2, after administering intravenously",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2106.0,CHEMBL632051,,Spleen,9614,A,12292,
1,,Autocuration,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL632052,,,10353,F,12293,
1,,Autocuration,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL632053,,,10353,F,12294,
1,,Autocuration,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL632054,,,10353,A,12295,
1,,Autocuration,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL632055,,,10353,F,12296,
1,,Autocuration,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631181,,,10353,F,12297,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631182,,,9196,A,12298,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631183,,,9196,A,12299,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631184,,,9196,A,12300,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629774,,,9196,A,12301,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629775,,,9196,A,12302,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL876549,,,9196,A,12303,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628172,,,9196,A,12304,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628173,,,9196,A,12305,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628174,,,9196,A,12306,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628175,,,9196,A,12307,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628176,,,9196,A,12308,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628177,,,9196,A,12309,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628178,,,9196,A,12310,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628179,,,9196,A,12311,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628180,,,9196,A,12312,
1,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628181,,,9196,A,12313,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628182,,,9196,A,12314,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628183,,,9196,A,12315,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628184,,,9196,A,12316,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628185,,,9196,A,12317,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875617,,,9196,A,12318,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628186,,,9196,A,12319,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628187,,,9196,A,12320,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628188,,,9196,A,12321,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628189,,,9196,A,12322,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628190,,,9196,A,12323,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628191,,,9196,A,12324,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626513,,,9196,A,12325,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626514,,Thyroid gland,8608,A,12326,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626515,,Thyroid gland,8608,A,12327,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626516,,Thyroid gland,8608,A,12328,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626517,,Thyroid gland,8608,A,12329,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626518,,Thyroid gland,8608,A,12330,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626519,,Thyroid gland,8608,A,12331,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626520,,Thyroid gland,8608,A,12332,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626521,,Thyroid gland,8608,A,12333,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626522,,Thyroid gland,8608,A,12334,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626523,,Thyroid gland,8608,A,12335,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626524,,Thyroid gland,8608,A,12336,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626688,,Thyroid gland,8608,A,12337,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626689,,Thyroid gland,8608,A,12338,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626690,,Thyroid gland,8608,A,12339,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626691,,Thyroid gland,8608,A,12340,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL627319,,Thyroid gland,8608,A,12341,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL624052,,Thyroid gland,8608,A,12342,
1,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL624053,,Thyroid gland,8608,A,12343,
1,,Intermediate,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624054,,,8085,A,12344,
1,,Intermediate,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624055,,,8085,A,12345,
1,,Intermediate,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624056,,,8085,A,12346,
1,,Intermediate,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL624057,,Uterus,8085,A,12347,
1,,Intermediate,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622281,,Uterus,8085,A,12348,
1,,Intermediate,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622282,,Uterus,8085,A,12349,
1,,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622283,,Uterus,8085,A,12350,
1,,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622284,,Uterus,8085,A,12351,
1,,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622285,,Uterus,8085,A,12352,
1,,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL622286,,Uterus,8085,A,12353,
1,,Autocuration,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL622287,,,7657,P,12354,
1,,Intermediate,Partition coefficient (logD7.4),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622288,,,8935,A,12355,
1,,Intermediate,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622289,,,13792,A,12356,
1,,Intermediate,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622290,,Brain,13792,A,12357,
1,,Intermediate,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622291,,,13792,A,12358,
1,,Intermediate,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622292,,Brain,13792,A,12359,
1,,Intermediate,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622293,,,13792,A,12360,
1,,Intermediate,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL622294,,Brain,13792,A,12361,
1,,Intermediate,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL622295,,,13792,A,12362,
1,,Intermediate,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL622296,,Brain,13792,A,12363,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL874409,,Plasma,14103,A,12364,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622297,,Plasma,14103,A,12365,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622298,,Plasma,14103,A,12366,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622299,,Plasma,14103,A,12367,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622300,,Plasma,14103,A,12368,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622301,,Plasma,14103,A,12369,
1,,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622302,,Plasma,14103,A,12370,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622303,,Plasma,14103,A,12371,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622304,,Plasma,14103,A,12372,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622305,,Plasma,14103,A,12373,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622306,,Plasma,14103,A,12374,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626864,,Plasma,14103,A,12375,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626865,,Plasma,14103,A,12376,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626866,,Plasma,14103,A,12377,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626867,,Plasma,14103,A,12378,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626868,,Plasma,14103,A,12379,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626869,,Plasma,14103,A,12380,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626870,,Plasma,14103,A,12381,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626871,,Plasma,14103,A,12382,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626872,,Plasma,14103,A,12383,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632185,,Plasma,14103,A,12384,
1,,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL632186,,Plasma,14103,A,12385,
1,,Autocuration,Amount of acetic acid produced by the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629310,,,12904,A,12386,
1,,Autocuration,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629311,,,12904,A,12387,
1,,Intermediate,Log of (Cbrain/Cblood) in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629312,,,9663,A,12388,
1,,Autocuration,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,,,,,,BAO_0000221,22224,0,,,CHEMBL629313,,,7652,A,12389,
1,,Autocuration,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000221,22224,0,,,CHEMBL629314,,,7652,A,12390,
1,,Autocuration,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,,,,,,BAO_0000221,22224,0,,,CHEMBL629315,,,7652,A,12391,
1,,Autocuration,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,,,,,,,BAO_0000219,22224,0,,,CHEMBL629316,,,7652,B,12392,
1,,Autocuration,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000221,22224,0,,,CHEMBL629317,,,7652,A,12393,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629318,,,7652,A,12394,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL877497,,,7652,A,12395,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629319,,,7652,A,12396,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629320,,,7652,A,12397,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629496,,,7652,A,12398,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629497,,,7652,A,12399,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629498,,,7652,A,12400,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629499,,,7652,A,12401,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629500,,,7652,A,12402,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629501,,,7652,A,12403,
1,,Autocuration,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629502,,,7652,A,12404,
1,,Autocuration,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629503,In vivo,,8267,F,12405,
1,,Intermediate,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629504,,,8267,A,12406,
1,,Autocuration,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629505,,,14479,A,12407,
1,,Autocuration,Compound was evaluated for total body clearance,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629506,,,17515,A,12408,
1,,Autocuration,Compound was evaluated for volume of distribution at steady state,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629507,,,17515,A,12409,
1,,Autocuration,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL877498,,,8142,A,12410,
1,,Autocuration,Percentage of the diamine which is monoprotonated at pH 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629508,,,14849,A,12411,
1,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629509,,,7653,A,12412,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629510,,Blood,8631,A,12413,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629511,,Blood,8631,A,12414,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629512,,Blood,8631,A,12415,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629513,,Blood,8631,A,12416,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629514,,Blood,8631,A,12417,
1,,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628447,,Blood,8631,A,12418,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628448,,Blood,8631,A,12419,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628449,,Blood,8631,A,12420,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631119,,Blood,8631,A,12421,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631120,,Blood,8631,A,12422,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631121,,Blood,8631,A,12423,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL874458,,Blood,8631,A,12424,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631122,,Blood,8631,A,12425,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631123,,Blood,8631,A,12426,
1,,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631124,,Blood,8631,A,12427,
1,,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631125,,Blood,8631,A,12428,
1,,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631290,,Blood,8631,A,12429,
1,,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631291,,Blood,8631,A,12430,
1,,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631292,,Blood,8631,A,12431,
1,,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631293,,Blood,8631,A,12432,
1,,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631294,,Blood,8631,A,12433,
1,,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631295,,Blood,8631,A,12434,
1,,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631296,,Blood,8631,A,12435,
1,,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631297,,Blood,8631,A,12436,
1,,Autocuration,Maximum biodistribution (Bmax) was determined.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631298,,,10263,A,12437,
1,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631299,,,12364,A,12438,
1,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631300,,,12364,A,12439,
1,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631301,,,12364,A,12440,
1,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630291,,,12364,A,12441,
1,,Autocuration,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630292,,,14793,A,12442,
1,,Autocuration,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630293,,,14793,A,12443,
1,,Autocuration,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630294,,,14793,A,12444,
1,,Autocuration,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630295,,,14793,A,12445,
1,,Autocuration,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630296,,,14793,A,12446,
1,,Autocuration,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626782,,,14793,A,12447,
1,,Autocuration,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626783,,,14793,A,12448,
1,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626784,,,14793,A,12449,
1,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626785,,,14793,A,12450,
1,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626786,,,14793,A,12451,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626787,,,9196,A,12452,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626788,,,9196,A,12453,
1,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625927,,,9196,A,12454,
1,,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625928,,Blood,8374,A,12455,
1,,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625929,,Blood,8374,A,12456,
1,,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625930,,Blood,8374,A,12457,
1,,Intermediate,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625931,,Blood,8374,A,12458,
1,,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627230,,Blood,8374,A,12459,
1,,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627231,,Blood,8374,A,12460,
1,,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627232,,Blood,8374,A,12461,
1,,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627233,,Blood,8374,A,12462,
1,,Intermediate,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL875470,,Blood,8374,A,12463,
1,,Intermediate,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627234,,Blood,8374,A,12464,
1,,Intermediate,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627235,,Blood,8374,A,12465,
1,,Intermediate,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627236,,Blood,8374,A,12466,
1,,Intermediate,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627237,,Blood,8374,A,12467,
1,,Intermediate,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627238,,Blood,8374,A,12468,
1,,Intermediate,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627239,,Blood,8374,A,12469,
1,,Intermediate,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627240,,Blood,8374,A,12470,
1,,Intermediate,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627241,,Blood,8374,A,12471,
1,,Intermediate,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627242,,Blood,8374,A,12472,
1,,Intermediate,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627243,,Blood,8374,A,12473,
1,,Intermediate,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627244,,Blood,8374,A,12474,
1,,Intermediate,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627245,,Blood,8374,A,12475,
1,,Intermediate,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627246,,Blood,8374,A,12476,
1,,Intermediate,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627247,,Blood,8374,A,12477,
1,,Intermediate,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627248,,Blood,8374,A,12478,
1,,Intermediate,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627249,,Blood,8374,A,12479,
1,,Intermediate,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625569,,Blood,8374,A,12480,
1,,Intermediate,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625570,,Blood,8374,A,12481,
1,,Intermediate,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625571,,Blood,8374,A,12482,
1,,Intermediate,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625572,,Blood,8374,A,12483,
1,,Intermediate,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625573,,Blood,8374,A,12484,
1,,Intermediate,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625574,,Blood,8374,A,12485,
1,,Intermediate,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626245,,Blood,8374,A,12486,
1,,Intermediate,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626246,,Blood,8374,A,12487,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626247,,,9196,A,12488,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626248,,,9196,A,12489,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626249,,,9196,A,12490,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626420,,,9196,A,12491,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626421,,,9196,A,12492,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626422,,,9196,A,12493,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626423,,,9196,A,12494,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626424,,,9196,A,12495,
1,,Intermediate,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626425,,,12023,A,12496,
1,,Intermediate,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875476,,,12023,A,12497,
1,,Intermediate,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL626426,,,12023,A,12498,
1,,Autocuration,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL626427,,,10580,P,12499,
1,,Autocuration,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL626428,,,10580,P,12500,
1,,Autocuration,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626429,,,16032,A,12501,
1,,Autocuration,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL625025,,Urine,16032,A,12502,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625026,,Blood,8594,A,12503,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625027,,Blood,8594,A,12504,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL874410,,Blood,8594,A,12505,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625028,,Blood,8594,A,12506,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625029,,Blood,8594,A,12507,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625030,,Blood,8594,A,12508,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625031,,Blood,8594,A,12509,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625032,,Blood,8594,A,12510,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625033,,Blood,8594,A,12511,
1,,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625034,,Blood,8594,A,12512,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624872,,Heart,8594,A,12513,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624873,,Heart,8594,A,12514,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624874,,Heart,8594,A,12515,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624875,,Heart,8594,A,12516,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624876,,Heart,8594,A,12517,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624877,,Heart,8594,A,12518,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624878,,Heart,8594,A,12519,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624879,,Heart,8594,A,12520,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624880,,Heart,8594,A,12521,
1,,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624881,,Heart,8594,A,12522,
1,,Intermediate,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL624882,,Heart,8594,A,12523,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624883,,Kidney,8594,A,12524,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624884,,Kidney,8594,A,12525,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624885,,Kidney,8594,A,12526,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624886,,Kidney,8594,A,12527,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624887,,Kidney,8594,A,12528,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624888,,Kidney,8594,A,12529,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624889,,Kidney,8594,A,12530,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL624890,,Kidney,8594,A,12531,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621964,,Kidney,8594,A,12532,
1,,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL621965,,Kidney,8594,A,12533,
1,,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621966,,Liver,8594,A,12534,
1,,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL621967,,Liver,8594,A,12535,
1,,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL622164,,Liver,8594,A,12536,
1,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623097,,,7653,A,12537,
1,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623098,,,7653,A,12538,
1,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623099,,,7653,A,12539,
1,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623100,,,7653,A,12540,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628673,,,9104,A,12541,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628674,,,9104,A,12542,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628675,,,9104,A,12543,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627644,,,9104,A,12544,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627645,,,9104,A,12545,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627646,,,9104,A,12546,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627647,,,9104,A,12547,
1,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627648,,,9104,A,12548,
1,,Intermediate,Free level in rat plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627649,,,12902,A,12549,
1,,Autocuration,Level reaching in blood plasma of rat or human was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628313,,,6614,A,12550,
1,,Intermediate,Log (Cbrain/Cblood) in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628314,,,9663,A,12551,
1,,Autocuration,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628315,,,17658,A,12552,
1,,Autocuration,Mean percentage of compound transport through membrane; expressed as membrane transport,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628316,,,17658,A,12553,
1,,Autocuration,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628317,,,14314,A,12554,
1,,Autocuration,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628473,,,7385,A,12555,
1,,Autocuration,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628474,,,7385,A,12556,
1,,Autocuration,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628475,,,7385,A,12557,
1,,Autocuration,Net water uptake by a carrier mediated transport (%cm) mechanism,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628476,,,1329,A,12558,
1,,Autocuration,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL628477,,,12187,A,12559,
1,,Intermediate,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL628478,,,12187,A,12560,
1,,Intermediate,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL628479,,,12187,A,12561,
1,,Autocuration,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL628480,,,12187,A,12562,
1,,Autocuration,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL628481,,,12187,A,12563,
1,,Intermediate,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628482,,,12187,A,12564,
1,,Intermediate,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628483,,,12187,A,12565,
1,,Intermediate,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628484,,Plasma,9278,A,12566,
1,,Intermediate,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628485,,Plasma,9278,A,12567,
1,,Intermediate,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL628486,,Plasma,9278,A,12568,
1,,Intermediate,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL628487,,Plasma,9278,A,12569,
1,,Intermediate,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628488,,Plasma,9278,A,12570,
1,,Intermediate,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628489,,Plasma,9278,A,12571,
1,,Intermediate,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628490,,Plasma,9278,A,12572,
1,,Intermediate,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL628491,,,12186,A,12573,
1,,Intermediate,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL877507,,,12186,A,12574,
1,,Autocuration,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628492,,,12186,A,12575,
1,,Autocuration,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL628493,,,12041,A,12576,
1,,Autocuration,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL628494,,,12041,A,12577,
1,,Autocuration,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,,,Simiiformes,,,314293.0,BAO_0000019,22224,0,,,CHEMBL628495,,,12041,A,12578,
1,,Intermediate,Permeability in Caco-2 assay at 10E-6,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL628496,,,6737,A,12579,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,,,,,,BAO_0000218,22224,0,,955.0,CHEMBL628497,,Brain,13758,A,12580,
1,,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,,,,,,BAO_0000218,22224,0,,955.0,CHEMBL628498,,Brain,13758,A,12581,
1,,Autocuration,Plasma protein binding was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628499,,,5676,A,12582,
1,,Autocuration,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627656,,,14793,A,12583,
1,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627657,,,14793,A,12584,
1,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626808,,,14793,A,12585,
1,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626809,,,14793,A,12586,
1,,Autocuration,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626810,,,14793,A,12587,
1,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626811,,,14793,A,12588,
1,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL874465,,,14793,A,12589,
1,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626812,,,14793,A,12590,
1,,Autocuration,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626813,,,14793,A,12591,
1,,Autocuration,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626814,,,14793,A,12592,
1,,Autocuration,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626815,,,14000,A,12593,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628566,,,5948,A,12594,
1,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL628567,,,13824,P,12595,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL628568,,,10778,P,12596,
1,,Intermediate,C max in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628569,In vivo,,17237,A,12597,
1,,Intermediate,C max in guinea pig,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL628570,In vivo,,17237,A,12598,
1,,Autocuration,C max value was evaluated,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628571,In vivo,,2809,A,12599,
1,,Autocuration,Cmax value after oral dose of 0.1 mg//kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628572,In vivo,,11954,A,12600,
1,,Autocuration,Cmax value after oral dose of 0.3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628573,In vivo,,11954,A,12601,
1,,Autocuration,Cmax value after oral dose of 1 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628574,In vivo,,11954,A,12602,
1,,Autocuration,Cmax value after oral dose of 10 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628575,In vivo,,11954,A,12603,
1,,Autocuration,Cmax value after oral dose of 23.4 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628576,In vivo,,11954,A,12604,
1,,Autocuration,Cmax value after oral dose of 3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628577,In vivo,,11954,A,12605,
1,,Autocuration,Cmax value after oral dose of 3.87 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628578,In vivo,,11954,A,12606,
1,,Intermediate,Cmax value in female Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL874466,In vivo,,12768,A,12607,
1,,Intermediate,Cmax value in male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628579,In vivo,,12768,A,12608,
1,,Intermediate,Cmax value in rat plasma when administered 20 mg/kg perorally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628580,In vivo,Plasma,12780,A,12609,
1,,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628581,In vivo,Plasma,15592,A,12610,
1,,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL628582,In vivo,Plasma,15592,A,12611,
1,,Intermediate,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628583,,,17025,A,12612,
1,,Autocuration,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625782,,,17025,A,12613,
1,,Intermediate,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL625783,,,17025,A,12614,
1,,Intermediate,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625784,,,17025,A,12615,
1,,Intermediate,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL625785,,Plasma,4236,A,12616,
1,,Intermediate,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625786,,,15791,A,12617,
1,,Autocuration,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874467,,,11149,A,12618,
1,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625787,,,15592,A,12619,
1,,Intermediate,cytotoxicity against HIV protease enzyme.,N,,,Human immunodeficiency virus,,,12721.0,BAO_0000218,50677,1,,,CHEMBL625964,,,15778,A,12620,
1,,Intermediate,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625965,,,12745,A,12621,
1,,Intermediate,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625966,,,12745,A,12622,
1,,Intermediate,The plasma clearance in dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625967,In vivo,Plasma,13941,A,12623,
1,,Intermediate,The plasma clearance in rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625968,In vivo,Plasma,13941,A,12624,
1,,Intermediate,Clearance from plasma in male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625969,In vivo,Plasma,16449,A,12625,
1,,Intermediate,Clearance from plasma in male cynomolgus monkeys,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,1969.0,CHEMBL625970,In vivo,Plasma,16449,A,12626,
1,,Intermediate,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625971,In vivo,Plasma,14224,A,12627,
1,,Intermediate,Clearance of compound in dog plasma,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625972,In vivo,Plasma,14224,A,12628,
1,,Intermediate,Clearance of compound in human plasma,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL625973,In vivo,Plasma,14224,A,12629,
1,,Intermediate,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625974,In vivo,,14317,A,12630,
1,,Intermediate,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625975,In vivo,,14317,A,12631,
1,,Intermediate,"Clearance (10 mg/kg, intravenously) in dog plasma",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625976,In vivo,Plasma,14224,A,12632,
1,,Intermediate,Clearance value in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625977,In vivo,,17237,A,12633,
1,,Intermediate,Clearance value in guinea pig,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL625978,In vivo,,17237,A,12634,
1,,Intermediate,Clearance values in rats after iv administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874468,In vivo,,14187,A,12635,
1,,Autocuration,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL625421,In vivo,Plasma,4806,A,12636,
1,,Intermediate,In vivo clearance (5 mg/kg) was determined in rabbits,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL625422,In vivo,,15025,A,12637,
1,,Intermediate,Plasma Clearance rate was determined for the compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625423,In vivo,,13197,A,12638,
1,,Autocuration,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,,,Saimiri,,,9520.0,BAO_0000218,22224,0,,,CHEMBL625424,In vivo,,13197,A,12639,
1,,Intermediate,Plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625425,In vivo,,13960,A,12640,
1,,Autocuration,Plasma clearance of the compound,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625426,In vivo,,17820,A,12641,
1,,Intermediate,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL625427,In vivo,,14706,A,12642,
1,,Intermediate,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL625428,In vivo,,14706,A,12643,
1,,Autocuration,Plasma clearance was determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625429,In vivo,,6504,A,12644,
1,,Intermediate,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625430,In vivo,,14925,A,12645,
1,,Intermediate,Plasma clearance rate was determined for the compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625431,In vivo,,13197,A,12646,
1,,Autocuration,Plasma clearance rate was determined for the compound in squirrel monkeys,U,,,Saimiri,,,9520.0,BAO_0000218,22224,0,,,CHEMBL627307,In vivo,,13197,A,12647,
1,,Autocuration,Slow clearance (CL) was determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627308,In vivo,,3437,A,12648,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627309,,,9196,A,12649,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627310,,,9196,A,12650,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627311,,,9196,A,12651,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627312,,,9196,A,12652,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627313,,,9196,A,12653,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627314,,,9196,A,12654,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627315,,,9196,A,12655,
1,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627316,,,9196,A,12656,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627317,,,9196,A,12657,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627318,,,9196,A,12658,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627999,,,9196,A,12659,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628000,,,9196,A,12660,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628001,,,9196,A,12661,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628002,,,9196,A,12662,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625610,,,9196,A,12663,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625611,,,9196,A,12664,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625612,,,9196,A,12665,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625613,,,9196,A,12666,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875479,,,9196,A,12667,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625614,,,9196,A,12668,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625615,,,9196,A,12669,
1,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626302,,,9196,A,12670,
1,,Intermediate,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626303,,Blood,8374,A,12671,
1,,Intermediate,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627420,,Blood,8374,A,12672,
1,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627421,,,13477,A,12673,
1,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625695,,,13477,A,12674,
1,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625696,,,13477,A,12675,
1,,Intermediate,Distribution of compound in mice brain was measured after 1 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL875606,,Brain,10009,A,12676,
1,,Intermediate,Distribution of compound in mice brain was measured after 24 hr r,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL625697,,Brain,10009,A,12677,
1,,Intermediate,Distribution of compound in mice brain was measured after 2 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL625698,,Brain,10009,A,12678,
1,,Intermediate,Distribution of compound in mice brain was measured after 3 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL625699,,Brain,10009,A,12679,
1,,Intermediate,Distribution of compound in mice brain was measured after 6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL625700,,Brain,10009,A,12680,
1,,Intermediate,Distribution of compound in mice liver was measured after 1 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625701,,,10009,A,12681,
1,,Intermediate,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625702,,,10009,A,12682,
1,,Intermediate,Distribution of compound in mice liver was measured after 2 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625703,,,10009,A,12683,
1,,Intermediate,Distribution of compound in mice liver was measured after 3 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625704,,,10009,A,12684,
1,,Intermediate,Distribution of compound in mice liver was measured after 6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625705,,,10009,A,12685,
1,,Intermediate,Distribution in dog adrenal medulla 30 min after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL625706,,Adrenal medulla,8170,A,12686,
1,,Intermediate,Distribution in dog adrenal medulla 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL625707,,Adrenal medulla,8170,A,12687,
1,,Intermediate,Distribution in female dog Ovary 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625708,,,8170,A,12688,
1,,Intermediate,Distribution in female dog Ovary 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625709,,,8170,A,12689,
1,,Intermediate,Distribution in female dog adipose 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624180,,,8170,A,12690,
1,,Intermediate,Distribution in female dog adipose 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624181,,,8170,A,12691,
1,,Intermediate,Distribution in female dog adrenal cortex 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1235.0,CHEMBL624182,,Adrenal cortex,8170,A,12692,
1,,Intermediate,Distribution in female dog adrenal cortex 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1235.0,CHEMBL624183,,Adrenal cortex,8170,A,12693,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624184,,Liver,8594,A,12694,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL877489,,Liver,8594,A,12695,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624185,,Liver,8594,A,12696,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624186,,Liver,8594,A,12697,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624187,,Liver,8594,A,12698,
1,,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL624188,,Liver,8594,A,12699,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624189,,Lung,8594,A,12700,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624190,,Lung,8594,A,12701,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624191,,Lung,8594,A,12702,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624192,,Lung,8594,A,12703,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624193,,Lung,8594,A,12704,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624194,,Lung,8594,A,12705,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624891,,Lung,8594,A,12706,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624892,,Lung,8594,A,12707,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL624893,,Lung,8594,A,12708,
1,,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627632,,Lung,8594,A,12709,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627633,,,8594,A,12710,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627634,,,8594,A,12711,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627635,,,8594,A,12712,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627636,,,8594,A,12713,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626816,,,8594,A,12714,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626817,,,8594,A,12715,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626818,,,8594,A,12716,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626819,,,8594,A,12717,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626820,,,8594,A,12718,
1,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626821,,,8594,A,12719,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626822,,Thyroid gland,8594,A,12720,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626823,,Thyroid gland,8594,A,12721,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626824,,Thyroid gland,8594,A,12722,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626825,,Thyroid gland,8594,A,12723,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626826,,Thyroid gland,8594,A,12724,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626827,,Thyroid gland,8594,A,12725,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626828,,Thyroid gland,8594,A,12726,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626829,,Thyroid gland,8594,A,12727,
1,,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL626830,,Thyroid gland,8594,A,12728,
1,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627150,,,8594,A,12729,
1,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627151,,,8594,A,12730,
1,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627152,,,8594,A,12731,
1,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627153,,,8594,A,12732,
1,,Autocuration,Rate of acetate production by the compound was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627154,,,12904,A,12733,
1,,Autocuration,Rate of acetate production by the compound was determined; Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627155,,,12904,A,12734,
1,,Autocuration,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627156,,,3730,A,12735,
1,,Autocuration,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627157,,,3627,A,12736,
1,,Intermediate,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL627158,,,13799,A,12737,
1,,Intermediate,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1969.0,CHEMBL627159,,Plasma,13799,A,12738,
1,,Intermediate,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627160,,,13799,A,12739,
1,,Intermediate,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628540,,,13799,A,12740,
1,,Intermediate,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628541,,Plasma,13799,A,12741,
1,,Intermediate,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628542,,Plasma,13799,A,12742,
1,,Autocuration,Solubility after at a pH 1.2,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL628543,,,6629,P,12743,
1,,Autocuration,Solubility after at pH 1.2,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL628544,,,6629,P,12744,
1,,Autocuration,Solubility after injection of water,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL628545,,,6629,P,12745,
1,,Autocuration,Statistical significance of IC 50 values; Expressed as R value,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628546,,,14000,A,12746,
1,,Autocuration,Systemic availability with respect to methyldopa was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874455,,,8267,A,12747,
1,,Intermediate,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628547,,,13799,A,12748,
1,,Intermediate,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL628548,,Plasma,13799,A,12749,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628549,,Feces,7132,A,12750,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628550,,Feces,7132,A,12751,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628551,,Feces,7132,A,12752,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628552,,Urine,7132,A,12753,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628553,,Urine,7132,A,12754,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628554,,Urine,7132,A,12755,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628555,,Urine,7132,A,12756,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628556,,Urine,7132,A,12757,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,2113.0,CHEMBL628557,,Kidney,7132,A,12758,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628558,,Feces,7132,A,12759,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628559,,Feces,7132,A,12760,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628560,,Feces,7132,A,12761,
1,,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL874456,,Urine,7132,A,12762,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628561,,Feces,7132,A,12763,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL628562,,Feces,7132,A,12764,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628563,,Urine,7132,A,12765,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628564,,Urine,7132,A,12766,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL628565,,Urine,7132,A,12767,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL631248,,Urine,7132,A,12768,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL631249,,Urine,7132,A,12769,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,2113.0,CHEMBL627214,,Kidney,7132,A,12770,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL874591,,Feces,7132,A,12771,
1,,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL627215,,Feces,7132,A,12772,
1,,Intermediate,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL625471,,Feces,7132,A,12773,
1,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL625472,,,7132,A,12774,
1,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL625473,,,7132,A,12775,
1,,Intermediate,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625474,In vivo,,13317,A,12776,
1,,Intermediate,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625475,In vivo,,15341,A,12777,
1,,Intermediate,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625476,In vivo,,15341,A,12778,
1,,Intermediate,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625477,In vivo,,15341,A,12779,
1,,Intermediate,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625478,In vivo,,15341,A,12780,
1,,Intermediate,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625479,In vitro,esophageal tunica muscularis mucosae,12801,A,12781,
1,,Intermediate,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625480,In vitro,esophageal tunica muscularis mucosae,12801,A,12782,
1,,Intermediate,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625481,In vivo,Plasma,14856,A,12783,
1,,Intermediate,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625482,In vivo,,14062,A,12784,
1,,Intermediate,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625483,In vivo,,14062,A,12785,
1,,Intermediate,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625484,In vivo,,14062,A,12786,
1,,Intermediate,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625485,In vivo,,14062,A,12787,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625486,In vivo,Plasma,14346,A,12788,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625487,In vivo,Plasma,14346,A,12789,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625488,In vivo,Plasma,14346,A,12790,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625489,In vivo,Plasma,14346,A,12791,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625490,In vivo,Plasma,14346,A,12792,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL625491,In vivo,Plasma,14346,A,12793,
1,,Intermediate,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625492,In vivo,Plasma,14346,A,12794,
1,,Intermediate,plasma clearance in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1969.0,CHEMBL625493,In vivo,Plasma,15711,A,12795,
1,,Intermediate,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625494,In vivo,,14886,A,12796,
1,,Intermediate,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625495,In vivo,,14886,A,12797,
1,,Intermediate,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625496,In vivo,,14886,A,12798,
1,,Autocuration,1-Octanol/water partition coefficient measured at 7.4,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625497,,,4115,P,12799,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625498,,,13733,P,12800,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625499,,,12102,A,12801,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625500,,,12676,P,12802,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625501,,,13733,P,12803,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625502,,,13740,P,12804,
1,,Autocuration,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625503,,,12766,P,12805,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625504,,,2764,P,12806,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625505,,,12355,P,12807,
1,,Autocuration,Calculated partition coefficient of the compound,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625506,,,11314,P,12808,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625507,,,12706,A,12809,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625508,,,12645,P,12810,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625509,,,13668,P,12811,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625510,,,12819,P,12812,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL883125,,,13668,P,12813,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625511,,,13017,P,12814,
1,,Autocuration,Partition coefficient of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874650,,,2448,A,12815,
1,,Autocuration,Partition coefficient of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625512,,,11526,A,12816,
1,,Autocuration,Partition coefficient of compound was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625513,,,12426,A,12817,
1,,Autocuration,Partition coefficient was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625514,,,2448,A,12818,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625515,,,12001,P,12819,
1,,Autocuration,partition coefficient of compound was determined,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625516,,,12426,P,12820,
1,,Intermediate,The total body administered intravenously in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625517,In vivo,,13204,A,12821,
1,,Intermediate,The total body administered intravenously in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625518,In vivo,,13204,A,12822,
1,,Intermediate,Time taken for the administration to female NIH mice weighing 25-30 g.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625519,,,13889,A,12823,
1,,Autocuration,Time taken for the administration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625520,,,13889,A,12824,
1,,Intermediate,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL874651,In vivo,,17025,A,12825,
1,,Autocuration,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625521,In vivo,,17025,A,12826,
1,,Intermediate,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL623171,In vivo,,17025,A,12827,
1,,Intermediate,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623853,In vivo,,17025,A,12828,
1,,Autocuration,Plasma clearance for the compound was determined.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623854,,,15067,A,12829,
1,,Autocuration,CLog P value of the compound,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL874405,,,3091,P,12830,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL623855,,,15592,P,12831,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL623856,,,14738,P,12832,
1,,Autocuration,ClogP value of the compound; nd ='no data',U,,,,,,,BAO_0000100,22224,0,,,CHEMBL623857,,,14738,P,12833,
1,,Autocuration,ClogP value of the compound; nd ='not determined',U,,,,,,,BAO_0000100,22224,0,,,CHEMBL623858,,,14738,P,12834,
1,,Autocuration,CLog P was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL623859,,,6076,P,12835,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL839829,,,17840,P,12836,
1,,Autocuration,CLogP was calculated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623860,,,13589,A,12837,
1,,Autocuration,CLogP value was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623861,,,17655,A,12838,
1,,Autocuration,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623862,,,5867,A,12839,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL874406,,,5867,P,12840,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL623863,,,10783,P,12841,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624021,,,14849,P,12842,
1,,Intermediate,Distribution in female dog adrenal medulla 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL624022,,Adrenal medulla,8170,A,12843,
1,,Intermediate,Distribution in female dog adrenal medulla 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1236.0,CHEMBL624023,,Adrenal medulla,8170,A,12844,
1,,Intermediate,Distribution in female dog bile 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624024,,,8170,A,12845,
1,,Intermediate,Distribution in female dog bile 72 hr after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624025,,,8170,A,12846,
1,,Intermediate,Distribution in female dog blood 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624026,,,8170,A,12847,
1,,Intermediate,Distribution in female dog blood 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624027,,,8170,A,12848,
1,,Intermediate,Distribution in female dog heart 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624028,,,8170,A,12849,
1,,Intermediate,Distribution in female dog heart 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624029,,,8170,A,12850,
1,,Intermediate,Distribution in female dog kidney 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624030,,,8170,A,12851,
1,,Intermediate,Distribution in female dog kidney 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624031,,,8170,A,12852,
1,,Intermediate,Distribution in female dog large intestine 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,160.0,CHEMBL624032,,Intestine,8170,A,12853,
1,,Intermediate,Distribution in female dog large intestine 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,160.0,CHEMBL874407,,Intestine,8170,A,12854,
1,,Intermediate,Distribution in female dog liver 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624033,,,8170,A,12855,
1,,Intermediate,Distribution in female dog liver 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624034,,,8170,A,12856,
1,,Intermediate,Distribution in female dog lung 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624035,,,8170,A,12857,
1,,Intermediate,Distribution in female dog lung 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624036,,,8170,A,12858,
1,,Intermediate,Distribution in female dog muscle 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2385.0,CHEMBL624037,,Muscle tissue,8170,A,12859,
1,,Intermediate,Distribution in female dog muscle 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2385.0,CHEMBL624038,,Muscle tissue,8170,A,12860,
1,,Intermediate,Distribution in female dog pancreas 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624039,,,8170,A,12861,
1,,Intermediate,Distribution in female dog pancreas 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624040,,,8170,A,12862,
1,,Intermediate,Distribution in female dog small intestine 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,160.0,CHEMBL624041,,Intestine,8170,A,12863,
1,,Intermediate,Distribution in female dog small intestine 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,160.0,CHEMBL624042,,Intestine,8170,A,12864,
1,,Intermediate,Distribution in female dog spleen 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2106.0,CHEMBL624043,,Spleen,8170,A,12865,
1,,Intermediate,Distribution in female dog spleen 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2106.0,CHEMBL624044,,Spleen,8170,A,12866,
1,,Intermediate,Distribution in female dog stomach 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,945.0,CHEMBL624045,,Stomach,8170,A,12867,
1,,Intermediate,Distribution in female dog stomach 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,945.0,CHEMBL624046,,Stomach,8170,A,12868,
1,,Intermediate,Distribution in female dog thyroid 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2046.0,CHEMBL624047,,Thyroid gland,8170,A,12869,
1,,Intermediate,Distribution in female dog thyroid 72 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,2046.0,CHEMBL624048,,Thyroid gland,8170,A,12870,
1,,Intermediate,Distribution in female dog urine 24 hours after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL874408,,Urine,8170,A,12871,
1,,Intermediate,Distribution in female dog urine 72 hr after administration.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL624049,,Urine,8170,A,12872,
1,,Autocuration,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL624050,,Plasma,14283,A,12873,
1,,Autocuration,Plasma concentration at 7 hr after intravenous dosing,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624051,,,5623,A,12874,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623278,,,13477,A,12875,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623279,,,13477,A,12876,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623280,,,13477,A,12877,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623963,,,13477,A,12878,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623964,,,13477,A,12879,
1,,Intermediate,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623965,,,13477,A,12880,
1,,Intermediate,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623966,,,13477,A,12881,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874415,,,13477,A,12882,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623967,,,13477,A,12883,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623968,,,13477,A,12884,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623969,,,13477,A,12885,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628409,,,13477,A,12886,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628410,,,13477,A,12887,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628411,,,13477,A,12888,
1,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628412,,,13477,A,12889,
1,,Autocuration,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628413,,,12553,A,12890,
1,,Autocuration,The concentration in plasmat; Not determined,U,,,,,,,BAO_0000019,22224,0,,1969.0,CHEMBL628414,,Plasma,14548,A,12891,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in blood,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628415,,,14393,A,12892,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628416,,,14393,A,12893,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in heart,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628417,,,14393,A,12894,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in liver,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL874908,,Liver,14393,A,12895,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628418,,,14393,A,12896,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL628419,,Muscle tissue,14393,A,12897,
1,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628420,,,14393,A,12898,
1,,Autocuration,Water solubility at 37 degree C.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628421,,,1629,A,12899,
1,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626726,,,8194,P,12900,
1,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626727,,,8194,P,12901,
1,,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626728,,Blood,8594,A,12902,
1,,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626729,,Blood,8594,A,12903,
1,,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626730,,Blood,8594,A,12904,
1,,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626731,,Blood,8594,A,12905,
1,,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL626732,,Blood,8594,A,12906,
1,,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626733,,Heart,8594,A,12907,
1,,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626734,,Heart,8594,A,12908,
1,,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626735,,Heart,8594,A,12909,
1,,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL874909,,Heart,8594,A,12910,
1,,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL626736,,Heart,8594,A,12911,
1,,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL626737,,Kidney,8594,A,12912,
1,,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630999,,Kidney,8594,A,12913,
1,,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631000,,Kidney,8594,A,12914,
1,,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631001,,Kidney,8594,A,12915,
1,,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631002,,Kidney,8594,A,12916,
1,,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631003,,Liver,8594,A,12917,
1,,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631004,,Liver,8594,A,12918,
1,,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631005,,Liver,8594,A,12919,
1,,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631006,,Liver,8594,A,12920,
1,,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631007,,Liver,8594,A,12921,
1,,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL631008,,Lung,8594,A,12922,
1,,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL631009,,Lung,8594,A,12923,
1,,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL631010,,Lung,8594,A,12924,
1,,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL631011,,Lung,8594,A,12925,
1,,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL631012,,Lung,8594,A,12926,
1,,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630271,,Thyroid gland,8594,A,12927,
1,,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630272,,Thyroid gland,8594,A,12928,
1,,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630273,,Thyroid gland,8594,A,12929,
1,,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630274,,Thyroid gland,8594,A,12930,
1,,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630275,,Thyroid gland,8594,A,12931,
1,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875782,,,8594,A,12932,
1,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630276,,,8594,A,12933,
1,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630277,,,8594,A,12934,
1,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630278,,,8594,A,12935,
1,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630279,,,8594,A,12936,
1,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630280,,,8151,A,12937,
1,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630281,,,8151,A,12938,
1,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630282,,,7132,A,12939,
1,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630283,,,7132,A,12940,
1,,Autocuration,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630284,,,5797,A,12941,
1,,Autocuration,Alkylating activity was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630285,,,7849,A,12942,
1,,Autocuration,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,,,,,Microsomes,,BAO_0000251,22224,0,,,CHEMBL630286,,,14220,A,12943,
1,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630069,,,8650,A,12944,
1,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630070,,,8650,A,12945,
1,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630071,,,8650,A,12946,
1,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL630072,,,8650,A,12947,
1,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL875110,,,8650,A,12948,
1,,Intermediate,Compound was tested for antidiuretic activity in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630073,,,7116,A,12949,
1,,Autocuration,Compound was tested for inactivation kinetic values,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630074,,,14131,A,12950,
1,,Autocuration,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL630075,In vivo,,7415,A,12951,
1,,Autocuration,Dissociation rate calculated from the first-order equation using the t1/2 value,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630076,,,13178,A,12952,
1,,Autocuration,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL630077,,,8815,P,12953,
1,,Autocuration,Aqueous solubility was measured,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL630078,,,1450,P,12954,
1,,Autocuration,Aqueous solubility was measured at a pH 4,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL630079,,,1450,P,12955,
1,,Autocuration,Aqueous solubility (pH 7),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL630080,,,1450,P,12956,
1,,Autocuration,Aqueous solubility was measured at a pH 9,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL630081,,,1450,P,12957,
1,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630082,,,12711,A,12958,
1,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630083,,,12711,A,12959,
1,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630084,,,12711,A,12960,
1,,Autocuration,Aqueous solubility of the compound,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL629198,,,15032,P,12961,
1,,Autocuration,Aqueous solubility at 37 degree Celsius at pH 7.38,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL629199,,,9964,P,12962,
1,,Autocuration,Aqueous solubility in pH 7.4 phosphate buffer,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL629200,,,14962,P,12963,
1,,Intermediate,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629201,,,12487,A,12964,
1,,Intermediate,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629202,,,12487,A,12965,
1,,Intermediate,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL875111,,,10026,A,12966,
1,,Intermediate,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL629203,,,10026,A,12967,
1,,Intermediate,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL629204,,,10026,A,12968,
1,,Intermediate,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL629205,,,10026,A,12969,
1,,Intermediate,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL629206,,,10026,A,12970,
1,,Autocuration,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631185,,,10026,A,12971,
1,,Intermediate,Compound was evaluated for the average bile flow rat in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631186,,,7415,A,12972,
1,,Intermediate,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL631187,,,17025,A,12973,
1,,Intermediate,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL631188,,,17025,A,12974,
1,,Autocuration,Average half life period was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL876419,,,10184,A,12975,
1,,Autocuration,Average half life period was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631189,,,10184,A,12976,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL631190,,,8613,A,12977,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL631191,,,8613,A,12978,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL631192,,,8613,A,12979,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632400,,,8613,A,12980,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL630564,,,8613,A,12981,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL630565,,,8613,A,12982,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL630566,,,8613,A,12983,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL631229,,,8613,A,12984,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL631230,,,8613,A,12985,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL876428,,,6030,P,12986,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631231,,,6147,P,12987,
1,,Autocuration,Calculated partition coefficient (clogP) (MacLogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631232,,,14556,P,12988,
1,,Autocuration,Hydrophilicity was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631233,,,768,A,12989,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631234,,,14452,P,12990,
1,,Autocuration,Increased absorption was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL883126,,,5237,A,12991,
1,,Autocuration,Lipophilicity value was evaluated,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL631235,,,14378,P,12992,
1,,Autocuration,Log P value of the compound.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL631236,,,14418,P,12993,
1,,Autocuration,Partition coefficient of compound was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631237,,,5249,A,12994,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631238,,,14621,P,12995,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL876429,,,12542,P,12996,
1,,Autocuration,Partition coefficient was measured by medchem software; Not calculated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631414,,,12542,A,12997,
1,,Autocuration,Partition coefficient was measured by octanol-water using standard shake-flask method,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL631415,,,12542,P,12998,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631416,,,15462,P,12999,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631417,,,14884,A,13000,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631418,,,16526,P,13001,
1,,Autocuration,The Octanol/Water partition coefficient CLogP,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631419,,,13693,P,13002,
1,,Autocuration,The pharmacokinetic parameter C Log p was reported,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631420,,,13693,A,13003,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631421,,,13779,P,13004,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631422,,,14772,P,13005,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL631423,,,14393,P,13006,
1,,Intermediate,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL876430,In vivo,Plasma,14793,A,13007,
1,,Intermediate,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL631424,In vivo,Plasma,14793,A,13008,
1,,Intermediate,Compound was administered intravenously in dog to evaluate plasma clearance values,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL631425,In vivo,Plasma,13744,A,13009,
1,,Autocuration,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL631426,In vivo,Plasma,13744,A,13010,
1,,Intermediate,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1969.0,CHEMBL631427,In vivo,Plasma,13744,A,13011,
1,,Intermediate,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL631428,In vivo,Plasma,13207,A,13012,
1,,Intermediate,Intrinsic clearance in Rhesus liver microsome,N,,,Macaca mulatta,,Microsomes,9544.0,BAO_0000218,50797,1,,2107.0,CHEMBL631429,In vitro,Liver,5669,A,13013,
1,,Intermediate,Intrinsic clearance in dog liver microsome,N,,,Canis lupus familiaris,,Microsomes,9615.0,BAO_0000218,50588,1,,2107.0,CHEMBL631430,In vitro,Liver,5669,A,13014,
1,,Intermediate,Intrinsic clearance in rat liver microsome,N,,,Rattus norvegicus,,Microsomes,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631431,In vitro,Liver,5669,A,13015,
1,,Intermediate,Low plasma clearance was calculated in rhesus monkey,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,1969.0,CHEMBL631432,In vivo,Plasma,4853,A,13016,
1,,Intermediate,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631433,In vivo,,16452,A,13017,
1,,Autocuration,Plasma clearance after intravenous dose of 0.3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631434,In vivo,,11954,A,13018,
1,,Autocuration,Plasma clearance after intravenous dose of 1 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631435,In vivo,,11954,A,13019,
1,,Autocuration,Plasma clearance after intravenous dose of 3 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631436,In vivo,,11954,A,13020,
1,,Autocuration,Plasma clearance after intravenous dose of 3.87 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631437,In vivo,,11954,A,13021,
1,,Intermediate,Plasma clearance after peroral administration at 10 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631438,In vivo,,5669,A,13022,
1,,Intermediate,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL876431,In vivo,,5669,A,13023,
1,,Intermediate,Plasma clearance after peroral administration at 10 mpk in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631439,In vivo,,5669,A,13024,
1,,Intermediate,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631440,In vivo,,13662,A,13025,
1,,Autocuration,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631441,,,8272,A,13026,
1,,Autocuration,Critical Micellar concentration was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631442,,,13410,A,13027,
1,,Autocuration,Critical Micellar concentration of the compound. was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626525,,,13410,A,13028,
1,,Autocuration,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627168,,,12628,A,13029,
1,,Autocuration,Critical micellar concentration was measured in water by the dye solubilization method,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875618,,,9675,A,13030,
1,,Autocuration,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626612,,,12628,B,13031,
1,,Autocuration,CMR value (relative to BAY K 8644),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626613,,,12766,A,13032,
1,,Autocuration,Carbamoylating activity was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626614,,,7849,A,13033,
1,,Autocuration,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL626615,,,12187,A,13034,
1,,Autocuration,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626616,,,2040,A,13035,
1,,Autocuration,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626617,,,2040,A,13036,
1,,Intermediate,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626618,In vivo,Plasma,14180,A,13037,
1,,Intermediate,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626619,In vivo,Plasma,14180,A,13038,
1,,Intermediate,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626620,In vivo,,14474,A,13039,
1,,Intermediate,"Clearance rate at 5.5 mg/kg, iv, in rat",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626621,In vivo,,14474,A,13040,
1,,Intermediate,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL626622,In vivo,,14548,A,13041,
1,,Intermediate,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL626623,In vivo,,14548,A,13042,
1,,Intermediate,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626624,In vivo,,14548,A,13043,
1,,Intermediate,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626625,In vivo,,14548,A,13044,
1,,Intermediate,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL626626,Ex vivo,Liver,6125,A,13045,
1,,Autocuration,Tested for the total clearance of the compound,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626627,In vivo,,6874,A,13046,
1,,Intermediate,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626628,In vivo,,15343,A,13047,
1,,Autocuration,Total body clearance was determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626629,In vivo,,6236,A,13048,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626630,,,11510,A,13049,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626631,,,11510,A,13050,
1,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626632,,,8194,P,13051,
1,,Autocuration,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626633,,,8194,P,13052,
1,,Autocuration,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626634,,,8194,P,13053,
1,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626635,,,8194,P,13054,
1,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626636,,,8194,P,13055,
1,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626637,,,8194,P,13056,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL626638,,,13273,A,13057,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL626639,,,13273,A,13058,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL626640,,,13273,A,13059,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL626641,,,13273,A,13060,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL627272,,,13273,A,13061,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL627273,,,13273,A,13062,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL627441,,,13273,A,13063,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL628355,,,13273,A,13064,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL628356,,,13273,A,13065,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL628357,,,13273,A,13066,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL628358,,,13273,A,13067,
1,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,,,Pneumocystis carinii,,,4754.0,BAO_0000218,50339,1,,,CHEMBL622307,,,13273,A,13068,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622527,,,13118,A,13069,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622528,,,13118,A,13070,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622529,,,13118,A,13071,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622992,,,13118,A,13072,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622993,,,13118,A,13073,
1,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622994,,,13118,A,13074,
1,,Intermediate,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622995,,,10633,A,13075,
1,,Intermediate,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622996,,,10633,A,13076,
1,,Intermediate,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622997,,,10633,A,13077,
1,,Intermediate,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622998,,,10633,A,13078,
1,,Autocuration,Cp max following ip administration at 1 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622999,,,5767,A,13079,
1,,Autocuration,Maximum concentration in plasma was reported at 0.5 hour,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL623000,In vivo,Plasma,3302,A,13080,
1,,Autocuration,Maximum concentration in plasma was reported at 2 hour,U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL623001,In vivo,Plasma,3302,A,13081,
1,,Intermediate,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL623002,,,12467,A,13082,
1,,Autocuration,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL623003,,,11778,P,13083,
1,,Autocuration,Steady state concentration was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623004,,,4321,A,13084,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623005,,,14884,A,13085,
1,,Autocuration,Partition coefficient (logD7.4),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623006,,,15234,A,13086,
1,,Intermediate,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623007,In vivo,Liver,14198,A,13087,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL623008,In vivo,Bone,14198,A,13088,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL876654,In vivo,Cerebellum,14198,A,13089,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623009,In vivo,,14198,A,13090,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623010,In vivo,,14198,A,13091,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623011,In vivo,Heart,14198,A,13092,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL623012,In vivo,Intestine,14198,A,13093,
1,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623013,,,8151,A,13094,
1,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623014,,,8151,A,13095,
1,,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL623015,,Urine,8151,A,13096,
1,,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL623016,,Urine,8151,A,13097,
1,,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL624858,,Urine,8151,A,13098,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624859,,,8151,A,13099,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624860,,,8151,A,13100,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624861,,,8151,A,13101,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624862,,,8151,A,13102,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624863,,,8151,A,13103,
1,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876655,,,8151,A,13104,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624864,,,6996,A,13105,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624865,,,6996,A,13106,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624866,,,6996,A,13107,
1,,Expert,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624867,,,6996,F,13108,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL624868,,,6996,A,13109,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628450,,,6996,A,13110,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628451,,,6996,A,13111,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628452,,,6996,A,13112,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628453,,,6996,A,13113,
1,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628454,,,6996,A,13114,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628455,,,6996,A,13115,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628456,,,6996,A,13116,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628457,,,6996,A,13117,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL877505,,,6996,A,13118,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628458,,,6996,A,13119,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628459,,,6996,A,13120,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628460,,,6996,A,13121,
1,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628461,,,6996,A,13122,
1,,Autocuration,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628462,,,6996,B,13123,
1,,Intermediate,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628463,,,6996,A,13124,
1,,Expert,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625666,,,6996,F,13125,
1,,Autocuration,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625667,,,6996,B,13126,
1,,Expert,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625668,,,6996,A,13127,
1,,Intermediate,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625669,,,6996,A,13128,
1,,Autocuration,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625670,,,7114,A,13129,
1,,Intermediate,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625671,,,7114,A,13130,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL625672,,,8613,A,13131,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL625673,,,8613,A,13132,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL625674,,,8613,A,13133,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL625675,,,8613,A,13134,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627637,,,8613,A,13135,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627638,,,8613,A,13136,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627639,,,8613,A,13137,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627640,,,8613,A,13138,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627641,,,8613,A,13139,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL627642,,,8613,A,13140,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL877506,,,8613,A,13141,
1,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627275,,,8613,A,13142,
1,,Intermediate,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL627643,,,11219,A,13143,
1,,Intermediate,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL631246,,,11219,A,13144,
1,,Intermediate,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL631247,,,11219,A,13145,
1,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL629532,,,11219,A,13146,
1,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL629533,,,11219,A,13147,
1,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL629534,,,11219,A,13148,
1,,Intermediate,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,,,Mustela putorius furo,,,9669.0,BAO_0000218,50506,1,,,CHEMBL629535,,,11219,A,13149,
1,,Autocuration,Pharmacokinetic parameter :drug bound to plasma was reported,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625932,,,14837,A,13150,
1,,Autocuration,compound was evaluated for drug bound in plasma,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625933,,,14837,A,13151,
1,,Intermediate,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625934,,,15343,A,13152,
1,,Autocuration,Bioavailability,U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL625935,,,13761,A,13153,
1,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625936,,,14810,A,13154,
1,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625937,,,14810,A,13155,
1,,Intermediate,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625938,,,13249,A,13156,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL625939,,Bile,9267,A,13157,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL625940,,Bile,9267,A,13158,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL874464,,Bile,9267,A,13159,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL625941,,Bile,9267,A,13160,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL625942,,Bile,9267,A,13161,
1,,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1970.0,CHEMBL625943,,Bile,9267,A,13162,
1,,Intermediate,In vitro protein binding in human serum at 5 ug/ml,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1977.0,CHEMBL625944,,Serum,15549,A,13163,
1,,Autocuration,Serum protein binding ability was measured,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625945,,,10929,A,13164,
1,,Autocuration,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625946,,,15444,A,13165,
1,,Autocuration,Oral bioavailability in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL625947,In vivo,,12860,A,13166,
1,,Intermediate,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625948,In vivo,,12170,A,13167,
1,,Autocuration,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625949,In vivo,,15173,A,13168,
1,,Autocuration,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625950,In vivo,,15173,A,13169,
1,,Autocuration,Oral bioavailability (dose 15 mg/kg i.v.),U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL625951,In vivo,,15173,A,13170,
1,,Autocuration,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625952,In vivo,,15173,A,13171,
1,,Autocuration,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625953,In vivo,,15173,A,13172,
1,,Autocuration,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625954,In vivo,,15173,A,13173,
1,,Autocuration,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL882959,In vivo,,15173,A,13174,
1,,Intermediate,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625955,In vivo,,11767,A,13175,
1,,Autocuration,Bioavailability in ferret,U,,,Mustela putorius furo,,,9669.0,BAO_0000218,22224,0,,,CHEMBL625956,In vivo,,11219,A,13176,
1,,Intermediate,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL625957,In vivo,,12186,A,13177,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625958,,,11510,A,13178,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625959,,,11510,A,13179,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626642,,,11510,A,13180,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631330,,,11510,A,13181,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631331,,,11510,A,13182,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631332,,,11510,A,13183,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631333,,,11510,A,13184,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632018,,,11510,A,13185,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632019,,,11510,A,13186,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632020,,,11510,A,13187,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632021,,,11510,A,13188,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632022,,,11510,A,13189,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632023,,,11510,A,13190,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632024,,,11510,A,13191,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874472,,,11510,A,13192,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632025,,,11510,A,13193,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632026,,,11510,A,13194,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632027,,,11510,A,13195,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632028,,,11510,A,13196,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626430,,,11510,A,13197,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626431,,,11510,A,13198,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626432,,,11510,A,13199,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626433,,,11510,A,13200,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626434,,,11510,A,13201,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627280,,,11510,A,13202,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627281,,,11510,A,13203,
1,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627282,,,11510,A,13204,
1,,Autocuration,Total body clearance was measured at given dose,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627283,,,7199,A,13205,
1,,Autocuration,Total body clearance was measured at given dose.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627284,,,7199,A,13206,
1,,Intermediate,Metabolic clearance from the body in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627285,,,7095,A,13207,
1,,Autocuration,Renal clearance from the body,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627286,In vivo,,7095,A,13208,
1,,Intermediate,Renal clearance from the body in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875477,In vivo,,7095,A,13209,
1,,Intermediate,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627287,In vivo,,12528,A,13210,
1,,Intermediate,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL627288,In vivo,,12528,A,13211,
1,,Intermediate,Total clearance from the body in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627289,,,7095,A,13212,
1,,Intermediate,Clearance into cortex from rat plasma or PBS,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627290,In vivo,Plasma,14223,A,13213,
1,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627291,In vivo,,13569,A,13214,
1,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627292,In vivo,,13569,A,13215,
1,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627293,In vivo,,13569,A,13216,
1,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627294,In vivo,,13569,A,13217,
1,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875478,In vivo,,13569,A,13218,
1,,Autocuration,Clearance was determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627295,In vivo,,13979,A,13219,
1,,Intermediate,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627296,In vivo,,14315,A,13220,
1,,Intermediate,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,,CHEMBL626119,In vivo,,14315,A,13221,
1,,Intermediate,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626120,In vivo,,14315,A,13222,
1,,Intermediate,Clearance in rat after iv dose (100 ug/kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626121,In vivo,,12174,A,13223,
1,,Autocuration,Clearance in guinea pig,U,,,Cavia porcellus,,,10141.0,BAO_0000218,22224,0,,,CHEMBL626122,In vivo,,12797,A,13224,
1,,Intermediate,Compound was evaluated for clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626123,In vivo,,12797,A,13225,
1,,Intermediate,Compound was evaluated for the clearance in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL623456,In vivo,,12797,A,13226,
1,,Intermediate,Compound was evaluated for the clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623457,In vivo,,12797,A,13227,
1,,Intermediate,Compound was tested in vivo for clearance after iv administration in the rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623458,In vivo,,11500,A,13228,
1,,Autocuration,IV clearance determined at an iv dose of 14 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623459,In vivo,,15173,A,13229,
1,,Autocuration,IV clearance determined at an iv dose of 15.2 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875484,In vivo,,15173,A,13230,
1,,Autocuration,IV clearance determined at an iv dose of 15 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623460,In vivo,,15173,A,13231,
1,,Autocuration,IV clearance determined at an peroral dose of 30 mg/kg.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623461,In vivo,,15173,A,13232,
1,,Autocuration,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL623462,In vivo,,15173,A,13233,
1,,Autocuration,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627386,In vivo,,15173,A,13234,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627387,In vivo,Kidney,14198,A,13235,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627388,In vivo,Liver,14198,A,13236,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627389,In vivo,Lung,14198,A,13237,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627390,In vivo,Muscle tissue,14198,A,13238,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627391,In vivo,Plasma,14198,A,13239,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627392,In vivo,,14198,A,13240,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL627393,In vivo,Spleen,14198,A,13241,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,3126.0,CHEMBL627394,In vivo,Trachea,14198,A,13242,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627395,In vivo,Bone,14198,A,13243,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL875485,In vivo,Cerebellum,14198,A,13244,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627396,In vivo,,14198,A,13245,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627397,In vivo,,14198,A,13246,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL627398,In vivo,Heart,14198,A,13247,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL627399,In vivo,Bone,14198,A,13248,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627400,In vivo,Kidney,14198,A,13249,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627401,In vivo,Liver,14198,A,13250,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627402,In vivo,Lung,14198,A,13251,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL627403,In vivo,Muscle tissue,14198,A,13252,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL627404,In vivo,Plasma,14198,A,13253,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623101,In vivo,,14198,A,13254,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL877480,In vivo,Spleen,14198,A,13255,
1,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,3126.0,CHEMBL623102,In vivo,Trachea,14198,A,13256,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL623103,In vivo,Bone,14198,A,13257,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL623104,In vivo,Cerebellum,14198,A,13258,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623105,In vivo,,14198,A,13259,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623106,In vivo,,14198,A,13260,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL623107,In vivo,Heart,14198,A,13261,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL623108,In vivo,Intestine,14198,A,13262,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL623109,In vivo,Kidney,14198,A,13263,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL623110,In vivo,Liver,14198,A,13264,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL623111,In vivo,Lung,14198,A,13265,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625060,In vivo,Muscle tissue,14198,A,13266,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625061,In vivo,Plasma,14198,A,13267,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625062,In vivo,,14198,A,13268,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625063,In vivo,Spleen,14198,A,13269,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,3126.0,CHEMBL625064,In vivo,Trachea,14198,A,13270,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000001.0,CHEMBL625065,In vivo,Bone,14198,A,13271,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL625066,In vivo,Cerebellum,14198,A,13272,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625067,In vivo,,14198,A,13273,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625068,In vivo,,14198,A,13274,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL622159,In vivo,Heart,14198,A,13275,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,160.0,CHEMBL622160,In vivo,Intestine,14198,A,13276,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL622161,In vivo,Kidney,14198,A,13277,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL622162,In vivo,Lung,14198,A,13278,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL622163,In vivo,Muscle tissue,14198,A,13279,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622313,In vivo,Plasma,14198,A,13280,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622314,In vivo,,14198,A,13281,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622315,In vivo,Spleen,14198,A,13282,
1,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,3126.0,CHEMBL622316,In vivo,Trachea,14198,A,13283,
1,,Intermediate,Normal diffusion coefficient in water for Escherichia coli,N,,,Escherichia coli,,,562.0,BAO_0000218,50212,1,,,CHEMBL877486,,,15599,A,13284,
1,,Autocuration,Average max percent decrease in RVR (renal vascular resistance) was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622317,,,8204,A,13285,
1,,Autocuration,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622318,,,8204,A,13286,
1,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622319,,,6154,A,13287,
1,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622320,,,6154,A,13288,
1,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622321,,,6154,A,13289,
1,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622322,,,6154,A,13290,
1,,Autocuration,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622323,,,7114,A,13291,
1,,Intermediate,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622324,,,7114,A,13292,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622325,,Urine,8133,A,13293,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622326,,Urine,8133,A,13294,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL877487,,Urine,8133,A,13295,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622327,,Urine,8133,A,13296,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622328,,Urine,8133,A,13297,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622329,,Urine,8133,A,13298,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622330,,Urine,8133,A,13299,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622331,,Urine,8133,A,13300,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622332,,Urine,8133,A,13301,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622333,,Urine,8133,A,13302,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL627658,,Urine,8133,A,13303,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL630428,,Urine,8133,A,13304,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL630429,,Urine,8133,A,13305,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL630430,,Urine,8133,A,13306,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL630431,,Urine,8133,A,13307,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL630432,,Urine,8133,A,13308,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL630433,,Urine,8133,A,13309,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL630434,,Urine,8133,A,13310,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629372,,Urine,8133,A,13311,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629553,,Urine,8133,A,13312,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629554,,Urine,8133,A,13313,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL874447,,Urine,8133,A,13314,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629555,,Urine,8133,A,13315,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629556,,Urine,8133,A,13316,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629557,,Urine,8133,A,13317,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629558,,Urine,8133,A,13318,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629559,,Urine,8133,A,13319,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629560,,Urine,8133,A,13320,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629561,,Urine,8133,A,13321,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629562,,Urine,8133,A,13322,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629563,,Urine,8133,A,13323,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629564,,Urine,8133,A,13324,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629565,,Urine,8133,A,13325,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629566,,Urine,8133,A,13326,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629567,,Urine,8133,A,13327,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629568,,Urine,8133,A,13328,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629569,,Urine,8133,A,13329,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL629570,,Urine,8133,A,13330,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL629571,,Urine,8133,A,13331,
1,,Autocuration,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL629572,In vivo,,12170,A,13332,
1,,Autocuration,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL629573,In vivo,,12170,A,13333,
1,,Autocuration,Bioavailability (dose 20 mg/kg),U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL629574,In vivo,,4985,A,13334,
1,,Autocuration,Bioavailability in dog,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL629575,In vivo,,15145,A,13335,
1,,Autocuration,Bioavailability in rat (Sprague-Dawley) (male),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL874448,In vivo,,14080,A,13336,
1,,Autocuration,Bioavailability in monkey (dose 10 mg/kg i.d.),U,,,Primates,,,9443.0,BAO_0000218,22224,0,,,CHEMBL629576,In vivo,,11219,A,13337,
1,,Autocuration,Bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL629577,In vivo,,15145,A,13338,
1,,Autocuration,Bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL629578,In vivo,,15145,A,13339,
1,,Autocuration,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL629579,In vivo,,1202,A,13340,
1,,Autocuration,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL882958,In vivo,,1202,A,13341,
1,,Intermediate,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,,,Pan troglodytes,,,9598.0,BAO_0000218,50505,1,,,CHEMBL629580,In vivo,,1202,A,13342,
1,,Autocuration,Bioavailability,U,,,Eutheria,,,9347.0,BAO_0000218,22224,0,,,CHEMBL629581,In vivo,,4026,A,13343,
1,,Autocuration,Bioavailability in squirrel monkey,U,,,Saimiri,,,9520.0,BAO_0000218,22224,0,,,CHEMBL629582,In vivo,,1492,A,13344,
1,,Intermediate,Bioavailability was evaluated in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628522,In vivo,,12793,A,13345,
1,,Intermediate,Bioavailability was evaluated in hamster,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL625432,In vivo,,12793,A,13346,
1,,Autocuration,Bioavailability in rat,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625433,In vivo,,12793,A,13347,
1,,Intermediate,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625434,In vivo,Plasma,14793,A,13348,
1,,Intermediate,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL625435,In vivo,Plasma,14793,A,13349,
1,,Autocuration,Bioavailability in rat (dose 10 mg/kg p.o.),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625436,In vivo,,14793,A,13350,
1,,Intermediate,Bioavailability was measured in cynomolgus monkeys.,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL874588,In vivo,,14731,A,13351,
1,,Intermediate,Bioavailability was measured in nude mice.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625437,In vivo,,14731,A,13352,
1,,Autocuration,Bioavailability in ferret (dose 10 mg/kg i.d.),U,,,Mustela putorius furo,,,9669.0,BAO_0000218,22224,0,,,CHEMBL625438,In vivo,,12187,A,13353,
1,,Autocuration,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625439,In vivo,,12187,A,13354,
1,,Autocuration,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625440,In vivo,,12187,A,13355,
1,,Autocuration,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,,CHEMBL625441,In vivo,,12187,A,13356,
1,,Autocuration,Bioavailability in rat (dose 10 mg/kg i.d.),U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625442,In vivo,,12187,A,13357,
1,,Intermediate,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625443,In vivo,,12187,A,13358,
1,,Autocuration,Bioavailability was determined; extremely poor,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625444,In vivo,,17431,A,13359,
1,,Intermediate,% bioavailability in mice after oral administration of prodrug,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625445,In vivo,,13318,A,13360,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625446,In vivo,,9025,A,13361,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL882960,In vivo,,9025,A,13362,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625447,In vivo,,9025,A,13363,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625448,In vivo,,9025,A,13364,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625449,In vivo,,9025,A,13365,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL874589,In vivo,,9025,A,13366,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625450,In vivo,,9025,A,13367,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625451,In vivo,,9025,A,13368,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626584,In vivo,,9025,A,13369,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626585,In vivo,,9025,A,13370,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626586,In vivo,,9025,A,13371,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626587,In vivo,,9025,A,13372,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626588,In vivo,,9025,A,13373,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626589,In vivo,,9025,A,13374,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626590,In vivo,,9025,A,13375,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626591,In vivo,,9025,A,13376,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL627181,In vivo,,9025,A,13377,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628083,In vivo,,9025,A,13378,
1,,Autocuration,IV clearance determined at an peroral dose of 15 mg/kg.,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628084,In vivo,,15173,A,13379,
1,,Expert,Mouse oral clearance was measured against Hymenolepiasis nana.,N,,,Hymenolepis nana,,,102285.0,BAO_0000218,50064,1,,,CHEMBL628085,In vivo,,7732,F,13380,
1,,Expert,Mouse oral clearance was measured against Nematospiroides dubius,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL628086,In vivo,,7732,F,13381,
1,,Autocuration,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628087,In vivo,,7732,F,13382,
1,,Intermediate,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628088,In vivo,,7732,A,13383,
1,,Autocuration,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628089,In vivo,,7732,B,13384,
1,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628090,In vivo,,8328,A,13385,
1,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628091,In vivo,,8328,A,13386,
1,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628092,In vivo,,8328,A,13387,
1,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL628093,In vivo,,8328,A,13388,
1,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL875607,In vivo,,8328,A,13389,
1,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625710,In vivo,,8328,A,13390,
1,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625711,In vivo,,8328,A,13391,
1,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625712,In vivo,,8328,A,13392,
1,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL625713,In vivo,,8328,A,13393,
1,,Intermediate,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625714,In vivo,,13376,A,13394,
1,,Intermediate,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL625715,In vivo,,13477,A,13395,
1,,Intermediate,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625716,In vivo,,13477,A,13396,
1,,Intermediate,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625717,In vivo,,13477,A,13397,
1,,Intermediate,Plasma clearance was determined for the compound in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625718,In vivo,,13313,A,13398,
1,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625719,In vivo,,12504,A,13399,
1,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625720,In vivo,,12504,A,13400,
1,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625721,In vivo,,12504,A,13401,
1,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625722,In vivo,,12504,A,13402,
1,,Intermediate,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625723,In vivo,,13129,A,13403,
1,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL625724,In vivo,,7732,A,13404,
1,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL625725,In vivo,,7732,A,13405,
1,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL625726,In vivo,,7732,A,13406,
1,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL875608,In vivo,,7732,A,13407,
1,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,,,Heligmosomoides polygyrus,,,6339.0,BAO_0000218,50545,1,,,CHEMBL625727,In vivo,,7732,A,13408,
1,,Autocuration,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1088.0,CHEMBL625728,In vivo,Urine,9278,A,13409,
1,,Autocuration,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625729,In vivo,,9278,A,13410,
1,,Autocuration,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL625730,In vivo,,9278,A,13411,
1,,Autocuration,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1088.0,CHEMBL625731,In vivo,Urine,9278,A,13412,
1,,Autocuration,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,1088.0,CHEMBL626417,In vivo,Urine,9278,A,13413,
1,,Intermediate,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,1088.0,CHEMBL626418,In vivo,Urine,9278,A,13414,
1,,Intermediate,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL626419,In vivo,Urine,9278,A,13415,
1,,Intermediate,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626592,In vivo,Plasma,5932,A,13416,
1,,Intermediate,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626593,In vivo,Plasma,5932,A,13417,
1,,Intermediate,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626594,In vivo,,5182,A,13418,
1,,Intermediate,Clearance rate in dogs,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625035,In vivo,,10499,A,13419,
1,,Autocuration,Compound was measured for intrinsic clearance,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625036,In vitro,,6051,A,13420,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625037,,,17508,P,13421,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625038,,,6228,P,13422,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625039,,,6231,P,13423,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625040,,,17740,P,13424,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625041,,,6495,P,13425,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625042,,,2171,P,13426,
1,,Autocuration,Partition coefficient of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874411,,,3255,A,13427,
1,,Autocuration,Permeability,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625043,,,6821,A,13428,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625044,,,2685,P,13429,
1,,Autocuration,Partition coefficient (logD),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625045,,,17584,A,13430,
1,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625046,,,13824,P,13431,
1,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625047,,,13824,P,13432,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625048,,,16479,P,13433,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625049,,,11997,P,13434,
1,,Autocuration,Calculated logarithm of partition coefficient (P) was determined,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625050,,,2988,P,13435,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625051,,,931,P,13436,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL874412,,,4381,P,13437,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625052,,,4397,P,13438,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL625053,,,5889,P,13439,
1,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623250,,,6154,A,13440,
1,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623251,,,6154,A,13441,
1,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623252,,,6154,A,13442,
1,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623253,,,6154,A,13443,
1,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623254,,,6154,A,13444,
1,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623255,,,6154,A,13445,
1,,Autocuration,Percent degradation of compound at a pH of 1 over a 18 hr period,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626831,,,6887,A,13446,
1,,Autocuration,Percent degradation of compound at pH of 1 over an 18 hr period,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL877494,,,6887,A,13447,
1,,Autocuration,Delta Logarithm of Partition Coefficient value was determined.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626832,,,14116,A,13448,
1,,Autocuration,Delta logPoct-cyc,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626833,,,11137,A,13449,
1,,Autocuration,Lipophilicity estimated on reversed phase TLC,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL626834,,,7230,P,13450,
1,,Autocuration,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626835,,,15741,A,13451,
1,,Autocuration,Delta logPoct-cyc,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626836,,,9663,A,13452,
1,,Autocuration,Change in logarithm of partition coefficient of the compound,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626837,,,9663,P,13453,
1,,Autocuration,Delta logD (pH 6.5),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626838,,,13807,A,13454,
1,,Autocuration,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,,,,,,,BAO_0000100,22224,0,,,CHEMBL626839,,,13807,P,13455,
1,,Autocuration,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626840,,,17425,A,13456,
1,,Autocuration,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626841,,,12143,A,13457,
1,,Autocuration,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,,,,,,,BAO_0000219,22224,0,,,CHEMBL626842,,,12608,A,13458,
1,,Autocuration,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,,,,,,,BAO_0000219,22224,0,,,CHEMBL626843,,,12608,A,13459,
1,,Intermediate,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626844,,,8649,A,13460,
1,,Intermediate,Amount of deuterium retained was reported after normal workup in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL877495,,,8649,A,13461,
1,,Intermediate,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626845,,,8649,A,13462,
1,,Intermediate,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626846,,,8649,A,13463,
1,,Intermediate,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626847,,,8649,A,13464,
1,,Intermediate,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628677,,,8649,A,13465,
1,,Intermediate,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628678,,,8649,A,13466,
1,,Autocuration,Compound was subjected to electrochemical oxidation,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628679,,,9659,A,13467,
1,,Autocuration,Compound was subjected to photochemical oxidation,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628680,,,9659,A,13468,
1,,Autocuration,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628681,,,9659,A,13469,
1,,Autocuration,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628682,,,9659,A,13470,
1,,Autocuration,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628683,,,9659,A,13471,
1,,Intermediate,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628684,,,9607,A,13472,
1,,Autocuration,Dissociation constant (pKa),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL877501,,,7057,P,13473,
1,,Autocuration,Dissociation constant value of the compound; ND means not determined.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL628685,,,7057,P,13474,
1,,Intermediate,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628686,,Blood,7911,A,13475,
1,,Intermediate,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL628687,,Blood,7911,A,13476,
1,,Intermediate,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628688,,,7911,A,13477,
1,,Intermediate,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628689,,,7911,A,13478,
1,,Intermediate,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628690,,Liver,7911,A,13479,
1,,Intermediate,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL629363,,Liver,7911,A,13480,
1,,Intermediate,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL629364,,Spleen,7911,A,13481,
1,,Intermediate,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL629365,,Spleen,7911,A,13482,
1,,Intermediate,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629366,,,7911,A,13483,
1,,Intermediate,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629367,,Urine,7911,A,13484,
1,,Intermediate,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL629368,,Feces,7911,A,13485,
1,,Intermediate,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL877502,,Urine,7911,A,13486,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2037.0,CHEMBL629369,,Cerebellum,13792,A,13487,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL629370,,Brain,13792,A,13488,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL629371,,Urine,8133,A,13489,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL626276,,Urine,8133,A,13490,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL626277,,Urine,8133,A,13491,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL631250,,Urine,8133,A,13492,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631251,,Urine,8133,A,13493,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631252,,Urine,8133,A,13494,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631253,,Urine,8133,A,13495,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631254,,Urine,8133,A,13496,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631255,,Urine,8133,A,13497,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631256,,Urine,8133,A,13498,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631257,,Urine,8133,A,13499,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628009,,Urine,8133,A,13500,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628010,,Urine,8133,A,13501,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628011,,Urine,8133,A,13502,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628012,,Urine,8133,A,13503,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628013,,Urine,8133,A,13504,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628014,,Urine,8133,A,13505,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628015,,Urine,8133,A,13506,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628016,,Urine,8133,A,13507,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL874461,,Urine,8133,A,13508,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628017,,Urine,8133,A,13509,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628018,,Urine,8133,A,13510,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628019,,Urine,8133,A,13511,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628020,,Urine,8133,A,13512,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628021,,Urine,8133,A,13513,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628022,,Urine,8133,A,13514,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL628023,,Urine,8133,A,13515,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL628024,,Urine,8133,A,13516,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL628025,,Urine,8133,A,13517,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL628026,,Urine,8133,A,13518,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL628027,,Urine,8133,A,13519,
1,,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1088.0,CHEMBL628028,,Urine,8133,A,13520,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628029,,Urine,8133,A,13521,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628030,,Urine,8133,A,13522,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628031,,Urine,8133,A,13523,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628032,,Urine,8133,A,13524,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628033,,Urine,8133,A,13525,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628034,,Urine,8133,A,13526,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628035,,Urine,8133,A,13527,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628036,,Urine,8133,A,13528,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL874462,,Urine,8133,A,13529,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628037,In vivo,,9025,A,13530,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628123,In vivo,,9025,A,13531,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628124,In vivo,,9025,A,13532,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628125,In vivo,,9025,A,13533,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628126,In vivo,,9025,A,13534,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628127,In vivo,,9025,A,13535,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628128,In vivo,,9025,A,13536,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628129,In vivo,,9025,A,13537,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628130,In vivo,,9025,A,13538,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628131,In vivo,,9025,A,13539,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628132,In vivo,,9025,A,13540,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628133,In vivo,,9025,A,13541,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628134,In vivo,,9025,A,13542,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628135,In vivo,,9025,A,13543,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628136,In vivo,,9025,A,13544,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628137,In vivo,,9025,A,13545,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628138,In vivo,,9025,A,13546,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628139,In vivo,,9025,A,13547,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628140,In vivo,,9025,A,13548,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628141,In vivo,,9025,A,13549,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628142,In vivo,,9025,A,13550,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628143,In vivo,,9025,A,13551,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628144,In vivo,,9025,A,13552,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628145,In vivo,,9025,A,13553,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL628146,In vivo,,9025,A,13554,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625355,In vivo,,9025,A,13555,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625356,In vivo,,9025,A,13556,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625357,In vivo,,9025,A,13557,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625527,In vivo,,9025,A,13558,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL875473,In vivo,,9025,A,13559,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL625528,In vivo,,9025,A,13560,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626304,In vivo,,9025,A,13561,
1,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1637.0,CHEMBL624138,In vivo,Artery,9025,A,13562,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624139,,,6448,P,13563,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624140,,,17221,P,13564,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624141,,,6545,P,13565,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624142,,,577,P,13566,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624143,,,6285,P,13567,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624144,,,6500,P,13568,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624145,,,6716,P,13569,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624146,,,13658,P,13570,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624147,,,6549,P,13571,
1,,Autocuration,Calculated partition coefficient (clogP) (MacLogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL883123,,,14685,P,13572,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624148,,,6893,A,13573,
1,,Autocuration,Kinetic parameter was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874416,,,3687,A,13574,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624149,,,4207,P,13575,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624150,,,4626,P,13576,
1,,Autocuration,Lipophilicity was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL624151,,,1021,P,13577,
1,,Autocuration,Lipophilicity was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL624152,,,3777,P,13578,
1,,Autocuration,Lipophilicity was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL622139,,,17533,P,13579,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622140,,,6524,P,13580,
1,,Autocuration,Lipophilicity was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL622141,,,17533,P,13581,
1,,Autocuration,Lipophilicity in octanol-water,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL622142,,,6480,P,13582,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622143,,,17606,P,13583,
1,,Autocuration,Octanol-water partition coefficient was determined,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622144,,,6863,P,13584,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL877473,,,1356,A,13585,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622145,,,3326,P,13586,
1,,Autocuration,Partition coefficient was determined; ND means not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622146,,,1356,A,13587,
1,,Autocuration,Calculated partition coefficient (clogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622147,,,12984,P,13588,
1,,Autocuration,Partition coefficient of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622148,,,17363,A,13589,
1,,Autocuration,Permeability was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL883124,,,6827,A,13590,
1,,Autocuration,The compound was evaluated for the partition coefficient,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622149,,,261,P,13591,
1,,Autocuration,Partition coefficient (logP),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622150,,,2685,A,13592,
1,,Autocuration,The lipophilicity was reported,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL622151,,,414,P,13593,
1,,Autocuration,logarithm of the octanol-water partition coefficient for the compound,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL622152,,,15769,P,13594,
1,,Autocuration,Clogp value was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL622153,,,17248,A,13595,
1,,Autocuration,Clp at a dose of 1.5 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL877474,In vivo,,16935,A,13596,
1,,Autocuration,Clp at a dose of 2.0 mg/kg,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622154,In vivo,,16935,A,13597,
1,,Autocuration,"Clp, plasma clearance at a dose of 10 mg/kg",U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL622155,In vivo,Plasma,14832,A,13598,
1,,Autocuration,"Clp, plasma clearance at a dose of 50 mg/kg",U,,,,,,,BAO_0000218,22224,0,,1969.0,CHEMBL622156,In vivo,Plasma,14832,A,13599,
1,,Intermediate,Compound was tested for plasma clearance in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622157,In vivo,Plasma,2399,A,13600,
1,,Intermediate,Compound was tested for plasma clearance in rat; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622158,In vivo,Plasma,2399,A,13601,
1,,Intermediate,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622807,In vivo,,6227,A,13602,
1,,Intermediate,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL622808,In vivo,,6227,A,13603,
1,,Autocuration,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622809,In vivo,,5623,A,13604,
1,,Autocuration,Plasma clearance determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622810,In vivo,,4854,A,13605,
1,,Intermediate,Plasma clearance after iv administration at 3 mg/kg in hamster,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL876653,In vivo,,4493,A,13606,
1,,Intermediate,Plasma clearance after iv administration at 4 mg/kg in hamster,N,,,Cricetinae,,,10026.0,BAO_0000218,100712,1,,,CHEMBL622811,In vivo,,4493,A,13607,
1,,Intermediate,Rate of clearance in rat was determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622986,In vivo,,14956,A,13608,
1,,Intermediate,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622987,In vivo,Plasma,15372,A,13609,
1,,Intermediate,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622988,In vivo,Plasma,15372,A,13610,
1,,Intermediate,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622989,In vivo,Plasma,15372,A,13611,
1,,Intermediate,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622990,In vivo,Plasma,15372,A,13612,
1,,Autocuration,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,,,Simiiformes,,,314293.0,BAO_0000218,22224,0,,1969.0,CHEMBL622991,In vivo,Plasma,15604,A,13613,
1,,Intermediate,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL622227,In vivo,Plasma,15604,A,13614,
1,,Intermediate,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL622228,In vivo,Plasma,15604,A,13615,
1,,Intermediate,Clpl value in rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622229,In vivo,,14964,A,13616,
1,,Intermediate,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,,CHEMBL622230,In vivo,,15240,A,13617,
1,,Intermediate,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL622231,In vivo,,16449,A,13618,
1,,Intermediate,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,,,Macaca fascicularis,,,9541.0,BAO_0000218,100710,1,,,CHEMBL622232,In vivo,,16449,A,13619,
1,,Autocuration,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622233,In vivo,,12902,A,13620,
1,,Autocuration,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622234,In vivo,,12902,A,13621,
1,,Autocuration,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622235,In vivo,,12902,A,13622,
1,,Autocuration,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622236,In vivo,,12902,A,13623,
1,,Autocuration,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622237,In vivo,,12902,A,13624,
1,,Autocuration,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL877482,In vivo,,12902,A,13625,
1,,Autocuration,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622238,In vivo,,12902,A,13626,
1,,Autocuration,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL622239,In vivo,,12902,A,13627,
1,,Autocuration,Cmax was calculated as maximum concentration reached in the blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL622240,In vivo,Blood,11149,A,13628,
1,,Autocuration,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL622241,In vivo,Blood,11149,A,13629,
1,,Intermediate,Cmax was determine after peroral administration at 10 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631013,In vivo,,5669,A,13630,
1,,Intermediate,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,,,Macaca mulatta,,,9544.0,BAO_0000218,50797,1,,,CHEMBL631014,In vivo,,5669,A,13631,
1,,Intermediate,Cmax was determine after peroral administration at 10 mpk in dog,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631015,In vivo,,5669,A,13632,
1,,Intermediate,Cmax was determine after peroral administration at 160 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631016,In vivo,,5669,A,13633,
1,,Intermediate,Cmax was determine after peroral administration at 20 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631017,In vivo,,5669,A,13634,
1,,Intermediate,Cmax was determine after peroral administration at 50 mpk in Rat,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631018,In vivo,,5669,A,13635,
1,,Autocuration,Cmax was determined,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL631019,In vivo,,4236,A,13636,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL875761,,Brain,13792,A,13637,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL631020,,Brain,13792,A,13638,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL631669,,Brain,13792,A,13639,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL631670,,Brain,13792,A,13640,
1,,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2435.0,CHEMBL631671,,Striatum,13792,A,13641,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631672,,Blood,8418,A,13642,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631673,,Blood,8418,A,13643,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631856,,Blood,8418,A,13644,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631857,,Blood,8418,A,13645,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631858,,Blood,8418,A,13646,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631859,,Blood,8418,A,13647,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631860,,Blood,8418,A,13648,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631861,,Blood,8418,A,13649,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631862,,Blood,8418,A,13650,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631863,,Blood,8418,A,13651,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631864,,Blood,8418,A,13652,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631865,,Blood,8418,A,13653,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631866,,Blood,8418,A,13654,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629360,,Blood,8418,A,13655,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629361,,Blood,8418,A,13656,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL629362,,Blood,8418,A,13657,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630740,,Blood,8418,A,13658,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630741,,Blood,8418,A,13659,
1,,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630742,,Blood,8418,A,13660,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630743,,,8418,A,13661,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630744,,,8418,A,13662,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630745,,,8418,A,13663,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630746,,,8418,A,13664,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630747,,,8418,A,13665,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630748,,,8418,A,13666,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632056,,,8418,A,13667,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632057,,,8418,A,13668,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632058,,,8418,A,13669,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632059,,,8418,A,13670,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632060,,,8418,A,13671,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632061,,,8418,A,13672,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629207,,,8418,A,13673,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629208,,,8418,A,13674,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629209,,,8418,A,13675,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629210,,,8418,A,13676,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629211,,,8418,A,13677,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629212,,,8418,A,13678,
1,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629213,,,8418,A,13679,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629214,,Urine,8133,A,13680,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629215,,Urine,8133,A,13681,
1,,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL635154,,Urine,8133,A,13682,
1,,Intermediate,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629216,,,6996,A,13683,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629217,,,6996,A,13684,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629218,,,6996,A,13685,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629219,,,6996,A,13686,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629220,,,6996,A,13687,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629221,,,6996,A,13688,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631127,,,6996,A,13689,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631128,,,6996,A,13690,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631129,,,6996,A,13691,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631130,,,6996,A,13692,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631131,,,6996,A,13693,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631132,,,6996,A,13694,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631133,,,6996,A,13695,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631134,,,6996,A,13696,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875120,,,6996,A,13697,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631135,,,6996,A,13698,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631136,,,6996,A,13699,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631137,,,6996,A,13700,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631138,,,6996,A,13701,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631139,,,6996,A,13702,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631140,,,6996,A,13703,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631141,,,6996,A,13704,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631142,,,6996,A,13705,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631143,,,6996,A,13706,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631144,,,6996,A,13707,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631145,,,6996,A,13708,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631146,,,6996,A,13709,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631147,,,6996,A,13710,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631148,,,6996,A,13711,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631149,,,6996,A,13712,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631150,,,6996,A,13713,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631151,,,6996,A,13714,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631152,,,6996,A,13715,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631443,,,6996,A,13716,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631444,,,6996,A,13717,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631445,,,6996,A,13718,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631446,,,6996,A,13719,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631447,,,6996,A,13720,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631448,,,6996,A,13721,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631449,,,6996,A,13722,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL631450,,,6996,A,13723,
1,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629724,,,6996,A,13724,
1,,Intermediate,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL629725,In vivo,Zone of skin,9716,A,13725,
1,,Intermediate,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,14.0,CHEMBL629726,In vivo,Zone of skin,9716,A,13726,
1,,Intermediate,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL629727,In vivo,Spleen,9716,A,13727,
1,,Intermediate,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL630404,In vivo,Spleen,9716,A,13728,
1,,Intermediate,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL630405,In vivo,Spleen,9716,A,13729,
1,,Intermediate,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL630406,In vivo,Spleen,9716,A,13730,
1,,Intermediate,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,945.0,CHEMBL630407,In vivo,Stomach,9716,A,13731,
1,,Intermediate,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,945.0,CHEMBL630573,In vivo,Stomach,9716,A,13732,
1,,Intermediate,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,945.0,CHEMBL630574,In vivo,Stomach,9716,A,13733,
1,,Intermediate,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,945.0,CHEMBL630575,In vivo,Stomach,9716,A,13734,
1,,Intermediate,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630576,In vivo,,9716,A,13735,
1,,Intermediate,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630577,In vivo,,9716,A,13736,
1,,Intermediate,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630578,In vivo,,9716,A,13737,
1,,Intermediate,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630579,In vivo,,9716,A,13738,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630580,,Kidney,12192,A,13739,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630581,,Kidney,12192,A,13740,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630582,,Kidney,12192,A,13741,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630583,,,12192,A,13742,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630584,,,12192,A,13743,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630585,,,12192,A,13744,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630586,,,12192,A,13745,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630587,,,12192,A,13746,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630588,,,12192,A,13747,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630589,,,12192,A,13748,
1,,Intermediate,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL630590,,,12192,A,13749,
1,,Autocuration,Removal of 238-Plutonium(IV) in feces at 24 h,U,,,,,,,BAO_0000019,22224,0,,1988.0,CHEMBL630591,,Feces,12192,A,13750,
1,,Autocuration,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1988.0,CHEMBL630592,,Feces,12192,A,13751,
1,,Autocuration,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630593,,,12192,A,13752,
1,,Autocuration,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630594,,,12192,A,13753,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630595,,Urine,12192,A,13754,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630596,,Urine,12192,A,13755,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630597,,Urine,12192,A,13756,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630598,,Urine,12192,A,13757,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630599,,Urine,12192,A,13758,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630600,,Urine,12192,A,13759,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630601,,Urine,12192,A,13760,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630602,,Urine,12192,A,13761,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630603,,Urine,12192,A,13762,
1,,Autocuration,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,,,,,,,BAO_0000019,22224,0,,1088.0,CHEMBL630604,,Urine,12192,A,13763,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624869,In vivo,Blood,12017,A,13764,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL624870,In vivo,Blood,12017,A,13765,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623189,In vivo,Blood,12017,A,13766,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623190,In vivo,Blood,12017,A,13767,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623191,In vivo,Blood,12017,A,13768,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623192,In vivo,,12017,A,13769,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623193,In vivo,,12017,A,13770,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623194,In vivo,,12017,A,13771,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623195,In vivo,,12017,A,13772,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623196,In vivo,,12017,A,13773,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623197,,,11836,A,13774,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623198,,,11836,A,13775,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623199,,,11836,A,13776,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623200,,Muscle tissue,11836,A,13777,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623201,,Muscle tissue,11836,A,13778,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623202,,Muscle tissue,11836,A,13779,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623203,,Muscle tissue,11836,A,13780,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623204,,Muscle tissue,11836,A,13781,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623205,,Muscle tissue,11836,A,13782,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623206,,Muscle tissue,11836,A,13783,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623207,,Muscle tissue,11836,A,13784,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623208,,Muscle tissue,11836,A,13785,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623209,,Muscle tissue,11836,A,13786,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL623210,,Muscle tissue,11836,A,13787,
1,,Intermediate,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623211,,,11836,A,13788,
1,,Intermediate,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL623212,,Uterus,11836,A,13789,
1,,Autocuration,Tested in vitro for intrinsic activity relative to quinpirole,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623213,,,12640,A,13790,
1,,Autocuration,"Relative ion enhancement, determined in pulsed ultrafiltration",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623214,,,14218,A,13791,
1,,Autocuration,% ionization at the pH 7.4 at 37 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623215,,,11296,A,13792,
1,,Autocuration,Percentage ionization was measured,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623216,,,10929,A,13793,
1,,Intermediate,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,,,Bos taurus,,,9913.0,BAO_0000218,50591,1,,,CHEMBL623217,,,13841,A,13794,
1,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623218,,,10431,A,13795,
1,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623913,,,10431,A,13796,
1,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL623914,,,10431,A,13797,
1,,Autocuration,Compound was evaluated for the partition coefficient in octanol/water,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL623915,,,8826,P,13798,
1,,Autocuration,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL624080,,,8826,P,13799,
1,,Autocuration,Equilibrium constant measured by the pulse radiolysis at pH 7,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL624081,,,9884,A,13800,
1,,Intermediate,In vitro hydrolytic rate constant determined in human blood,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL624082,,,9827,A,13801,
1,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL625054,,,10009,A,13802,
1,,Autocuration,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL877485,,,10009,A,13803,
1,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625055,,,10009,A,13804,
1,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625056,,,10009,A,13805,
1,,Intermediate,In vitro oxidation of compound in presence of human plasma,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL625057,,,10009,A,13806,
1,,Autocuration,In vitro oxidation of compound in presence of hydrogen peroxide,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625058,,,10009,A,13807,
1,,Intermediate,In vitro oxidation of compound in presence of mouse brain homogenate,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625059,,,10009,A,13808,
1,,Intermediate,In vitro oxidation of compound in presence of mouse liver homogenate,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629536,,,10009,A,13809,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629537,,,11510,A,13810,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629538,,,11510,A,13811,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629539,,,11510,A,13812,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL874445,,,11510,A,13813,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629540,,,11510,A,13814,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629541,,,11510,A,13815,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629542,,,11510,A,13816,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630243,,,11510,A,13817,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630244,,,11510,A,13818,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630245,,,11510,A,13819,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630246,,,11510,A,13820,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630247,,,11510,A,13821,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630248,,,11510,A,13822,
1,,Intermediate,Biodistribution in rat blood at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630249,In vivo,Blood,13100,A,13823,
1,,Intermediate,Biodistribution in rat blood at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630250,In vivo,Blood,13100,A,13824,
1,,Intermediate,Biodistribution in rat blood at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630251,In vivo,Blood,13100,A,13825,
1,,Intermediate,Biodistribution in rat blood at 3 hr after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630252,In vivo,Blood,13100,A,13826,
1,,Intermediate,Biodistribution in rat blood at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL630408,In vivo,Blood,13100,A,13827,
1,,Intermediate,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630409,In vivo,Cerebellum,13100,A,13828,
1,,Intermediate,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL874446,In vivo,Cerebellum,13100,A,13829,
1,,Intermediate,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630410,In vivo,Cerebellum,13100,A,13830,
1,,Intermediate,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630411,In vivo,Cerebellum,13100,A,13831,
1,,Intermediate,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630412,In vivo,Cerebellum,13100,A,13832,
1,,Intermediate,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630413,In vivo,Cerebellum,13100,A,13833,
1,,Intermediate,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630414,In vivo,Cerebellum,13100,A,13834,
1,,Intermediate,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL630415,In vivo,Cerebellum,13100,A,13835,
1,,Intermediate,Biodistribution in rat cortex at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630416,In vivo,,13100,A,13836,
1,,Intermediate,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630417,In vivo,,13100,A,13837,
1,,Intermediate,Biodistribution in rat cortex at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630418,In vivo,,13100,A,13838,
1,,Intermediate,Biodistribution in rat cortex at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630419,In vivo,,13100,A,13839,
1,,Intermediate,Biodistribution in rat cortex at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630420,In vivo,,13100,A,13840,
1,,Intermediate,Biodistribution in rat cortex at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630421,In vivo,,13100,A,13841,
1,,Intermediate,Biodistribution in rat cortex at 3 hr after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630422,In vivo,,13100,A,13842,
1,,Intermediate,Biodistribution in rat cortex at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630423,In vivo,,13100,A,13843,
1,,Intermediate,Biodistribution in rat heart at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630424,In vivo,Heart,13100,A,13844,
1,,Intermediate,Biodistribution in rat heart at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630425,In vivo,Heart,13100,A,13845,
1,,Intermediate,Biodistribution in rat heart at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL629462,In vivo,Heart,13100,A,13846,
1,,Intermediate,Biodistribution in rat heart at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630426,In vivo,Heart,13100,A,13847,
1,,Intermediate,Biodistribution in rat heart at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL630427,In vivo,Heart,13100,A,13848,
1,,Intermediate,Biodistribution in rat heart at 3 hr after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625877,In vivo,Heart,13100,A,13849,
1,,Intermediate,Biodistribution in rat heart at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625878,In vivo,Heart,13100,A,13850,
1,,Intermediate,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625879,In vivo,Hippocampus,13100,A,13851,
1,,Intermediate,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625880,In vivo,Hippocampus,13100,A,13852,
1,,Intermediate,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625881,In vivo,Hippocampus,13100,A,13853,
1,,Intermediate,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625882,In vivo,Hippocampus,13100,A,13854,
1,,Intermediate,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625883,In vivo,Hippocampus,13100,A,13855,
1,,Intermediate,Biodistribution in rat kidney at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625884,In vivo,Kidney,13100,A,13856,
1,,Intermediate,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625885,In vivo,Kidney,13100,A,13857,
1,,Intermediate,Biodistribution in rat kidney at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628649,In vivo,Kidney,13100,A,13858,
1,,Intermediate,Biodistribution in rat kidney at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628650,In vivo,Kidney,13100,A,13859,
1,,Intermediate,Biodistribution in rat kidney at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628651,In vivo,Kidney,13100,A,13860,
1,,Intermediate,Biodistribution in rat kidney at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628652,In vivo,Kidney,13100,A,13861,
1,,Intermediate,Biodistribution in rat kidney at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL628653,In vivo,Kidney,13100,A,13862,
1,,Intermediate,Biodistribution in rat liver at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628654,In vivo,Liver,13100,A,13863,
1,,Intermediate,Biodistribution in rat liver at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL628655,In vivo,Liver,13100,A,13864,
1,,Intermediate,Biodistribution in rat liver at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625238,In vivo,Liver,13100,A,13865,
1,,Intermediate,Biodistribution in rat liver at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625239,In vivo,Liver,13100,A,13866,
1,,Intermediate,Biodistribution in rat liver at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625240,In vivo,Liver,13100,A,13867,
1,,Intermediate,Biodistribution in rat liver at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625241,In vivo,Liver,13100,A,13868,
1,,Intermediate,Biodistribution in rat liver at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625242,In vivo,Liver,13100,A,13869,
1,,Intermediate,Biodistribution in rat lung at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL874587,In vivo,Lung,13100,A,13870,
1,,Intermediate,Biodistribution in rat lung at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625405,In vivo,Lung,13100,A,13871,
1,,Intermediate,Biodistribution in rat lung at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625406,In vivo,Lung,13100,A,13872,
1,,Intermediate,Biodistribution in rat lung at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625407,In vivo,Lung,13100,A,13873,
1,,Intermediate,Biodistribution in rat lung at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625408,In vivo,Lung,13100,A,13874,
1,,Intermediate,Biodistribution in rat lung at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625409,In vivo,Lung,13100,A,13875,
1,,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625410,,Thoracic aorta,12361,A,13876,
1,,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625411,,Thoracic aorta,12361,A,13877,
1,,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625412,,Thoracic aorta,12361,A,13878,
1,,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625413,,Thoracic aorta,12361,A,13879,
1,,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625414,,Thoracic aorta,12361,A,13880,
1,,Intermediate,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625415,,Thoracic aorta,12361,A,13881,
1,,Intermediate,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1515.0,CHEMBL625416,,Thoracic aorta,12361,A,13882,
1,,Intermediate,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625417,,Urine,12712,A,13883,
1,,Intermediate,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL625418,,Feces,7415,A,13884,
1,,Intermediate,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625419,,Urine,7415,A,13885,
1,,Intermediate,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625420,,,7415,A,13886,
1,,Intermediate,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626996,,,7415,A,13887,
1,,Intermediate,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL626997,,Feces,7415,A,13888,
1,,Intermediate,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626998,,Urine,7415,A,13889,
1,,Intermediate,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626999,,,7415,A,13890,
1,,Intermediate,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627000,,,8050,A,13891,
1,,Intermediate,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627001,,,8050,A,13892,
1,,Intermediate,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627002,,,8050,A,13893,
1,,Intermediate,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627003,,,8050,A,13894,
1,,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627004,,Urine,8050,A,13895,
1,,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627005,,Urine,8050,A,13896,
1,,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL874594,,Urine,8050,A,13897,
1,,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627006,,Urine,8050,A,13898,
1,,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627007,,Urine,8050,A,13899,
1,,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627884,,Urine,8050,A,13900,
1,,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627885,,Urine,8050,A,13901,
1,,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627886,,Urine,8050,A,13902,
1,,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627887,,Urine,8050,A,13903,
1,,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627888,,Urine,8050,A,13904,
1,,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL628057,,Urine,8050,A,13905,
1,,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627405,,Urine,8050,A,13906,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627406,,Urine,12582,A,13907,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627407,,Urine,12582,A,13908,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627408,,Urine,12582,A,13909,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627409,,Urine,12582,A,13910,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL875486,,Urine,12582,A,13911,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627410,,Urine,12582,A,13912,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627411,,Urine,12582,A,13913,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627412,,Urine,12582,A,13914,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627413,,Urine,12582,A,13915,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627414,,Urine,12582,A,13916,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627415,,Urine,12582,A,13917,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627416,,Urine,12582,A,13918,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627417,,Urine,12582,A,13919,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627418,,Urine,12582,A,13920,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627419,,Urine,12582,A,13921,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627320,,Urine,12582,A,13922,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627321,,Urine,12582,A,13923,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627322,In vivo,Kidney,12017,A,13924,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627323,In vivo,Kidney,12017,A,13925,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627491,In vivo,Kidney,12017,A,13926,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627492,In vivo,Kidney,12017,A,13927,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL627493,In vivo,Kidney,12017,A,13928,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627494,In vivo,Liver,12017,A,13929,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627495,In vivo,Liver,12017,A,13930,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627496,In vivo,Liver,12017,A,13931,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627497,In vivo,Liver,12017,A,13932,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL627498,In vivo,Liver,12017,A,13933,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627499,In vivo,Lung,12017,A,13934,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627500,In vivo,Lung,12017,A,13935,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627501,In vivo,Lung,12017,A,13936,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625616,In vivo,Lung,12017,A,13937,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625617,In vivo,Lung,12017,A,13938,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625618,In vivo,Muscle tissue,12017,A,13939,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625619,In vivo,Muscle tissue,12017,A,13940,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625620,In vivo,Muscle tissue,12017,A,13941,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625621,In vivo,Muscle tissue,12017,A,13942,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625622,In vivo,Muscle tissue,12017,A,13943,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625788,In vivo,Spleen,12017,A,13944,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625789,In vivo,Spleen,12017,A,13945,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625790,In vivo,Spleen,12017,A,13946,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625791,In vivo,Spleen,12017,A,13947,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL622334,In vivo,Spleen,12017,A,13948,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622335,In vivo,Thyroid gland,12017,A,13949,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622336,In vivo,Thyroid gland,12017,A,13950,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622337,In vivo,Thyroid gland,12017,A,13951,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622338,In vivo,Thyroid gland,12017,A,13952,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL622339,In vivo,Thyroid gland,12017,A,13953,
1,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL624153,In vivo,,12017,A,13954,
1,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628430,In vivo,,12017,A,13955,
1,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628431,In vivo,,12017,A,13956,
1,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628432,In vivo,,12017,A,13957,
1,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628433,In vivo,,12017,A,13958,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL628434,In vivo,Spleen,12017,A,13959,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL626789,In vivo,Spleen,12017,A,13960,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL626790,In vivo,Spleen,12017,A,13961,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL626791,In vivo,Spleen,12017,A,13962,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL626792,In vivo,Spleen,12017,A,13963,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL626793,In vivo,Spleen,12017,A,13964,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627436,,,11510,A,13965,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627437,,,11510,A,13966,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627438,,,11510,A,13967,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627439,,,11510,A,13968,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627440,,,11510,A,13969,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627602,,,11510,A,13970,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627603,,,11510,A,13971,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627604,,,11510,A,13972,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627605,,,11510,A,13973,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627606,,,11510,A,13974,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627607,,,11510,A,13975,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627608,,,11510,A,13976,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627609,,,11510,A,13977,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627610,,,11510,A,13978,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627611,,,11510,A,13979,
1,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627612,,,11510,A,13980,
1,,Autocuration,Octanol:water partition coefficient is evaluated,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL627613,,,8362,P,13981,
1,,Autocuration,Partition coefficient in 1-octanol/water system,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL627614,,,8257,P,13982,
1,,Autocuration,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL627615,,,8257,P,13983,
1,,Autocuration,Partition coefficient in octanol/water system was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL627616,,,9468,P,13984,
1,,Autocuration,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL627617,,,9468,P,13985,
1,,Autocuration,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627618,,,10568,A,13986,
1,,Autocuration,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627619,,,10568,A,13987,
1,,Autocuration,Pseudo-first-order rate constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627620,,,15359,A,13988,
1,,Autocuration,Pseudo-first-order rate constant with 1-min time point,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627621,,,15359,A,13989,
1,,Autocuration,Pseudo-first-order rate constant without 1-min time point,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627622,,,15359,A,13990,
1,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627623,,,10431,A,13991,
1,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627624,,,10431,A,13992,
1,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627625,,,10431,A,13993,
1,,Autocuration,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628523,,,15704,A,13994,
1,,Autocuration,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628524,,,15287,A,13995,
1,,Autocuration,The efflux rate constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628525,,,7516,A,13996,
1,,Autocuration,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625732,,,12973,A,13997,
1,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625733,,,12973,A,13998,
1,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625734,,,12973,F,13999,
1,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625913,,,12973,A,14000,
1,,Autocuration,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625914,,,8696,A,14001,
1,,Autocuration,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625915,,,15052,A,14002,
1,,Autocuration,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625916,,,15052,A,14003,
1,,Autocuration,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625917,,,10503,A,14004,
1,,Autocuration,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625918,,,8354,A,14005,
1,,Autocuration,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625919,,,8354,A,14006,
1,,Autocuration,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625920,,,8354,A,14007,
1,,Autocuration,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874453,,,8354,A,14008,
1,,Autocuration,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625921,,,8354,A,14009,
1,,Autocuration,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625922,,,10503,A,14010,
1,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625923,,,8354,A,14011,
1,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625924,,,8354,A,14012,
1,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625925,,,8354,A,14013,
1,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625926,,,8354,A,14014,
1,,Intermediate,Biodistribution in rat lung at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL627704,In vivo,Lung,13100,A,14015,
1,,Intermediate,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627705,In vivo,,13100,A,14016,
1,,Intermediate,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627706,In vivo,,13100,A,14017,
1,,Intermediate,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627707,In vivo,,13100,A,14018,
1,,Intermediate,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627708,In vivo,,13100,A,14019,
1,,Intermediate,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628361,In vivo,,13100,A,14020,
1,,Intermediate,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628362,In vivo,,13100,A,14021,
1,,Intermediate,Biodistribution in rat striatum at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628363,In vivo,Striatum,13100,A,14022,
1,,Intermediate,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628364,In vivo,Striatum,13100,A,14023,
1,,Intermediate,Biodistribution in rat striatum at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628365,In vivo,Striatum,13100,A,14024,
1,,Intermediate,Biodistribution in rat striatum at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL874454,In vivo,Striatum,13100,A,14025,
1,,Intermediate,Biodistribution in rat striatum at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628531,In vivo,Striatum,13100,A,14026,
1,,Intermediate,Biodistribution in rat striatum at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628532,In vivo,Striatum,13100,A,14027,
1,,Intermediate,Biodistribution in rat striatum at 3 hr after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628533,In vivo,Striatum,13100,A,14028,
1,,Intermediate,Biodistribution in rat striatum at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2435.0,CHEMBL628534,In vivo,Striatum,13100,A,14029,
1,,Intermediate,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628535,In vivo,Thyroid gland,13100,A,14030,
1,,Intermediate,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628536,In vivo,Thyroid gland,13100,A,14031,
1,,Intermediate,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628537,In vivo,Thyroid gland,13100,A,14032,
1,,Intermediate,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628538,In vivo,Thyroid gland,13100,A,14033,
1,,Intermediate,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL628539,In vivo,Thyroid gland,13100,A,14034,
1,,Intermediate,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630297,In vivo,Thyroid gland,13100,A,14035,
1,,Intermediate,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL630298,In vivo,Thyroid gland,13100,A,14036,
1,,Intermediate,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL630299,In vivo,Brain,13100,A,14037,
1,,Intermediate,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL628094,In vivo,Brain,13100,A,14038,
1,,Intermediate,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL628095,In vivo,Brain,13100,A,14039,
1,,Intermediate,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL874648,In vivo,Brain,13100,A,14040,
1,,Intermediate,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL628096,In vivo,Brain,13100,A,14041,
1,,Intermediate,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL628097,In vivo,Brain,13100,A,14042,
1,,Intermediate,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL628098,In vivo,Brain,13100,A,14043,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628099,,,13331,A,14044,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628100,,,13331,A,14045,
1,,Autocuration,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628101,,,13331,A,14046,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628102,,,13331,A,14047,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628103,,,13331,A,14048,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628104,,,13331,A,14049,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628105,,,13331,A,14050,
1,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628106,,,13331,A,14051,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628107,,Urine,10086,A,14052,
1,,Autocuration,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,,,,,,,BAO_0000218,22224,0,,1088.0,CHEMBL628108,,Urine,10086,F,14053,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628109,,Urine,10086,A,14054,
1,,Autocuration,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,,,,,,,BAO_0000218,22224,0,,1088.0,CHEMBL625299,,Urine,10086,F,14055,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625300,,Urine,10086,A,14056,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625301,,Urine,10086,A,14057,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625302,,Urine,10086,A,14058,
1,,Intermediate,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL874649,,Urine,10086,A,14059,
1,,Intermediate,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625303,,,13248,A,14060,
1,,Intermediate,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625463,,,13248,A,14061,
1,,Intermediate,In vitro metabolism in human liver microsomes,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,2107.0,CHEMBL625464,,Liver,14527,A,14062,
1,,Intermediate,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL625465,,,3008,A,14063,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625466,,Urine,12582,A,14064,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625467,,Urine,12582,A,14065,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625468,,Urine,12582,A,14066,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625469,,Urine,12582,A,14067,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625470,,Urine,12582,A,14068,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL632418,,Urine,12582,A,14069,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627250,,Urine,12582,A,14070,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627251,,Urine,12582,A,14071,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627252,,Urine,12582,A,14072,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627253,,Urine,12582,A,14073,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627254,,Urine,12582,A,14074,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875471,,Urine,12582,A,14075,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627255,,Urine,12582,A,14076,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627256,,Urine,12582,A,14077,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627257,,Urine,12582,A,14078,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627258,,Urine,12582,A,14079,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627259,,Urine,12582,A,14080,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627260,,Urine,12582,A,14081,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623256,,Urine,12582,A,14082,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL874413,,Urine,12582,A,14083,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623257,,Urine,12582,A,14084,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623258,,Urine,12582,A,14085,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623259,,Urine,12582,A,14086,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623260,,Urine,12582,A,14087,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623261,,Urine,12582,A,14088,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623262,,Urine,12582,A,14089,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623263,,Urine,12582,A,14090,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623264,,Urine,12582,A,14091,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623265,,Urine,12582,A,14092,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623266,,Urine,12582,A,14093,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623267,,Urine,12582,A,14094,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623268,,Urine,12582,A,14095,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623269,,Urine,12582,A,14096,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623270,,Urine,12582,A,14097,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623271,,Urine,12582,A,14098,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623272,,Urine,12582,A,14099,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623273,,Urine,12582,A,14100,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623274,,Urine,12582,A,14101,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL874414,,Urine,12582,A,14102,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623275,,Urine,12582,A,14103,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629150,,Urine,12582,A,14104,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623276,,Urine,12582,A,14105,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623277,,Urine,12582,A,14106,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623112,,Urine,12582,A,14107,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623113,,Urine,12582,A,14108,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623800,,Urine,12582,A,14109,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623801,,Urine,12582,A,14110,
1,,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL623802,In vivo,Spleen,12017,A,14111,
1,,Intermediate,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL623803,In vivo,Uterus,12017,A,14112,
1,,Intermediate,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL623970,In vivo,Uterus,12017,A,14113,
1,,Intermediate,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,995.0,CHEMBL623971,In vivo,Uterus,12017,A,14114,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623972,In vivo,Blood,14045,A,14115,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623973,In vivo,Blood,14045,A,14116,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623974,In vivo,Blood,14045,A,14117,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL623975,In vivo,Blood,14045,A,14118,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623976,In vivo,Brain,14045,A,14119,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623977,In vivo,Brain,14045,A,14120,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623978,In vivo,Brain,14045,A,14121,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL623979,In vivo,Brain,14045,A,14122,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623980,In vivo,,14045,A,14123,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL623981,In vivo,,14045,A,14124,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626278,In vivo,,14045,A,14125,
1,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626279,In vivo,,14045,A,14126,
1,,Intermediate,Biodistribution in mice bladder plus excreted urine was determined,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626280,In vivo,,14045,A,14127,
1,,Intermediate,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626281,,,14045,A,14128,
1,,Intermediate,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626282,,,14045,A,14129,
1,,Intermediate,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626283,,,14045,A,14130,
1,,Intermediate,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626284,,,14045,A,14131,
1,,Intermediate,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL626285,,Brain,14045,A,14132,
1,,Intermediate,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL626286,,Brain,14045,A,14133,
1,,Intermediate,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL626287,,Brain,14045,A,14134,
1,,Intermediate,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,955.0,CHEMBL626288,,Brain,14045,A,14135,
1,,Intermediate,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626289,,,14045,A,14136,
1,,Intermediate,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626290,,,14045,A,14137,
1,,Intermediate,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL626291,,,14045,A,14138,
1,,Intermediate,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL839888,,,14045,A,14139,
1,,Intermediate,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,160.0,CHEMBL626292,,Intestine,14045,A,14140,
1,,Intermediate,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,160.0,CHEMBL626293,,Intestine,14045,A,14141,
1,,Intermediate,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,160.0,CHEMBL626294,,Intestine,14045,A,14142,
1,,Intermediate,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,160.0,CHEMBL626295,,Intestine,14045,A,14143,
1,,Intermediate,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627659,,Liver,14045,A,14144,
1,,Intermediate,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627660,,Liver,14045,A,14145,
1,,Intermediate,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627661,,Liver,14045,A,14146,
1,,Intermediate,Biodistribution in mice liver at 60 minutes of post injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL627662,In vivo,Liver,14045,A,14147,
1,,Intermediate,Biodistribution in mice lungs at 10 min of post injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL627663,In vivo,Lung,14045,A,14148,
1,,Intermediate,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627664,,,14045,A,14149,
1,,Intermediate,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL627665,,,14045,A,14150,
1,,Intermediate,Biodistribution in mice lungs at 60 min of post injection,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2048.0,CHEMBL627666,In vivo,Lung,14045,A,14151,
1,,Intermediate,Percentage biodistribution in mouse spleen,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL627667,,Spleen,14045,A,14152,
1,,Intermediate,Percentage biodistribution in mouse stomach,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,945.0,CHEMBL627668,,Stomach,14045,A,14153,
1,,Intermediate,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,1088.0,CHEMBL627669,,Urine,11745,A,14154,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,,,,,,,BAO_0000218,22224,0,,1255.0,CHEMBL627670,In vivo,Urinary bladder,13257,A,14155,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL627671,In vivo,Blood,13257,A,14156,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,,,,,,,BAO_0000218,22224,0,,1474.0,CHEMBL627672,In vivo,Bone element,13257,A,14157,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627673,In vivo,,13257,A,14158,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,,,,,,,BAO_0000218,22224,0,,2113.0,CHEMBL627674,In vivo,Kidney,13257,A,14159,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,,,,,,,BAO_0000218,22224,0,,2107.0,CHEMBL627675,In vivo,Liver,13257,A,14160,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,,,,,,,BAO_0000218,22224,0,,2048.0,CHEMBL627676,In vivo,Lung,13257,A,14161,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627677,In vivo,Muscle tissue,13257,A,14162,
1,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627678,,,8354,A,14163,
1,,Intermediate,Affinity for protein binding expressed as association constant in fresh rat serum,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL627679,,Serum,7095,A,14164,
1,,Autocuration,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627680,,,12185,A,14165,
1,,Autocuration,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627681,,,12185,A,14166,
1,,Autocuration,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627682,,,12185,A,14167,
1,,Autocuration,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627683,,,12185,A,14168,
1,,Autocuration,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627684,,,12686,A,14169,
1,,Autocuration,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874441,,,12686,A,14170,
1,,Autocuration,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627685,,,12686,A,14171,
1,,Autocuration,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627686,,,12686,A,14172,
1,,Autocuration,Apparent rate constant Koff for inactivation of dTMP synthase.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627687,,,8057,A,14173,
1,,Autocuration,The irreversible inhibitor activity by second order rate equation.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627688,,,15778,A,14174,
1,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628038,,,12375,A,14175,
1,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628039,,,12375,A,14176,
1,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628040,,,12375,A,14177,
1,,Autocuration,Dissociation rate calculated from the first-order equation using t1/2 value,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628041,,,13588,A,14178,
1,,Autocuration,The compound was tested for Binding constant against DNA,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630226,,,15039,A,14179,
1,,Autocuration,First order rate constant for cyclization of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628042,,,9500,A,14180,
1,,Autocuration,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625232,,,10014,A,14181,
1,,Autocuration,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625233,,,10014,A,14182,
1,,Autocuration,Hydrolysis rate constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625979,,,568,A,14183,
1,,Autocuration,Observed first order rate constant,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625980,,,10026,A,14184,
1,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625981,,,10281,A,14185,
1,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625982,,,10281,A,14186,
1,,Autocuration,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625983,,,9680,A,14187,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625984,,,13028,A,14188,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625985,,,13028,A,14189,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625986,,,13028,A,14190,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625987,,,13028,A,14191,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625988,,,13028,A,14192,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625989,,,13028,A,14193,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625990,,,13028,A,14194,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625991,,,13028,A,14195,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625992,,,13028,A,14196,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625993,,,13028,A,14197,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631973,,,13028,A,14198,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632143,,,13028,A,14199,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632144,,,13028,A,14200,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632145,,,13028,A,14201,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632146,,,13028,A,14202,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632147,,,13028,A,14203,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632148,,,13028,A,14204,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632149,,,13028,A,14205,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632150,,,13028,A,14206,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632151,,,13028,A,14207,
1,,Intermediate,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL632152,,,3008,A,14208,
1,,Intermediate,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL632153,,,4509,A,14209,
1,,Intermediate,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL632154,,,4509,A,14210,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632155,,,8613,A,14211,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632156,,,8613,A,14212,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632157,,,8613,A,14213,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632158,,,8613,A,14214,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL632159,,,8613,A,14215,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626305,,,8613,A,14216,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626306,,,8613,A,14217,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626307,,,8613,A,14218,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626308,,,8613,A,14219,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626479,,,8613,A,14220,
1,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,,,Human herpesvirus 1,,,10298.0,BAO_0000218,50602,1,,,CHEMBL626480,,,8613,A,14221,
1,,Autocuration,Calculated partition coefficient (clogP) (MlogP),U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626481,,,6021,P,14222,
1,,Autocuration,Equipotent potent ratio relative to carbachol (nicotinic activity),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626482,,,9348,A,14223,
1,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626483,,,15592,A,14224,
1,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL626484,,,15592,A,14225,
1,,Autocuration,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626485,,,15592,P,14226,
1,,Autocuration,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626486,,,15592,P,14227,
1,,Autocuration,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626487,,,15592,P,14228,
1,,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1969.0,CHEMBL626488,In vivo,Plasma,15592,A,14229,
1,,Intermediate,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1977.0,CHEMBL626489,,Serum,7095,A,14230,
1,,Autocuration,Area under the MAP curve measured over 5 min; ND means Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626490,,,16618,A,14231,
1,,Autocuration,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL626491,,,16835,P,14232,
1,,Autocuration,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL626492,,,15284,P,14233,
1,,Autocuration,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626493,,,15750,A,14234,
1,,Intermediate,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626494,In vivo,,16618,A,14235,
1,,Autocuration,Half life after oral tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626495,In vivo,,16618,A,14236,
1,,Intermediate,Half life was determined in plasma of rat; NT indicates not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626496,,Plasma,15812,A,14237,
1,,Intermediate,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626497,In vivo,,16618,A,14238,
1,,Autocuration,Oral bioavailability after oral tested,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL626498,In vivo,,16618,A,14239,
1,,Intermediate,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626499,,,13098,A,14240,
1,,Intermediate,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626500,,,13098,A,14241,
1,,Intermediate,half life was determined in plasma of rat; NT indicates not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626501,,Plasma,15812,A,14242,
1,,Intermediate,half life was determined in plasma of rat; NT means not tested,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1969.0,CHEMBL626502,,Plasma,15812,A,14243,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626503,,,11510,A,14244,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626504,,,11510,A,14245,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626505,,,11510,A,14246,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626506,,,11510,A,14247,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626507,,,11510,A,14248,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626508,,,11510,A,14249,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626509,,,11510,A,14250,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875480,,,11510,A,14251,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626510,,,11510,A,14252,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626511,,,11510,A,14253,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL626512,,,11510,A,14254,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628208,,,11510,A,14255,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628209,,,11510,A,14256,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628210,,,11510,A,14257,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628211,,,11510,A,14258,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628212,,,11510,A,14259,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628213,,,11510,A,14260,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628214,,Urine,12582,A,14261,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628215,,Urine,12582,A,14262,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628216,,Urine,12582,A,14263,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626595,,Urine,12582,A,14264,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626596,,Urine,12582,A,14265,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626597,,Urine,12582,A,14266,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626598,,Urine,12582,A,14267,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622242,,Urine,12582,A,14268,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622243,,Urine,12582,A,14269,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622244,,Urine,12582,A,14270,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622245,,Urine,12582,A,14271,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622246,,Urine,12582,A,14272,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622247,,Urine,12582,A,14273,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622248,,Urine,12582,A,14274,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL877483,,Urine,12582,A,14275,
1,,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL622249,,Urine,12582,A,14276,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622250,,Urine,12582,A,14277,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622251,,Urine,12582,A,14278,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622252,,Urine,12582,A,14279,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622253,,Urine,12582,A,14280,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622254,,Urine,12582,A,14281,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622255,,Urine,12582,A,14282,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622256,,Urine,12582,A,14283,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622257,,Urine,12582,A,14284,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622258,,Urine,12582,A,14285,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622259,,Urine,12582,A,14286,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622927,,Urine,12582,A,14287,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622928,,Urine,12582,A,14288,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL622929,,Urine,12582,A,14289,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL623182,,Urine,12582,A,14290,
1,,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL623183,,Urine,12582,A,14291,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623184,,Urine,12582,A,14292,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623185,,Urine,12582,A,14293,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL877484,,Urine,12582,A,14294,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL627274,,Urine,12582,A,14295,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623186,,Urine,12582,A,14296,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623187,,Urine,12582,A,14297,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL623188,,Urine,12582,A,14298,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628055,,Urine,12582,A,14299,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628056,,Urine,12582,A,14300,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628200,,Urine,12582,A,14301,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628201,,Urine,12582,A,14302,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628202,,Urine,12582,A,14303,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628203,,Urine,12582,A,14304,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628204,,Urine,12582,A,14305,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628205,,Urine,12582,A,14306,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628206,,Urine,12582,A,14307,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL628207,In vivo,Prostate gland,13257,A,14308,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627220,In vivo,Prostate gland,13257,A,14309,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627221,In vivo,Muscle tissue,13257,A,14310,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627222,In vivo,Prostate gland,13257,A,14311,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627223,In vivo,,13257,A,14312,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL632062,In vivo,Muscle tissue,13257,A,14313,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,,,,,,,BAO_0000218,22224,0,,2106.0,CHEMBL632063,In vivo,Spleen,13257,A,14314,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,,,,,,,BAO_0000218,22224,0,,1255.0,CHEMBL632064,In vivo,Urinary bladder,13257,A,14315,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL632065,In vivo,Blood,13257,A,14316,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,,,,,,,BAO_0000218,22224,0,,1474.0,CHEMBL632066,In vivo,Bone element,13257,A,14317,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL632067,In vivo,,13257,A,14318,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,,,,,,,BAO_0000218,22224,0,,2113.0,CHEMBL629188,In vivo,Kidney,13257,A,14319,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,,,,,,,BAO_0000218,22224,0,,2107.0,CHEMBL629189,In vivo,Liver,13257,A,14320,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,,,,,,,BAO_0000218,22224,0,,2048.0,CHEMBL629190,In vivo,Lung,13257,A,14321,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629191,In vivo,Muscle tissue,13257,A,14322,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629192,In vivo,Prostate gland,13257,A,14323,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629193,In vivo,Muscle tissue,13257,A,14324,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629194,In vivo,Prostate gland,13257,A,14325,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629195,In vivo,,13257,A,14326,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629373,In vivo,Muscle tissue,13257,A,14327,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,,,,,,,BAO_0000218,22224,0,,2106.0,CHEMBL629374,In vivo,Spleen,13257,A,14328,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629375,In vivo,Prostate gland,13257,A,14329,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,,,,,,,BAO_0000218,22224,0,,1255.0,CHEMBL629376,In vivo,Urinary bladder,13257,A,14330,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL629377,In vivo,Blood,13257,A,14331,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,,,,,,,BAO_0000218,22224,0,,1474.0,CHEMBL629378,In vivo,Bone element,13257,A,14332,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629379,In vivo,,13257,A,14333,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,,,,,,,BAO_0000218,22224,0,,2113.0,CHEMBL629151,In vivo,Kidney,13257,A,14334,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,,,,,,,BAO_0000218,22224,0,,2107.0,CHEMBL629152,In vivo,Liver,13257,A,14335,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,,,,,,,BAO_0000218,22224,0,,2048.0,CHEMBL629153,In vivo,Lung,13257,A,14336,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629154,In vivo,Muscle tissue,13257,A,14337,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629155,In vivo,Prostate gland,13257,A,14338,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629156,In vivo,Prostate gland,13257,A,14339,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629157,In vivo,Muscle tissue,13257,A,14340,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL629158,In vivo,Prostate gland,13257,A,14341,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629159,In vivo,,13257,A,14342,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629160,In vivo,Muscle tissue,13257,A,14343,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,,,,,,,BAO_0000218,22224,0,,2106.0,CHEMBL629161,In vivo,Spleen,13257,A,14344,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,,,,,,,BAO_0000218,22224,0,,1255.0,CHEMBL629162,In vivo,Urinary bladder,13257,A,14345,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL629163,In vivo,Blood,13257,A,14346,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,,,,,,,BAO_0000218,22224,0,,1474.0,CHEMBL629164,In vivo,Bone element,13257,A,14347,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL629165,In vivo,,13257,A,14348,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,,,,,,,BAO_0000218,22224,0,,2107.0,CHEMBL629166,In vivo,Liver,13257,A,14349,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,,,,,,,BAO_0000218,22224,0,,2048.0,CHEMBL629167,In vivo,Lung,13257,A,14350,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL629168,In vivo,Muscle tissue,13257,A,14351,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629169,,,2193,A,14352,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629170,,,2193,A,14353,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631153,,,2193,A,14354,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875121,,,2193,A,14355,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631154,,,2193,A,14356,
1,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631155,,,2193,A,14357,
1,,Autocuration,Hydrolysis rate constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631156,,,568,A,14358,
1,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631157,,,9680,A,14359,
1,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631158,,,9680,A,14360,
1,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631159,,,9680,A,14361,
1,,Autocuration,Observed second order rate constant,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631160,,,10026,A,14362,
1,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631161,,,10281,A,14363,
1,,Autocuration,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631162,,,10014,A,14364,
1,,Autocuration,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630313,,,10014,A,14365,
1,,Autocuration,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630314,,,9680,A,14366,
1,,Autocuration,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630315,,,9680,A,14367,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630316,,,13028,A,14368,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630986,,,13028,A,14369,
1,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630987,,,13028,A,14370,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630988,,,13028,A,14371,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630989,,,13028,A,14372,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630990,,,13028,A,14373,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630991,,,13028,A,14374,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630992,,,13028,A,14375,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630993,,,13028,A,14376,
1,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630994,,,13028,A,14377,
1,,Intermediate,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630995,,,10014,A,14378,
1,,Autocuration,Association constant for compound at 31 degree C was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629252,,,9962,A,14379,
1,,Autocuration,Calculated antagonist equilibrium dissociation constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629253,,,12029,A,14380,
1,,Autocuration,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629944,,,12029,A,14381,
1,,Intermediate,Dissociation constants vs LTE4 on guinea pig trachea,N,,,Cavia porcellus,,,10141.0,BAO_0000218,50512,1,,3126.0,CHEMBL629945,,Trachea,10583,A,14382,
1,,Autocuration,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629946,,,568,A,14383,
1,,Autocuration,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629947,,,568,A,14384,
1,,Autocuration,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629948,,,568,A,14385,
1,,Autocuration,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL856024,,,568,A,14386,
1,,Autocuration,Affinity constant KD value was derived from TMP,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629949,,,7493,A,14387,
1,,Autocuration,Apparent dissociation (binding) rate constant was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629950,,,8371,A,14388,
1,,Autocuration,Dissociation constant (KD) of the compound,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL630127,,,13114,P,14389,
1,,Autocuration,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL630128,,,15515,P,14390,
1,,Autocuration,Dissociation constant from ESR titration experiments,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL630129,,,522,P,14391,
1,,Autocuration,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630130,,,13888,,14392,
1,,Autocuration,Dissociation constant was evaluated.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL875234,,,2616,P,14393,
1,,Autocuration,Dissociation constant was reported,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL630131,,,3798,P,14394,
1,,Intermediate,Dissociation constant was determined in rat pituitary cells.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630132,,,8731,A,14395,
1,,Autocuration,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630133,,,11892,A,14396,
1,,Autocuration,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630134,,,11892,A,14397,
1,,Autocuration,Equilibrium dissociation constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630135,,,2582,A,14398,
1,,Autocuration,Equilibrium dissociation constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630136,,,11892,A,14399,
1,,Autocuration,Kinetic constant KD was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630137,,,13396,A,14400,
1,,Autocuration,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630138,,,603,A,14401,
1,,Autocuration,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630139,,,15673,A,14402,
1,,Autocuration,Rate constant for hydrolysis in aqueous acetone.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630140,,,10368,A,14403,
1,,Autocuration,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875235,,,14228,A,14404,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876439,,,11510,A,14405,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630605,,,11510,A,14406,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630606,,,11510,A,14407,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630607,,,11510,A,14408,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630608,,,11510,A,14409,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630609,,,11510,A,14410,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630610,,,11510,A,14411,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630611,,,11510,A,14412,
1,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629552,,,11510,A,14413,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629733,,,11510,A,14414,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629734,,,11510,A,14415,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629735,,,11510,A,14416,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629736,,,11510,A,14417,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629737,,,11510,A,14418,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629738,,,11510,A,14419,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629739,,,11510,A,14420,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629740,,,11510,A,14421,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629741,,,11510,A,14422,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629742,,,11510,A,14423,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629743,,,11510,A,14424,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629744,,,11510,A,14425,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629745,,,11510,A,14426,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629746,,,11510,A,14427,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629747,,,11510,A,14428,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629748,,,11510,A,14429,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629749,,,11510,A,14430,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629750,,,11510,A,14431,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629751,,,11510,A,14432,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629752,,,11510,A,14433,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629753,,,11510,A,14434,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629754,,,11510,A,14435,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629755,,,11510,A,14436,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629756,,,11510,A,14437,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629757,,,11510,A,14438,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629758,,,11510,A,14439,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629759,,,11510,A,14440,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL629760,,,11510,A,14441,
1,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876443,,,11510,A,14442,
1,,Intermediate,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629761,,,8310,A,14443,
1,,Intermediate,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629762,,,8310,A,14444,
1,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629763,,,8310,A,14445,
1,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629764,,,8310,A,14446,
1,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629765,,,8310,A,14447,
1,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629766,,,8310,A,14448,
1,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629767,,,8310,A,14449,
1,,Intermediate,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629768,,,8310,A,14450,
1,,Intermediate,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629769,,,8310,A,14451,
1,,Intermediate,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629770,,,8310,A,14452,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,,CHEMBL629771,,,8310,A,14453,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629772,,,8310,A,14454,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL629773,,,8310,A,14455,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625455,,,8310,A,14456,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625456,,,8310,A,14457,
1,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL625457,,,8310,A,14458,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625458,,Urine,12582,A,14459,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625459,,Urine,12582,A,14460,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875483,,Urine,12582,A,14461,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL634779,,Urine,12582,A,14462,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625460,,Urine,12582,A,14463,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626117,,Urine,12582,A,14464,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626118,,Urine,12582,A,14465,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628342,,Urine,12582,A,14466,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628343,,Urine,12582,A,14467,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628344,,Urine,12582,A,14468,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628345,,Urine,12582,A,14469,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628346,,Urine,12582,A,14470,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628347,,Urine,12582,A,14471,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628348,,Urine,12582,A,14472,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628349,,Urine,12582,A,14473,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875611,,Urine,12582,A,14474,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628350,,Urine,12582,A,14475,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628351,,Urine,12582,A,14476,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628352,,Urine,12582,A,14477,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628353,,Urine,12582,A,14478,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628354,,Urine,12582,A,14479,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626667,,Urine,12582,A,14480,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626668,,Urine,12582,A,14481,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626669,,Urine,12582,A,14482,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626670,,Urine,12582,A,14483,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626671,,Urine,12582,A,14484,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626672,,Urine,12582,A,14485,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626673,,Urine,12582,A,14486,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626674,,Urine,12582,A,14487,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626675,,Urine,12582,A,14488,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626676,,Urine,12582,A,14489,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626677,,Urine,12582,A,14490,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626678,,Urine,12582,A,14491,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626679,,Urine,12582,A,14492,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875612,,Urine,12582,A,14493,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626680,,Urine,12582,A,14494,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626681,,Urine,12582,A,14495,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626682,,Urine,12582,A,14496,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626683,,Urine,12582,A,14497,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626684,,Urine,12582,A,14498,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626685,,Urine,12582,A,14499,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626686,,Urine,12582,A,14500,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626687,,Urine,12582,A,14501,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624978,,Urine,12582,A,14502,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624979,,Urine,12582,A,14503,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624980,,Urine,12582,A,14504,
1,,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL624981,,Urine,12582,A,14505,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL624982,,Urine,12582,A,14506,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627564,In vivo,Prostate gland,13257,A,14507,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627565,In vivo,Prostate gland,13257,A,14508,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627566,In vivo,,13257,A,14509,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627567,In vivo,Muscle tissue,13257,A,14510,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,,,,,,,BAO_0000218,22224,0,,2106.0,CHEMBL627568,In vivo,Spleen,13257,A,14511,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,,,,,,,BAO_0000218,22224,0,,2113.0,CHEMBL627569,In vivo,Kidney,13257,A,14512,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,,,,,,,BAO_0000218,22224,0,,1255.0,CHEMBL627570,In vivo,Urinary bladder,13257,A,14513,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,,,,,,,BAO_0000218,22224,0,,178.0,CHEMBL627571,In vivo,Blood,13257,A,14514,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,,,,,,,BAO_0000218,22224,0,,1474.0,CHEMBL627572,In vivo,Bone element,13257,A,14515,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627573,In vivo,,13257,A,14516,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,,,,,,,BAO_0000218,22224,0,,2113.0,CHEMBL627574,In vivo,Kidney,13257,A,14517,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,,,,,,,BAO_0000218,22224,0,,2107.0,CHEMBL627575,In vivo,Liver,13257,A,14518,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,,,,,,,BAO_0000218,22224,0,,2048.0,CHEMBL627576,In vivo,Lung,13257,A,14519,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627577,In vivo,Muscle tissue,13257,A,14520,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627578,In vivo,Prostate gland,13257,A,14521,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627579,In vivo,Prostate gland,13257,A,14522,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627580,In vivo,Muscle tissue,13257,A,14523,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627581,In vivo,Prostate gland,13257,A,14524,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,,,,,,,BAO_0000218,22224,0,,,CHEMBL627582,In vivo,,13257,A,14525,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627583,In vivo,Muscle tissue,13257,A,14526,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,,,,,,,BAO_0000218,22224,0,,2106.0,CHEMBL627584,In vivo,Spleen,13257,A,14527,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,,,,,,,BAO_0000218,22224,0,,2367.0,CHEMBL627585,In vivo,Prostate gland,13257,A,14528,
1,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,,,,,,,BAO_0000218,22224,0,,2385.0,CHEMBL627586,In vivo,Muscle tissue,13257,A,14529,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627587,In vivo,,15413,A,14530,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL627588,In vivo,,15413,A,14531,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628250,In vivo,,15413,A,14532,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628251,In vivo,,15413,A,14533,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628252,In vivo,Hippocampus,15413,A,14534,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628253,In vivo,Hippocampus,15413,A,14535,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL628254,In vivo,Hypothalamus,15413,A,14536,
1,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL877493,In vivo,Hypothalamus,15413,A,14537,
1,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628255,In vivo,,15413,A,14538,
1,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628256,In vivo,,15413,A,14539,
1,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL628257,In vivo,Hippocampus,15413,A,14540,
1,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL628258,In vivo,Hypothalamus,15413,A,14541,
1,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628259,In vivo,,15413,A,14542,
1,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628429,In vivo,,15413,A,14543,
1,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL626862,In vivo,Hippocampus,15413,A,14544,
1,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL626863,In vivo,Hypothalamus,15413,A,14545,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL625886,In vivo,Cerebellum,15413,A,14546,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL625887,In vivo,Cerebellum,15413,A,14547,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625888,In vivo,,15413,A,14548,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625889,In vivo,,15413,A,14549,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625890,In vivo,Hippocampus,15413,A,14550,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL625891,In vivo,Hippocampus,15413,A,14551,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL625892,In vivo,Hypothalamus,15413,A,14552,
1,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL625893,In vivo,Hypothalamus,15413,A,14553,
1,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2037.0,CHEMBL625894,In vivo,Cerebellum,15413,A,14554,
1,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625895,In vivo,,15413,A,14555,
1,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625896,,,12404,A,14556,
1,,Autocuration,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625897,,,568,A,14557,
1,,Autocuration,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625898,,,568,A,14558,
1,,Autocuration,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL625899,,,568,A,14559,
1,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL626124,,,12404,A,14560,
1,,Intermediate,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,,,Escherichia coli,,,562.0,BAO_0000218,50212,1,,,CHEMBL628500,,,7624,A,14561,
1,,Intermediate,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL857856,,,7624,A,14562,
1,,Intermediate,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628501,,,7624,A,14563,
1,,Autocuration,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628502,,,4643,A,14564,
1,,Autocuration,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628503,,,11532,A,14565,
1,,Autocuration,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628504,,,11018,A,14566,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628505,,,2276,A,14567,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL874452,,,2276,A,14568,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628506,,,2276,A,14569,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628507,,,2276,A,14570,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628508,,,2276,A,14571,
1,,Autocuration,Michaelis constant (KM) was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628509,,,8949,A,14572,
1,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628510,,,12404,A,14573,
1,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628511,,,7625,B,14574,
1,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628512,,,7625,B,14575,
1,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628513,,,7625,B,14576,
1,,Autocuration,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628514,,,7625,B,14577,
1,,Autocuration,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628515,,,12908,A,14578,
1,,Autocuration,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628516,,,10368,A,14579,
1,,Autocuration,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628517,,,13108,A,14580,
1,,Autocuration,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628518,,,13108,A,14581,
1,,Autocuration,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628519,,,15217,A,14582,
1,,Autocuration,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628520,,,15217,A,14583,
1,,Autocuration,Binding constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628521,,,10933,A,14584,
1,,Autocuration,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630443,,,2363,A,14585,
1,,Autocuration,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630444,,,2363,A,14586,
1,,Autocuration,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL857732,,,2276,A,14587,
1,,Autocuration,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL630445,,,14915,P,14588,
1,,Autocuration,Catalytic rate constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630446,,,8847,A,14589,
1,,Autocuration,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630447,,,15357,B,14590,
1,,Autocuration,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630448,,,2869,A,14591,
1,,Autocuration,Catalytic rate constant against phospholipase A2 was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630449,,,3484,A,14592,
1,,Autocuration,"Compound was evaluated for catalytic constant, Kcat",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630450,,,1373,A,14593,
1,,Autocuration,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630451,,,8142,A,14594,
1,,Autocuration,Kcat calculated from 0.693/T1/2,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630452,,,14131,A,14595,
1,,Autocuration,Kcat was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630453,,,17269,A,14596,
1,,Autocuration,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630454,,,3485,A,14597,
1,,Autocuration,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630455,,,3485,A,14598,
1,,Autocuration,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631487,,,3485,A,14599,
1,,Autocuration,Kcat value was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631488,,,5962,A,14600,
1,,Autocuration,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL876440,,,3133,A,14601,
1,,Autocuration,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631489,,,3133,A,14602,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL857742,,,2276,A,14603,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631490,,,2276,A,14604,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631491,,,2276,A,14605,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631492,,,2276,A,14606,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631493,,,2276,A,14607,
1,,Autocuration,Kinetic parameter for rate of conversion to PABA was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631494,,,4892,A,14608,
1,,Autocuration,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631495,,,3133,A,14609,
1,,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1988.0,CHEMBL631496,,Feces,11488,A,14610,
1,,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631497,,Urine,11488,A,14611,
1,,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631498,,Urine,11488,A,14612,
1,,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629776,,Urine,11488,A,14613,
1,,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629777,,Urine,11488,A,14614,
1,,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL629778,,Urine,11488,A,14615,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630456,,,11488,A,14616,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630457,,,11488,A,14617,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630458,,,11488,A,14618,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630459,,,11488,A,14619,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630460,,,11488,A,14620,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL876550,,,11488,A,14621,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630461,,,11488,A,14622,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630462,,,11488,A,14623,
1,,Intermediate,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630463,,,11488,A,14624,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630464,,,11488,A,14625,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630465,,,11488,A,14626,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630466,,,11488,A,14627,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630467,,,11488,A,14628,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630633,,,11488,A,14629,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630634,,,11488,A,14630,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630635,,,11488,A,14631,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630636,,,11488,A,14632,
1,,Intermediate,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630637,,,11488,A,14633,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL630638,,Feces,7132,A,14634,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL630639,,Feces,7132,A,14635,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL630640,,Feces,7132,A,14636,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL876551,,Feces,7132,A,14637,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL630641,,Urine,7132,A,14638,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL630642,,Urine,7132,A,14639,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL630643,,Urine,7132,A,14640,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL630644,,Urine,7132,A,14641,
1,,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL630645,,Urine,7132,A,14642,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL625599,,Feces,7132,A,14643,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL625600,,Feces,7132,A,14644,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL625601,,Feces,7132,A,14645,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1988.0,CHEMBL625602,,Feces,7132,A,14646,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL627470,,Urine,7132,A,14647,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL627471,,Urine,7132,A,14648,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL627472,,Urine,7132,A,14649,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL627473,,Urine,7132,A,14650,
1,,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,1088.0,CHEMBL627474,,Urine,7132,A,14651,
1,,Intermediate,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627475,In vivo,Blood,13925,A,14652,
1,,Intermediate,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL627476,In vivo,Blood,13925,A,14653,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627477,,Urine,12582,A,14654,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627478,,Urine,12582,A,14655,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627479,,Urine,12582,A,14656,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627480,,Urine,12582,A,14657,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627481,,Urine,12582,A,14658,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627482,,Urine,12582,A,14659,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL627483,,Urine,12582,A,14660,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL875636,,Urine,12582,A,14661,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625764,,Urine,12582,A,14662,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625765,,Urine,12582,A,14663,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625766,,Urine,12582,A,14664,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625767,,Urine,12582,A,14665,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625768,,Urine,12582,A,14666,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625769,,Urine,12582,A,14667,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625770,,Urine,12582,A,14668,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625771,,Urine,12582,A,14669,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625772,,Urine,12582,A,14670,
1,,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,,,Canis lupus familiaris,,,9615.0,BAO_0000218,50588,1,,1088.0,CHEMBL625773,,Urine,12582,A,14671,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625774,,Urine,12582,A,14672,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625775,,Urine,12582,A,14673,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625776,,Urine,12582,A,14674,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625777,,Urine,12582,A,14675,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625778,,Urine,12582,A,14676,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625779,,Urine,12582,A,14677,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625780,,Urine,12582,A,14678,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL625781,,Urine,12582,A,14679,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875637,,Urine,12582,A,14680,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626473,,Urine,12582,A,14681,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626474,,Urine,12582,A,14682,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626475,,Urine,12582,A,14683,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626476,,Urine,12582,A,14684,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL634397,,Urine,12582,A,14685,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL626477,,Urine,12582,A,14686,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631069,,Urine,12582,A,14687,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631070,,Urine,12582,A,14688,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631071,,Urine,12582,A,14689,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631072,,Urine,12582,A,14690,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631073,,Urine,12582,A,14691,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631074,,Urine,12582,A,14692,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631075,,Urine,12582,A,14693,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631725,,Urine,12582,A,14694,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631726,,Urine,12582,A,14695,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631727,,Urine,12582,A,14696,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631728,,Urine,12582,A,14697,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631729,,Urine,12582,A,14698,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631730,,Urine,12582,A,14699,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631731,,Urine,12582,A,14700,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631910,,Urine,12582,A,14701,
1,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,10000000.0,CHEMBL631911,In vivo,Hippocampus,15413,A,14702,
1,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL631912,In vivo,Hypothalamus,15413,A,14703,
1,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1898.0,CHEMBL631913,In vivo,Hypothalamus,15413,A,14704,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631914,In vivo,Blood,12017,A,14705,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631915,In vivo,Blood,12017,A,14706,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL875778,In vivo,Blood,12017,A,14707,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631916,In vivo,Blood,12017,A,14708,
1,,Intermediate,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631917,In vivo,Blood,12017,A,14709,
1,,Intermediate,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631918,In vivo,Blood,12017,A,14710,
1,,Intermediate,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631919,In vivo,Blood,12017,A,14711,
1,,Intermediate,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631920,In vivo,Blood,12017,A,14712,
1,,Intermediate,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631921,In vivo,Blood,12017,A,14713,
1,,Intermediate,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631922,In vivo,Blood,12017,A,14714,
1,,Intermediate,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL631923,In vivo,Blood,12017,A,14715,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631924,In vivo,,12017,A,14716,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630234,In vivo,,12017,A,14717,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630235,In vivo,,12017,A,14718,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630236,In vivo,,12017,A,14719,
1,,Intermediate,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630237,In vivo,,12017,A,14720,
1,,Intermediate,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630238,In vivo,,12017,A,14721,
1,,Intermediate,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630239,In vivo,,12017,A,14722,
1,,Intermediate,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630303,In vivo,,12017,A,14723,
1,,Intermediate,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630304,In vivo,,12017,A,14724,
1,,Intermediate,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630305,In vivo,,12017,A,14725,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630306,In vivo,Kidney,12017,A,14726,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630307,In vivo,Kidney,12017,A,14727,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630308,In vivo,Kidney,12017,A,14728,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL630309,In vivo,Kidney,12017,A,14729,
1,,Intermediate,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL629309,In vivo,Kidney,12017,A,14730,
1,,Intermediate,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL629993,In vivo,Kidney,12017,A,14731,
1,,Intermediate,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL629994,In vivo,Kidney,12017,A,14732,
1,,Intermediate,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL629995,In vivo,Kidney,12017,A,14733,
1,,Intermediate,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631993,In vivo,Kidney,12017,A,14734,
1,,Intermediate,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631994,In vivo,Kidney,12017,A,14735,
1,,Intermediate,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL631995,In vivo,Kidney,12017,A,14736,
1,,Intermediate,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631996,In vivo,Liver,12017,A,14737,
1,,Intermediate,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631997,In vivo,Liver,12017,A,14738,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631998,In vivo,Liver,12017,A,14739,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631999,In vivo,Liver,12017,A,14740,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL632000,In vivo,Liver,12017,A,14741,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL632001,In vivo,Liver,12017,A,14742,
1,,Intermediate,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL874424,In vivo,Liver,12017,A,14743,
1,,Intermediate,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL632002,In vivo,Liver,12017,A,14744,
1,,Intermediate,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL632003,In vivo,Liver,12017,A,14745,
1,,Autocuration,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632004,,,3133,A,14746,
1,,Autocuration,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632005,,,2742,A,14747,
1,,Autocuration,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632006,,,2742,A,14748,
1,,Autocuration,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632007,,,2742,A,14749,
1,,Autocuration,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632008,,,2742,A,14750,
1,,Autocuration,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632009,,,2742,A,14751,
1,,Autocuration,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632010,,,2742,A,14752,
1,,Autocuration,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL857750,,,2742,A,14753,
1,,Autocuration,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632011,,,2742,A,14754,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632012,,,2276,A,14755,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632013,,,2276,A,14756,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL632014,,,2276,A,14757,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629622,,,2276,A,14758,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629623,,,2276,A,14759,
1,,Autocuration,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629624,,,2276,A,14760,
1,,Autocuration,Ratio of Kcat to that of Km was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629625,,,17269,A,14761,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629626,,,2276,A,14762,
1,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629627,,,2276,A,14763,
1,,Autocuration,"Compound was evaluated for constant, Kd",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629628,,,15917,A,14764,
1,,Autocuration,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629629,,,10933,A,14765,
1,,Autocuration,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629630,,,10933,A,14766,
1,,Autocuration,Dissociation Constant of compound determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL856030,,,14293,A,14767,
1,,Autocuration,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629631,,,6698,B,14768,
1,,Autocuration,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629632,,,6698,B,14769,
1,,Autocuration,Dissociation constant of compound with Fructose was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629633,,,4318,P,14770,
1,,Autocuration,Dissociation constant of compound with Fructose was determined; Not determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629634,,,4318,P,14771,
1,,Autocuration,Dissociation constant of compound with Lactulose was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629635,,,4318,P,14772,
1,,Autocuration,Dissociation constant of compound with Lactulose was determined; Not determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629636,,,4318,P,14773,
1,,Autocuration,Dissociation constant of the Compound,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629637,,,14959,P,14774,
1,,Autocuration,Dissociation constant by non-linear regression analysis,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629638,,,5913,P,14775,
1,,Autocuration,Dissociation constant was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629639,,,14218,P,14776,
1,,Autocuration,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629640,,,10689,P,14777,
1,,Autocuration,Dissociation constant was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629641,,,13925,P,14778,
1,,Autocuration,Dissociation constant was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL631344,,,16359,P,14779,
1,,Intermediate,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631345,,Muscle tissue,10944,A,14780,
1,,Autocuration,The dissociation constant determined by fluorescence displacement assay,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631346,,,11080,A,14781,
1,,Autocuration,kd value surface plasmon resonance (SPR) method,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631524,,,17805,A,14782,
1,,Intermediate,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631525,,Muscle tissue,10944,A,14783,
1,,Autocuration,First dissociation constant of the binding of compound to V30M TTR,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631526,,,16645,F,14784,
1,,Autocuration,Second dissociation constant of the binding of compound to V30M TTR,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631527,,,16645,F,14785,
1,,Autocuration,"Compound was evaluated for equilibrium constant, Ke",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631528,,,7793,A,14786,
1,,Autocuration,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,,,,,,,BAO_0000019,22224,0,,1898.0,CHEMBL631529,,Hypothalamus,12199,A,14787,
1,,Autocuration,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,,,,,,,BAO_0000019,22224,0,,1898.0,CHEMBL631530,,Hypothalamus,12199,A,14788,
1,,Autocuration,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631531,,,9680,A,14789,
1,,Autocuration,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631532,,,9680,A,14790,
1,,Autocuration,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL631533,,,9680,A,14791,
1,,Intermediate,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL876552,,,13758,A,14792,
1,,Intermediate,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631534,,,13758,A,14793,
1,,Intermediate,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631535,,,13758,A,14794,
1,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631536,,,13758,A,14795,
1,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631537,,,13758,A,14796,
1,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631538,,,13758,A,14797,
1,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631539,,,13758,A,14798,
1,,Intermediate,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631540,,,13758,A,14799,
1,,Intermediate,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625637,,,14393,A,14800,
1,,Intermediate,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625638,,,14393,A,14801,
1,,Intermediate,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL625639,,,15078,A,14802,
1,,Intermediate,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625640,In vivo,Brain,13925,A,14803,
1,,Intermediate,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625641,In vivo,Brain,13925,A,14804,
1,,Intermediate,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625642,In vivo,Heart,13925,A,14805,
1,,Intermediate,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625643,In vivo,Heart,13925,A,14806,
1,,Intermediate,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625644,In vivo,Kidney,13925,A,14807,
1,,Intermediate,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2113.0,CHEMBL625645,In vivo,Kidney,13925,A,14808,
1,,Intermediate,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625646,In vivo,Liver,13925,A,14809,
1,,Intermediate,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625647,In vivo,Liver,13925,A,14810,
1,,Intermediate,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625648,In vivo,Lung,13925,A,14811,
1,,Intermediate,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL625649,In vivo,Lung,13925,A,14812,
1,,Intermediate,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625650,In vivo,Muscle tissue,13925,A,14813,
1,,Intermediate,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL625651,In vivo,Muscle tissue,13925,A,14814,
1,,Intermediate,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL625652,In vivo,Zone of skin,13925,A,14815,
1,,Intermediate,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,14.0,CHEMBL625653,In vivo,Zone of skin,13925,A,14816,
1,,Intermediate,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625654,In vivo,Spleen,13925,A,14817,
1,,Intermediate,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL625655,In vivo,Spleen,13925,A,14818,
1,,Intermediate,Biodistribution of Compound in rat blood after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625656,In vivo,Blood,9712,A,14819,
1,,Intermediate,Biodistribution of Compound in rat blood after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,178.0,CHEMBL625657,In vivo,Blood,9712,A,14820,
1,,Intermediate,Biodistribution of Compound in rat brain after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625658,In vivo,Brain,9712,A,14821,
1,,Intermediate,Biodistribution of Compound in rat brain after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,955.0,CHEMBL625659,In vivo,Brain,9712,A,14822,
1,,Intermediate,Biodistribution of Compound in rat heart after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625660,In vivo,Heart,9712,A,14823,
1,,Intermediate,Biodistribution of Compound in rat heart after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,948.0,CHEMBL625661,In vivo,Heart,9712,A,14824,
1,,Intermediate,Biodistribution of Compound in rat liver after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625662,In vivo,Liver,9712,A,14825,
1,,Intermediate,Biodistribution of Compound in rat liver after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL625663,In vivo,Liver,9712,A,14826,
1,,Intermediate,Biodistribution of Compound in rat lung after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL875621,In vivo,Lung,9712,A,14827,
1,,Intermediate,Biodistribution of Compound in rat lung after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL628382,In vivo,Lung,9712,A,14828,
1,,Intermediate,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL628383,In vivo,Muscle tissue,9712,A,14829,
1,,Intermediate,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL628384,In vivo,Muscle tissue,9712,A,14830,
1,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628385,,,13925,A,14831,
1,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875753,,,13925,A,14832,
1,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628386,,,13925,A,14833,
1,,Intermediate,Organ distribution in rat blood 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628387,,,6941,A,14834,
1,,Intermediate,Organ distribution in rat blood 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628388,,,6941,A,14835,
1,,Intermediate,Organ distribution in rat blood 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628389,,,6941,A,14836,
1,,Intermediate,Organ distribution in rat blood 30 min after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL632756,,,6941,A,14837,
1,,Intermediate,Organ distribution in rat brain 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628390,,,6941,A,14838,
1,,Intermediate,Organ distribution in rat brain 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631811,,,6941,A,14839,
1,,Intermediate,Organ distribution in rat brain 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631812,,,6941,A,14840,
1,,Intermediate,Organ distribution in rat heart 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631813,,,6941,A,14841,
1,,Intermediate,Organ distribution in rat heart 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631814,,,6941,A,14842,
1,,Intermediate,Organ distribution in rat heart 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631815,,,6941,A,14843,
1,,Intermediate,Organ distribution in rat kidney 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631816,,,6941,A,14844,
1,,Intermediate,Organ distribution in rat kidney 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL875758,,,6941,A,14845,
1,,Intermediate,Organ distribution in rat kidney 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631817,,,6941,A,14846,
1,,Intermediate,Organ distribution in rat liver 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631818,,Liver,6941,A,14847,
1,,Intermediate,Organ distribution in rat liver 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631819,,Liver,6941,A,14848,
1,,Intermediate,Organ distribution in rat liver 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL631820,,Liver,6941,A,14849,
1,,Intermediate,Organ distribution in rat lung 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631821,,,6941,A,14850,
1,,Intermediate,Organ distribution in rat lung 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631822,,,6941,A,14851,
1,,Intermediate,Organ distribution in rat lung 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL631823,,,6941,A,14852,
1,,Intermediate,Organ distribution in rat muscle 2 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631824,,Muscle tissue,6941,A,14853,
1,,Intermediate,Organ distribution in rat muscle 2 hr after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631825,,Muscle tissue,6941,A,14854,
1,,Intermediate,Organ distribution in rat muscle 30 minutes after intravenous injection,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631826,,Muscle tissue,6941,A,14855,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631827,In vivo,,14439,A,14856,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631828,In vivo,,14439,A,14857,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL631829,In vivo,,14439,A,14858,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875759,,Urine,12582,A,14859,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631830,,Urine,12582,A,14860,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631831,,Urine,12582,A,14861,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631832,,Urine,12582,A,14862,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631833,,Urine,12582,A,14863,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631834,,Urine,12582,A,14864,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631835,,Urine,12582,A,14865,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631836,,Urine,12582,A,14866,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631837,,Urine,12582,A,14867,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631838,,Urine,12582,A,14868,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631839,,Urine,12582,A,14869,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631840,,Urine,12582,A,14870,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631841,,Urine,12582,A,14871,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631842,,Urine,12582,A,14872,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631843,,Urine,12582,A,14873,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631844,,Urine,12582,A,14874,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631845,,Urine,12582,A,14875,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631846,,Urine,12582,A,14876,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL875760,,Urine,12582,A,14877,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL632199,,Urine,12582,A,14878,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631847,,Urine,12582,A,14879,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL631848,,Urine,12582,A,14880,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628707,,Urine,12582,A,14881,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628708,,Urine,12582,A,14882,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628709,,Urine,12582,A,14883,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628710,,Urine,12582,A,14884,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628711,,Urine,12582,A,14885,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628712,,Urine,12582,A,14886,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628713,,Urine,12582,A,14887,
1,,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,1088.0,CHEMBL628714,,Urine,12582,A,14888,
1,,Intermediate,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL628715,,,7415,A,14889,
1,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629179,,,7313,A,14890,
1,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629180,,,7313,A,14891,
1,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL875108,,,7313,A,14892,
1,,Autocuration,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629181,,Adrenal cortex,7570,A,14893,
1,,Autocuration,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629182,,Adrenal cortex,7570,A,14894,
1,,Autocuration,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629183,,,7570,A,14895,
1,,Autocuration,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629184,,,7570,A,14896,
1,,Autocuration,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629185,,Adrenal cortex,7570,A,14897,
1,,Autocuration,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629186,,Adrenal cortex,7570,A,14898,
1,,Autocuration,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629187,,,7570,A,14899,
1,,Autocuration,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629887,,,7570,A,14900,
1,,Autocuration,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629888,,,7570,A,14901,
1,,Autocuration,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629889,,,7570,A,14902,
1,,Autocuration,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629890,,Adrenal cortex,7570,A,14903,
1,,Autocuration,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629891,,,7570,A,14904,
1,,Autocuration,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629892,,,7570,A,14905,
1,,Autocuration,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,1235.0,CHEMBL629893,,Adrenal cortex,7570,A,14906,
1,,Autocuration,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629894,,,7570,A,14907,
1,,Autocuration,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629895,,,7570,A,14908,
1,,Autocuration,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,,,Canis lupus familiaris,,,9615.0,BAO_0000218,22224,0,,,CHEMBL875109,In vivo,,14122,A,14909,
1,,Autocuration,Absolute bioavailability in male cynomolgus monkeys,U,,,Macaca fascicularis,,,9541.0,BAO_0000218,22224,0,,,CHEMBL629896,In vivo,,16449,A,14910,
1,,Autocuration,Absolute bioavailability in maleSprague-Dawley rats,U,,,Rattus norvegicus,,,10116.0,BAO_0000218,22224,0,,,CHEMBL629897,In vivo,,16449,A,14911,
1,,Intermediate,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL629898,In vivo,Liver,12017,A,14912,
1,,Intermediate,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL630057,In vivo,Liver,12017,A,14913,
1,,Intermediate,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2107.0,CHEMBL630058,In vivo,Liver,12017,A,14914,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630059,In vivo,Lung,12017,A,14915,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630060,In vivo,Lung,12017,A,14916,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630061,In vivo,Lung,12017,A,14917,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630062,In vivo,Lung,12017,A,14918,
1,,Intermediate,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630063,In vivo,Lung,12017,A,14919,
1,,Intermediate,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630064,In vivo,Lung,12017,A,14920,
1,,Intermediate,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630065,In vivo,Lung,12017,A,14921,
1,,Intermediate,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630066,In vivo,Lung,12017,A,14922,
1,,Intermediate,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630067,In vivo,Lung,12017,A,14923,
1,,Intermediate,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2048.0,CHEMBL630068,In vivo,Lung,12017,A,14924,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631113,In vivo,Muscle tissue,12017,A,14925,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631114,In vivo,Muscle tissue,12017,A,14926,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631115,In vivo,Muscle tissue,12017,A,14927,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL631116,In vivo,Muscle tissue,12017,A,14928,
1,,Intermediate,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630528,In vivo,Muscle tissue,12017,A,14929,
1,,Intermediate,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630529,In vivo,Muscle tissue,12017,A,14930,
1,,Intermediate,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630530,In vivo,Muscle tissue,12017,A,14931,
1,,Intermediate,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630531,In vivo,Muscle tissue,12017,A,14932,
1,,Intermediate,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630532,In vivo,Muscle tissue,12017,A,14933,
1,,Intermediate,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2385.0,CHEMBL630533,In vivo,Muscle tissue,12017,A,14934,
1,,Intermediate,Biodistribution in normal mice blood after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL630534,In vivo,Blood,15045,A,14935,
1,,Intermediate,Biodistribution in normal mice blood after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL630535,In vivo,Blood,15045,A,14936,
1,,Intermediate,Biodistribution in normal mice blood after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,178.0,CHEMBL630536,In vivo,Blood,15045,A,14937,
1,,Intermediate,Biodistribution in normal mice bone after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,10000001.0,CHEMBL630537,In vivo,Bone,15045,A,14938,
1,,Intermediate,Biodistribution in normal mice bone after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,10000001.0,CHEMBL630538,In vivo,Bone,15045,A,14939,
1,,Intermediate,Biodistribution in normal mice bone after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,10000001.0,CHEMBL630539,In vivo,Bone,15045,A,14940,
1,,Intermediate,Biodistribution in normal mice heart after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL630540,In vivo,Heart,15045,A,14941,
1,,Intermediate,Biodistribution in normal mice heart after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL630541,In vivo,Heart,15045,A,14942,
1,,Intermediate,Biodistribution in normal mice heart after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,948.0,CHEMBL630542,In vivo,Heart,15045,A,14943,
1,,Intermediate,Biodistribution in normal mice kidney after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630543,In vivo,Kidney,15045,A,14944,
1,,Intermediate,Biodistribution in normal mice kidney after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630544,In vivo,Kidney,15045,A,14945,
1,,Intermediate,Biodistribution in normal mice kidney after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2113.0,CHEMBL630545,In vivo,Kidney,15045,A,14946,
1,,Intermediate,Biodistribution in normal mice liver after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL630546,In vivo,Liver,15045,A,14947,
1,,Intermediate,Biodistribution in normal mice liver after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL630547,In vivo,Liver,15045,A,14948,
1,,Intermediate,Biodistribution in normal mice liver after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2107.0,CHEMBL630548,In vivo,Liver,15045,A,14949,
1,,Intermediate,Biodistribution in normal mice spleen after 120 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL630549,In vivo,Spleen,15045,A,14950,
1,,Intermediate,Biodistribution in normal mice spleen after 24 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL630550,In vivo,Spleen,15045,A,14951,
1,,Intermediate,Biodistribution in normal mice spleen after 4 hr,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,2106.0,CHEMBL876426,In vivo,Spleen,15045,A,14952,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630551,In vivo,Spleen,12017,A,14953,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630552,In vivo,Spleen,12017,A,14954,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630553,In vivo,Spleen,12017,A,14955,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630554,In vivo,Spleen,12017,A,14956,
1,,Intermediate,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630555,In vivo,Spleen,12017,A,14957,
1,,Intermediate,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630556,In vivo,Spleen,12017,A,14958,
1,,Intermediate,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630557,In vivo,Spleen,12017,A,14959,
1,,Intermediate,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630558,In vivo,Spleen,12017,A,14960,
1,,Intermediate,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630559,In vivo,Spleen,12017,A,14961,
1,,Intermediate,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2106.0,CHEMBL630560,In vivo,Spleen,12017,A,14962,
1,,Intermediate,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,2046.0,CHEMBL876427,In vivo,Thyroid gland,12017,A,14963,
1,,Intermediate,The Kel values in female wistar rats.,N,,,Rattus norvegicus,,,10116.0,BAO_0000218,50597,1,,,CHEMBL630561,,,14941,A,14964,
1,,Autocuration,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630562,,,4646,A,14965,
1,,Autocuration,Hydrolysis rate constant of the compound,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL630563,,,8847,A,14966,
1,,Autocuration,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,,,,,,,BAO_0000100,22229,0,,,CHEMBL629673,,,11778,P,14967,
1,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629674,,,2363,A,14968,
1,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629675,,,2363,A,14969,
1,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629676,,,2363,A,14970,
1,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629677,,,2363,A,14971,
1,,Autocuration,Apparent inactivation rate constant was evaluated,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629678,,,8371,A,14972,
1,,Autocuration,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629679,,,14883,A,14973,
1,,Autocuration,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629680,,,14883,A,14974,
1,,Autocuration,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629681,,,4643,A,14975,
1,,Autocuration,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629682,,,3519,A,14976,
1,,Autocuration,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629683,,,10600,A,14977,
1,,Autocuration,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL629684,,,8501,F,14978,
1,,Autocuration,Dissociation constant was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629685,,,8505,P,14979,
1,,Autocuration,Dissociation constant was determined,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629686,,,9778,P,14980,
1,,Autocuration,Dissociation constant at pH 7.4,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL872932,,,9778,P,14981,
1,,Autocuration,Dissociation constant in presence of 1 mM dithiothreitol,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL629687,,,9778,P,14982,
1,,Autocuration,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL872931,,,13007,A,14983,
1,,Autocuration,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628151,,,13007,A,14984,
1,,Autocuration,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628152,,,13007,A,14985,
1,,Autocuration,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628153,,,13007,A,14986,
1,,Autocuration,Kinetic constant for aromatization of androstenedione,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628154,,,11482,A,14987,
1,,Autocuration,Kinetic constant for aromatization of testosterone,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628155,,,11482,A,14988,
1,,Autocuration,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628156,,,2303,A,14989,
1,,Autocuration,Local inhibition constant was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628157,,,11964,A,14990,
1,,Intermediate,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,,,Saccharomyces cerevisiae,,,4932.0,BAO_0000218,50347,1,,,CHEMBL857533,,,3140,A,14991,
1,,Autocuration,Dissociation constant value of the compound,U,,,,,,,BAO_0000100,22224,0,,,CHEMBL628158,,,10650,P,14992,
1,,Autocuration,In vitro permeability through cornea without epithelium,U,,,,,,,BAO_0000019,22224,0,,964.0,CHEMBL628159,,Cornea,4667,A,14993,
1,,Autocuration,In vitro permeability through intact cornea,U,,,,,,,BAO_0000019,22224,0,,964.0,CHEMBL875616,,Cornea,4667,A,14994,
1,,Intermediate,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,,,Oryctolagus cuniculus,,,9986.0,BAO_0000218,50592,1,,964.0,CHEMBL628160,,Cornea,9199,A,14995,
1,,Autocuration,Rate of enzyme inactivation for the compound was determined,U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628161,,,11966,A,14996,
1,,Autocuration,In vitro permeability through cornea without epithelium,U,,,,,,,BAO_0000019,22224,0,,964.0,CHEMBL628162,,Cornea,4667,A,14997,
1,,Autocuration,In vitro permeability through intact cornea,U,,,,,,,BAO_0000019,22224,0,,964.0,CHEMBL628163,,Cornea,4667,A,14998,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628164,,,8354,A,14999,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628165,,,8354,A,15000,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628166,,,8354,A,15001,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628167,,,8354,A,15002,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628168,,,8354,A,15003,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628169,,,8354,A,15004,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628170,,,8354,A,15005,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628171,,,8354,A,15006,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627434,,,8354,A,15007,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL627435,,,8354,A,15008,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628110,,,8354,A,15009,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628111,,,8354,A,15010,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628112,,,8354,A,15011,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628260,,,8354,A,15012,
1,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,,,,,BAO_0000019,22224,0,,,CHEMBL628261,,,8354,A,15013,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628262,In vivo,,14439,A,15014,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,,,Homo sapiens,,,9606.0,BAO_0000218,50587,1,,,CHEMBL628263,In vivo,,14439,A,15015,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628264,In vivo,,14439,A,15016,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628265,In vivo,,14439,A,15017,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628266,In vivo,,14439,A,15018,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628267,In vivo,,14439,A,15019,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628268,In vivo,,14439,A,15020,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628269,In vivo,,14439,A,15021,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628270,In vivo,,14439,A,15022,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628271,In vivo,,14439,A,15023,
1,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,,,Mus musculus,,,10090.0,BAO_0000218,50594,1,,,CHEMBL628272,In vivo,,14439,A,15024,
